PMC:7205724 / 1763-30161 JSONTXT 28 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T266 0-1 CD denotes 1
T267 3-15 NN denotes Introduction
T268 16-23 JJ denotes Several
T269 24-35 NNS denotes generations
T270 36-40 VBP denotes have
T271 41-45 VBN denotes been
T272 46-53 VBN denotes exposed
T273 54-56 TO denotes to
T274 57-65 NN denotes COVID-19
T275 66-71 IN denotes under
T276 72-81 JJ denotes different
T277 82-92 NNS denotes conditions
T278 93-95 IN denotes of
T279 96-100 NN denotes life
T280 101-103 IN denotes at
T281 104-111 VBG denotes varying
T282 112-121 NNS denotes locations
T283 122-128 IN denotes around
T284 129-132 DT denotes the
T285 133-138 NN denotes world
T286 140-142 RB denotes As
T287 143-147 RB denotes long
T288 148-150 IN denotes as
T289 151-154 DT denotes the
T290 155-163 NN denotes COVID-19
T291 164-173 VBZ denotes continues
T292 174-176 TO denotes to
T293 177-183 VB denotes spread
T294 183-184 -COMMA- denotes ,
T295 185-188 PRP-DOLLAR- denotes its
T296 189-194 NN denotes power
T297 195-197 IN denotes of
T298 198-204 NN denotes genome
T299 205-217 NN denotes modification
T300 218-223 MD denotes would
T301 224-232 RB denotes probably
T302 233-235 VB denotes be
T303 236-245 VBN denotes increased
T304 247-251 WP denotes What
T305 252-260 VBZ denotes concerns
T306 261-263 PRP denotes us
T307 264-268 RBR denotes more
T308 269-271 VBZ denotes is
T309 272-276 IN denotes that
T310 277-280 DT denotes the
T311 281-290 NN denotes 2019-nCoV
T312 290-291 -COMMA- denotes ,
T313 292-294 IN denotes by
T314 295-298 DT denotes the
T315 299-306 NN denotes process
T316 307-309 IN denotes of
T317 310-322 NN denotes modification
T318 323-325 IN denotes of
T319 326-332 NN denotes genome
T320 333-342 NN denotes structure
T321 342-343 -COMMA- denotes ,
T322 344-349 MD denotes might
T323 350-356 VB denotes become
T324 357-361 RBR denotes more
T325 362-365 CC denotes and
T326 366-370 RBR denotes more
T327 371-377 VBN denotes fitted
T328 378-380 TO denotes to
T329 381-387 NNS denotes humans
T330 388-390 TO denotes to
T331 391-401 RB denotes profoundly
T332 402-408 VB denotes affect
T333 409-414 DT denotes those
T334 415-418 WP denotes who
T335 419-423 VBP denotes have
T336 424-431 RB denotes already
T337 432-439 VBN denotes escaped
T338 440-441 NN denotes
T339 442-450 NNS denotes children
T340 451-454 CC denotes and
T341 455-460 JJ denotes young
T342 461-467 NNS denotes people
T343 468-475 IN denotes without
T344 476-477 DT denotes a
T345 478-490 JJ denotes pre-existing
T346 491-500 NN denotes condition
T347 502-504 DT denotes No
T348 505-508 NN denotes one
T349 509-512 MD denotes can
T350 513-517 VB denotes tell
T351 518-521 WRB denotes how
T352 522-526 JJ denotes much
T353 527-531 NN denotes time
T354 532-534 PRP denotes it
T355 535-540 VBZ denotes takes
T356 541-543 TO denotes to
T357 544-549 VB denotes reach
T358 550-551 DT denotes a
T359 552-555 JJ denotes new
T360 556-561 NN denotes level
T361 562-564 IN denotes of
T362 565-575 NN denotes perfection
T363 575-576 -COMMA- denotes ,
T364 577-580 CC denotes and
T365 581-585 IN denotes that
T366 586-589 DT denotes the
T367 590-601 NN denotes development
T368 602-604 IN denotes of
T369 605-613 NNS denotes vaccines
T370 614-617 IN denotes for
T371 618-624 JJ denotes active
T372 625-637 NN denotes immunization
T373 638-640 VBZ denotes is
T374 641-642 DT denotes a
T375 643-647 JJ denotes long
T376 648-655 NN denotes process
T377 657-665 RB denotes Moreover
T378 665-666 -COMMA- denotes ,
T379 667-671 JJS denotes most
T380 672-674 IN denotes of
T381 675-678 DT denotes the
T382 679-683 JJS denotes best
T383 684-693 JJ denotes available
T384 694-704 JJ denotes anti-viral
T385 705-711 NNS denotes agents
T386 712-715 VBP denotes are
T387 716-719 RB denotes not
T388 720-727 JJ denotes helpful
T389 728-730 IN denotes in
T390 731-734 DT denotes the
T391 735-744 NN denotes treatment
T392 745-747 IN denotes of
T393 748-756 NN denotes COVID-19
T394 758-759 DT denotes A
T395 760-770 VBN denotes randomized
T396 771-781 VBN denotes controlled
T397 782-787 NN denotes trial
T398 788-790 IN denotes of
T399 791-794 CD denotes 199
T400 795-807 VBN denotes hospitalized
T401 808-814 NNS denotes adults
T402 815-819 IN denotes with
T403 820-829 VBN denotes confirmed
T404 830-838 NN denotes COVID-19
T405 839-851 VBD denotes demonstrated
T406 852-854 DT denotes no
T407 855-861 JJ denotes actual
T408 862-872 NN denotes difference
T409 873-880 IN denotes between
T410 881-889 NNS denotes patients
T411 890-893 WP denotes who
T412 894-902 VBD denotes received
T413 903-922 NN denotes lopinavir-ritonavir
T414 923-926 CC denotes and
T415 927-935 NNS denotes patients
T416 936-939 WP denotes who
T417 940-948 VBD denotes received
T418 949-957 JJ denotes standard
T419 958-962 NN denotes care
T420 963-968 RB denotes alone
T421 969-971 IN denotes in
T422 972-980 JJ denotes clinical
T423 981-992 NN denotes improvement
T424 992-993 -COMMA- denotes ,
T425 994-999 NN denotes death
T426 1000-1004 NN denotes rate
T427 1004-1005 -COMMA- denotes ,
T428 1006-1009 CC denotes and
T429 1010-1018 JJ denotes positive
T430 1019-1024 NN denotes virus
T431 1025-1029 NN denotes test
T432 1030-1034 NN denotes rate
T433 1035-1037 IN denotes at
T434 1038-1041 NN denotes day
T435 1042-1044 CD denotes 28
T436 1045-1046 -LRB- denotes [
T437 1046-1047 CD denotes 1
T438 1047-1048 -RRB- denotes ]
T439 1050-1054 RB denotes Here
T440 1055-1057 PRP denotes we
T441 1058-1064 VBP denotes review
T442 1065-1077 JJ denotes intermediate
T443 1078-1088 NNS denotes indicators
T444 1089-1091 IN denotes of
T445 1092-1095 DT denotes the
T446 1096-1108 NN denotes pathogenesis
T447 1109-1111 IN denotes of
T448 1112-1120 NN denotes COVID-19
T449 1121-1125 WDT denotes that
T450 1126-1130 VBP denotes have
T451 1131-1134 DT denotes the
T452 1135-1144 NN denotes potential
T453 1145-1147 IN denotes of
T454 1148-1153 VBG denotes being
T455 1154-1164 VBN denotes considered
T456 1165-1168 IN denotes for
T457 1169-1172 DT denotes the
T458 1173-1182 NN denotes treatment
T459 1183-1185 IN denotes of
T460 1186-1194 NN denotes COVID-19
T461 1197-1198 CD denotes 2
T462 1200-1209 NN denotes SARS-CoV2
T463 1210-1214 NN denotes cell
T464 1215-1220 NN denotes entry
T465 1221-1223 VBZ denotes is
T466 1224-1227 RB denotes not
T467 1228-1235 JJ denotes complex
T468 1236-1240 NNP denotes Fig.
T469 1241-1242 CD denotes 1
T470 1243-1245 VBZ denotes is
T471 1246-1247 DT denotes a
T472 1248-1257 JJ denotes schematic
T473 1258-1270 NN denotes illustration
T474 1271-1273 IN denotes of
T475 1274-1277 DT denotes the
T476 1278-1285 JJ denotes minimum
T477 1286-1294 NNS denotes proteins
T478 1295-1303 VBN denotes required
T479 1304-1306 TO denotes to
T480 1307-1314 VB denotes mediate
T481 1315-1318 DT denotes the
T482 1319-1328 NN denotes SARS-CoV2
T483 1329-1333 NN denotes cell
T484 1334-1339 NN denotes entry
T485 1341-1344 DT denotes The
T486 1345-1353 JJ denotes trimeric
T487 1353-1354 -COMMA- denotes ,
T488 1355-1368 JJ denotes transmembrane
T489 1369-1374 NN denotes spike
T490 1375-1376 -LRB- denotes (
T491 1376-1377 NN denotes S
T492 1377-1378 -RRB- denotes )
T493 1379-1391 NN denotes glycoprotein
T494 1392-1394 IN denotes of
T495 1395-1398 DT denotes the
T496 1399-1404 NN denotes virus
T497 1404-1405 -COMMA- denotes ,
T498 1406-1414 NN denotes SARS-2-S
T499 1414-1415 -COMMA- denotes ,
T500 1416-1424 VBZ denotes includes
T501 1425-1428 CD denotes two
T502 1429-1433 JJ denotes main
T503 1434-1444 JJ denotes functional
T504 1445-1453 NNS denotes subunits
T505 1453-1454 -COLON- denotes :
T506 1455-1457 NN denotes S1
T507 1458-1461 CC denotes and
T508 1462-1464 NN denotes S2
T509 1466-1469 DT denotes The
T510 1470-1476 JJ denotes former
T511 1476-1477 -COMMA- denotes ,
T512 1478-1480 IN denotes in
T513 1481-1485 NN denotes turn
T514 1485-1486 -COMMA- denotes ,
T515 1487-1495 VBZ denotes consists
T516 1496-1498 IN denotes of
T517 1499-1502 DT denotes the
T518 1503-1507 CD denotes four
T519 1508-1512 NN denotes core
T520 1513-1520 NNS denotes domains
T521 1520-1521 -COMMA- denotes ,
T522 1522-1525 NN denotes S1A
T523 1525-1526 -COMMA- denotes ,
T524 1527-1530 NN denotes S1B
T525 1530-1531 -COMMA- denotes ,
T526 1532-1535 NN denotes S1C
T527 1535-1536 -COMMA- denotes ,
T528 1537-1540 CC denotes and
T529 1541-1544 NN denotes S1D
T530 1544-1545 -COMMA- denotes ,
T531 1546-1550 WDT denotes that
T532 1551-1561 VBP denotes contribute
T533 1562-1564 TO denotes to
T534 1565-1568 DT denotes the
T535 1569-1579 NN denotes attachment
T536 1580-1582 TO denotes to
T537 1583-1586 DT denotes the
T538 1587-1594 NN denotes surface
T539 1595-1603 NN denotes receptor
T540 1604-1606 IN denotes of
T541 1607-1613 NN denotes target
T542 1614-1619 NNS denotes cells
T543 1621-1625 RB denotes Then
T544 1625-1626 -COMMA- denotes ,
T545 1627-1630 DT denotes the
T546 1631-1637 JJ denotes latter
T547 1638-1649 VBZ denotes coordinates
T548 1650-1653 DT denotes the
T549 1654-1660 NN denotes fusion
T550 1661-1663 IN denotes of
T551 1664-1669 JJ denotes viral
T552 1670-1673 CC denotes and
T553 1674-1682 JJ denotes cellular
T554 1683-1692 NNS denotes membranes
T555 1694-1702 NN denotes Receptor
T556 1703-1710 NN denotes binding
T557 1711-1720 VBZ denotes activates
T558 1721-1730 NNS denotes proteases
T559 1731-1735 WDT denotes that
T560 1736-1739 MD denotes can
T561 1740-1745 VB denotes carry
T562 1746-1749 RP denotes out
T563 1750-1761 JJ denotes proteolytic
T564 1762-1770 NN denotes cleavage
T565 1771-1773 IN denotes of
T566 1774-1777 DT denotes the
T567 1778-1779 NN denotes S
T568 1780-1787 NN denotes protein
T569 1789-1791 IN denotes In
T570 1792-1805 NNS denotes coronaviruses
T571 1805-1806 -COMMA- denotes ,
T572 1807-1815 NN denotes cleavage
T573 1816-1822 VBZ denotes occurs
T574 1823-1825 IN denotes at
T575 1826-1829 CD denotes two
T576 1830-1835 NNS denotes sites
T577 1835-1836 -COLON- denotes :
T578 1837-1840 DT denotes the
T579 1841-1846 NN denotes S1/S2
T580 1847-1855 NN denotes junction
T581 1856-1859 CC denotes and
T582 1860-1862 IN denotes at
T583 1863-1866 DT denotes the
T584 1867-1870 NN denotes S2′
T585 1870-1871 -COMMA- denotes ,
T586 1872-1873 DT denotes a
T587 1874-1880 NN denotes region
T588 1881-1886 JJ denotes close
T589 1887-1889 TO denotes to
T590 1890-1893 DT denotes the
T591 1894-1899 JJ denotes viral
T592 1900-1906 NN denotes fusion
T593 1907-1914 NN denotes peptide
T594 1915-1916 -LRB- denotes [
T595 1916-1917 CD denotes 2
T596 1917-1918 -RRB- denotes ]
T597 1920-1931 JJ denotes Proteolytic
T598 1932-1940 NN denotes cleavage
T599 1941-1943 IN denotes of
T600 1944-1947 DT denotes the
T601 1948-1949 NN denotes S
T602 1950-1957 NN denotes protein
T603 1958-1964 VBZ denotes causes
T604 1965-1979 JJ denotes conformational
T605 1980-1987 NNS denotes changes
T606 1988-1990 IN denotes so
T607 1991-1995 IN denotes that
T608 1996-2000 PRP denotes they
T609 2001-2004 MD denotes can
T610 2004-2007 RB denotes not
T611 2008-2014 VB denotes revert
T612 2015-2017 TO denotes to
T613 2018-2021 DT denotes the
T614 2022-2030 JJ denotes original
T615 2031-2040 NN denotes structure
T616 2041-2044 CC denotes and
T617 2045-2053 JJ denotes profound
T618 2054-2060 RB denotes enough
T619 2061-2063 TO denotes to
T620 2064-2069 VB denotes prime
T621 2070-2073 DT denotes the
T622 2074-2076 NN denotes S2
T623 2077-2084 NN denotes subunit
T624 2085-2088 IN denotes for
T625 2089-2092 DT denotes the
T626 2093-2099 NN denotes fusion
T627 2100-2102 IN denotes of
T628 2103-2108 JJ denotes viral
T629 2109-2112 CC denotes and
T630 2113-2121 JJ denotes cellular
T631 2122-2131 NNS denotes membranes
T632 2133-2137 NNP denotes Fig.
T633 2138-2139 CD denotes 1
T634 2140-2148 NNS denotes Proteins
T635 2149-2157 VBN denotes required
T636 2158-2161 IN denotes for
T637 2162-2165 DT denotes the
T638 2166-2180 NN denotes SARS-CoV2-cell
T639 2181-2186 NN denotes entry
T640 2189-2190 CD denotes 3
T641 2192-2199 JJ denotes Certain
T642 2200-2215 NNS denotes characteristics
T643 2216-2218 IN denotes of
T644 2219-2228 NN denotes SARS-CoV2
T645 2230-2233 CD denotes 3.1
T646 2235-2244 NN denotes SARS-CoV2
T647 2245-2248 VBZ denotes has
T648 2249-2257 VBN denotes acquired
T649 2258-2260 DT denotes an
T650 2261-2262 NN denotes S
T651 2263-2275 NN denotes glycoprotein
T652 2276-2280 WDT denotes that
T653 2281-2287 RB denotes highly
T654 2288-2297 VBD denotes underwent
T655 2298-2305 JJ denotes genetic
T656 2306-2315 NN denotes variation
T657 2316-2319 CC denotes and
T658 2320-2333 NN denotes glycosylation
T659 2335-2340 CD denotes 3.1.1
T660 2342-2351 JJ denotes Polybasic
T661 2352-2360 NN denotes cleavage
T662 2361-2365 NN denotes site
T663 2366-2368 IN denotes As
T664 2369-2378 VBN denotes evidenced
T665 2379-2381 IN denotes by
T666 2382-2390 NN denotes sequence
T667 2391-2399 NN denotes analysis
T668 2399-2400 -COMMA- denotes ,
T669 2401-2406 EX denotes there
T670 2407-2409 VBZ denotes is
T671 2410-2411 DT denotes a
T672 2412-2419 NN denotes residue
T673 2420-2429 NN denotes insertion
T674 2430-2436 VBN denotes formed
T675 2437-2439 IN denotes of
T676 2440-2444 CD denotes four
T677 2445-2450 NN denotes amino
T678 2451-2456 NNS denotes acids
T679 2457-2458 -LRB- denotes (
T680 2458-2460 CD denotes 12
T681 2461-2472 NNS denotes nucleotides
T682 2472-2473 -RRB- denotes )
T683 2474-2476 IN denotes at
T684 2477-2480 DT denotes the
T685 2481-2489 NN denotes boundary
T686 2490-2497 IN denotes between
T687 2498-2500 NN denotes S1
T688 2501-2504 CC denotes and
T689 2505-2507 NN denotes S2
T690 2508-2516 NNS denotes subunits
T691 2517-2519 IN denotes of
T692 2520-2523 DT denotes the
T693 2524-2532 NN denotes SARS-CoV
T694 2533-2534 CD denotes 2
T695 2535-2537 NNP denotes S.
T696 2538-2540 PRP denotes It
T697 2541-2548 VBZ denotes defines
T698 2549-2550 DT denotes a
T699 2551-2560 JJ denotes polybasic
T700 2561-2566 NN denotes furin
T701 2567-2575 NN denotes cleavage
T702 2576-2580 NN denotes site
T703 2581-2583 IN denotes of
T704 2584-2588 NN denotes RRAR
T705 2589-2592 IN denotes for
T706 2593-2596 DT denotes the
T707 2597-2602 JJ denotes human
T708 2603-2611 NN denotes SARS-CoV
T709 2612-2613 CD denotes 2
T710 2614-2618 WDT denotes that
T711 2619-2622 VBD denotes was
T712 2623-2629 JJ denotes absent
T713 2630-2632 IN denotes in
T714 2633-2638 JJ denotes human
T715 2639-2647 NN denotes SARS-CoV
T716 2647-2648 -COMMA- denotes ,
T717 2649-2652 NN denotes bat
T718 2653-2662 JJ denotes SARS-like
T719 2663-2667 NNS denotes CoVs
T720 2667-2668 -COMMA- denotes ,
T721 2669-2672 CC denotes and
T722 2673-2681 NN denotes pangolin
T723 2682-2691 JJ denotes SARS-like
T724 2692-2695 NN denotes CoV
T725 2696-2701 NN denotes while
T726 2702-2707 MD denotes might
T727 2708-2710 VB denotes be
T728 2711-2718 JJ denotes present
T729 2719-2721 IN denotes in
T730 2722-2727 JJ denotes other
T731 2728-2735 NNS denotes species
T732 2736-2737 -LRB- denotes [
T733 2737-2738 CD denotes 3
T734 2738-2739 -RRB- denotes ]
T735 2741-2746 IN denotes After
T736 2747-2750 DT denotes the
T737 2751-2763 NN denotes introduction
T738 2764-2766 IN denotes of
T739 2767-2775 NN denotes mutation
T740 2776-2778 TO denotes to
T741 2779-2782 DT denotes the
T742 2783-2790 NN denotes residue
T743 2791-2800 NN denotes insertion
T744 2801-2804 CC denotes and
T745 2805-2810 NN denotes furin
T746 2811-2819 NN denotes cleavage
T747 2820-2824 NN denotes site
T748 2824-2825 -COMMA- denotes ,
T749 2826-2829 DT denotes the
T750 2830-2835 NN denotes S1/S2
T751 2836-2844 NN denotes cleavage
T752 2845-2847 IN denotes of
T753 2848-2851 DT denotes the
T754 2852-2860 JJ denotes SARS-CoV
T755 2861-2862 CD denotes 2
T756 2863-2864 NN denotes S
T757 2865-2868 VBD denotes did
T758 2869-2872 RB denotes not
T759 2873-2879 RBR denotes longer
T760 2880-2884 VB denotes take
T761 2885-2890 NN denotes place
T762 2892-2899 RB denotes However
T763 2899-2900 -COMMA- denotes ,
T764 2901-2904 DT denotes the
T765 2905-2913 JJ denotes SARS-CoV
T766 2914-2915 CD denotes 2
T767 2916-2917 NN denotes S
T768 2918-2923 NN denotes entry
T769 2924-2930 VBN denotes raised
T770 2931-2934 IN denotes for
T771 2935-2941 NN denotes VeroE6
T772 2942-2947 NNS denotes cells
T773 2948-2951 CC denotes and
T774 2952-2960 VBD denotes remained
T775 2961-2965 JJ denotes high
T776 2966-2968 IN denotes in
T777 2969-2972 NN denotes BHK
T778 2973-2978 NNS denotes cells
T779 2979-2983 WDT denotes that
T780 2984-2991 VBP denotes express
T781 2992-2997 JJ denotes human
T782 2998-3001 NN denotes ACE
T783 3003-3012 RB denotes Therefore
T784 3012-3013 -COMMA- denotes ,
T785 3014-3016 PRP denotes it
T786 3017-3022 VBZ denotes seems
T787 3023-3027 IN denotes that
T788 3028-3037 NN denotes SARS-CoV2
T789 3038-3054 NN denotes transmissibility
T790 3055-3059 VBZ denotes does
T791 3060-3063 RB denotes not
T792 3064-3070 VB denotes depend
T793 3071-3073 IN denotes on
T794 3074-3077 DT denotes the
T795 3078-3083 NN denotes S1/S2
T796 3084-3092 NN denotes cleavage
T797 3094-3095 DT denotes A
T798 3096-3105 JJ denotes polybasic
T799 3106-3114 NN denotes cleavage
T800 3115-3119 NN denotes site
T801 3120-3128 VBZ denotes explains
T802 3129-3130 DT denotes a
T803 3131-3136 NN denotes virus
T804 3137-3141 WDT denotes that
T805 3142-3144 VBZ denotes is
T806 3145-3162 JJ denotes highly-pathogenic
T807 3163-3166 IN denotes for
T808 3167-3173 NNS denotes humans
T809 3174-3179 IN denotes while
T810 3180-3182 PRP denotes it
T811 3183-3185 VBZ denotes is
T812 3186-3200 JJ denotes low-pathogenic
T813 3201-3204 IN denotes for
T814 3205-3210 JJ denotes other
T815 3211-3218 NNS denotes species
T816 3220-3223 IN denotes For
T817 3224-3231 NN denotes example
T818 3231-3232 -COMMA- denotes ,
T819 3233-3238 VBG denotes using
T820 3239-3246 JJ denotes reverse
T821 3247-3254 JJ denotes genetic
T822 3255-3260 NNS denotes tools
T823 3260-3261 -COMMA- denotes ,
T824 3262-3264 DT denotes an
T825 3265-3270 JJ denotes avian
T826 3271-3284 NN denotes paramyxovirus
T827 3285-3289 NN denotes type
T828 3290-3291 CD denotes 7
T829 3292-3293 -LRB- denotes (
T830 3293-3299 NN denotes APMV-7
T831 3299-3300 -RRB- denotes )
T832 3301-3304 VBD denotes was
T833 3305-3314 VBN denotes developed
T834 3315-3317 IN denotes by
T835 3318-3326 VBG denotes mutating
T836 3327-3330 DT denotes the
T837 3331-3337 NN denotes fusion
T838 3338-3339 -LRB- denotes (
T839 3339-3340 NN denotes F
T840 3340-3341 -RRB- denotes )
T841 3342-3349 NN denotes protein
T842 3350-3358 NN denotes cleavage
T843 3359-3363 NN denotes site
T844 3364-3365 -LRB- denotes [
T845 3365-3366 CD denotes 4
T846 3366-3367 -RRB- denotes ]
T847 3369-3372 DT denotes The
T848 3373-3384 VBN denotes constructed
T849 3385-3391 NN denotes APMV-7
T850 3392-3398 VBD denotes showed
T851 3399-3404 NN denotes furin
T852 3405-3413 NN denotes cleavage
T853 3414-3417 CC denotes and
T854 3418-3427 VBD denotes increased
T855 3428-3439 NN denotes replication
T856 3440-3443 CC denotes and
T857 3444-3453 NN denotes syncytium
T858 3454-3463 NN denotes formation
T859 3464-3466 IN denotes in
T860 3467-3471 NN denotes cell
T861 3472-3480 NNS denotes cultures
T862 3482-3489 RB denotes However
T863 3489-3490 -COMMA- denotes ,
T864 3491-3498 NN denotes chicken
T865 3499-3506 VBN denotes exposed
T866 3507-3509 TO denotes to
T867 3510-3513 DT denotes the
T868 3514-3519 NN denotes virus
T869 3520-3523 VBD denotes did
T870 3524-3527 RB denotes not
T871 3528-3535 VB denotes exhibit
T872 3536-3545 NN denotes infection
T873 3548-3553 CD denotes 3.1.2
T874 3555-3568 NN denotes Glycosylation
T875 3569-3582 NN denotes Glycosylation
T876 3583-3586 CC denotes and
T877 3587-3590 PRP-DOLLAR- denotes its
T878 3591-3598 JJ denotes related
T879 3599-3607 NNS denotes products
T880 3607-3608 -COMMA- denotes ,
T881 3609-3613 FW denotes i.e.
T882 3613-3614 -COMMA- denotes ,
T883 3615-3622 NNS denotes glycans
T884 3622-3623 -COMMA- denotes ,
T885 3624-3633 VBP denotes introduce
T886 3634-3641 NNS denotes changes
T887 3642-3644 TO denotes to
T888 3645-3648 DT denotes the
T889 3649-3654 JJ denotes viral
T890 3655-3663 NN denotes envelope
T891 3664-3668 WDT denotes that
T892 3669-3673 VBP denotes make
T893 3674-3677 DT denotes the
T894 3678-3683 NN denotes virus
T895 3684-3690 VBN denotes fitted
T896 3691-3694 IN denotes for
T897 3695-3706 NN denotes interaction
T898 3707-3711 IN denotes with
T899 3712-3715 DT denotes the
T900 3716-3720 NN denotes host
T901 3721-3725 NN denotes cell
T902 3726-3734 NN denotes membrane
T903 3735-3736 -LRB- denotes [
T904 3736-3737 CD denotes 5
T905 3737-3738 -RRB- denotes ]
T906 3740-3749 RB denotes Generally
T907 3749-3750 -COMMA- denotes ,
T908 3751-3758 NNS denotes glycans
T909 3759-3762 VBP denotes are
T910 3763-3779 NNS denotes oligosaccharides
T911 3780-3786 VBN denotes linked
T912 3787-3789 TO denotes to
T913 3790-3793 DT denotes the
T914 3794-3799 JJ denotes dense
T915 3800-3810 NN denotes decoration
T916 3811-3813 IN denotes of
T917 3814-3817 DT denotes the
T918 3818-3823 NN denotes spike
T919 3824-3836 NN denotes glycoprotein
T920 3838-3840 IN denotes In
T921 3841-3851 JJ denotes particular
T922 3851-3852 -COMMA- denotes ,
T923 3853-3858 DT denotes these
T924 3859-3875 NNS denotes oligosaccharides
T925 3876-3880 VBP denotes have
T926 3881-3886 VBN denotes shown
T927 3887-3889 TO denotes to
T928 3890-3899 VB denotes influence
T929 3900-3903 DT denotes the
T930 3904-3911 NN denotes folding
T931 3912-3914 IN denotes of
T932 3915-3918 DT denotes the
T933 3919-3920 NN denotes S
T934 3921-3928 NN denotes protein
T935 3929-3932 CC denotes and
T936 3933-3944 JJ denotes proteolytic
T937 3945-3952 NN denotes process
T938 3953-3955 IN denotes so
T939 3956-3960 IN denotes that
T940 3961-3965 PRP denotes they
T941 3966-3976 VBP denotes facilitate
T942 3977-3980 DT denotes the
T943 3981-3986 NN denotes virus
T944 3987-3991 NN denotes cell
T945 3992-3997 NN denotes entry
T946 3999-4007 RB denotes Moreover
T947 4007-4008 -COMMA- denotes ,
T948 4009-4010 DT denotes a
T949 4011-4016 NN denotes virus
T950 4017-4021 IN denotes with
T951 4022-4025 DT denotes the
T952 4026-4038 VBN denotes glycosylated
T953 4039-4051 NN denotes glycoprotein
T954 4052-4057 VBZ denotes gains
T955 4058-4060 DT denotes an
T956 4061-4066 JJ denotes extra
T957 4067-4074 NN denotes feature
T958 4075-4078 IN denotes for
T959 4079-4081 DT denotes an
T960 4082-4088 NN denotes escape
T961 4089-4093 IN denotes from
T962 4094-4097 DT denotes the
T963 4098-4104 JJ denotes immune
T964 4105-4114 NNS denotes responses
T965 4116-4125 RB denotes Therefore
T966 4125-4126 -COMMA- denotes ,
T967 4127-4134 NNS denotes glycans
T968 4135-4138 VBP denotes are
T969 4139-4140 DT denotes a
T970 4141-4145 JJ denotes good
T971 4146-4152 NN denotes target
T972 4153-4156 IN denotes for
T973 4157-4164 NN denotes vaccine
T974 4165-4171 NN denotes design
T975 4173-4176 CD denotes Two
T976 4177-4181 JJ denotes main
T977 4182-4187 NNS denotes types
T978 4188-4190 IN denotes of
T979 4191-4198 NNS denotes glycans
T980 4199-4202 VBP denotes are
T981 4203-4211 VBN denotes N-linked
T982 4212-4215 CC denotes and
T983 4216-4224 JJ denotes O-linked
T984 4225-4232 NNS denotes glycans
T985 4234-4238 DT denotes Both
T986 4239-4242 VBP denotes are
T987 4243-4251 VBN denotes released
T988 4252-4256 IN denotes from
T989 4257-4270 NNS denotes glycoproteins
T990 4272-4279 IN denotes Whereas
T991 4280-4287 NNS denotes enzymes
T992 4288-4295 VBP denotes fulfill
T993 4296-4299 DT denotes the
T994 4300-4312 NN denotes construction
T995 4313-4315 IN denotes of
T996 4316-4325 NNS denotes N-glycans
T997 4325-4326 -COMMA- denotes ,
T998 4327-4335 JJ denotes chemical
T999 4336-4343 NNS denotes methods
T1000 4344-4351 VBP denotes perform
T1001 4352-4355 DT denotes the
T1002 4356-4363 NN denotes release
T1003 4364-4366 IN denotes of
T1004 4367-4376 NNS denotes O-glycans
T1005 4378-4387 NNS denotes N-glycans
T1006 4388-4391 VBP denotes are
T1007 4392-4398 VBN denotes linked
T1008 4399-4401 TO denotes to
T1009 4402-4405 DT denotes the
T1010 4406-4411 JJ denotes amino
T1011 4412-4416 NN denotes acid
T1012 4417-4427 NN denotes asparagine
T1013 4428-4429 -LRB- denotes (
T1014 4429-4432 NN denotes Asn
T1015 4432-4433 -RRB- denotes )
T1016 4434-4442 NNS denotes residues
T1017 4443-4444 -LRB- denotes (
T1018 4444-4451 JJ denotes Asn-any
T1019 4452-4457 NN denotes amino
T1020 4458-4463 NNS denotes acids
T1021 4464-4470 IN denotes except
T1022 4471-4474 IN denotes for
T1023 4475-4483 NN denotes proline-
T1024 4484-4487 NN denotes Ser
T1025 4488-4490 CC denotes or
T1026 4491-4494 NN denotes Thr
T1027 4494-4495 -RRB- denotes )
T1028 4496-4505 VBG denotes utilizing
T1029 4506-4508 DT denotes an
T1030 4509-4521 JJ denotes N-glycosidic
T1031 4522-4526 NN denotes bond
T1032 4526-4527 -COMMA- denotes ,
T1033 4528-4534 RB denotes mostly
T1034 4535-4554 NN denotes N-acetylglucosamine
T1035 4556-4565 NNS denotes O-glycans
T1036 4566-4569 VBP denotes are
T1037 4570-4578 VBN denotes attached
T1038 4579-4581 TO denotes to
T1039 4582-4585 DT denotes the
T1040 4586-4591 JJ denotes amino
T1041 4592-4596 NN denotes acid
T1042 4597-4603 NN denotes serine
T1043 4604-4605 -LRB- denotes (
T1044 4605-4608 NN denotes Ser
T1045 4608-4609 -RRB- denotes )
T1046 4610-4613 CC denotes and
T1047 4614-4623 NN denotes threonine
T1048 4624-4625 -LRB- denotes (
T1049 4625-4628 NN denotes Thr
T1050 4628-4629 -RRB- denotes )
T1051 4630-4638 NNS denotes residues
T1052 4639-4641 IN denotes by
T1053 4642-4645 DT denotes the
T1054 4646-4654 NN denotes addition
T1055 4655-4657 IN denotes of
T1056 4658-4660 DT denotes an
T1057 4661-4669 NN denotes N-acetyl
T1058 4670-4683 NN denotes galactosamine
T1059 4684-4685 -LRB- denotes (
T1060 4685-4691 NN denotes GalNAc
T1061 4691-4692 -RRB- denotes )
T1062 4694-4697 IN denotes For
T1063 4698-4705 NN denotes example
T1064 4705-4706 -COMMA- denotes ,
T1065 4707-4716 NNS denotes N-glycans
T1066 4717-4722 VBP denotes exist
T1067 4723-4725 IN denotes in
T1068 4726-4732 NNP denotes Hendra
T1069 4733-4738 NN denotes virus
T1070 4738-4739 -COMMA- denotes ,
T1071 4740-4748 NN denotes SARS-CoV
T1072 4748-4749 -COMMA- denotes ,
T1073 4750-4759 NN denotes influenza
T1074 4760-4765 NN denotes virus
T1075 4765-4766 -COMMA- denotes ,
T1076 4767-4776 NN denotes hepatitis
T1077 4777-4782 NN denotes virus
T1078 4782-4783 -COMMA- denotes ,
T1079 4784-4789 NN denotes HIV-1
T1080 4789-4790 -COMMA- denotes ,
T1081 4791-4794 CC denotes and
T1082 4795-4799 NNP denotes West
T1083 4800-4804 NNP denotes Nile
T1084 4805-4810 NN denotes virus
T1085 4811-4812 -LRB- denotes [
T1086 4812-4813 CD denotes 6
T1087 4813-4814 -RRB- denotes ]
T1088 4814-4815 -COMMA- denotes ,
T1089 4816-4819 CC denotes and
T1090 4820-4829 NNS denotes O-glycans
T1091 4830-4834 VBP denotes have
T1092 4835-4843 VBN denotes occurred
T1093 4844-4846 IN denotes in
T1094 4847-4850 DT denotes the
T1095 4851-4856 NNP denotes Ebola
T1096 4857-4862 NN denotes virus
T1097 4864-4867 DT denotes The
T1098 4868-4877 JJ denotes 2019-nCoV
T1099 4878-4879 NN denotes S
T1100 4880-4887 NN denotes protein
T1101 4888-4896 VBZ denotes includes
T1102 4897-4899 CD denotes 13
T1103 4900-4903 CC denotes and
T1104 4904-4913 JJ denotes 9N-linked
T1105 4914-4927 NN denotes glycosylation
T1106 4928-4935 NNS denotes sequons
T1107 4936-4938 IN denotes in
T1108 4939-4942 DT denotes the
T1109 4943-4945 NN denotes S1
T1110 4946-4949 CC denotes and
T1111 4950-4952 NN denotes S2
T1112 4953-4960 NN denotes subunit
T1113 4960-4961 -COMMA- denotes ,
T1114 4962-4974 RB denotes respectively
T1115 4975-4976 -LRB- denotes [
T1116 4976-4977 CD denotes 3
T1117 4977-4978 -RRB- denotes ]
T1118 4980-4983 DT denotes All
T1119 4984-4986 IN denotes of
T1120 4987-4992 DT denotes these
T1121 4993-4997 VBP denotes have
T1122 4998-5008 RB denotes previously
T1123 5009-5017 VBD denotes occurred
T1124 5018-5020 IN denotes in
T1125 5021-5024 DT denotes the
T1126 5025-5033 JJ denotes SARS-CoV
T1127 5034-5035 NN denotes S
T1128 5036-5048 NN denotes glycoprotein
T1129 5048-5049 -COMMA- denotes ,
T1130 5050-5056 IN denotes except
T1131 5057-5060 IN denotes for
T1132 5061-5072 JJ denotes four-linked
T1133 5073-5086 NN denotes glycosylation
T1134 5087-5094 NNS denotes sequons
T1135 5095-5097 IN denotes in
T1136 5098-5101 DT denotes the
T1137 5102-5104 NN denotes S1
T1138 5106-5110 RB denotes Also
T1139 5110-5111 -COMMA- denotes ,
T1140 5112-5115 JJ denotes due
T1141 5116-5118 TO denotes to
T1142 5119-5122 DT denotes the
T1143 5123-5132 NN denotes existence
T1144 5133-5135 IN denotes of
T1145 5136-5138 DT denotes an
T1146 5139-5144 JJ denotes amino
T1147 5145-5149 NN denotes acid
T1148 5150-5157 NN denotes proline
T1149 5158-5160 IN denotes in
T1150 5161-5164 DT denotes the
T1151 5165-5174 JJ denotes polybasic
T1152 5175-5183 NN denotes cleavage
T1153 5184-5188 NN denotes site
T1154 5188-5189 -COMMA- denotes ,
T1155 5190-5195 WDT denotes which
T1156 5196-5201 VBZ denotes makes
T1157 5202-5205 DT denotes the
T1158 5206-5214 VBN denotes inserted
T1159 5215-5223 NN denotes sequence
T1160 5224-5228 NN denotes PRRA
T1161 5228-5229 -COMMA- denotes ,
T1162 5230-5235 EX denotes there
T1163 5236-5239 VBP denotes are
T1164 5240-5245 CD denotes three
T1165 5246-5254 JJ denotes O-linked
T1166 5255-5262 NNS denotes glycans
T1167 5263-5273 VBN denotes introduced
T1168 5274-5276 TO denotes to
T1169 5277-5280 DT denotes the
T1170 5281-5290 JJ denotes 2019-nCoV
T1171 5291-5294 NN denotes RBD
T1172 5295-5303 NNS denotes residues
T1173 5304-5308 NN denotes S673
T1174 5308-5309 -COMMA- denotes ,
T1175 5310-5314 NN denotes T678
T1176 5314-5315 -COMMA- denotes ,
T1177 5316-5319 CC denotes and
T1178 5320-5324 NN denotes S686
T1179 5325-5326 -LRB- denotes [
T1180 5326-5327 CD denotes 7
T1181 5327-5328 -RRB- denotes ]
T1182 5331-5336 CD denotes 3.1.3
T1183 5338-5347 NN denotes SARS-CoV2
T1184 5348-5356 NN denotes receptor
T1185 5357-5364 NN denotes binding
T1186 5365-5371 NN denotes domain
T1187 5372-5380 VBZ denotes contains
T1188 5381-5384 CD denotes six
T1189 5385-5390 NN denotes amino
T1190 5391-5396 NNS denotes acids
T1191 5397-5406 VBG denotes providing
T1192 5407-5416 JJ denotes favorable
T1193 5417-5426 NNS denotes positions
T1194 5427-5430 IN denotes for
T1195 5431-5438 VBG denotes binding
T1196 5439-5441 TO denotes to
T1197 5442-5447 JJ denotes human
T1198 5448-5452 NN denotes ACE2
T1199 5453-5457 WRB denotes When
T1200 5458-5466 VBN denotes compared
T1201 5467-5469 TO denotes to
T1202 5470-5478 NNP denotes SARS-CoV
T1203 5479-5481 NNP denotes SB
T1204 5481-5482 -COMMA- denotes ,
T1205 5483-5486 DT denotes the
T1206 5487-5492 NN denotes motif
T1207 5493-5500 VBG denotes binding
T1208 5501-5504 DT denotes the
T1209 5505-5510 JJ denotes human
T1210 5511-5515 NN denotes ACE2
T1211 5516-5518 TO denotes to
T1212 5519-5522 DT denotes the
T1213 5523-5531 JJ denotes SARS-CoV
T1214 5532-5533 CD denotes 2
T1215 5534-5536 NN denotes SB
T1216 5537-5543 VBD denotes showed
T1217 5544-5545 DT denotes a
T1218 5546-5556 RB denotes relatively
T1219 5557-5563 JJR denotes higher
T1220 5564-5571 NN denotes binding
T1221 5572-5580 NN denotes affinity
T1222 5581-5584 IN denotes for
T1223 5585-5590 JJ denotes human
T1224 5591-5595 NN denotes ACE2
T1225 5596-5598 IN denotes as
T1226 5599-5608 VBN denotes indicated
T1227 5609-5611 IN denotes in
T1228 5612-5619 JJR denotes smaller
T1229 5620-5631 NN denotes equilibrium
T1230 5632-5644 NN denotes dissociation
T1231 5645-5653 NN denotes constant
T1232 5654-5655 -LRB- denotes (
T1233 5655-5661 NN denotes 2.9 nM
T1234 5662-5665 IN denotes vs.
T1235 5666-5672 NN denotes 7.7 nM
T1236 5672-5673 -RRB- denotes )
T1237 5674-5675 -LRB- denotes [
T1238 5675-5676 CD denotes 3
T1239 5676-5677 -RRB- denotes ]
T1240 5679-5689 JJ denotes Structural
T1241 5690-5698 NN denotes analysis
T1242 5699-5702 VBZ denotes has
T1243 5703-5715 VBN denotes demonstrated
T1244 5716-5720 IN denotes that
T1245 5721-5729 CD denotes fourteen
T1246 5730-5739 NNS denotes positions
T1247 5740-5750 RB denotes critically
T1248 5751-5755 VBP denotes take
T1249 5756-5760 NN denotes part
T1250 5761-5763 IN denotes in
T1251 5764-5767 DT denotes the
T1252 5768-5784 JJ denotes receptor-binding
T1253 5785-5791 NN denotes domain
T1254 5792-5794 IN denotes of
T1255 5795-5798 DT denotes the
T1256 5799-5807 NN denotes SARS-CoV
T1257 5808-5810 NN denotes SB
T1258 5811-5815 WDT denotes that
T1259 5816-5823 VBP denotes contain
T1260 5824-5829 CD denotes eight
T1261 5830-5839 VBN denotes conserved
T1262 5840-5841 -LRB- denotes (
T1263 5841-5845 NN denotes T402
T1264 5845-5846 -COMMA- denotes ,
T1265 5847-5851 NN denotes Y436
T1266 5851-5852 -COMMA- denotes ,
T1267 5853-5857 NN denotes Y440
T1268 5857-5858 -COMMA- denotes ,
T1269 5859-5863 NN denotes N473
T1270 5863-5864 -COMMA- denotes ,
T1271 5865-5869 NN denotes Y475
T1272 5869-5870 -COMMA- denotes ,
T1273 5871-5875 NN denotes T486
T1274 5875-5876 -COMMA- denotes ,
T1275 5877-5881 NN denotes G488
T1276 5881-5882 -COMMA- denotes ,
T1277 5883-5886 CC denotes and
T1278 5887-5891 NN denotes Y491
T1279 5891-5892 -RRB- denotes )
T1280 5893-5902 NNS denotes positions
T1281 5903-5906 CC denotes and
T1282 5907-5910 CD denotes six
T1283 5911-5925 JJ denotes semi-conserved
T1284 5926-5927 -LRB- denotes (
T1285 5927-5931 NN denotes R426
T1286 5932-5934 TO denotes to
T1287 5935-5939 NN denotes N448
T1288 5939-5940 -COMMA- denotes ,
T1289 5941-5945 NN denotes Y442
T1290 5946-5948 TO denotes to
T1291 5949-5953 NN denotes L464
T1292 5953-5954 -COMMA- denotes ,
T1293 5955-5959 NN denotes L472
T1294 5960-5962 TO denotes to
T1295 5963-5967 NN denotes F495
T1296 5967-5968 -COMMA- denotes ,
T1297 5969-5973 NN denotes N479
T1298 5974-5976 TO denotes to
T1299 5977-5981 NN denotes Q502
T1300 5981-5982 -COMMA- denotes ,
T1301 5983-5987 NN denotes Y484
T1302 5988-5990 TO denotes to
T1303 5991-5995 NN denotes Q507
T1304 5995-5996 -COMMA- denotes ,
T1305 5997-6000 CC denotes and
T1306 6001-6005 NN denotes T487
T1307 6006-6008 TO denotes to
T1308 6009-6013 NN denotes N510
T1309 6013-6014 -RRB- denotes )
T1310 6015-6028 NNS denotes substitutions
T1311 6029-6033 IN denotes with
T1312 6034-6041 NN denotes respect
T1313 6042-6044 TO denotes to
T1314 6045-6048 DT denotes the
T1315 6049-6057 JJ denotes SARS-CoV
T1316 6058-6059 CD denotes 2
T1317 6060-6062 NN denotes SB
T1318 6065-6070 CD denotes 3.1.4
T1319 6072-6081 NN denotes SARS-CoV2
T1320 6082-6090 NN denotes receptor
T1321 6091-6098 NN denotes binding
T1322 6099-6105 NN denotes domain
T1323 6106-6114 VBZ denotes contains
T1324 6115-6121 JJ denotes cyclic
T1325 6122-6129 NNS denotes regions
T1326 6130-6134 WDT denotes that
T1327 6135-6138 MD denotes can
T1328 6139-6143 VB denotes make
T1329 6144-6155 NN denotes interaction
T1330 6156-6160 IN denotes with
T1331 6161-6173 JJ denotes cell-surface
T1332 6174-6179 NN denotes GRP78
T1333 6180-6185 NN denotes Pep42
T1334 6186-6188 VBZ denotes is
T1335 6189-6190 DT denotes a
T1336 6191-6197 JJ denotes cyclic
T1337 6198-6210 NN denotes oligopeptide
T1338 6211-6215 IN denotes that
T1339 6215-6216 -COMMA- denotes ,
T1340 6217-6221 IN denotes with
T1341 6222-6225 PRP-DOLLAR- denotes its
T1342 6226-6237 JJ denotes hydrophobic
T1343 6238-6247 NN denotes character
T1344 6247-6248 -COMMA- denotes ,
T1345 6249-6252 MD denotes can
T1346 6253-6264 RB denotes selectively
T1347 6265-6273 VB denotes interact
T1348 6274-6278 IN denotes with
T1349 6279-6283 NN denotes cell
T1350 6284-6291 NN denotes surface
T1351 6292-6309 VBN denotes glucose‐regulated
T1352 6310-6317 NN denotes protein
T1353 6318-6320 CD denotes 78
T1354 6321-6322 -LRB- denotes (
T1355 6322-6327 NN denotes GRP78
T1356 6327-6328 -RRB- denotes )
T1357 6328-6329 -COMMA- denotes ,
T1358 6330-6331 DT denotes a
T1359 6332-6338 NN denotes member
T1360 6339-6341 IN denotes of
T1361 6342-6348 NN denotes 70 kDa
T1362 6349-6353 NN denotes heat
T1363 6354-6359 NN denotes shock
T1364 6360-6368 NNS denotes proteins
T1365 6370-6375 NN denotes GRP78
T1366 6375-6376 -COMMA- denotes ,
T1367 6377-6381 RB denotes also
T1368 6382-6387 VBN denotes known
T1369 6388-6390 IN denotes as
T1370 6391-6394 NN denotes BiP
T1371 6395-6397 CC denotes or
T1372 6398-6403 NN denotes HSPA5
T1373 6403-6404 -COMMA- denotes ,
T1374 6405-6410 IN denotes under
T1375 6411-6422 JJ denotes endoplasmic
T1376 6423-6432 NN denotes reticulum
T1377 6433-6439 NN denotes stress
T1378 6439-6440 -COMMA- denotes ,
T1379 6441-6444 MD denotes can
T1380 6445-6447 VB denotes be
T1381 6448-6460 VBN denotes translocated
T1382 6461-6465 IN denotes from
T1383 6466-6469 DT denotes the
T1384 6470-6481 JJ denotes endoplasmic
T1385 6482-6491 NN denotes reticulum
T1386 6492-6494 TO denotes to
T1387 6495-6498 DT denotes the
T1388 6499-6507 NN denotes membrane
T1389 6508-6511 CC denotes and
T1390 6512-6517 VBZ denotes helps
T1391 6518-6520 TO denotes to
T1392 6521-6529 VB denotes maintain
T1393 6530-6538 JJ denotes cellular
T1394 6539-6548 NN denotes integrity
T1395 6549-6554 IN denotes under
T1396 6555-6566 JJ denotes physiologic
T1397 6567-6570 CC denotes and
T1398 6571-6583 JJ denotes pathological
T1399 6584-6590 NN denotes stress
T1400 6592-6594 PRP denotes It
T1401 6595-6605 RB denotes critically
T1402 6606-6617 VBZ denotes contributes
T1403 6618-6620 TO denotes to
T1404 6621-6628 JJ denotes various
T1405 6629-6638 NNS denotes functions
T1406 6639-6646 VBG denotes ranging
T1407 6647-6651 IN denotes from
T1408 6652-6659 NN denotes protein
T1409 6660-6667 NN denotes folding
T1410 6667-6668 -COMMA- denotes ,
T1411 6669-6683 NN denotes transportation
T1412 6683-6684 -COMMA- denotes ,
T1413 6685-6688 CC denotes and
T1414 6689-6700 NN denotes degradation
T1415 6701-6703 TO denotes to
T1416 6704-6718 JJ denotes cell-signaling
T1417 6718-6719 -COMMA- denotes ,
T1418 6720-6733 NN denotes proliferation
T1419 6733-6734 -COMMA- denotes ,
T1420 6735-6743 NN denotes survival
T1421 6743-6744 -COMMA- denotes ,
T1422 6745-6754 NN denotes apoptosis
T1423 6754-6755 -COMMA- denotes ,
T1424 6756-6768 NN denotes inflammation
T1425 6768-6769 -COMMA- denotes ,
T1426 6770-6773 CC denotes and
T1427 6774-6782 NN denotes immunity
T1428 6784-6787 DT denotes The
T1429 6788-6798 NN denotes expression
T1430 6799-6801 IN denotes of
T1431 6802-6807 NN denotes GRP78
T1432 6808-6817 VBZ denotes decreases
T1433 6818-6822 IN denotes with
T1434 6823-6826 NN denotes age
T1435 6828-6830 IN denotes On
T1436 6831-6834 DT denotes the
T1437 6835-6844 JJ denotes 2019-nCoV
T1438 6845-6850 NN denotes spike
T1439 6851-6858 NN denotes protein
T1440 6858-6859 -COMMA- denotes ,
T1441 6860-6862 CD denotes 13
T1442 6863-6872 NN denotes disulfide
T1443 6873-6878 NNS denotes bonds
T1444 6879-6882 VBP denotes are
T1445 6883-6896 VBG denotes corresponding
T1446 6897-6899 TO denotes to
T1447 6900-6902 CD denotes 13
T1448 6903-6912 JJ denotes different
T1449 6913-6919 JJ denotes cyclic
T1450 6920-6927 NNS denotes regions
T1451 6928-6935 VBN denotes thought
T1452 6936-6938 TO denotes to
T1453 6939-6941 VB denotes be
T1454 6942-6949 JJ denotes similar
T1455 6950-6952 TO denotes to
T1456 6953-6956 DT denotes the
T1457 6957-6963 JJ denotes cyclic
T1458 6964-6968 NN denotes form
T1459 6969-6971 IN denotes of
T1460 6972-6977 NN denotes Pep42
T1461 6978-6979 -LRB- denotes [
T1462 6979-6980 CD denotes 8
T1463 6980-6981 -RRB- denotes ]
T1464 6983-6988 IN denotes Among
T1465 6989-6994 DT denotes these
T1466 6994-6995 -COMMA- denotes ,
T1467 6996-7000 CD denotes four
T1468 7001-7008 NNS denotes regions
T1469 7009-7013 NN denotes I-IV
T1470 7014-7018 VBP denotes take
T1471 7019-7024 NN denotes place
T1472 7025-7027 IN denotes in
T1473 7028-7031 DT denotes the
T1474 7032-7037 JJ denotes outer
T1475 7038-7045 NN denotes surface
T1476 7046-7048 IN denotes of
T1477 7049-7050 DT denotes a
T1478 7051-7059 JJ denotes putative
T1479 7060-7076 JJ denotes receptor-binding
T1480 7077-7083 NN denotes domain
T1481 7084-7085 -LRB- denotes (
T1482 7085-7088 NN denotes RBD
T1483 7088-7089 -RRB- denotes )
T1484 7090-7092 IN denotes on
T1485 7093-7096 DT denotes the
T1486 7097-7102 JJ denotes viral
T1487 7103-7109 NN denotes spike.
T1488 7109-7110 -COMMA- denotes ,
T1489 7111-7120 VBG denotes including
T1490 7121-7125 NN denotes C361
T1491 7125-7126 -COMMA- denotes ,
T1492 7127-7131 NN denotes C379
T1493 7131-7132 -COMMA- denotes ,
T1494 7133-7137 NN denotes C391
T1495 7137-7138 -COMMA- denotes ,
T1496 7139-7142 CC denotes and
T1497 7143-7147 NN denotes C480
T1498 7149-7154 DT denotes These
T1499 7155-7162 NNS denotes regions
T1500 7163-7168 VBP denotes share
T1501 7169-7177 NN denotes sequence
T1502 7178-7188 NN denotes similarity
T1503 7189-7193 IN denotes with
T1504 7194-7199 NN denotes Pep42
T1505 7199-7200 -COMMA- denotes ,
T1506 7201-7208 VBG denotes ranging
T1507 7209-7213 IN denotes from
T1508 7214-7219 CD denotes 15.38
T1509 7219-7220 NN denotes %
T1510 7221-7223 TO denotes to
T1511 7224-7229 CD denotes 46.15
T1512 7229-7230 NN denotes %
T1513 7232-7239 RB denotes However
T1514 7239-7240 -COMMA- denotes ,
T1515 7241-7245 RB denotes only
T1516 7246-7249 CD denotes one
T1517 7250-7252 IN denotes of
T1518 7253-7257 PRP denotes them
T1519 7257-7258 -COMMA- denotes ,
T1520 7259-7263 FW denotes i.e.
T1521 7263-7264 -COMMA- denotes ,
T1522 7265-7271 NN denotes region
T1523 7272-7274 CD denotes IV
T1524 7275-7276 -LRB- denotes (
T1525 7276-7288 NN denotes GRAVY = 0.08
T1526 7288-7289 -RRB- denotes )
T1527 7289-7290 -COMMA- denotes ,
T1528 7291-7293 VBZ denotes is
T1529 7294-7295 DT denotes a
T1530 7296-7307 JJ denotes hydrophobic
T1531 7308-7314 NN denotes region
T1532 7314-7315 -COMMA- denotes ,
T1533 7316-7320 IN denotes like
T1534 7321-7326 NN denotes Pep42
T1535 7327-7328 -LRB- denotes (
T1536 7328-7339 NN denotes GRAVY = 1.1
T1537 7339-7340 -RRB- denotes )
T1538 7342-7352 JJ denotes Structural
T1539 7353-7359 NNS denotes models
T1540 7360-7368 VBP denotes evaluate
T1541 7369-7372 DT denotes the
T1542 7373-7379 NN denotes energy
T1543 7380-7392 NN denotes contribution
T1544 7393-7396 IN denotes for
T1545 7397-7403 NN denotes region
T1546 7404-7406 CD denotes IV
T1547 7407-7409 IN denotes as
T1548 7410-7411 DT denotes a
T1549 7412-7416 NN denotes part
T1550 7417-7419 IN denotes of
T1551 7420-7426 NN denotes region
T1552 7427-7430 CD denotes III
T1553 7431-7433 TO denotes to
T1554 7434-7437 DT denotes the
T1555 7438-7443 NN denotes GRP78
T1556 7444-7446 TO denotes to
T1557 7447-7449 VB denotes be
T1558 7450-7455 IN denotes about
T1559 7456-7457 -LRB- denotes (
T1560 7457-7461 CD denotes −9.8
T1561 7462-7465 IN denotes out
T1562 7466-7468 IN denotes of
T1563 7469-7483 NN denotes −14.0 kcal/mol
T1564 7483-7484 -RRB- denotes )
T1565 7484-7485 -COMMA- denotes ,
T1566 7486-7489 CC denotes and
T1567 7490-7493 DT denotes the
T1568 7494-7501 NN denotes docking
T1569 7502-7510 NN denotes platform
T1570 7511-7519 VBZ denotes proposes
T1571 7520-7526 NN denotes region
T1572 7527-7529 CD denotes IV
T1573 7530-7532 IN denotes as
T1574 7533-7536 DT denotes the
T1575 7537-7541 JJS denotes best
T1576 7542-7548 NN denotes region
T1577 7549-7556 VBG denotes binding
T1578 7557-7559 TO denotes to
T1579 7560-7565 NN denotes GRP78
T1580 7567-7570 DT denotes The
T1581 7571-7577 NN denotes region
T1582 7578-7580 CD denotes IV
T1583 7581-7584 MD denotes can
T1584 7585-7587 VB denotes be
T1585 7588-7594 VBN denotes linked
T1586 7595-7597 TO denotes to
T1587 7598-7601 DT denotes the
T1588 7602-7619 JJ denotes substrate-binding
T1589 7620-7626 NN denotes domain
T1590 7627-7628 NN denotes β
T1591 7629-7630 -LRB- denotes (
T1592 7630-7634 NN denotes SBDB
T1593 7634-7635 -RRB- denotes )
T1594 7636-7638 IN denotes of
T1595 7639-7644 NN denotes GRP78
T1596 7645-7650 VBG denotes using
T1597 7651-7655 CD denotes five
T1598 7656-7663 NNS denotes H-bonds
T1599 7664-7665 -LRB- denotes (
T1600 7665-7672 IN denotes through
T1601 7673-7677 NN denotes P479
T1602 7677-7678 -COMMA- denotes ,
T1603 7679-7683 NN denotes N481
T1604 7683-7684 -COMMA- denotes ,
T1605 7685-7689 NN denotes E484
T1606 7689-7690 -COMMA- denotes ,
T1607 7691-7694 CC denotes and
T1608 7695-7699 NN denotes N487
T1609 7699-7700 -RRB- denotes )
T1610 7701-7704 CC denotes and
T1611 7705-7709 CD denotes four
T1612 7710-7721 JJ denotes hydrophobic
T1613 7722-7734 NNS denotes interactions
T1614 7735-7736 -LRB- denotes (
T1615 7736-7743 IN denotes through
T1616 7744-7748 NN denotes T478
T1617 7748-7749 -COMMA- denotes ,
T1618 7750-7754 NN denotes E484
T1619 7754-7755 -COMMA- denotes ,
T1620 7756-7759 CC denotes and
T1621 7760-7764 NN denotes F486
T1622 7764-7765 -RRB- denotes )
T1623 7768-7769 CD denotes 4
T1624 7771-7778 JJ denotes Passive
T1625 7779-7791 NN denotes immunization
T1626 7792-7797 EX denotes There
T1627 7798-7801 VBP denotes are
T1628 7802-7805 CD denotes two
T1629 7806-7810 JJ denotes main
T1630 7811-7815 NNS denotes ways
T1631 7816-7818 TO denotes to
T1632 7819-7825 VB denotes induce
T1633 7826-7836 NN denotes protection
T1634 7837-7844 IN denotes against
T1635 7845-7855 NNS denotes infections
T1636 7855-7856 -COLON- denotes :
T1637 7857-7863 JJ denotes active
T1638 7864-7867 CC denotes and
T1639 7868-7875 JJ denotes passive
T1640 7876-7888 NN denotes immunization
T1641 7890-7896 JJ denotes Active
T1642 7897-7909 NN denotes immunization
T1643 7910-7915 VBZ denotes comes
T1644 7916-7918 TO denotes to
T1645 7919-7924 VB denotes exist
T1646 7925-7929 WRB denotes when
T1647 7930-7933 DT denotes the
T1648 7934-7938 NN denotes body
T1649 7938-7940 POS denotes 's
T1650 7941-7944 JJ denotes own
T1651 7945-7951 JJ denotes immune
T1652 7952-7958 NN denotes system
T1653 7959-7962 MD denotes can
T1654 7963-7970 VB denotes produce
T1655 7971-7981 NNS denotes antibodies
T1656 7982-7990 RB denotes actively
T1657 7991-8000 VBG denotes following
T1658 8001-8009 NN denotes exposure
T1659 8010-8012 TO denotes to
T1660 8013-8014 DT denotes a
T1661 8015-8020 JJ denotes viral
T1662 8021-8028 NN denotes antigen
T1663 8030-8032 IN denotes On
T1664 8033-8036 DT denotes the
T1665 8037-8045 NN denotes contrary
T1666 8045-8046 -COMMA- denotes ,
T1667 8047-8052 EX denotes there
T1668 8053-8055 VBZ denotes is
T1669 8056-8057 DT denotes a
T1670 8058-8065 NN denotes passive
T1671 8066-8073 VBG denotes working
T1672 8074-8078 NN denotes mode
T1673 8079-8081 IN denotes of
T1674 8082-8085 DT denotes the
T1675 8086-8092 JJ denotes immune
T1676 8093-8099 NN denotes system
T1677 8100-8104 WDT denotes that
T1678 8105-8110 MD denotes would
T1679 8111-8117 VB denotes appear
T1680 8118-8127 VBG denotes following
T1681 8128-8131 DT denotes the
T1682 8132-8140 NN denotes transfer
T1683 8141-8143 IN denotes of
T1684 8144-8154 NNS denotes antibodies
T1685 8155-8159 WDT denotes that
T1686 8160-8163 VBP denotes act
T1687 8164-8172 RB denotes directly
T1688 8173-8175 TO denotes to
T1689 8176-8186 VB denotes neutralize
T1690 8187-8192 JJ denotes viral
T1691 8193-8204 NN denotes infectivity
T1692 8207-8210 CD denotes 4.1
T1693 8212-8217 NN denotes Serum
T1694 8218-8225 NN denotes therapy
T34096 8227-8232 CD denotes 4.1.1
T81207 8234-8246 JJ denotes Convalescent
T7654 8247-8253 NN denotes plasma
T71050 8254-8258 IN denotes from
T25890 8259-8267 NNS denotes patients
T44174 8268-8277 VBN denotes recovered
T26910 8278-8282 IN denotes from
T41378 8283-8291 NN denotes COVID-19
T88463 8293-8300 CD denotes 4.1.1.1
T5371 8302-8312 NN denotes Hypothesis
T65084 8312-8313 -COLON- denotes :
T11805 8314-8320 NN denotes Plasma
T86158 8321-8325 IN denotes from
T7828 8326-8334 NNS denotes patients
T20215 8335-8344 VBN denotes recovered
T19523 8345-8349 IN denotes from
T35336 8350-8358 NN denotes COVID-19
T99442 8359-8366 VBP denotes contain
T6188 8367-8377 NNS denotes antibodies
T80510 8378-8385 IN denotes against
T57397 8386-8395 NN denotes 2019-nCoV
T57607 8396-8397 DT denotes A
T47460 8398-8402 NN denotes look
T44003 8403-8405 IN denotes at
T20122 8406-8409 DT denotes the
T89678 8410-8417 NN denotes history
T33850 8418-8420 IN denotes of
T21640 8421-8426 JJ denotes viral
T53029 8427-8436 NNS denotes outbreaks
T73113 8437-8443 VBZ denotes offers
T71269 8444-8456 JJ denotes convalescent
T26722 8457-8463 NN denotes plasma
T32817 8464-8466 IN denotes as
T73367 8467-8470 DT denotes the
T23573 8471-8475 JJ denotes only
T80270 8476-8482 NN denotes remedy
T50380 8483-8485 TO denotes to
T14621 8486-8491 VB denotes avoid
T15138 8492-8499 JJ denotes further
T77639 8500-8510 NNS denotes fatalities
T94916 8512-8515 DT denotes The
T85352 8516-8520 RBS denotes most
T26901 8521-8527 JJ denotes recent
T70143 8528-8536 NNS denotes examples
T49434 8537-8544 VBP denotes include
T54973 8545-8548 DT denotes the
T39553 8549-8557 NN denotes pandemic
T56433 8558-8560 IN denotes of
T99958 8561-8570 NN denotes influenza
T27857 8571-8572 NN denotes A
T52981 8573-8577 NN denotes H1N1
T85532 8578-8579 -LRB- denotes (
T70555 8579-8588 NN denotes H1N1pdm09
T58026 8588-8589 -RRB- denotes )
T49738 8590-8592 IN denotes in
T7553 8593-8598 NN denotes virus
T41345 8599-8608 NN denotes infection
T46256 8609-8613 CD denotes 2009
T28857 8613-8614 -COMMA- denotes ,
T13934 8615-8618 DT denotes the
T20739 8619-8626 NNP denotes Western
T80018 8627-8634 NNP denotes African
T70659 8635-8640 NNP denotes Ebola
T34284 8641-8646 NN denotes virus
T92495 8647-8655 JJ denotes epidemic
T36003 8656-8658 IN denotes in
T12982 8659-8663 CD denotes 2014
T49803 8663-8664 -COMMA- denotes ,
T90021 8665-8668 CC denotes and
T16664 8669-8672 DT denotes the
T58899 8673-8681 NN denotes outbreak
T11963 8682-8684 IN denotes of
T71906 8685-8693 NN denotes MERS-CoV
T74174 8694-8696 IN denotes in
T70278 8697-8701 CD denotes 2015
T44828 8702-8703 -LRB- denotes [
T58846 8703-8704 CD denotes 9
T98769 8704-8705 -RRB- denotes ]
T44041 8707-8720 NN denotes Meta-analysis
T92755 8721-8728 NNS denotes studies
T83388 8729-8733 VBP denotes have
T75238 8734-8739 VBN denotes shown
T72067 8740-8741 DT denotes a
T19254 8742-8749 VBN denotes reduced
T86955 8750-8754 NN denotes risk
T79896 8755-8757 IN denotes of
T13682 8758-8767 NN denotes mortality
T55812 8768-8770 IN denotes in
T18322 8771-8779 NNS denotes patients
T80297 8780-8784 IN denotes with
T10571 8785-8793 NN denotes SARS-CoV
T28781 8794-8797 CC denotes and
T12582 8798-8807 NN denotes influenza
T82834 8808-8817 VBG denotes receiving
T84690 8818-8830 JJ denotes convalescent
T47738 8831-8837 NN denotes plasma
T87902 8838-8839 -LRB- denotes [
T15127 8839-8841 CD denotes 10
T21677 8841-8842 -RRB- denotes ]
T51845 8845-8852 CD denotes 4.1.1.2
T81264 8854-8863 NNP denotes Rationale
T56248 8863-8864 -COLON- denotes :
T77485 8865-8877 JJ denotes Convalescent
T80710 8878-8884 NN denotes plasma
T37520 8885-8889 IN denotes from
T57657 8890-8898 NNS denotes patients
T22774 8899-8908 VBN denotes recovered
T85435 8909-8913 IN denotes from
T50571 8914-8922 NN denotes COVID-19
T48141 8923-8926 MD denotes can
T93212 8927-8932 VB denotes treat
T48287 8933-8941 NNS denotes patients
T91679 8942-8946 IN denotes with
T80666 8947-8953 JJ denotes severe
T17217 8954-8962 NN denotes COVID-19
T94687 8963-8964 DT denotes A
T22655 8965-8970 NN denotes pilot
T19573 8971-8976 NN denotes study
T23972 8977-8978 -LRB- denotes [
T55337 8978-8980 CD denotes 11
T96728 8980-8981 -RRB- denotes ]
T92410 8982-8990 RB denotes recently
T26265 8991-8994 VBZ denotes has
T35997 8995-9007 VBN denotes investigated
T92380 9008-9011 DT denotes the
T38590 9012-9018 NN denotes safety
T37156 9019-9022 CC denotes and
T24661 9023-9029 NN denotes effect
T94632 9030-9032 IN denotes of
T56352 9033-9045 JJ denotes convalescent
T65134 9046-9052 NN denotes plasma
T64844 9053-9057 WDT denotes that
T95987 9058-9065 VBP denotes contain
T86655 9066-9074 NN denotes antibody
T45118 9075-9081 NNS denotes levels
T26321 9082-9088 JJR denotes higher
T17226 9089-9093 IN denotes than
T2522 9094-9095 CD denotes 1
T48589 9095-9096 -COLON- denotes :
T90182 9096-9099 CD denotes 640
T89317 9100-9108 VBN denotes combined
T28925 9109-9113 IN denotes with
T68950 9114-9121 JJ denotes regular
T58621 9122-9132 JJ denotes anti-viral
T22929 9133-9139 NNS denotes agents
T50644 9140-9143 CC denotes and
T63224 9144-9152 JJ denotes standard
T22041 9153-9163 JJ denotes supportive
T89053 9164-9168 NN denotes care
T94835 9169-9171 IN denotes on
T20257 9172-9180 JJ denotes clinical
T49329 9181-9189 NNS denotes outcomes
T91601 9190-9192 IN denotes of
T6238 9193-9196 CD denotes ten
T3048 9197-9205 NNS denotes patients
T18696 9206-9210 IN denotes with
T93206 9211-9217 JJ denotes severe
T71443 9218-9226 NN denotes COVID-19
T46997 9228-9231 DT denotes The
T7672 9232-9237 NN denotes study
T83098 9238-9244 VBD denotes showed
T5017 9245-9253 JJ denotes clinical
T96870 9254-9265 NN denotes improvement
T42442 9266-9268 IN denotes of
T61149 9269-9272 PDT denotes all
T89276 9273-9276 DT denotes the
T53728 9277-9280 CD denotes ten
T50396 9281-9289 NNS denotes patients
T59179 9290-9301 VBN denotes accompanied
T83510 9302-9304 IN denotes by
T2183 9305-9307 DT denotes an
T4240 9308-9316 NN denotes increase
T18383 9317-9319 IN denotes in
T99269 9320-9330 NN denotes lymphocyte
T12131 9331-9336 NN denotes count
T36613 9337-9340 CC denotes and
T91622 9341-9342 DT denotes a
T39579 9343-9351 NN denotes decrease
T72559 9352-9354 IN denotes in
T31686 9355-9358 NN denotes CRP
T20580 9360-9369 VBG denotes Following
T23341 9370-9381 NN denotes transfusion
T23846 9382-9384 IN denotes of
T23496 9385-9397 JJ denotes convalescent
T68740 9398-9404 NN denotes plasma
T74721 9404-9405 -COMMA- denotes ,
T3255 9406-9409 PDT denotes all
T47829 9410-9413 DT denotes the
T16466 9414-9419 CD denotes seven
T26913 9420-9428 NNS denotes patients
T47643 9429-9432 WP denotes who
T10299 9433-9437 VBD denotes were
T19318 9438-9447 NN denotes SARS-CoV2
T2642 9448-9451 NN denotes RNA
T76428 9452-9460 JJ denotes positive
T59448 9461-9467 IN denotes before
T49967 9468-9479 NN denotes transfusion
T2352 9480-9482 IN denotes of
T3020 9483-9495 JJ denotes convalescent
T57517 9496-9502 NN denotes plasma
T55829 9503-9509 VBD denotes turned
T39392 9510-9519 NN denotes SARS-CoV2
T26456 9520-9528 JJ denotes negative
T52249 9530-9535 EX denotes There
T13795 9536-9540 VBD denotes were
T15563 9541-9543 DT denotes no
T53693 9544-9551 NN denotes control
T35357 9552-9558 NNS denotes groups
T16756 9559-9568 VBG denotes receiving
T53621 9569-9581 JJ denotes convalescent
T81904 9582-9588 NN denotes plasma
T11852 9589-9594 RB denotes alone
T58859 9595-9597 CC denotes or
T35171 9598-9606 JJ denotes standard
T39367 9607-9614 NN denotes therapy
T20306 9615-9622 IN denotes without
T63670 9623-9635 JJ denotes convalescent
T44856 9636-9643 NN denotes therapy
T15733 9644-9646 TO denotes to
T71428 9647-9655 VB denotes evaluate
T29390 9656-9659 DT denotes the
T54708 9660-9664 JJ denotes main
T64138 9665-9671 NN denotes effect
T21425 9672-9674 IN denotes of
T75685 9675-9687 JJ denotes convalescent
T78861 9688-9694 NN denotes plasma
T16328 9697-9702 CD denotes 4.1.2
T3323 9704-9709 NN denotes Serum
T79102 9710-9714 IN denotes from
T73342 9715-9719 NNS denotes bats
T89375 9720-9724 IN denotes with
T36397 9725-9734 JJ denotes SARS-like
T22412 9735-9738 NN denotes CoV
T58124 9740-9747 CD denotes 4.1.2.1
T5376 9749-9759 NN denotes Hypothesis
T34741 9759-9760 -COLON- denotes :
T62090 9761-9773 JJ denotes whole-genome
T52998 9774-9784 NN denotes sequencing
T20323 9785-9788 CC denotes and
T7728 9789-9801 JJ denotes phylogenetic
T67504 9802-9810 NN denotes analysis
T76343 9811-9815 VBD denotes shed
T36219 9816-9821 NN denotes light
T40337 9822-9824 IN denotes on
T54452 9825-9828 DT denotes the
T33856 9829-9835 NN denotes origin
T37831 9836-9838 IN denotes of
T28355 9839-9842 DT denotes the
T31802 9843-9852 JJ denotes 2019-nCoV
T95515 9853-9858 NN denotes virus
T64814 9859-9860 VBP denotes
T87875 9861-9863 PRP denotes It
T46333 9864-9867 VBZ denotes has
T28188 9868-9872 VBN denotes been
T22492 9873-9881 RB denotes probably
T62169 9882-9892 VBN denotes introduced
T13328 9893-9897 IN denotes from
T96521 9898-9902 NNS denotes bats
T30811 9903-9905 TO denotes to
T52514 9906-9909 NNS denotes men
T28843 9910-9916 NN denotes Genome
T46450 9917-9927 NN denotes sequencing
T27748 9928-9930 IN denotes of
T27295 9931-9932 DT denotes a
T62671 9933-9938 JJ denotes fecal
T93555 9939-9942 NN denotes bat
T52375 9943-9949 NN denotes sample
T30106 9949-9950 -COMMA- denotes ,
T79240 9951-9954 NN denotes Rp3
T51658 9954-9955 -COMMA- denotes ,
T48337 9956-9961 MD denotes could
T23533 9962-9968 VB denotes detect
T45372 9969-9971 DT denotes an
T48569 9972-9979 NN denotes isolate
T20680 9980-9982 IN denotes of
T19302 9983-9996 NNS denotes coronaviruses
T18234 9996-9997 -COMMA- denotes ,
T77212 9998-10003 WDT denotes which
T37427 10004-10007 VBD denotes was
T90838 10008-10014 RB denotes almost
T69281 10015-10024 JJ denotes identical
T30703 10025-10027 TO denotes to
T45933 10028-10031 DT denotes the
T53102 10032-10041 JJ denotes causative
T21161 10042-10047 NN denotes agent
T31651 10048-10050 IN denotes of
T24092 10051-10054 DT denotes the
T76932 10055-10063 JJ denotes SARS-CoV
T42133 10064-10072 NN denotes outbreak
T26029 10073-10075 IN denotes of
T7676 10076-10085 CD denotes 2002–2003
T55417 10087-10092 RB denotes Hence
T40490 10092-10093 -COMMA- denotes ,
T99577 10094-10096 PRP denotes it
T85900 10097-10105 VBD denotes attained
T84303 10106-10109 DT denotes the
T99794 10110-10114 NN denotes name
T28667 10115-10124 JJ denotes SARS-like
T13194 10125-10136 NN denotes coronavirus
T40481 10137-10144 NN denotes isolate
T51053 10145-10148 NN denotes Rp3
T84085 10149-10150 -LRB- denotes (
T37600 10150-10156 NN denotes SL-CoV
T96263 10157-10160 NN denotes Rp3
T15140 10160-10161 -RRB- denotes )
T87895 10162-10163 -LRB- denotes [
T40198 10163-10165 CD denotes 12
T79787 10165-10166 -RRB- denotes ]
T87849 10168-10171 DT denotes The
T82417 10172-10187 JJ denotes bronchoalveolar
T31054 10188-10194 NN denotes lavage
T37752 10195-10200 NN denotes fluid
T74238 10201-10202 -LRB- denotes (
T3228 10202-10206 NN denotes BALF
T70930 10206-10207 -RRB- denotes )
T9092 10208-10210 IN denotes of
T49696 10211-10212 DT denotes a
T42278 10213-10220 NN denotes patient
T77065 10221-10225 IN denotes with
T56445 10226-10230 NNS denotes SARS
T91231 10231-10240 VBD denotes contained
T55260 10241-10244 DT denotes the
T14876 10245-10254 NN denotes 2019-nCoV
T41253 10256-10259 NN denotes RNA
T76927 10260-10270 NN denotes sequencing
T21523 10271-10276 MD denotes could
T61033 10277-10283 VB denotes reveal
T57735 10284-10289 RB denotes about
T17027 10290-10292 CD denotes 90
T88762 10292-10293 NN denotes %
T56862 10294-10304 NN denotes similarity
T58084 10305-10307 IN denotes in
T42893 10308-10319 NNS denotes nucleotides
T28737 10320-10322 IN denotes of
T98581 10323-10326 DT denotes the
T54378 10327-10332 JJ denotes novel
T41408 10333-10344 NN denotes coronavirus
T8820 10345-10348 CC denotes and
T82233 10349-10351 IN denotes of
T87395 10352-10361 JJ denotes SARS-like
T25315 10362-10373 NN denotes coronavirus
T40001 10374-10378 WDT denotes that
T50563 10379-10382 VBD denotes had
T73327 10383-10393 RB denotes previously
T43308 10394-10401 VBN denotes related
T87528 10402-10404 TO denotes to
T18784 10405-10409 NNS denotes bats
T21998 10410-10411 -LRB- denotes [
T45109 10411-10413 CD denotes 13
T62980 10413-10414 -RRB- denotes ]
T34259 10414-10415 -COMMA- denotes ,
T56176 10416-10417 -LRB- denotes [
T43975 10417-10419 CD denotes 14
T89437 10419-10420 -RRB- denotes ]
T32040 10422-10424 IN denotes In
T92103 10425-10435 JJ denotes particular
T46259 10435-10436 -COMMA- denotes ,
T37699 10437-10440 DT denotes the
T72545 10441-10442 NN denotes S
T24131 10443-10450 NN denotes protein
T44437 10451-10453 IN denotes of
T20264 10454-10457 DT denotes the
T45006 10458-10467 NN denotes 2019-nCoV
T85613 10468-10471 VBZ denotes has
T77820 10472-10473 DT denotes a
T51362 10474-10478 JJ denotes high
T86629 10479-10487 NN denotes sequence
T85333 10488-10496 NN denotes identity
T4126 10497-10499 IN denotes of
T23106 10500-10505 CD denotes 80–98
T47986 10505-10506 NN denotes %
T62529 10507-10511 IN denotes with
T47180 10512-10515 DT denotes the
T64906 10516-10517 NN denotes S
T55893 10518-10525 NN denotes protein
T84276 10526-10528 IN denotes of
T27337 10529-10532 NN denotes bat
T65227 10533-10542 JJ denotes SARS-like
T48841 10543-10547 NNS denotes CoVs
T43941 10547-10548 -COMMA- denotes ,
T76487 10549-10553 JJ denotes such
T69082 10554-10556 IN denotes as
T24341 10557-10566 JJ denotes SARSr-CoV
T77949 10567-10572 NN denotes ZXC21
T33016 10573-10574 NNP denotes S
T45981 10574-10575 -COMMA- denotes ,
T58714 10576-10580 NNP denotes ZC45
T47242 10581-10582 NNP denotes S
T24128 10582-10583 -COMMA- denotes ,
T33217 10584-10587 CC denotes and
T49688 10588-10594 NN denotes RaTG13
T48117 10595-10596 -LRB- denotes [
T8349 10596-10597 CD denotes 3
T82587 10597-10598 -RRB- denotes ]
T26826 10600-10608 RB denotes Moreover
T40424 10608-10609 -COMMA- denotes ,
T82603 10610-10612 IN denotes in
T83961 10613-10625 JJ denotes phylogenomic
T26439 10626-10631 NNS denotes trees
T36143 10631-10632 -COMMA- denotes ,
T1931 10633-10641 NNS denotes branches
T94548 10642-10645 IN denotes for
T9564 10646-10649 DT denotes the
T82190 10650-10659 NN denotes 2019-nCoV
T51998 10660-10663 VBP denotes are
T48884 10664-10666 IN denotes of
T84416 10667-10674 JJR denotes greater
T46091 10675-10681 NN denotes length
T44026 10682-10686 IN denotes than
T19745 10687-10692 DT denotes those
T66697 10693-10696 IN denotes for
T66659 10697-10700 DT denotes the
T22981 10701-10705 CD denotes 2003
T47496 10706-10714 NN denotes SARS-CoV
T18117 10714-10715 -COMMA- denotes ,
T90160 10716-10719 CC denotes and
T86256 10720-10729 RB denotes therefore
T89702 10730-10734 RBR denotes more
T19375 10735-10744 JJ denotes favorable
T58982 10745-10747 TO denotes to
T17546 10748-10752 NNS denotes bats
T69872 10755-10762 CD denotes 4.1.2.2
T72014 10764-10773 NNP denotes Rationale
T36633 10773-10774 -COLON- denotes :
T95726 10775-10778 NN denotes Bat
T12601 10779-10784 NN denotes serum
T14267 10785-10787 VBZ denotes is
T39971 10788-10791 RB denotes not
T40602 10792-10796 JJ denotes able
T35003 10797-10799 TO denotes to
T99887 10800-10811 RB denotes efficiently
T76540 10812-10822 VB denotes neutralize
T13120 10823-10831 NN denotes SARS-CoV
T35896 10832-10835 DT denotes The
T64598 10836-10841 NN denotes range
T32273 10842-10844 IN denotes of
T17280 10845-10849 NNS denotes bats
T96367 10849-10850 -COMMA- denotes ,
T68610 10851-10860 VBG denotes belonging
T26256 10861-10863 TO denotes to
T16732 10864-10867 DT denotes the
T46544 10868-10873 NN denotes genus
T77475 10874-10885 NN denotes Rhinolophus
T40616 10886-10887 -LRB- denotes (
T58340 10887-10896 NN denotes horseshoe
T54336 10897-10901 NNS denotes bats
T12834 10901-10902 -RRB- denotes )
T98779 10903-10906 CC denotes and
T38088 10907-10910 DT denotes the
T30678 10911-10917 NN denotes family
T95468 10918-10931 NNP denotes Rhinolophidae
T49538 10931-10932 -COMMA- denotes ,
T57549 10933-10940 VBP denotes produce
T22931 10941-10944 DT denotes the
T96372 10945-10953 JJ denotes SARS-CoV
T96617 10954-10962 NN denotes antibody
T26331 10963-10964 -LRB- denotes [
T79958 10964-10966 CD denotes 12
T94954 10966-10967 -RRB- denotes ]
T31150 10969-10979 NN denotes Polymerase
T34558 10980-10985 NN denotes chain
T29624 10986-10994 NN denotes reaction
T20040 10995-10996 -LRB- denotes (
T66963 10996-10999 NN denotes PCR
T86417 10999-11000 -RRB- denotes )
T74170 11001-11005 MD denotes will
T58244 11006-11013 VB denotes confirm
T34209 11014-11017 DT denotes the
T81644 11018-11026 NN denotes presence
T94659 11027-11029 IN denotes of
T93490 11030-11038 NN denotes SARS-CoV
T60580 11039-11051 NN denotes nucleocapsid
T19399 11052-11053 -LRB- denotes (
T43412 11053-11054 NN denotes N
T97174 11054-11055 -RRB- denotes )
T57901 11056-11059 CC denotes and
T74666 11060-11070 NN denotes polymerase
T46614 11071-11072 -LRB- denotes (
T2670 11072-11073 NN denotes P
T11868 11073-11074 -RRB- denotes )
T4452 11075-11083 NNS denotes proteins
T18709 11084-11086 IN denotes in
T53625 11087-11092 JJ denotes fecal
T33015 11093-11100 NNS denotes samples
T22237 11101-11103 IN denotes if
T47566 11104-11106 DT denotes an
T64813 11107-11117 JJ denotes individual
T7157 11118-11121 NN denotes bat
T16625 11122-11127 VBG denotes being
T28791 11128-11140 JJ denotes seropositive
T57534 11141-11144 IN denotes for
T8160 11145-11153 NN denotes SARS-CoV
T13336 11154-11155 -LRB- denotes [
T37204 11155-11157 CD denotes 12
T59200 11157-11158 -RRB- denotes ]
T53492 11160-11165 EX denotes There
T25066 11166-11168 VBZ denotes is
T54103 11169-11170 DT denotes a
T67673 11171-11182 JJ denotes significant
T81378 11183-11189 NN denotes degree
T78835 11190-11192 IN denotes of
T5389 11193-11204 NN denotes resemblance
T55726 11205-11207 IN denotes of
T9133 11208-11215 JJR denotes greater
T51866 11216-11220 IN denotes than
T67947 11221-11223 CD denotes 90
T67121 11223-11224 NN denotes %
T42920 11225-11227 IN denotes in
T98118 11228-11231 DT denotes the
T35947 11232-11242 NN denotes nucleotide
T39927 11243-11251 NN denotes sequence
T7432 11252-11254 IN denotes of
T69163 11255-11258 DT denotes the
T80745 11259-11264 JJ denotes viral
T20946 11265-11272 NNS denotes genomes
T60639 11273-11280 IN denotes between
T51508 11281-11287 NN denotes SL-CoV
T38342 11288-11291 NN denotes Rp3
T27996 11292-11293 -LRB- denotes [
T68906 11293-11295 CD denotes 12
T31717 11295-11296 -RRB- denotes ]
T45580 11297-11300 CC denotes and
T28138 11301-11304 DT denotes the
T93675 11305-11309 NN denotes Tor2
T7628 11310-11316 NN denotes strain
T18229 11317-11319 IN denotes of
T74591 11320-11328 NN denotes SARS-CoV
T32520 11329-11330 NN denotes
T53721 11331-11336 WDT denotes which
T18272 11337-11340 VBD denotes was
T81326 11341-11349 VBN denotes isolated
T85814 11350-11352 IN denotes in
T8090 11353-11360 NNP denotes Toronto
T96099 11361-11362 -LRB- denotes [
T48626 11362-11364 CD denotes 15
T63640 11364-11365 -RRB- denotes ]
T47685 11367-11370 DT denotes The
T95952 11371-11382 NNS denotes differences
T83153 11383-11385 IN denotes in
T89898 11386-11389 DT denotes the
T5455 11390-11396 NN denotes genome
T57783 11397-11406 NNS denotes sequences
T32904 11407-11409 IN denotes of
T64654 11410-11418 NN denotes SARS-CoV
T33080 11419-11421 IN denotes in
T20399 11422-11425 DT denotes the
T6021 11426-11429 CD denotes two
T91889 11430-11437 NNS denotes species
T16420 11438-11443 VBP denotes occur
T17928 11444-11450 RB denotes merely
T18957 11451-11453 IN denotes in
T30016 11454-11457 DT denotes the
T55882 11458-11459 NN denotes S
T98573 11460-11464 NN denotes gene
T52934 11465-11466 NN denotes
T45076 11467-11472 WDT denotes which
T16269 11473-11480 VBZ denotes encodes
T35597 11481-11484 DT denotes the
T87578 11485-11487 NN denotes S1
T90762 11488-11494 NN denotes domain
T47778 11495-11497 IN denotes of
T34405 11498-11501 DT denotes the
T12863 11502-11513 NN denotes coronavirus
T32427 11514-11519 NN denotes spike
T45316 11520-11527 NN denotes protein
T15815 11528-11531 CC denotes and
T13365 11532-11540 VBZ denotes contains
T22966 11541-11548 NNS denotes regions
T35366 11549-11553 IN denotes with
T87135 11554-11558 JJ denotes high
T71483 11559-11567 NN denotes mutation
T52732 11568-11573 NNS denotes rates
T42165 11574-11575 -LRB- denotes [
T12526 11575-11577 CD denotes 12
T31829 11577-11578 -RRB- denotes ]
T48594 11580-11583 DT denotes The
T43996 11584-11597 NNS denotes coronaviruses
T64690 11598-11606 RB denotes commonly
T94005 11607-11614 VBP denotes possess
T52748 11615-11619 CD denotes five
T25177 11620-11624 JJ denotes open
T13269 11625-11632 NN denotes reading
T8033 11633-11639 NNS denotes frames
T6150 11640-11641 -LRB- denotes (
T75001 11641-11644 NN denotes ORF
T23258 11644-11645 -RRB- denotes )
T31588 11646-11650 WDT denotes that
T98349 11651-11660 VBP denotes correlate
T84544 11661-11665 IN denotes with
T88926 11666-11669 DT denotes the
T71973 11670-11680 NN denotes production
T7216 11681-11683 IN denotes of
T15921 11684-11687 DT denotes the
T20599 11688-11697 NN denotes replicase
T83272 11698-11709 NN denotes polyprotein
T61529 11710-11711 -LRB- denotes (
T58827 11711-11712 NN denotes P
T90447 11712-11713 -RRB- denotes )
T70573 11713-11714 -COMMA- denotes ,
T42366 11715-11718 DT denotes the
T58682 11719-11724 NN denotes spike
T13646 11725-11726 -LRB- denotes (
T70419 11726-11727 NN denotes S
T16399 11727-11728 -RRB- denotes )
T28149 11728-11729 -COMMA- denotes ,
T93891 11730-11738 NN denotes envelope
T12498 11739-11740 -LRB- denotes (
T49731 11740-11741 NN denotes E
T56677 11741-11742 -RRB- denotes )
T64104 11742-11743 -COMMA- denotes ,
T31208 11744-11747 CC denotes and
T67550 11748-11756 NN denotes membrane
T28810 11757-11758 -LRB- denotes (
T38106 11758-11759 NN denotes M
T30434 11759-11760 -RRB- denotes )
T87007 11761-11774 NNS denotes glycoproteins
T95580 11775-11778 CC denotes and
T76152 11779-11782 DT denotes the
T84704 11783-11795 NN denotes nucleocapsid
T19426 11796-11797 -LRB- denotes (
T15241 11797-11798 NN denotes N
T55062 11798-11799 -RRB- denotes )
T28738 11800-11807 NN denotes protein
T87202 11809-11812 DT denotes The
T16130 11813-11818 JJ denotes human
T9407 11819-11827 NN denotes SARS-CoV
T28228 11828-11832 NN denotes Tor2
T71564 11833-11836 CC denotes and
T14942 11837-11840 NN denotes bat
T87890 11841-11847 NN denotes SL-CoV
T92515 11848-11851 NN denotes Rp3
T40210 11852-11859 NNS denotes strains
T99566 11860-11866 VBP denotes remain
T25851 11867-11871 JJR denotes more
T93008 11872-11876 IN denotes than
T9385 11877-11879 CD denotes 90
T64424 11879-11880 NN denotes %
T39551 11881-11890 JJ denotes identical
T74931 11891-11893 IN denotes at
T24944 11894-11897 DT denotes the
T54178 11898-11906 NNS denotes proteins
T40259 11907-11908 NN denotes P
T38116 11908-11909 -COMMA- denotes ,
T14257 11910-11911 NN denotes E
T31483 11911-11912 -COMMA- denotes ,
T90324 11913-11914 NN denotes M
T13349 11914-11915 -COMMA- denotes ,
T43323 11916-11919 CC denotes and
T37619 11920-11922 NNP denotes N.
T58268 11923-11926 DT denotes the
T53333 11927-11934 NN denotes protein
T21482 11935-11936 NN denotes S
T15154 11937-11945 VBZ denotes consists
T15378 11946-11948 IN denotes of
T8893 11949-11952 CD denotes two
T80047 11953-11957 JJ denotes main
T39154 11958-11965 NNS denotes domains
T63966 11965-11966 -COLON- denotes :
T14525 11967-11968 LS denotes 1
T24485 11968-11969 -RRB- denotes )
T14573 11970-11973 DT denotes the
T2720 11974-11976 NN denotes S1
T53057 11977-11983 NN denotes domain
T52808 11984-11991 VBZ denotes conveys
T40693 11992-11995 DT denotes the
T99923 11996-12000 NN denotes role
T37838 12001-12003 IN denotes of
T16526 12004-12012 NN denotes receptor
T67511 12013-12020 NN denotes binding
T34590 12021-12024 CC denotes and
T11269 12025-12026 LS denotes 2
T5490 12026-12027 -RRB- denotes )
T64378 12028-12031 DT denotes the
T5826 12032-12034 NN denotes S2
T79439 12035-12041 NN denotes domain
T56787 12042-12049 VBZ denotes assumes
T43097 12050-12053 DT denotes the
T86961 12054-12058 NN denotes role
T18963 12059-12061 IN denotes of
T97770 12062-12065 DT denotes the
T77887 12066-12072 NN denotes fusion
T55259 12073-12075 IN denotes of
T85369 12076-12081 JJ denotes viral
T77390 12082-12085 CC denotes and
T15313 12086-12095 NN denotes host-cell
T74327 12096-12105 NNS denotes membranes
T22912 12107-12109 IN denotes In
T58392 12110-12120 JJ denotes particular
T84749 12120-12121 -COMMA- denotes ,
T94019 12122-12125 DT denotes the
T82008 12126-12131 JJ denotes human
T43891 12132-12140 NN denotes SARS-CoV
T54296 12141-12145 NN denotes Tor2
T34731 12146-12152 NN denotes strain
T75489 12153-12158 VBZ denotes shows
T56235 12159-12160 DT denotes a
T89657 12161-12171 JJ denotes noticeable
T75815 12172-12178 NN denotes degree
T92988 12179-12181 IN denotes of
T77130 12182-12192 NN denotes difference
T40843 12193-12195 IN denotes in
T41545 12196-12199 DT denotes the
T39219 12200-12202 NN denotes S1
T50007 12203-12209 NN denotes domain
T5367 12210-12214 IN denotes from
T8711 12215-12218 DT denotes the
T66860 12219-12222 NN denotes bat
T62453 12223-12229 NN denotes SL-CoV
T71117 12230-12233 NN denotes Rp3
T88382 12234-12240 NN denotes strain
T88085 12242-12246 DT denotes This
T48832 12247-12256 NN denotes diversity
T76304 12257-12262 MD denotes would
T15359 12263-12270 VB denotes suffice
T62259 12271-12273 TO denotes to
T18888 12274-12281 VB denotes produce
T72744 12282-12292 JJ denotes functional
T24144 12293-12304 NNS denotes differences
T88673 12305-12312 IN denotes between
T38511 12313-12316 DT denotes the
T76844 12317-12324 NNS denotes species
T33948 12324-12325 -COMMA- denotes ,
T64840 12326-12329 CC denotes and
T43993 12330-12332 VBZ denotes is
T4517 12333-12335 DT denotes an
T84855 12336-12344 JJ denotes apparent
T42902 12345-12351 NN denotes reason
T40921 12352-12355 WRB denotes why
T70648 12356-12359 NN denotes bat
T53907 12360-12364 NNS denotes sera
T57340 12365-12371 VBG denotes having
T85409 12372-12376 JJ denotes high
T54783 12377-12383 NNS denotes levels
T45640 12384-12386 IN denotes of
T58628 12387-12401 JJ denotes cross-reactive
T52676 12402-12412 NNS denotes antibodies
T45941 12413-12416 RB denotes not
T27008 12417-12422 VBD denotes acted
T78461 12423-12434 RB denotes efficiently
T42258 12435-12437 TO denotes to
T33747 12438-12448 VB denotes neutralize
T77904 12449-12457 NN denotes SARS-CoV
T98558 12460-12465 CD denotes 4.1.3
T38385 12467-12472 NN denotes Serum
T65035 12473-12477 IN denotes from
T20625 12478-12490 JJ denotes convalescent
T20197 12491-12495 NN denotes SARS
T37092 12496-12504 NNS denotes patients
T79043 12506-12513 CD denotes 4.1.3.1
T13076 12515-12525 NN denotes Hypothesis
T75604 12525-12526 -COLON- denotes :
T99993 12527-12535 NN denotes SARS-CoV
T3009 12536-12539 CC denotes and
T80950 12540-12549 NN denotes SARS-CoV2
T92082 12550-12553 VBP denotes are
T32575 12554-12561 RB denotes ideally
T79226 12562-12569 JJ denotes similar
T33377 12570-12572 IN denotes in
T59896 12573-12576 DT denotes the
T19520 12577-12586 NN denotes structure
T87934 12587-12590 CC denotes and
T72009 12591-12594 DT denotes the
T96172 12595-12599 NN denotes cell
T92132 12600-12605 NN denotes entry
T55153 12606-12614 NN denotes receptor
T65675 12615-12618 CC denotes and
T29199 12619-12627 NN denotes protease
T27640 12628-12636 NN denotes SARS-CoV
T74776 12637-12640 CC denotes and
T21368 12641-12650 NN denotes SARS-CoV2
T82506 12651-12656 NN denotes share
T68425 12657-12667 RB denotes absolutely
T18098 12668-12671 DT denotes the
T56482 12672-12676 JJ denotes same
T5709 12677-12685 NN denotes cleavage
T53777 12686-12695 NNS denotes junctions
T48942 12695-12696 -COMMA- denotes ,
T23620 12697-12703 RB denotes almost
T31417 12704-12707 DT denotes the
T14679 12708-12712 JJ denotes same
T16845 12713-12721 NN denotes sequence
T94095 12722-12723 -LRB- denotes (
T72721 12723-12725 CD denotes 96
T51290 12725-12726 NN denotes %
T3648 12726-12727 -RRB- denotes )
T81238 12728-12730 IN denotes of
T80974 12731-12736 PRP-DOLLAR- denotes their
T24041 12737-12741 JJ denotes main
T97737 12742-12750 NN denotes protease
T89215 12750-12751 -COMMA- denotes ,
T68838 12752-12753 DT denotes a
T10566 12754-12758 JJ denotes high
T25132 12759-12765 NN denotes degree
T56803 12766-12767 -LRB- denotes (
T85670 12767-12769 CD denotes 76
T72732 12769-12770 NN denotes %
T51047 12770-12771 -RRB- denotes )
T87365 12772-12774 IN denotes of
T31118 12775-12785 NN denotes similarity
T29516 12786-12788 IN denotes in
T55756 12789-12792 DT denotes the
T19117 12793-12798 JJ denotes amino
T38328 12799-12803 NN denotes acid
T71701 12804-12812 NN denotes sequence
T52612 12813-12815 IN denotes of
T55072 12816-12821 PRP-DOLLAR- denotes their
T61270 12822-12823 NN denotes S
T71641 12824-12831 NN denotes protein
T35396 12831-12832 -COMMA- denotes ,
T5992 12833-12834 DT denotes a
T7278 12835-12842 JJ denotes similar
T86199 12843-12846 NN denotes S2′
T47005 12847-12855 NN denotes cleavage
T82402 12856-12860 NN denotes site
T47763 12860-12861 -COMMA- denotes ,
T84821 12862-12863 DT denotes a
T82586 12864-12871 JJ denotes similar
T33761 12872-12880 NN denotes spectrum
T77477 12881-12883 IN denotes of
T52803 12884-12889 NNS denotes cells
T10303 12890-12894 PRP denotes they
T7764 12895-12898 MD denotes can
T28508 12899-12904 VB denotes enter
T62400 12904-12905 -COMMA- denotes ,
T63048 12906-12909 CC denotes and
T36374 12910-12913 DT denotes the
T14538 12914-12924 NN denotes similarity
T20437 12925-12927 IN denotes of
T68062 12928-12931 DT denotes the
T38190 12932-12936 JJS denotes most
T74458 12937-12945 NNS denotes residues
T87029 12946-12955 JJ denotes essential
T85323 12956-12959 IN denotes for
T99917 12960-12967 VBG denotes binding
T21537 12968-12972 NN denotes ACE2
T6014 12973-12974 -LRB- denotes [
T41035 12974-12976 CD denotes 16
T8340 12976-12977 -RRB- denotes ]
T30067 12977-12978 -COMMA- denotes ,
T62375 12979-12980 -LRB- denotes [
T93474 12980-12982 CD denotes 17
T91627 12982-12983 -RRB- denotes ]
T61038 12983-12984 -COMMA- denotes ,
T23050 12985-12986 -LRB- denotes [
T2153 12986-12988 CD denotes 18
T12115 12988-12989 -RRB- denotes ]
T92800 12991-12995 RB denotes Also
T47629 12995-12996 -COMMA- denotes ,
T61968 12997-13001 DT denotes both
T81337 13002-13004 IN denotes of
T3352 13005-13009 PRP denotes them
T94564 13010-13017 VBP denotes utilize
T79549 13018-13021 DT denotes the
T81034 13022-13026 JJ denotes same
T66440 13027-13033 NN denotes domain
T64350 13034-13036 IN denotes of
T84214 13037-13040 NN denotes S1B
T9559 13041-13043 TO denotes to
T41916 13044-13052 VB denotes interact
T92667 13053-13057 IN denotes with
T6335 13058-13061 DT denotes the
T19773 13062-13066 NN denotes ACE2
T62479 13067-13075 NN denotes receptor
T90671 13077-13084 RB denotes However
T39710 13084-13085 -COMMA- denotes ,
T81474 13086-13090 PRP denotes they
T56686 13091-13097 VBP denotes differ
T68640 13098-13100 IN denotes in
T87109 13101-13112 JJ denotes proteolytic
T98211 13113-13123 NN denotes processing
T71821 13124-13126 TO denotes to
T76662 13127-13131 DT denotes some
T50781 13132-13138 NN denotes degree
T10243 13140-13145 NN denotes Study
T47759 13146-13147 -LRB- denotes [
T98110 13147-13149 CD denotes 16
T87807 13149-13150 -RRB- denotes ]
T21860 13151-13153 IN denotes of
T41284 13154-13157 DT denotes the
T98832 13158-13163 JJ denotes human
T59673 13164-13173 JJ denotes embryonic
T56471 13174-13180 NN denotes kidney
T99239 13181-13182 -LRB- denotes (
T14503 13182-13185 NN denotes HEK
T28717 13185-13186 -RRB- denotes )
T37299 13187-13191 NN denotes cell
T7184 13192-13196 NN denotes line
T85187 13196-13197 -COMMA- denotes ,
T92189 13198-13203 NN denotes 293 T
T15543 13203-13204 -COMMA- denotes ,
T94164 13205-13208 VBZ denotes has
T43431 13209-13214 VBN denotes shown
T43613 13215-13219 IN denotes that
T18285 13220-13221 DT denotes a
T61673 13222-13228 NN denotes signal
T89124 13229-13232 IN denotes for
T39220 13233-13236 DT denotes the
T95765 13237-13239 NN denotes S2
T75829 13240-13247 NN denotes subunit
T59345 13248-13250 VBZ denotes is
T37161 13251-13258 JJ denotes present
T63565 13259-13261 IN denotes in
T66184 13262-13267 NNS denotes cells
T20519 13268-13278 VBN denotes inoculated
T83162 13279-13283 IN denotes with
T31219 13284-13292 NN denotes SARS-2-S
T44086 13292-13293 -COMMA- denotes ,
T88144 13294-13297 CC denotes but
T98702 13298-13301 RB denotes not
T7566 13302-13304 IN denotes in
T55250 13305-13310 NNS denotes cells
T72973 13311-13321 VBN denotes inoculated
T20341 13322-13326 IN denotes with
T62455 13327-13333 NN denotes SARS-S
T10680 13335-13338 CD denotes Two
T43316 13339-13343 JJ denotes main
T55924 13344-13353 NNS denotes proteases
T2463 13354-13357 IN denotes for
T44465 13358-13362 DT denotes both
T77880 13363-13369 NN denotes SARS-S
T81456 13370-13373 CC denotes and
T6788 13374-13382 NN denotes SARS-2-S
T40938 13383-13386 VBP denotes are
T56973 13387-13396 JJ denotes endosomal
T42812 13397-13405 NN denotes cysteine
T96337 13406-13415 VBZ denotes proteases
T16443 13416-13425 NN denotes cathepsin
T42466 13426-13427 NN denotes B
T71562 13428-13431 CC denotes and
T46478 13432-13433 NN denotes L
T46398 13434-13435 -LRB- denotes (
T65344 13435-13441 NN denotes CatB/L
T41087 13441-13442 -RRB- denotes )
T20678 13443-13446 CC denotes and
T62149 13447-13450 DT denotes the
T68064 13451-13464 JJ denotes transmembrane
T32448 13465-13473 NN denotes protease
T6092 13473-13474 -COMMA- denotes ,
T91380 13475-13481 NN denotes serine
T21495 13482-13490 NN denotes 2TMPRSS2
T43810 13491-13492 -LRB- denotes [
T10431 13492-13494 CD denotes 16
T63388 13494-13495 -RRB- denotes ]
T22680 13497-13499 IN denotes In
T74423 13500-13505 NN denotes 293 T
T35266 13506-13511 NNS denotes cells
T64338 13512-13519 VBG denotes lacking
T10485 13520-13528 NN denotes 2TMPRSS2
T85298 13528-13529 -COMMA- denotes ,
T71577 13530-13538 VBG denotes blocking
T94566 13539-13545 NN denotes CatB/L
T53535 13546-13554 NN denotes activity
T97443 13555-13562 IN denotes through
T35988 13563-13573 VBG denotes increasing
T24686 13574-13577 DT denotes the
T21828 13578-13587 JJ denotes endosomal
T57882 13588-13590 NN denotes pH
T2438 13591-13593 IN denotes by
T55605 13594-13602 NN denotes ammonium
T50104 13603-13611 NN denotes chloride
T36913 13612-13617 MD denotes could
T77508 13618-13631 RB denotes significantly
T70941 13632-13637 VB denotes limit
T75185 13638-13641 DT denotes the
T35511 13642-13647 NN denotes entry
T1792 13648-13650 IN denotes of
T53436 13651-13655 CC denotes both
T60629 13656-13662 NN denotes SARS-S
T78080 13663-13666 CC denotes and
T63658 13667-13676 JJ denotes SARS-2-S.
T98368 13677-13679 IN denotes In
T93115 13680-13696 NN denotes TMPRSS2 + Caco-2
T76285 13697-13702 NNS denotes cells
T31590 13702-13703 -COMMA- denotes ,
T25862 13704-13707 DT denotes the
T10314 13708-13714 NN denotes effect
T77548 13715-13717 IN denotes of
T48002 13718-13726 NN denotes ammonium
T31059 13727-13735 NN denotes chloride
T96902 13736-13743 VBD denotes existed
T81416 13744-13746 TO denotes to
T58350 13747-13748 DT denotes a
T53199 13749-13755 JJR denotes lesser
T72133 13756-13762 NN denotes extent
T12695 13764-13765 DT denotes A
T69785 13766-13777 NN denotes combination
T73262 13778-13780 IN denotes of
T77261 13781-13789 NN denotes camostat
T41765 13790-13798 NN denotes mesylate
T55852 13798-13799 -COMMA- denotes ,
T81348 13800-13801 DT denotes a
T88599 13802-13809 NN denotes blocker
T30022 13810-13812 IN denotes of
T40170 13813-13820 NN denotes TMPRSS2
T89506 13820-13821 -COMMA- denotes ,
T96381 13822-13825 CC denotes and
T31415 13826-13831 NN denotes E-64d
T14631 13831-13832 -COMMA- denotes ,
T42969 13833-13835 DT denotes an
T53416 13836-13845 NN denotes inhibitor
T3946 13846-13848 IN denotes of
T26871 13849-13855 NN denotes CatB/L
T27079 13855-13856 -COMMA- denotes ,
T56133 13857-13864 VBD denotes yielded
T87218 13865-13868 DT denotes the
T70471 13869-13877 JJ denotes complete
T11646 13878-13888 NN denotes inhibition
T91858 13889-13891 IN denotes of
T75023 13892-13900 NN denotes SARS-2-S
T21695 13901-13906 NN denotes entry
T17052 13907-13909 IN denotes in
T24463 13910-13926 NN denotes TMPRSS2 + Caco-2
T57029 13927-13932 NNS denotes cells
T57582 13934-13936 IN denotes In
T21513 13937-13941 CC denotes both
T67184 13942-13945 DT denotes the
T39137 13946-13951 JJ denotes human
T99828 13952-13956 NN denotes lung
T68094 13957-13963 NN denotes cancer
T76607 13964-13968 NN denotes cell
T55102 13969-13973 NN denotes line
T50829 13974-13980 NN denotes Calu-3
T53491 13981-13984 CC denotes and
T43867 13985-13988 DT denotes the
T21723 13989-13996 JJ denotes primary
T29104 13997-14002 JJ denotes human
T3411 14003-14007 NN denotes lung
T60390 14008-14013 NNS denotes cells
T81391 14013-14014 -COMMA- denotes ,
T33129 14015-14020 EX denotes there
T59040 14021-14024 VBD denotes was
T39475 14025-14026 DT denotes a
T15256 14027-14036 NN denotes reduction
T39714 14037-14039 IN denotes of
T49107 14040-14043 DT denotes the
T3461 14044-14049 NN denotes entry
T40063 14050-14052 IN denotes of
T3764 14053-14057 CC denotes both
T3726 14058-14064 NN denotes SARS-S
T74021 14065-14068 CC denotes and
T38308 14069-14077 NN denotes SARS-2-S
T3019 14078-14080 IN denotes by
T41127 14081-14089 NN denotes camostat
T6987 14090-14098 NN denotes mesylate
T21310 14098-14099 -COMMA- denotes ,
T88073 14100-14110 VBG denotes indicating
T47825 14111-14115 IN denotes that
T44262 14116-14122 NN denotes SARS-S
T25723 14123-14126 CC denotes and
T39073 14127-14135 NN denotes SARS-2-S
T85073 14136-14145 RB denotes partially
T75386 14146-14153 VBP denotes require
T13575 14154-14161 NN denotes TMPRSS2
T81091 14162-14165 IN denotes for
T10997 14166-14167 DT denotes a
T93402 14168-14172 NN denotes lung
T86423 14173-14182 NN denotes infection
T22068 14185-14192 CD denotes 4.1.3.2
T96302 14194-14202 NNP denotes Rational
T46108 14202-14203 -COLON- denotes :
T36509 14204-14209 NN denotes Serum
T11172 14210-14214 IN denotes from
T88528 14215-14227 JJ denotes convalescent
T76648 14228-14232 NN denotes SARS
T87601 14233-14241 NNS denotes patients
T31307 14242-14244 VBZ denotes is
T95865 14245-14249 JJ denotes able
T8130 14250-14252 TO denotes to
T87404 14253-14263 VB denotes neutralize
T83073 14264-14273 NN denotes SARS-CoV2
T56983 14274-14285 RB denotes efficiently
T85498 14286-14295 NN denotes Antiserum
T54727 14296-14300 WDT denotes that
T58025 14301-14309 VBZ denotes contains
T31794 14310-14320 NNS denotes antibodies
T72017 14321-14328 IN denotes against
T23410 14329-14334 JJ denotes human
T51011 14335-14339 NN denotes ACE2
T21969 14340-14345 MD denotes could
T10956 14346-14352 VB denotes hinder
T54161 14353-14356 DT denotes the
T78002 14357-14362 NN denotes entry
T48418 14363-14365 IN denotes of
T60794 14366-14370 CC denotes both
T68393 14371-14377 NN denotes SARS-S
T60207 14378-14381 CC denotes and
T37089 14382-14390 NN denotes SARS-2-S
T99631 14391-14402 NNS denotes pseudotypes
T70219 14403-14408 IN denotes while
T16218 14409-14412 RB denotes not
T76542 14413-14421 VBN denotes affected
T34278 14422-14425 DT denotes the
T2430 14426-14431 NN denotes entry
T98023 14432-14434 IN denotes of
T1819 14435-14440 NN denotes VSV-G
T13278 14441-14444 CC denotes and
T45315 14445-14451 NN denotes MERS-S
T32075 14452-14463 NNS denotes pseudotypes
T4602 14465-14467 PRP denotes It
T44962 14468-14476 VBZ denotes supports
T87111 14477-14480 DT denotes the
T50457 14481-14487 NN denotes notion
T41218 14488-14492 IN denotes that
T5721 14493-14499 NN denotes SARS-S
T21671 14500-14503 CC denotes and
T31105 14504-14512 NN denotes SARS-2-S
T49586 14513-14520 VBP denotes utilize
T31036 14521-14524 DT denotes the
T80074 14525-14529 JJ denotes same
T64684 14530-14537 JJ denotes primary
T36069 14538-14543 NN denotes entry
T27754 14544-14552 NN denotes receptor
T79207 14552-14553 -COMMA- denotes ,
T14629 14554-14558 FW denotes i.e.
T9665 14558-14559 -COMMA- denotes ,
T94116 14560-14564 NN denotes ACE2
T13974 14564-14565 -COMMA- denotes ,
T82487 14566-14571 WDT denotes which
T59931 14572-14574 VBZ denotes is
T21885 14575-14584 JJ denotes different
T2868 14585-14589 IN denotes from
T75369 14590-14593 DT denotes the
T44853 14594-14601 JJ denotes primary
T60868 14602-14611 NNS denotes receptors
T62157 14612-14617 NN denotes VSV-G
T53624 14618-14621 CC denotes and
T83630 14622-14628 NN denotes MERS-S
T67890 14629-14635 NN denotes engage
T48926 14636-14639 IN denotes for
T62543 14640-14644 NN denotes cell
T63733 14645-14650 NN denotes entry
T54619 14651-14655 WDT denotes that
T50860 14656-14658 VBZ denotes is
T99869 14659-14663 NN denotes LDLR
T6180 14664-14667 CC denotes and
T74051 14668-14672 NN denotes DPP4
T7846 14672-14673 -COMMA- denotes ,
T3162 14674-14686 RB denotes respectively
T66548 14688-14692 NN denotes Sera
T80239 14693-14697 IN denotes from
T68000 14698-14703 CD denotes three
T48403 14704-14716 JJ denotes convalescent
T51594 14717-14721 NN denotes SARS
T70519 14722-14730 NNS denotes patients
T59987 14731-14738 VBD denotes reduced
T66409 14739-14742 DT denotes the
T72671 14743-14749 JJ denotes SARS-S
T28601 14750-14755 NN denotes entry
T35673 14756-14759 CC denotes and
T3889 14759-14760 -COMMA- denotes ,
T61995 14761-14763 TO denotes to
T2565 14764-14765 VB denotes e
T43059 14766-14772 JJR denotes lesser
T78742 14773-14779 NN denotes degree
T89272 14779-14780 -COMMA- denotes ,
T22714 14781-14784 DT denotes the
T31064 14785-14793 NN denotes SARS-2-S
T32416 14794-14799 NN denotes entry
T56518 14801-14804 DT denotes The
T9724 14805-14812 NN denotes patient
T98703 14813-14818 NN denotes serum
T27055 14819-14825 NN denotes effect
T61320 14826-14829 VBD denotes was
T14991 14830-14832 IN denotes in
T7555 14833-14834 DT denotes a
T3238 14835-14849 JJ denotes dose-dependent
T1832 14850-14856 NN denotes manner
T4817 14857-14858 -LRB- denotes [
T18384 14858-14860 CD denotes 16
T62562 14860-14861 -RRB- denotes ]
T84996 14864-14869 CD denotes 4.1.4
T68842 14871-14876 NN denotes Serum
T82613 14877-14881 IN denotes from
T24477 14882-14889 NNS denotes rabbits
T81104 14890-14899 VBN denotes immunized
T21841 14900-14904 IN denotes with
T30838 14905-14909 NNS denotes SARS
T35613 14911-14918 CD denotes 4.1.4.1
T83832 14920-14930 NNS denotes Hypotheses
T16280 14930-14931 -COLON- denotes :
T65972 14932-14937 NN denotes Serum
T73609 14938-14942 IN denotes from
T96815 14943-14950 NNS denotes rabbits
T6431 14951-14960 VBN denotes immunized
T54166 14961-14965 IN denotes with
T55032 14966-14970 NN denotes SARS
T95142 14971-14973 VBZ denotes is
T10678 14974-14978 RBR denotes more
T7214 14979-14988 JJ denotes effective
T72082 14989-14993 IN denotes than
T89782 14994-14999 NN denotes serum
T96392 15000-15004 IN denotes from
T87687 15005-15017 JJ denotes convalescent
T5869 15018-15022 NN denotes SARS
T64875 15023-15031 NNS denotes patients
T2963 15032-15044 NNS denotes Paraoxonases
T18623 15045-15046 -LRB- denotes (
T27053 15046-15049 NN denotes PON
T42842 15049-15050 -RRB- denotes )
T5339 15051-15054 VBP denotes are
T35148 15055-15064 JJ denotes mammalian
T14128 15065-15072 NNS denotes enzymes
T4681 15073-15083 VBN denotes associated
T2648 15084-15088 IN denotes with
T63688 15089-15101 JJ denotes anti-oxidant
T88373 15102-15105 CC denotes and
T98716 15106-15123 JJ denotes anti-inflammatory
T71072 15124-15131 NNS denotes effects
T76904 15132-15133 -LRB- denotes [
T27198 15133-15135 CD denotes 19
T48276 15135-15136 -RRB- denotes ]
T62798 15138-15144 NN denotes Rabbit
T34931 15145-15148 NN denotes PON
T82559 15149-15156 VBZ denotes differs
T8248 15157-15161 IN denotes from
T26023 15162-15167 JJ denotes human
T64809 15168-15171 NN denotes PON
T83097 15172-15174 IN denotes in
T94817 15175-15180 NNS denotes terms
T39961 15181-15183 IN denotes of
T83536 15184-15188 JJR denotes more
T49542 15189-15197 NN denotes activity
T61619 15198-15201 CC denotes and
T61844 15202-15206 JJR denotes more
T24171 15207-15216 NN denotes stability
T99497 15217-15222 IN denotes under
T93581 15223-15226 DT denotes the
T23558 15227-15240 NNS denotes circumstances
T47798 15241-15242 -LRB- denotes [
T59949 15242-15244 CD denotes 20
T86756 15244-15245 -RRB- denotes ]
T78823 15248-15255 CD denotes 4.1.4.2
T89333 15257-15265 NNP denotes Rational
T87452 15265-15266 -COLON- denotes :
T28611 15267-15272 NN denotes Serum
T66778 15273-15277 IN denotes from
T92001 15278-15285 NNS denotes rabbits
T54331 15286-15295 VBN denotes immunized
T18102 15296-15300 IN denotes with
T49296 15301-15304 DT denotes the
T69690 15305-15307 NN denotes S1
T51504 15308-15315 NN denotes subunit
T98332 15316-15318 IN denotes of
T14000 15319-15325 NN denotes SARS-S
T69045 15326-15328 VBZ denotes is
T53543 15329-15333 JJ denotes able
T27081 15334-15336 TO denotes to
T20769 15337-15347 VB denotes neutralize
T66488 15348-15357 NN denotes SARS-CoV2
T92493 15358-15362 RB denotes very
T43055 15363-15374 RB denotes efficiently
T32795 15375-15379 NN denotes Sera
T88629 15380-15384 IN denotes from
T14011 15385-15392 NNS denotes rabbits
T36351 15393-15402 VBN denotes immunized
T2907 15403-15407 IN denotes with
T56297 15408-15411 DT denotes the
T15332 15412-15414 NN denotes S1
T42640 15415-15422 NN denotes subunit
T11917 15423-15425 IN denotes of
T11280 15426-15432 NN denotes SARS-S
T18675 15433-15438 MD denotes could
T31387 15439-15450 RB denotes effectively
T89944 15451-15457 VB denotes reduce
T32181 15458-15461 DT denotes the
T20355 15462-15467 NN denotes entry
T50423 15468-15470 IN denotes of
T12207 15471-15475 CC denotes both
T17436 15476-15482 NN denotes SARS-S
T17683 15483-15486 CC denotes and
T60936 15487-15495 NN denotes SARS-2-S
T11032 15496-15497 -LRB- denotes [
T73993 15497-15499 CD denotes 16
T40781 15499-15500 -RRB- denotes ]
T44829 15502-15506 WRB denotes When
T16892 15507-15515 VBN denotes compared
T48251 15516-15520 IN denotes with
T63812 15521-15528 NN denotes patient
T14554 15529-15534 NN denotes serum
T79753 15534-15535 -COMMA- denotes ,
T23241 15536-15542 NN denotes rabbit
T96424 15543-15548 NN denotes serum
T15191 15549-15557 VBD denotes revealed
T24898 15558-15560 TO denotes to
T77150 15561-15563 PRP denotes us
T91525 15564-15570 JJR denotes higher
T71552 15571-15581 NN denotes efficiency
T68477 15582-15584 IN denotes in
T44667 15585-15595 NN denotes inhibition
T25201 15596-15598 IN denotes of
T77635 15599-15607 NN denotes SARS-2-S
T92600 15608-15613 NN denotes entry
T81647 15614-15616 IN denotes at
T93940 15617-15620 DT denotes the
T15244 15621-15625 JJ denotes same
T33265 15626-15639 NN denotes concentration
T55819 15642-15645 CD denotes 4.2
T56180 15647-15658 JJ denotes Intravenous
T2182 15659-15674 NNS denotes immunoglobulins
T41175 15675-15676 -LRB- denotes (
T97867 15676-15680 NN denotes IVIG
T16816 15680-15681 -RRB- denotes )
T56020 15683-15688 CD denotes 4.2.1
T95212 15690-15700 NN denotes Hypothesis
T84611 15700-15701 -COLON- denotes :
T95417 15702-15706 NN denotes IVIG
T50853 15707-15715 VBZ denotes contains
T65863 15716-15717 DT denotes a
T68527 15718-15723 JJ denotes large
T83960 15724-15728 NN denotes pool
T57480 15729-15731 IN denotes of
T98962 15732-15737 JJ denotes human
T50450 15738-15748 NNS denotes antibodies
T12037 15749-15753 NN denotes IVIG
T52317 15754-15756 VBZ denotes is
T83276 15757-15759 DT denotes an
T47689 15760-15776 JJ denotes immunomodulatory
T32201 15777-15786 NN denotes treatment
T26744 15787-15796 RB denotes currently
T6595 15797-15803 JJ denotes useful
T61951 15804-15807 IN denotes for
T78252 15808-15809 DT denotes a
T96672 15810-15817 NN denotes variety
T75647 15818-15820 IN denotes of
T64366 15821-15826 JJ denotes human
T37666 15827-15835 NNS denotes diseases
T30663 15836-15840 WDT denotes that
T71611 15841-15846 VBP denotes share
T4369 15847-15849 DT denotes an
T95969 15850-15860 JJ denotes idiopathic
T35011 15861-15867 NN denotes origin
T94518 15867-15868 -COMMA- denotes ,
T34533 15869-15876 VBG denotes ranging
T57537 15877-15881 IN denotes from
T47481 15882-15892 JJ denotes autoimmune
T10634 15893-15902 NNS denotes disorders
T96539 15903-15905 TO denotes to
T18270 15906-15913 JJ denotes primary
T92790 15914-15922 NN denotes antibody
T91348 15923-15935 NNS denotes deficiencies
T23275 15937-15941 RB denotes Also
T97483 15941-15942 -COMMA- denotes ,
T12179 15943-15947 NNP denotes IVIG
T44219 15948-15951 VBZ denotes has
T10629 15952-15957 VBN denotes shown
T45168 15958-15967 JJ denotes promising
T67208 15968-15975 NNS denotes results
T77083 15976-15978 IN denotes in
T72909 15979-15983 NN denotes case
T84121 15984-15986 IN denotes of
T92712 15987-15993 JJ denotes severe
T79863 15994-15995 -LRB- denotes (
T66824 15995-15999 JJ denotes such
T43956 16000-16002 IN denotes as
T9832 16003-16009 NN denotes sepsis
T13628 16009-16010 -COMMA- denotes ,
T62406 16011-16021 NN denotes Parvovirus
T99835 16022-16025 NN denotes B19
T14835 16026-16035 NN denotes infection
T15497 16035-16036 -COMMA- denotes ,
T90831 16037-16041 NNP denotes West
T76795 16042-16046 NNP denotes Nile
T72325 16047-16052 NN denotes virus
T62294 16053-16065 NN denotes encephalitis
T79163 16065-16066 -COMMA- denotes ,
T42313 16067-16070 NN denotes HIV
T73958 16070-16071 -COMMA- denotes ,
T29310 16072-16083 NNP denotes Clostridium
T49447 16084-16093 JJ denotes difficile
T8038 16094-16104 NNS denotes infections
T10219 16104-16105 -COMMA- denotes ,
T3443 16106-16119 NN denotes Mycobacterium
T55185 16120-16125 NN denotes avium
T2677 16125-16126 -COMMA- denotes ,
T67405 16127-16140 NN denotes Mycobacterium
T65630 16141-16153 NN denotes tuberculosis
T60726 16153-16154 -COMMA- denotes ,
T52785 16155-16158 CC denotes and
T44446 16159-16167 NNP denotes Nocardia
T90848 16168-16178 NNS denotes infections
T80386 16178-16179 -RRB- denotes )
T6178 16180-16183 CC denotes and
T68317 16184-16193 JJ denotes recurrent
T17705 16194-16204 NNS denotes infections
T68999 16205-16207 IN denotes in
T18422 16208-16215 JJ denotes primary
T52471 16216-16226 NNS denotes antibodies
T62247 16227-16239 NNS denotes deficiencies
T55724 16240-16241 -LRB- denotes [
T27007 16241-16243 CD denotes 21
T97422 16243-16244 -RRB- denotes ]
T8813 16246-16250 JJS denotes Most
T48684 16251-16259 NNS denotes patients
T37814 16260-16267 VBP denotes develop
T41895 16268-16278 NNS denotes antibodies
T32237 16279-16286 IN denotes against
T55833 16287-16290 DT denotes the
T23466 16291-16293 NN denotes NP
T51386 16294-16297 CC denotes and
T97267 16298-16301 NN denotes RBD
T48238 16302-16304 IN denotes of
T17626 16305-16314 NN denotes 2019-nCoV
T87676 16315-16321 IN denotes during
T56543 16322-16325 DT denotes the
T74019 16326-16332 JJ denotes second
T36179 16333-16337 NN denotes week
T61939 16338-16343 IN denotes after
T53819 16344-16353 NN denotes infection
T47949 16354-16359 NN denotes onset
T10621 16360-16361 -LRB- denotes [
T31327 16361-16363 CD denotes 22
T53799 16363-16364 -RRB- denotes ]
T76985 16366-16374 NN denotes Analysis
T6758 16375-16377 IN denotes of
T88720 16378-16383 NN denotes serum
T73739 16384-16391 NNS denotes samples
T20072 16392-16401 VBD denotes collected
T30704 16402-16404 CD denotes 14
T66398 16405-16407 CC denotes or
T43796 16408-16412 JJR denotes more
T64515 16413-16417 NNS denotes days
T88119 16418-16423 IN denotes after
T33297 16424-16431 NN denotes symptom
T78997 16432-16437 NN denotes onset
T69102 16438-16446 VBD denotes revealed
T51393 16447-16456 NN denotes detection
T49412 16457-16459 IN denotes of
T86080 16460-16463 NN denotes IgG
T42365 16464-16467 CC denotes and
T24248 16468-16471 NN denotes IgM
T84785 16472-16482 NNS denotes antibodies
T33598 16483-16490 IN denotes against
T65176 16491-16493 NN denotes NP
T29543 16494-16496 IN denotes in
T67075 16497-16499 CD denotes 94
T4274 16499-16500 NN denotes %
T73088 16501-16504 CC denotes and
T74097 16505-16507 CD denotes 88
T71868 16507-16508 NN denotes %
T54079 16509-16512 CC denotes and
T73098 16513-16516 NN denotes RBD
T69539 16517-16519 IN denotes in
T87988 16520-16523 CD denotes 100
T78691 16523-16524 NN denotes %
T18580 16525-16528 CC denotes and
T46489 16529-16531 CD denotes 94
T64615 16531-16532 NN denotes %
T60810 16533-16538 IN denotes among
T38563 16539-16547 NNS denotes patients
T93829 16548-16552 IN denotes with
T24980 16553-16560 NN denotes COVID19
T89545 16562-16569 NNS denotes Studies
T44838 16570-16582 RB denotes consistently
T54246 16583-16587 VBP denotes show
T20581 16588-16592 IN denotes that
T54967 16593-16602 VBN denotes increased
T27422 16603-16617 NN denotes immunoglobulin
T48431 16618-16624 NNS denotes levels
T7060 16625-16634 VBP denotes accompany
T92743 16635-16638 DT denotes the
T24866 16639-16649 NN denotes transition
T9522 16650-16654 IN denotes from
T69120 16655-16660 JJ denotes early
T81312 16661-16663 TO denotes to
T7048 16664-16668 JJ denotes late
T25388 16669-16675 NN denotes course
T44741 16676-16678 IN denotes of
T20679 16679-16686 NN denotes COVID19
T6735 16688-16690 PRP denotes It
T32751 16691-16696 VBZ denotes poses
T41840 16697-16700 DT denotes the
T21434 16701-16712 NN denotes possibility
T75450 16713-16717 IN denotes that
T55251 16718-16722 NN denotes IVIG
T48129 16723-16730 NN denotes therapy
T90120 16731-16736 MD denotes might
T91321 16737-16741 VB denotes help
T89890 16742-16744 TO denotes to
T64443 16745-16755 VB denotes accelerate
T5150 16756-16764 NN denotes recovery
T43666 16765-16769 IN denotes from
T85289 16770-16778 NN denotes COVID-19
T72940 16781-16786 CD denotes 4.2.2
T31699 16788-16797 NNP denotes Rationale
T6254 16797-16798 -COLON- denotes :
T80516 16799-16803 NN denotes IVIG
T69063 16804-16809 MD denotes might
T22631 16810-16814 VB denotes help
T88012 16815-16817 TO denotes to
T98862 16818-16825 VB denotes improve
T98671 16826-16829 DT denotes the
T20348 16830-16837 NN denotes outcome
T65200 16838-16840 IN denotes of
T90061 16841-16849 NNS denotes patients
T66297 16850-16854 IN denotes with
T53417 16855-16863 NN denotes COVID-19
T18993 16864-16867 DT denotes The
T21718 16868-16873 NN denotes study
T64168 16874-16875 -LRB- denotes [
T66430 16875-16877 CD denotes 23
T95152 16877-16878 -RRB- denotes ]
T31198 16879-16887 VBD denotes included
T55004 16888-16891 CD denotes ten
T65830 16892-16900 NNS denotes patients
T56952 16901-16905 IN denotes with
T98815 16906-16914 NN denotes COVID-19
T69048 16915-16918 WP denotes who
T75376 16919-16931 VBD denotes demonstrated
T59786 16932-16941 VBG denotes worsening
T24326 16942-16950 NNS denotes symptoms
T13700 16950-16951 -COMMA- denotes ,
T79561 16952-16956 FW denotes e.g.
T83448 16956-16957 -COMMA- denotes ,
T77014 16958-16967 VBD denotes decreased
T40148 16968-16978 NN denotes lymphocyte
T31095 16979-16984 NN denotes count
T13833 16985-16988 CC denotes and
T80531 16989-16998 VBD denotes decreased
T26060 16999-17008 NN denotes PaO2/FIO2
T3471 17009-17014 NN denotes ratio
T11859 17015-17018 CC denotes and
T6067 17019-17025 NN denotes oxygen
T65980 17026-17036 NN denotes saturation
T58632 17036-17037 -COMMA- denotes ,
T52543 17038-17047 VBG denotes following
T84435 17048-17057 NN denotes treatment
T44273 17058-17062 IN denotes with
T99668 17063-17064 DT denotes a
T65524 17065-17075 JJ denotes short-term
T66169 17076-17089 JJ denotes moderate-dose
T25963 17090-17104 NN denotes corticosteroid
T54040 17105-17106 -LRB- denotes (
T15835 17106-17124 NN denotes methylprednisolone
T75851 17125-17132 NN denotes 80 mg/d
T55858 17132-17133 -RRB- denotes )
T6426 17134-17138 CC denotes plus
T60445 17139-17153 NN denotes immunoglobulin
T91733 17154-17155 -LRB- denotes (
T10263 17155-17161 CD denotes 10 g/d
T89099 17161-17162 -RRB- denotes )
T32422 17164-17169 IN denotes After
T38661 17170-17179 VBG denotes switching
T47400 17180-17182 TO denotes to
T27854 17183-17186 DT denotes the
T88178 17187-17193 JJ denotes double
T22917 17194-17198 NN denotes dose
T27562 17199-17201 IN denotes of
T69861 17202-17211 NN denotes 1600 mg/d
T26688 17212-17230 NN denotes methylprednisolone
T91618 17231-17235 CC denotes plus
T63033 17236-17242 NN denotes 20 g/d
T82872 17243-17257 NN denotes immunoglobulin
T48110 17257-17258 -COMMA- denotes ,
T64285 17259-17262 DT denotes all
T67888 17263-17265 IN denotes of
T16788 17266-17269 DT denotes the
T67776 17270-17278 NNS denotes patients
T6163 17279-17287 VBN denotes improved
T27596 17288-17290 IN denotes in
T10929 17291-17294 DT denotes the
T87507 17295-17303 JJ denotes clinical
T10805 17303-17304 -COMMA- denotes ,
T49266 17305-17315 NN denotes laboratory
T95692 17315-17316 -COMMA- denotes ,
T51590 17317-17320 CC denotes and
T63732 17321-17333 JJ denotes paraclinical
T58895 17334-17342 NNS denotes outcomes
T85504 17344-17351 JJ denotes Passive
T86520 17352-17364 NN denotes immunization
T22143 17365-17373 VBZ denotes protects
T80547 17374-17381 IN denotes against
T21735 17382-17389 NN denotes disease
T15590 17389-17390 -COMMA- denotes ,
T4169 17391-17394 CC denotes and
T50400 17395-17397 IN denotes so
T4187 17398-17400 PRP denotes it
T38504 17401-17407 MD denotes should
T8453 17408-17410 VB denotes be
T27914 17411-17423 VBN denotes administered
T25991 17424-17426 RB denotes as
T54707 17427-17432 RB denotes early
T29802 17433-17435 IN denotes as
T24869 17436-17444 JJ denotes possible
T10896 17445-17449 WRB denotes when
T25638 17450-17453 DT denotes the
T29960 17454-17461 NN denotes patient
T20464 17462-17464 VBZ denotes is
T3036 17465-17474 VBN denotes diagnosed
T87261 17476-17483 NNS denotes Studies
T96660 17484-17488 VBP denotes show
T29990 17489-17493 IN denotes that
T81080 17494-17497 DT denotes the
T36950 17498-17503 JJ denotes viral
T53426 17504-17507 NN denotes RNA
T78293 17508-17510 IN denotes of
T18048 17511-17520 NN denotes 2019-nCoV
T93176 17521-17528 VBZ denotes reaches
T83675 17529-17532 PRP-DOLLAR- denotes its
T2594 17533-17537 NN denotes peak
T62926 17538-17544 IN denotes during
T35185 17545-17548 DT denotes the
T47524 17549-17554 JJ denotes first
T79772 17555-17559 NN denotes week
T85972 17560-17563 CC denotes and
T60597 17564-17568 RB denotes then
T18711 17569-17578 RB denotes gradually
T40522 17579-17588 VBZ denotes decreases
T67874 17589-17592 CC denotes and
T80013 17593-17597 IN denotes that
T48373 17598-17601 NN denotes IgG
T85015 17602-17605 CC denotes and
T48892 17606-17609 NN denotes IgM
T97802 17610-17615 VBP denotes begin
T54813 17616-17618 TO denotes to
T87582 17619-17623 VB denotes rise
T15243 17624-17628 IN denotes from
T79089 17629-17632 DT denotes the
T92830 17633-17637 JJ denotes 10th
T91091 17638-17641 NN denotes day
T75308 17642-17644 IN denotes so
T98992 17645-17649 IN denotes that
T91226 17650-17654 JJS denotes most
T66875 17655-17663 NNS denotes patients
T44373 17664-17668 VBP denotes have
T45012 17669-17679 JJ denotes anti-viral
T2304 17680-17690 NNS denotes antibodies
T90719 17691-17693 IN denotes by
T66178 17694-17697 DT denotes the
T38757 17698-17702 JJ denotes 14th
T73930 17703-17706 NN denotes day
T52733 17709-17710 CD denotes 5
T83488 17712-17723 JJ denotes Recombinant
T93217 17724-17728 NN denotes type
T64716 17729-17730 CD denotes I
T68579 17731-17734 NN denotes IFN
T12001 17736-17739 CD denotes 5.1
T9969 17741-17751 NN denotes Hypothesis
T15939 17751-17752 -COLON- denotes :
T64893 17753-17757 NNS denotes IFNs
T64532 17758-17762 VBP denotes play
T66496 17763-17764 DT denotes a
T99130 17765-17769 NN denotes role
T16405 17770-17772 IN denotes in
T11399 17773-17783 JJ denotes anti-viral
T89696 17784-17792 NN denotes immunity
T96681 17793-17797 NN denotes Type
T4789 17798-17799 CD denotes I
T85645 17800-17804 NNS denotes IFNs
T76626 17805-17809 VBP denotes play
T51847 17810-17811 DT denotes a
T51548 17812-17819 JJ denotes primary
T78533 17820-17824 NN denotes role
T65875 17825-17827 IN denotes in
T16934 17828-17831 DT denotes the
T59480 17832-17842 NN denotes inhibition
T64120 17843-17845 IN denotes of
T42209 17846-17851 JJ denotes viral
T92412 17852-17863 NN denotes replication
T19053 17864-17871 IN denotes through
T85138 17872-17875 DT denotes the
T89603 17876-17888 NN denotes coordination
T52542 17889-17891 IN denotes of
T13645 17892-17902 JJ denotes anti-viral
T39632 17903-17909 JJ denotes immune
T42144 17910-17919 NNS denotes responses
T54149 17920-17923 CC denotes and
T13001 17924-17934 NN denotes modulation
T2287 17935-17937 IN denotes of
T72730 17938-17950 JJ denotes inflammatory
T37912 17951-17960 NNS denotes responses
T64464 17961-17962 -LRB- denotes [
T89396 17962-17964 CD denotes 24
T17915 17964-17965 -RRB- denotes ]
T44068 17968-17971 CD denotes 5.2
T95208 17973-17981 NNP denotes Rational
T91019 17981-17982 -COLON- denotes :
T95927 17983-17994 JJ denotes Recombinant
T3712 17995-17999 NN denotes type
T46872 18000-18001 CD denotes I
T95232 18002-18005 NN denotes IFN
T83801 18006-18009 MD denotes can
T31121 18010-18021 RB denotes effectively
T50200 18022-18029 VB denotes inhibit
T51383 18030-18039 NN denotes SARS-CoV2
T97492 18040-18051 NN denotes replication
T96177 18052-18054 IN denotes In
T72452 18055-18062 NN denotes 24–48 h
T50493 18063-18068 IN denotes after
T17096 18069-18078 NN denotes infection
T97012 18078-18079 -COMMA- denotes ,
T67170 18080-18089 NN denotes SARS-CoV2
T9761 18090-18101 NN denotes replication
T69880 18102-18109 VBZ denotes reaches
T9709 18110-18115 NN denotes titer
T49785 18116-18120 WDT denotes that
T71708 18121-18127 VBZ denotes causes
T52777 18128-18131 DT denotes the
T56623 18132-18142 JJ denotes cytopathic
T87850 18143-18149 NN denotes effect
T47272 18150-18152 IN denotes in
T71726 18153-18157 NN denotes Vero
T42629 18158-18160 NN denotes E6
T73531 18161-18166 NNS denotes cells
T60353 18166-18167 -COMMA- denotes ,
T83400 18168-18173 WDT denotes which
T80948 18174-18181 VBP denotes express
T12338 18182-18186 NN denotes ACE2
T60658 18187-18190 CC denotes and
T41368 18191-18195 RB denotes thus
T89464 18196-18199 VBP denotes are
T62340 18200-18211 JJ denotes susceptible
T6873 18212-18214 TO denotes to
T68175 18215-18224 NN denotes SARS-CoV2
T16296 18225-18234 NN denotes infection
T12529 18235-18236 -LRB- denotes [
T55131 18236-18238 CD denotes 25
T28678 18238-18239 -RRB- denotes ]
T52876 18241-18243 PRP denotes It
T21084 18244-18246 VBZ denotes is
T70918 18247-18254 JJ denotes similar
T20327 18255-18257 TO denotes to
T13471 18258-18261 DT denotes the
T26039 18262-18267 JJ denotes viral
T64125 18268-18279 NN denotes replication
T62855 18280-18288 NNS denotes kinetics
T68614 18289-18292 IN denotes for
T64958 18293-18301 NN denotes SARS-CoV
T62199 18302-18303 -LRB- denotes [
T27403 18303-18305 CD denotes 25
T34963 18305-18306 -RRB- denotes ]
T49689 18308-18320 NN denotes Pretreatment
T74739 18321-18325 IN denotes with
T62356 18326-18337 JJ denotes recombinant
T67333 18338-18342 NN denotes type
T31833 18343-18344 CD denotes I
T78772 18345-18348 NN denotes IFN
T57406 18349-18354 MD denotes could
T5100 18355-18366 RB denotes effectively
T32529 18367-18374 VB denotes inhibit
T31501 18375-18384 NN denotes SARS-CoV2
T43668 18385-18396 NN denotes replication
T86722 18397-18399 IN denotes at
T26971 18400-18404 CC denotes both
T35627 18405-18407 CD denotes 24
T29701 18408-18411 CC denotes and
T48153 18412-18416 NN denotes 48 h
T93874 18417-18422 IN denotes after
T7550 18423-18432 NN denotes infection
T23827 18433-18434 -LRB- denotes [
T6071 18434-18436 CD denotes 25
T91011 18436-18437 -RRB- denotes ]
T51029 18439-18442 IN denotes For
T64526 18443-18451 NN denotes SARS-CoV
T41819 18451-18452 -COMMA- denotes ,
T5764 18453-18457 PDT denotes such
T79954 18458-18460 DT denotes an
T48924 18461-18467 NN denotes effect
T40034 18468-18471 VBD denotes was
T1935 18472-18479 JJ denotes present
T31311 18480-18482 IN denotes at
T94385 18483-18487 CD denotes 24 h
T84543 18488-18491 CC denotes but
T64490 18492-18498 JJ denotes absent
T33679 18499-18501 IN denotes at
T68271 18502-18506 NN denotes 48 h
T69307 18507-18512 IN denotes after
T51672 18513-18522 NN denotes infection
T85433 18523-18524 -LRB- denotes [
T72350 18524-18526 CD denotes 25
T63406 18526-18527 -RRB- denotes ]
T46096 18529-18532 DT denotes The
T71403 18533-18543 NN denotes difference
T17651 18544-18551 IN denotes between
T77482 18552-18561 NN denotes SARS-CoV2
T6733 18562-18565 CC denotes and
T6622 18566-18574 NN denotes SARS-CoV
T66580 18575-18577 IN denotes in
T74975 18578-18586 NN denotes response
T1853 18587-18589 TO denotes to
T87892 18590-18594 NN denotes type
T83308 18595-18596 CD denotes I
T81934 18597-18600 NN denotes IFN
T42652 18601-18610 NN denotes treatment
T91527 18611-18614 MD denotes may
T42839 18615-18617 VB denotes be
T98810 18618-18621 JJ denotes due
T31126 18622-18624 TO denotes to
T23141 18625-18636 NNS denotes differences
T45488 18637-18639 IN denotes in
T39296 18640-18650 JJ denotes structural
T12723 18651-18659 NNS denotes proteins
T40582 18660-18662 IN denotes of
T48639 18663-18668 DT denotes these
T20513 18669-18676 NNS denotes viruses
T37519 18676-18677 -COMMA- denotes ,
T18237 18678-18687 VBG denotes including
T17094 18688-18692 NN denotes NSP3
T86991 18692-18693 -COMMA- denotes ,
T14810 18694-18699 NN denotes ORF3b
T9269 18699-18700 -COMMA- denotes ,
T18064 18701-18704 CC denotes and
T40695 18705-18709 NN denotes ORF6
T59456 18710-18711 -LRB- denotes [
T34145 18711-18713 CD denotes 25
T98303 18713-18714 -RRB- denotes ]
T22399 18717-18718 CD denotes 6
T82716 18720-18731 NN denotes Development
T5151 18732-18734 IN denotes of
T20950 18735-18736 DT denotes a
T64967 18737-18742 JJ denotes human
T94716 18743-18753 JJ denotes monoclonal
T29466 18754-18762 NN denotes antibody
T27300 18763-18764 -LRB- denotes (
T65405 18764-18767 NN denotes mAb
T53967 18767-18768 -RRB- denotes )
T20998 18770-18773 CD denotes 6.1
T79456 18775-18784 VBG denotes Targeting
T24060 18785-18788 DT denotes the
T56819 18789-18790 NN denotes S
T25577 18791-18798 NN denotes protein
T96682 18800-18805 CD denotes 6.1.1
T17328 18807-18817 NN denotes Hypothesis
T61727 18817-18818 -COLON- denotes :
T32221 18819-18820 DT denotes A
T25878 18821-18824 NN denotes mAb
T8625 18825-18832 IN denotes against
T32030 18833-18836 DT denotes the
T55531 18837-18844 NN denotes binding
T9970 18845-18851 NN denotes domain
T76093 18852-18854 IN denotes of
T80345 18855-18858 DT denotes the
T93532 18859-18864 NN denotes virus
T16199 18865-18868 MD denotes can
T28417 18869-18876 VB denotes inhibit
T48409 18877-18886 NN denotes SARS-CoV2
T36310 18887-18896 NN denotes infection
T27915 18897-18905 RB denotes Recently
T56144 18905-18906 -COMMA- denotes ,
T55915 18907-18916 NN denotes hybridoma
T72012 18917-18929 NNS denotes supernatants
T47163 18930-18940 VBG denotes containing
T24138 18941-18949 NN denotes antibody
T98139 18950-18961 NNS denotes repertoires
T66535 18962-18966 IN denotes from
T86473 18967-18976 VBN denotes immunized
T66245 18977-18987 JJ denotes transgenic
T17100 18988-18992 NNS denotes mice
T85324 18993-18997 WDT denotes that
T55347 18998-19005 VBP denotes express
T14738 19006-19009 DT denotes the
T52540 19010-19015 JJ denotes human
T35586 19016-19030 NN denotes immunoglobulin
T72563 19031-19036 JJ denotes heavy
T65069 19037-19040 CC denotes and
T5967 19041-19046 JJ denotes light
T98095 19047-19053 NNS denotes chains
T78221 19054-19057 CC denotes and
T28318 19058-19061 NN denotes rat
T19776 19062-19068 NN denotes origin
T32531 19069-19083 NN denotes immunoglobulin
T16968 19084-19092 NN denotes constant
T56920 19093-19100 NNS denotes regions
T36716 19101-19105 VBD denotes were
T74827 19106-19110 VBN denotes used
T21382 19111-19113 TO denotes to
T11788 19114-19120 VB denotes detect
T40665 19121-19131 NNS denotes antibodies
T56747 19132-19136 WDT denotes that
T54239 19137-19140 MD denotes can
T71867 19141-19146 VB denotes cross
T35671 19147-19157 VB denotes neutralize
T77445 19158-19164 NN denotes SARS-S
T34654 19165-19168 CC denotes and
T83470 19169-19177 NN denotes SARS-2-S
T76245 19178-19179 -LRB- denotes [
T33581 19179-19181 CD denotes 26
T80577 19181-19182 -RRB- denotes ]
T78516 19184-19187 CD denotes One
T34464 19188-19196 JJ denotes chimeric
T13041 19197-19202 NN denotes 47D11
T83927 19203-19207 NN denotes H2L2
T57345 19208-19216 NN denotes antibody
T44833 19217-19226 VBD denotes displayed
T94688 19227-19231 PDT denotes such
T52983 19232-19233 DT denotes a
T30646 19234-19252 JJ denotes cross-neutralizing
T37245 19253-19261 NN denotes activity
T11300 19261-19262 -COMMA- denotes ,
T30814 19263-19272 VBD denotes decreased
T23282 19273-19281 NN denotes syncytia
T72581 19282-19291 NN denotes formation
T71888 19292-19299 VBN denotes induced
T44111 19300-19302 IN denotes by
T7869 19303-19309 NN denotes SARS-S
T80909 19310-19313 CC denotes and
T58127 19314-19321 NN denotes SARS2-S
T9479 19321-19322 -COMMA- denotes ,
T96346 19323-19326 CC denotes and
T43362 19327-19332 MD denotes could
T48435 19333-19340 VB denotes protect
T44775 19341-19347 NN denotes VeroE6
T25625 19348-19353 NNS denotes cells
T19104 19354-19361 IN denotes against
T51640 19362-19368 NN denotes SARS-S
T22676 19369-19372 CC denotes and
T37470 19373-19380 NN denotes SARS2-S
T64695 19381-19392 VBD denotes pseudotyped
T26978 19393-19398 NN denotes virus
T79137 19399-19400 -LRB- denotes [
T95558 19400-19402 CD denotes 26
T95168 19402-19403 -RRB- denotes ]
T45371 19405-19407 PRP denotes It
T75403 19408-19411 MD denotes may
T86603 19412-19415 VB denotes lie
T91829 19416-19418 IN denotes in
T48175 19419-19422 PRP-DOLLAR- denotes its
T69338 19423-19430 JJ denotes similar
T68140 19431-19441 NNS denotes affinities
T76951 19442-19445 IN denotes for
T38362 19446-19457 VBG denotes interacting
T39715 19458-19462 IN denotes with
T48378 19463-19466 DT denotes the
T63623 19467-19471 JJ denotes same
T2491 19472-19478 NN denotes domain
T57621 19479-19481 IN denotes of
T77993 19482-19485 DT denotes the
T52886 19486-19488 NN denotes S1
T27554 19489-19496 NN denotes subunit
T41139 19496-19497 -COMMA- denotes ,
T99819 19498-19502 FW denotes i.e.
T40027 19502-19503 -COMMA- denotes ,
T73637 19504-19507 NN denotes S1B
T71055 19507-19508 -COMMA- denotes ,
T88888 19509-19511 IN denotes of
T40209 19512-19516 DT denotes each
T2572 19517-19523 NN denotes SARS-S
T97128 19524-19527 CC denotes and
T91104 19528-19536 NN denotes SARS-2-S
T63608 19539-19544 CD denotes 6.1.2
T11815 19546-19554 NNP denotes Rational
T73902 19554-19555 -COLON- denotes :
T21134 19556-19559 DT denotes The
T30867 19560-19568 JJ denotes chimeric
T42126 19569-19574 NN denotes 47D11
T93924 19575-19579 NN denotes H2L2
T85248 19580-19585 MD denotes might
T92338 19586-19589 RB denotes not
T49873 19590-19592 VB denotes be
T69919 19593-19602 JJ denotes effective
T60557 19603-19605 IN denotes in
T77242 19606-19611 JJ denotes human
T86725 19612-19616 NN denotes lung
T18333 19617-19622 NNS denotes cells
T22947 19623-19625 IN denotes as
T22184 19626-19628 PRP denotes it
T1922 19629-19631 VBZ denotes is
T72123 19632-19634 FW denotes in
T38972 19635-19640 FW denotes vitro
T22398 19641-19646 NN denotes 47D11
T15962 19647-19654 VBD denotes carried
T83196 19655-19656 DT denotes a
T61532 19657-19663 JJR denotes higher
T47874 19664-19672 NN denotes affinity
T77580 19673-19676 IN denotes for
T95631 19677-19688 VBG denotes interacting
T94847 19689-19693 IN denotes with
T20163 19694-19697 DT denotes the
T18520 19698-19700 NN denotes S2
T89003 19701-19708 NN denotes subunit
T41606 19709-19711 IN denotes of
T4784 19712-19718 NN denotes SARS-S
T32288 19719-19723 IN denotes than
T68894 19724-19728 DT denotes that
T97000 19729-19731 IN denotes of
T32517 19732-19741 NN denotes SARS-2-S.
T24633 19742-19744 PRP denotes It
T45480 19745-19747 VBZ denotes is
T10954 19748-19757 JJ denotes important
T96386 19758-19762 IN denotes that
T80967 19763-19766 IN denotes for
T24571 19767-19771 DT denotes both
T18211 19772-19778 NN denotes SARS-S
T39196 19779-19782 CC denotes and
T83081 19783-19791 NN denotes SARS-2-S
T70298 19791-19792 -COMMA- denotes ,
T91479 19793-19796 DT denotes the
T56884 19797-19804 NN denotes binding
T11559 19805-19807 IN denotes of
T2922 19808-19811 DT denotes the
T11592 19812-19817 NN denotes 47D11
T36887 19818-19826 NN denotes antibody
T46706 19827-19829 TO denotes to
T40788 19830-19833 DT denotes the
T37833 19834-19840 NN denotes target
T37378 19841-19842 VBZ denotes
T15003 19843-19846 DT denotes the
T4372 19847-19850 NN denotes S1B
T31100 19851-19857 NN denotes domain
T82065 19858-19859 NN denotes
T43926 19860-19864 VBZ denotes does
T69422 19865-19868 RB denotes not
T3419 19869-19874 VB denotes block
T21955 19875-19878 DT denotes the
T12942 19879-19886 NN denotes binding
T83444 19887-19889 IN denotes of
T49120 19890-19893 NN denotes S1B
T55070 19894-19897 CC denotes and
T98634 19898-19900 NN denotes S2
T48321 19901-19903 TO denotes to
T80580 19904-19908 NN denotes ACE2
T18877 19909-19917 NN denotes receptor
T18503 19918-19919 -LRB- denotes [
T33177 19919-19921 CD denotes 26
T92006 19921-19922 -RRB- denotes ]
T53652 19924-19926 IN denotes By
T58622 19927-19935 NN denotes contrast
T35381 19935-19936 -COMMA- denotes ,
T41843 19937-19949 VBG denotes neutralizing
T81589 19950-19960 NNS denotes antibodies
T68196 19961-19965 WDT denotes that
T30816 19966-19978 RB denotes specifically
T53446 19979-19985 NN denotes target
T89813 19986-19992 NN denotes SARS-S
T95236 19993-19998 MD denotes could
T7888 19999-20006 VB denotes compete
T34125 20007-20011 IN denotes with
T82101 20012-20015 NN denotes S1B
T1902 20016-20019 CC denotes and
T24277 20020-20022 NN denotes S2
T37015 20023-20026 IN denotes for
T86465 20027-20034 VBG denotes binding
T1893 20035-20037 TO denotes to
T91196 20038-20042 NN denotes ACE2
T54390 20045-20048 CD denotes 6.2
T7377 20050-20059 VBG denotes Targeting
T2754 20060-20076 JJ denotes pro-inflammatory
T79617 20077-20086 NNS denotes cytokines
T42975 20088-20093 CD denotes 6.2.1
T96891 20095-20105 NN denotes Hypothesis
T41163 20105-20106 -COLON- denotes :
T35174 20107-20108 DT denotes A
T74401 20109-20112 NN denotes mAb
T75556 20113-20120 IN denotes against
T83617 20121-20124 NN denotes IL6
T67953 20125-20128 MD denotes can
T68840 20129-20138 VB denotes attenuate
T2426 20139-20144 NN denotes hyper
T92661 20145-20157 NN denotes inflammation
T86439 20158-20169 NNP denotes Tocilizumab
T21494 20169-20170 -COMMA- denotes ,
T50157 20171-20175 RB denotes also
T26283 20176-20181 VBN denotes known
T43571 20182-20184 IN denotes as
T44785 20185-20194 NN denotes atlizumab
T96810 20194-20195 -COMMA- denotes ,
T58761 20196-20198 VBZ denotes is
T56416 20199-20200 DT denotes a
T79548 20201-20210 JJ denotes humanized
T29074 20211-20221 JJ denotes anti-human
T88685 20222-20225 NN denotes IL6
T26777 20226-20234 NN denotes receptor
T24185 20235-20243 NN denotes antibody
T17221 20244-20252 VBN denotes approved
T32471 20253-20255 IN denotes by
T53882 20256-20259 NNP denotes FDA
T24580 20260-20263 IN denotes for
T33924 20264-20271 JJ denotes several
T90119 20272-20284 JJ denotes inflammatory
T59846 20285-20288 CC denotes and
T31666 20289-20299 JJ denotes autoimmune
T46803 20300-20308 NNS denotes diseases
T80969 20309-20315 JJ denotes severe
T13017 20315-20316 -COMMA- denotes ,
T79015 20317-20321 JJ denotes such
T43255 20322-20324 IN denotes as
T47553 20325-20333 NN denotes cytokine
T34694 20334-20341 NN denotes release
T36705 20342-20350 NN denotes syndrome
T68837 20350-20351 -COMMA- denotes ,
T30269 20352-20362 JJ denotes rheumatoid
T54700 20363-20372 NN denotes arthritis
T81658 20372-20373 -COMMA- denotes ,
T84650 20374-20379 JJ denotes giant
T11095 20380-20384 NN denotes cell
T15987 20385-20394 NN denotes arteritis
T88887 20394-20395 -COMMA- denotes ,
T31599 20396-20409 JJ denotes polyarticular
T93322 20410-20418 JJ denotes juvenile
T49595 20419-20429 JJ denotes idiopathic
T62141 20430-20439 NN denotes arthritis
T76737 20439-20440 -COMMA- denotes ,
T30470 20441-20444 CC denotes and
T13999 20445-20455 JJ denotes systematic
T88238 20456-20464 JJ denotes juvenile
T89892 20465-20475 JJ denotes idiopathic
T97598 20476-20485 NN denotes arthritis
T25454 20487-20489 PRP denotes It
T28665 20490-20492 VBZ denotes is
T15312 20493-20497 JJ denotes safe
T18121 20498-20501 CC denotes and
T2467 20502-20511 JJ denotes effective
T39207 20512-20515 IN denotes for
T89869 20516-20520 DT denotes both
T32842 20521-20527 NNS denotes adults
T38357 20528-20531 CC denotes and
T13891 20532-20540 NNS denotes children
T61388 20541-20544 CD denotes two
T66576 20545-20550 NNS denotes years
T46590 20551-20553 IN denotes of
T15404 20554-20557 NN denotes age
T19164 20558-20561 CC denotes and
T99851 20562-20567 JJR denotes older
T41884 20570-20575 CD denotes 6.2.2
T3706 20577-20586 NNP denotes Rationale
T87509 20586-20587 -COLON- denotes :
T72411 20588-20599 NNP denotes Tocilizumab
T46139 20600-20603 MD denotes can
T80638 20604-20609 VB denotes treat
T14365 20610-20614 NN denotes lung
T88114 20615-20621 NN denotes injury
T76208 20622-20624 IN denotes in
T24628 20625-20633 NNS denotes patients
T15777 20634-20638 IN denotes with
T58130 20639-20647 JJ denotes critical
T31522 20648-20651 CC denotes and
T55163 20652-20658 JJ denotes severe
T92225 20659-20667 NN denotes COVID-19
T21073 20668-20670 IN denotes In
T65150 20671-20674 DT denotes the
T61991 20675-20680 NN denotes study
T18474 20681-20682 -LRB- denotes [
T8341 20682-20684 CD denotes 27
T6430 20684-20685 -RRB- denotes ]
T29393 20685-20686 -COMMA- denotes ,
T77821 20687-20689 CD denotes 21
T79215 20690-20698 NNS denotes patients
T5404 20699-20703 IN denotes with
T75582 20704-20712 NN denotes COVID-19
T89299 20713-20718 WP-DOLLAR- denotes whose
T66055 20719-20728 NN denotes condition
T80340 20729-20732 VBD denotes was
T3490 20733-20739 JJ denotes severe
T44653 20740-20742 CC denotes or
T55941 20743-20751 JJ denotes critical
T85453 20752-20760 VBD denotes received
T98598 20761-20764 CD denotes one
T96881 20765-20767 CC denotes or
T24534 20768-20771 CD denotes two
T70238 20772-20777 NNS denotes doses
T20616 20778-20780 IN denotes of
T68912 20781-20792 NNP denotes Tocilizumab
T98192 20793-20797 CC denotes plus
T20706 20798-20806 JJ denotes standard
T58005 20807-20814 NN denotes therapy
T96625 20816-20824 NNS denotes Patients
T75572 20825-20828 WP denotes who
T31917 20829-20832 VBD denotes had
T15301 20833-20834 DT denotes a
T24848 20835-20839 JJ denotes mean
T84688 20840-20843 NN denotes IL6
T96963 20844-20849 NN denotes level
T6930 20850-20852 IN denotes of
T90933 20853-20857 JJR denotes more
T81944 20858-20862 IN denotes than
T75581 20863-20872 NN denotes 100 pg/ml
T64021 20873-20879 IN denotes before
T9387 20880-20891 NN denotes tocilizumab
T84664 20892-20901 NN denotes treatment
T18203 20902-20908 VBD denotes showed
T60803 20909-20920 NN denotes improvement
T44490 20921-20923 IN denotes in
T81402 20924-20932 JJ denotes clinical
T14228 20933-20941 NNS denotes symptoms
T94537 20942-20945 CC denotes and
T83697 20946-20956 JJ denotes peripheral
T13978 20957-20963 NN denotes oxygen
T35808 20964-20974 NN denotes saturation
T34900 20975-20978 CC denotes and
T75964 20979-20992 NN denotes normalization
T84268 20993-20996 IN denotes for
T65028 20997-21007 NN denotes lymphocyte
T34390 21008-21018 NN denotes proportion
T96610 21019-21022 CC denotes and
T30755 21023-21026 NN denotes CRP
T63070 21027-21033 NNS denotes levels
T31791 21035-21039 RB denotes Also
T31152 21039-21040 -COMMA- denotes ,
T79595 21041-21045 NN denotes lung
T51431 21046-21052 NN denotes lesion
T10130 21053-21060 NN denotes opacity
T31388 21061-21064 VBD denotes was
T1824 21065-21073 VBN denotes absorbed
T60055 21074-21076 IN denotes in
T38598 21077-21079 CD denotes 90
T67288 21079-21080 NN denotes %
T48683 21081-21083 IN denotes of
T41529 21084-21092 NNS denotes patients
T69670 21094-21101 CC denotes Neither
T9277 21102-21109 JJ denotes serious
T15021 21110-21117 JJ denotes adverse
T23626 21118-21125 NNS denotes effects
T98539 21126-21129 CC denotes nor
T65699 21130-21136 NNS denotes deaths
T50204 21137-21145 VBD denotes occurred
T20973 21146-21150 IN denotes with
T14012 21151-21162 NN denotes tocilizumab
T66286 21163-21172 NN denotes treatment
T24269 21174-21179 EX denotes There
T26765 21180-21183 VBP denotes are
T84711 21184-21191 VBG denotes ongoing
T74304 21192-21200 JJ denotes clinical
T68003 21201-21207 NNS denotes trials
T5000 21208-21211 IN denotes for
T64198 21212-21223 NN denotes tocilizumab
T83078 21224-21233 NN denotes treatment
T11331 21234-21236 IN denotes in
T42834 21237-21245 NNS denotes patients
T27205 21246-21250 IN denotes with
T23786 21251-21259 JJ denotes moderate
T45333 21260-21263 CC denotes and
T9137 21264-21270 JJ denotes severe
T27842 21271-21279 NN denotes COVID-19
T92236 21281-21290 RB denotes Currently
T32112 21290-21291 -COMMA- denotes ,
T54987 21292-21295 DT denotes the
T85855 21296-21299 NN denotes use
T69355 21300-21302 IN denotes of
T40115 21303-21314 NNP denotes Tocilizumab
T10850 21315-21317 VBZ denotes is
T78367 21318-21329 VBN denotes recommended
T33042 21330-21333 IN denotes for
T36466 21334-21342 NNS denotes patients
T61983 21343-21347 IN denotes with
T2749 21348-21356 NN denotes COVID-19
T17580 21357-21360 WP denotes who
T69055 21361-21365 VBP denotes have
T71996 21366-21373 VBG denotes warning
T59356 21374-21379 NNS denotes signs
T65527 21380-21382 IN denotes of
T99769 21383-21388 NN denotes hyper
T44301 21389-21401 NN denotes inflammation
T54453 21401-21402 -COMMA- denotes ,
T58078 21403-21405 IN denotes as
T75237 21406-21409 MD denotes can
T7496 21410-21412 VB denotes be
T53845 21413-21421 VBN denotes measured
T78207 21422-21424 IN denotes by
T88455 21425-21428 NN denotes IL6
T77671 21428-21429 -COMMA- denotes ,
T67481 21430-21438 NN denotes ferritin
T99390 21438-21439 -COMMA- denotes ,
T23484 21440-21448 NN denotes platelet
T65701 21449-21455 NNS denotes counts
T30323 21455-21456 -COMMA- denotes ,
T72053 21457-21469 JJ denotes inflammatory
T81575 21470-21477 NNS denotes markers
T96428 21477-21478 -COMMA- denotes ,
T36542 21479-21482 CC denotes and
T88469 21483-21484 NN denotes H
T51141 21485-21490 NN denotes score
T97739 21491-21492 -LRB- denotes [
T29313 21492-21494 CD denotes 28
T54016 21494-21495 -RRB- denotes ]
T24370 21498-21499 CD denotes 7
T36802 21501-21516 NNS denotes Corticosteroids
T3294 21518-21521 CD denotes 7.1
T91345 21523-21533 NN denotes Hypothesis
T83198 21533-21534 -COLON- denotes :
T5476 21535-21550 NNS denotes Corticosteroids
T19383 21551-21554 MD denotes can
T18906 21555-21563 VB denotes modulate
T94029 21564-21576 NN denotes inflammation
T27658 21577-21592 NNS denotes Corticosteroids
T8138 21593-21596 VBP denotes are
T91474 21597-21605 RB denotes commonly
T89187 21606-21610 VBN denotes used
T38824 21611-21614 IN denotes for
T21445 21615-21625 NN denotes modulation
T58316 21626-21628 IN denotes of
T58021 21629-21630 DT denotes a
T37655 21631-21638 NN denotes variety
T87627 21639-21641 IN denotes of
T8391 21642-21654 JJ denotes inflammatory
T71073 21655-21665 NNS denotes conditions
T68994 21667-21669 IN denotes In
T59818 21670-21678 NN denotes addition
T18282 21679-21681 TO denotes to
T76082 21682-21683 DT denotes a
T38966 21684-21689 JJ denotes daily
T35672 21690-21697 NN denotes regimen
T41748 21697-21698 -COMMA- denotes ,
T45789 21699-21703 PRP denotes they
T91069 21704-21707 MD denotes can
T84858 21708-21710 VB denotes be
T11971 21711-21715 VBN denotes used
T91181 21716-21718 IN denotes in
T55573 21719-21722 DT denotes the
T52866 21723-21727 NN denotes form
T8605 21728-21730 IN denotes of
T21111 21731-21736 NN denotes pulse
T43357 21737-21744 NN denotes therapy
T46430 21745-21747 TO denotes to
T90499 21748-21753 VB denotes treat
T36198 21754-21760 NNS denotes flares
T16735 21761-21763 IN denotes of
T37577 21764-21774 JJ denotes autoimmune
T82392 21775-21783 NNS denotes diseases
T8787 21785-21792 RB denotes However
T74715 21792-21793 -COMMA- denotes ,
T63832 21794-21801 NN denotes caution
T88619 21802-21804 IN denotes in
T72548 21805-21808 DT denotes the
T74757 21809-21812 NN denotes use
T50691 21813-21815 IN denotes of
T75348 21816-21831 NNS denotes corticosteroids
T98869 21832-21834 VBZ denotes is
T37602 21835-21841 VBN denotes needed
T93826 21842-21845 IN denotes due
T27767 21846-21848 TO denotes to
T91545 21849-21852 DT denotes the
T30802 21853-21862 JJ denotes potential
T82688 21863-21870 JJ denotes serious
T84923 21871-21875 NN denotes side
T90339 21876-21883 NNS denotes effects
T67748 21884-21894 VBN denotes associated
T22188 21895-21899 IN denotes with
T5158 21900-21914 NN denotes corticosteroid
T29681 21915-21920 NNS denotes drugs
T1981 21921-21924 CC denotes and
T7707 21925-21929 IN denotes that
T73209 21930-21945 NNS denotes corticosteroids
T32353 21946-21955 RB denotes generally
T32990 21956-21964 VBP denotes suppress
T84727 21965-21968 DT denotes the
T72594 21969-21975 JJ denotes immune
T82578 21976-21982 NN denotes system
T98970 21984-21987 DT denotes The
T73202 21988-21994 JJ denotes latter
T49682 21995-22000 VBZ denotes means
T56698 22001-22005 IN denotes that
T44497 22006-22021 NNS denotes corticosteroids
T44722 22022-22030 VBP denotes modulate
T39029 22031-22036 NN denotes hyper
T14674 22037-22049 NN denotes inflammation
T31300 22050-22053 CC denotes and
T40275 22053-22054 -COMMA- denotes ,
T84174 22055-22057 IN denotes on
T84917 22058-22061 DT denotes the
T41471 22062-22067 JJ denotes other
T79253 22068-22072 NN denotes hand
T80094 22072-22073 -COMMA- denotes ,
T14361 22074-22081 VBP denotes inhibit
T92448 22082-22088 JJ denotes immune
T32652 22089-22098 NNS denotes responses
T58197 22099-22103 WDT denotes that
T6432 22104-22107 VBP denotes are
T65734 22108-22113 JJ denotes vital
T7857 22114-22117 IN denotes for
T27355 22118-22121 DT denotes the
T81023 22122-22126 NN denotes host
T39598 22127-22134 NN denotes defense
T97712 22135-22142 IN denotes against
T6736 22143-22146 DT denotes the
T59893 22147-22152 NN denotes virus
T48542 22153-22154 -LRB- denotes [
T9013 22154-22156 CD denotes 29
T33036 22156-22157 -RRB- denotes ]
T37227 22160-22163 CD denotes 7.2
T83170 22165-22174 NNP denotes Rationale
T22490 22174-22175 -COLON- denotes :
T92502 22176-22191 NNS denotes Corticosteroids
T30425 22192-22197 MD denotes might
T17782 22198-22202 VB denotes help
T8496 22203-22213 VB denotes accelerate
T16617 22214-22222 NN denotes recovery
T39745 22223-22227 IN denotes from
T7154 22228-22236 NN denotes COVID-19
T19799 22237-22240 DT denotes The
T20594 22241-22246 NN denotes study
T82079 22247-22248 -LRB- denotes [
T66365 22248-22250 CD denotes 30
T51925 22250-22251 -RRB- denotes ]
T58773 22252-22264 VBD denotes investigated
T62943 22265-22268 DT denotes the
T17766 22269-22275 NN denotes effect
T91507 22276-22278 IN denotes of
T41721 22279-22286 VBN denotes inhaled
T68865 22287-22302 NNS denotes corticosteroids
T72129 22303-22314 NN denotes ciclesonide
T75975 22314-22315 -COMMA- denotes ,
T94153 22316-22325 NN denotes cortisone
T58635 22325-22326 -COMMA- denotes ,
T32129 22327-22339 NN denotes prednisolone
T52544 22339-22340 -COMMA- denotes ,
T7734 22341-22354 NN denotes dexamethasone
T48772 22354-22355 -COMMA- denotes ,
T59239 22356-22359 CC denotes and
T36302 22360-22371 NN denotes fluticasone
T2290 22372-22374 IN denotes on
T42645 22375-22378 DT denotes the
T67274 22379-22390 NN denotes replication
T25492 22391-22393 IN denotes of
T52796 22394-22397 DT denotes the
T27491 22398-22406 NN denotes MERS-CoV
T5267 22408-22413 IN denotes Among
T36393 22414-22417 DT denotes the
T1788 22418-22422 CD denotes four
T60636 22423-22432 NNS denotes compounds
T50162 22432-22433 -COMMA- denotes ,
T78874 22434-22437 DT denotes the
T22199 22438-22442 JJ denotes only
T45806 22443-22454 NN denotes ciclesonide
T86672 22455-22458 VBD denotes was
T12794 22459-22466 JJ denotes capable
T91797 22467-22469 IN denotes of
T13593 22470-22480 VBG denotes inhibiting
T5717 22481-22486 JJ denotes viral
T7401 22487-22498 NN denotes replication
T65340 22500-22504 RB denotes Also
T92623 22504-22505 -COMMA- denotes ,
T81617 22506-22517 NN denotes ciclesonide
T95958 22518-22525 VBD denotes induced
T85366 22526-22527 DT denotes a
T21714 22528-22539 JJ denotes significant
T15429 22540-22550 NN denotes inhibition
T16699 22551-22553 IN denotes of
T25584 22554-22559 JJ denotes viral
T73696 22560-22571 NN denotes replication
T7458 22572-22574 IN denotes of
T20174 22575-22580 JJ denotes other
T58259 22581-22586 JJ denotes human
T40953 22587-22600 NNS denotes coronaviruses
T84867 22600-22601 -COMMA- denotes ,
T83672 22602-22606 JJ denotes such
T19443 22607-22609 IN denotes as
T95806 22610-22619 NN denotes HCoV-229E
T84685 22620-22623 CC denotes and
T17277 22624-22632 NN denotes SARS-CoV
T94349 22632-22633 -COMMA- denotes ,
T72578 22634-22637 CC denotes and
T26171 22638-22645 DT denotes another
T39629 22646-22661 JJ denotes positive-strand
T10581 22662-22665 NN denotes RNA
T42602 22666-22671 NN denotes virus
T70474 22671-22672 -COMMA- denotes ,
T82553 22673-22680 NN denotes rubella
T68058 22681-22686 NN denotes virus
T24019 22686-22687 -COMMA- denotes ,
T62462 22688-22693 IN denotes while
T32300 22694-22697 RB denotes not
T38146 22698-22704 VB denotes affect
T72944 22705-22708 DT denotes the
T97423 22709-22714 JJ denotes viral
T43382 22715-22726 NN denotes replication
T16861 22727-22729 IN denotes of
T53501 22730-22745 JJ denotes negative-strand
T3387 22746-22749 NN denotes RNA
T51732 22750-22757 NNS denotes viruses
T35282 22757-22758 -COMMA- denotes ,
T32607 22759-22763 FW denotes e.g.
T24756 22763-22764 -COMMA- denotes ,
T29751 22765-22774 NN denotes influenza
T16801 22775-22778 CC denotes and
T19789 22779-22790 JJ denotes respiratory
T17323 22791-22800 JJ denotes syncytial
T9582 22801-22806 NN denotes virus
T55931 22808-22811 IN denotes For
T42084 22812-22815 DT denotes the
T92915 22816-22824 NN denotes MERS-CoV
T45016 22824-22825 -COMMA- denotes ,
T62094 22826-22827 DT denotes a
T52727 22828-22841 JJ denotes nonstructural
T37738 22842-22849 NN denotes protein
T44869 22850-22852 CD denotes 15
T12678 22853-22854 -LRB- denotes (
T67952 22854-22859 NN denotes NSP15
T62960 22859-22860 -RRB- denotes )
T99202 22861-22869 VBD denotes appeared
T16450 22870-22872 TO denotes to
T75671 22873-22876 VB denotes act
T10168 22877-22879 IN denotes as
T75263 22880-22883 DT denotes the
T95644 22884-22890 NN denotes target
T19735 22891-22893 IN denotes of
T45429 22894-22905 NN denotes ciclesonide
T28790 22907-22909 DT denotes An
T72966 22910-22915 JJ denotes amino
T10430 22916-22920 NN denotes acid
T13644 22921-22933 NN denotes substitution
T66951 22934-22936 IN denotes in
T16733 22937-22940 DT denotes the
T82047 22941-22946 NN denotes NSP15
T5298 22947-22956 VBD denotes conferred
T82196 22957-22967 NN denotes resistance
T91861 22968-22970 IN denotes of
T16541 22971-22974 DT denotes the
T11735 22975-22982 VBN denotes mutated
T77495 22983-22991 NN denotes MERS-CoV
T54348 22992-22994 TO denotes to
T98167 22995-23006 NN denotes ciclesonide
T36698 23008-23018 NN denotes Mometasone
T83057 23019-23024 MD denotes could
T32973 23025-23029 VB denotes help
T81462 23030-23034 VB denotes deal
T7177 23035-23046 RB denotes effectively
T91822 23047-23051 IN denotes with
T40647 23052-23055 DT denotes the
T69218 23056-23063 VBN denotes mutated
T94051 23064-23072 NN denotes MERS-CoV
T94597 23074-23077 IN denotes For
T52862 23078-23081 DT denotes the
T49143 23082-23091 NN denotes SARS-CoV2
T76216 23091-23092 -COMMA- denotes ,
T48579 23093-23096 DT denotes all
T87735 23097-23102 CD denotes three
T54792 23103-23114 NN denotes ciclesonide
T41003 23114-23115 -COMMA- denotes ,
T64594 23116-23126 NN denotes mometasone
T89636 23126-23127 -COMMA- denotes ,
T45337 23128-23131 CC denotes and
T31426 23132-23141 NN denotes lopinavir
T30995 23142-23146 VBD denotes were
T47275 23147-23151 JJ denotes able
T43506 23152-23154 TO denotes to
T13737 23155-23162 VB denotes inhibit
T48184 23163-23168 JJ denotes viral
T45532 23169-23180 NN denotes replication
T78456 23181-23183 TO denotes to
T84667 23184-23185 DT denotes a
T50127 23186-23193 JJ denotes similar
T63329 23194-23200 NN denotes degree
T13824 23202-23215 RB denotes Interestingly
T97722 23215-23216 -COMMA- denotes ,
T32551 23217-23222 PRP-DOLLAR- denotes their
T29877 23223-23229 NN denotes effect
T26799 23230-23233 VBD denotes was
T38163 23234-23238 RBR denotes more
T71857 23239-23249 JJ denotes noticeable
T13399 23250-23254 IN denotes than
T61277 23255-23261 NN denotes serine
T95334 23262-23270 NN denotes protease
T18879 23271-23281 NNS denotes inhibitors
T2889 23281-23282 -COMMA- denotes ,
T73448 23283-23287 FW denotes e.g.
T12218 23287-23288 -COMMA- denotes ,
T97193 23289-23299 NN denotes nafamostat
T84364 23300-23303 CC denotes and
T56231 23304-23312 NN denotes camostat
T36295 23313-23315 IN denotes in
T50002 23316-23321 NNS denotes cells
T41374 23322-23326 WDT denotes that
T64051 23327-23331 NN denotes Vero
T69995 23332-23337 NNS denotes cells
T3328 23338-23342 WDT denotes that
T80806 23343-23350 VBP denotes express
T14927 23351-23358 NN denotes TMPRSS2
T77594 23360-23362 PRP denotes It
T50088 23363-23372 VBZ denotes indicates
T80437 23373-23376 DT denotes the
T11181 23377-23385 NN denotes tendency
T22059 23386-23388 IN denotes of
T93173 23389-23392 DT denotes the
T10513 23393-23402 NN denotes SARS-CoV2
T35356 23403-23405 TO denotes to
T95799 23406-23411 VB denotes enter
T54387 23412-23415 DT denotes the
T81737 23416-23420 NN denotes cell
T49362 23421-23428 IN denotes through
T16554 23429-23432 DT denotes the
T7152 23433-23452 JJ denotes cathepsin/endosomal
T53710 23453-23460 NN denotes pathway
T21481 23461-23467 RB denotes rather
T71892 23468-23472 IN denotes than
T13882 23473-23480 IN denotes through
T1912 23481-23484 DT denotes the
T96928 23485-23497 NN denotes TMPRSS2/cell
T71956 23498-23505 NN denotes surface
T74893 23506-23513 NN denotes pathway
T35160 23515-23518 DT denotes The
T65117 23519-23524 NN denotes study
T45353 23525-23526 -LRB- denotes [
T58501 23526-23528 CD denotes 31
T88016 23528-23529 -RRB- denotes ]
T88407 23530-23538 VBD denotes included
T16300 23539-23541 CD denotes 46
T33446 23542-23550 NNS denotes patients
T87886 23551-23555 IN denotes with
T58994 23556-23562 JJ denotes severe
T97970 23563-23571 NN denotes COVID-19
T41758 23571-23572 -COMMA- denotes ,
T58135 23573-23575 IN denotes of
T85647 23576-23581 DT denotes these
T95602 23582-23584 CD denotes 26
T73561 23585-23593 NNS denotes patients
T76496 23594-23602 VBD denotes received
T42976 23603-23621 NN denotes methylprednisolone
T32544 23622-23623 -LRB- denotes (
T60914 23623-23634 NN denotes 1–2 mg/kg/d
T95632 23635-23638 IN denotes for
T23094 23639-23647 NNS denotes 5–7 days
T28841 23647-23648 -RRB- denotes )
T83750 23648-23649 -COMMA- denotes ,
T5759 23650-23653 CC denotes and
T23681 23654-23656 CD denotes 20
T13615 23657-23665 NNS denotes patients
T96732 23666-23674 VBD denotes received
T97501 23675-23683 JJ denotes standard
T84414 23684-23691 NN denotes therapy
T2990 23692-23699 IN denotes without
T83484 23700-23718 NN denotes methylprednisolone
T55303 23720-23723 DT denotes The
T42547 23724-23729 JJ denotes first
T58218 23730-23735 NN denotes group
T37085 23736-23744 VBD denotes achieved
T74264 23745-23751 JJR denotes faster
T54798 23752-23763 NN denotes improvement
T77136 23764-23766 IN denotes in
T46765 23767-23775 JJ denotes clinical
T98040 23776-23784 NNS denotes symptoms
T23999 23785-23786 -LRB- denotes (
T37402 23786-23791 NN denotes fever
T65661 23792-23795 CC denotes and
T89758 23796-23806 JJ denotes peripheral
T63703 23807-23813 NN denotes oxygen
T9527 23814-23824 NN denotes saturation
T5300 23824-23825 -RRB- denotes )
T34896 23826-23829 CC denotes and
T9982 23830-23834 NN denotes lung
T64673 23835-23842 NNS denotes lesions
T90980 23843-23851 VBN denotes detected
T16483 23852-23854 IN denotes by
T31403 23855-23857 NN denotes CT
T8195 23858-23865 NN denotes imaging
T7710 23867-23874 RB denotes However
T57863 23874-23875 -COMMA- denotes ,
T19219 23876-23879 CD denotes two
T43356 23880-23886 NNS denotes deaths
T32769 23887-23895 VBD denotes occurred
T5412 23896-23898 IN denotes in
T52171 23899-23902 DT denotes the
T5683 23903-23908 JJ denotes first
T18985 23909-23914 NN denotes group
T72564 23915-23918 CC denotes and
T66890 23919-23922 CD denotes one
T21460 23923-23928 NN denotes death
T49866 23929-23931 IN denotes in
T26278 23932-23935 DT denotes the
T96270 23936-23942 JJ denotes second
T89439 23943-23948 NN denotes group
T61059 23950-23958 RB denotes Moreover
T97295 23958-23959 -COMMA- denotes ,
T66784 23960-23963 DT denotes the
T32526 23964-23967 CD denotes two
T39437 23968-23974 NNS denotes groups
T87016 23975-23978 VBD denotes did
T42838 23979-23982 RB denotes not
T18576 23983-23989 VB denotes differ
T50188 23990-23992 IN denotes in
T80686 23993-24003 NN denotes laboratory
T16685 24004-24014 NNS denotes parameters
T92910 24014-24015 -COMMA- denotes ,
T79314 24016-24025 VBG denotes including
T58552 24026-24029 NNP denotes WBC
T52445 24029-24030 -COMMA- denotes ,
T19300 24031-24041 NN denotes lymphocyte
T50601 24042-24047 NN denotes count
T15065 24047-24048 -COMMA- denotes ,
T27527 24049-24057 NN denotes monocyte
T31332 24058-24063 NN denotes count
T62470 24063-24064 -COMMA- denotes ,
T39782 24065-24068 CC denotes and
T74286 24069-24078 NNS denotes cytokines
T39990 24079-24080 -LRB- denotes (
T86188 24080-24084 NN denotes IL-2
T98181 24084-24085 -COMMA- denotes ,
T95707 24086-24090 NN denotes IL-4
T51521 24090-24091 -COMMA- denotes ,
T13191 24092-24096 NN denotes IL-6
T97649 24096-24097 -COMMA- denotes ,
T67884 24098-24101 CC denotes and
T96461 24102-24107 NN denotes IL-10
T46182 24107-24108 -RRB- denotes )
T71095 24109-24112 CD denotes six
T75519 24113-24117 NNS denotes days
T70281 24118-24123 IN denotes after
T58821 24124-24133 NN denotes treatment
T68602 24135-24140 EX denotes There
T35641 24141-24143 VBZ denotes is
T96551 24144-24145 DT denotes a
T4246 24146-24152 NN denotes report
T68154 24153-24155 IN denotes of
T38317 24156-24159 DT denotes the
T15000 24160-24167 NN denotes patient
T78684 24168-24172 IN denotes with
T75392 24173-24181 NN denotes COVID-19
T66370 24182-24189 VBN denotes treated
T30686 24190-24194 IN denotes with
T52580 24195-24213 NN denotes methylprednisolone
T48202 24214-24219 IN denotes since
T9113 24220-24223 NN denotes day
T95658 24224-24225 CD denotes 8
T45554 24226-24228 IN denotes of
T3986 24229-24232 DT denotes the
T39007 24233-24240 NN denotes disease
T69348 24241-24247 NN denotes course
T97762 24249-24256 RB denotes However
T96472 24256-24257 -COMMA- denotes ,
T86008 24258-24261 PRP-DOLLAR- denotes his
T42849 24262-24271 NN denotes situation
T60930 24272-24280 VBD denotes worsened
T29454 24281-24284 CC denotes and
T36559 24285-24294 VBD denotes developed
T85992 24295-24306 JJ denotes respiratory
T55480 24307-24314 NN denotes failure
T13828 24315-24318 CC denotes and
T63285 24319-24323 VBD denotes died
T37916 24324-24326 IN denotes on
T9153 24327-24330 NN denotes day
T54332 24331-24333 CD denotes 14
T22231 24334-24335 -LRB- denotes [
T45405 24335-24337 CD denotes 32
T54531 24337-24338 -RRB- denotes ]
T33004 24341-24342 CD denotes 8
T58581 24344-24348 NNS denotes Eggs
T97114 24349-24352 IN denotes for
T27689 24353-24363 VBG denotes increasing
T63081 24364-24368 NN denotes ACE2
T72667 24369-24372 CC denotes and
T79511 24373-24379 NN denotes copper
T38004 24380-24383 NN denotes Egg
T27506 24384-24398 NN denotes ovotransferrin
T37276 24399-24407 VBZ denotes contains
T34098 24408-24410 DT denotes an
T97147 24411-24433 JJ denotes angiotensin-converting
T86608 24434-24440 NN denotes enzyme
T66871 24441-24442 -LRB- denotes (
T13854 24442-24445 NN denotes ACE
T64698 24445-24446 -RRB- denotes )
T83677 24447-24457 JJ denotes inhibitory
T66003 24458-24465 NN denotes peptide
T77918 24465-24466 -COMMA- denotes ,
T89508 24467-24472 VBN denotes known
T88322 24473-24475 IN denotes as
T66546 24476-24479 NNP denotes IRW
T45851 24479-24480 -COMMA- denotes ,
T60984 24481-24485 WDT denotes that
T46693 24486-24489 VBZ denotes has
T76296 24490-24495 VBN denotes shown
T28156 24496-24498 TO denotes to
T90573 24499-24507 VB denotes decrease
T38759 24508-24513 NN denotes blood
T21018 24514-24522 NN denotes pressure
T30544 24523-24525 IN denotes in
T99198 24526-24538 JJ denotes hypertensive
T98401 24539-24543 NNS denotes rats
T50903 24544-24545 -LRB- denotes [
T33947 24545-24547 CD denotes 33
T14997 24547-24548 -RRB- denotes ]
T50077 24550-24557 IN denotes Through
T34549 24558-24561 DT denotes the
T35438 24562-24575 NN denotes up-regulation
T84846 24576-24578 IN denotes of
T82446 24579-24583 NN denotes ACE2
T51616 24583-24584 -COMMA- denotes ,
T55154 24585-24595 NN denotes E-cadherin
T8679 24595-24596 -COMMA- denotes ,
T45090 24597-24603 NN denotes ABCB-1
T32702 24603-24604 -COMMA- denotes ,
T32352 24605-24608 CC denotes and
T2901 24609-24614 NN denotes IRF-8
T24097 24614-24615 -COMMA- denotes ,
T97074 24616-24619 NNP denotes IRW
T68802 24620-24623 MD denotes can
T39838 24624-24632 VB denotes decrease
T60149 24633-24636 NN denotes RAS
T50074 24637-24645 NN denotes activity
T49953 24645-24646 -COMMA- denotes ,
T70369 24647-24658 NN denotes hyperplasia
T91445 24658-24659 -COMMA- denotes ,
T20067 24660-24663 CC denotes and
T30801 24664-24672 JJ denotes vascular
T51592 24673-24685 NN denotes inflammation
T28168 24686-24689 CC denotes and
T93235 24690-24693 NN denotes aid
T43180 24694-24706 JJ denotes differential
T82201 24707-24717 NN denotes regulation
T72254 24718-24720 IN denotes of
T87852 24721-24731 NNS denotes leukocytes
T80434 24733-24735 IN denotes On
T8306 24736-24739 DT denotes the
T52921 24740-24745 JJ denotes other
T81543 24746-24750 NN denotes hand
T20825 24750-24751 -COMMA- denotes ,
T78284 24752-24754 IN denotes by
T10667 24755-24758 DT denotes the
T59443 24759-24774 NN denotes down-regulation
T14412 24775-24777 IN denotes of
T13570 24778-24794 JJ denotes pro-inflammatory
T20179 24795-24804 NNS denotes molecules
T42843 24804-24805 -COMMA- denotes ,
T68303 24806-24810 FW denotes e.g.
T5913 24810-24811 -COMMA- denotes ,
T53611 24812-24818 NN denotes ICAM-1
T22569 24819-24822 CC denotes and
T86123 24823-24829 NN denotes VCAM-1
T88206 24829-24830 -COMMA- denotes ,
T14786 24831-24834 NN denotes IRW
T56782 24835-24838 MD denotes can
T84385 24839-24845 VB denotes reduce
T54198 24846-24849 DT denotes the
T53586 24850-24861 NN denotes recruitment
T18273 24862-24864 IN denotes of
T25763 24865-24875 NNS denotes leukocytes
T50471 24876-24879 CC denotes and
T39944 24880-24888 JJ denotes vascular
T95815 24889-24901 NN denotes inflammation
T32229 24903-24909 NN denotes Copper
T37620 24910-24915 MD denotes might
T49191 24916-24920 VB denotes help
T32412 24921-24924 DT denotes the
T49707 24925-24931 JJ denotes immune
T77430 24932-24938 NN denotes system
T78509 24939-24941 TO denotes to
T84428 24942-24948 VB denotes combat
T52262 24949-24954 JJ denotes viral
T25569 24955-24965 NNS denotes infections
T85825 24967-24968 DT denotes A
T86532 24969-24981 NN denotes High-content
T37905 24982-24984 IN denotes of
T38135 24985-24991 NN denotes copper
T5313 24992-24998 VBZ denotes exists
T26683 24999-25001 IN denotes in
T69996 25002-25006 NNS denotes eggs
T88154 25007-25010 CC denotes and
T28753 25011-25020 NNS denotes eggshells
T68700 25021-25023 IN denotes of
T82775 25024-25032 JJ denotes domestic
T68554 25033-25038 NNS denotes birds
T12507 25040-25042 IN denotes In
T63866 25043-25053 JJ denotes particular
T96163 25053-25054 -COMMA- denotes ,
T60294 25055-25058 DT denotes the
T93066 25059-25067 NN denotes eggshell
T75912 25068-25070 IN denotes of
T52328 25071-25077 NN denotes pigeon
T61958 25078-25079 -LRB- denotes (
T56156 25079-25080 CD denotes 4
T26914 25081-25082 NN denotes ±
T94273 25083-25092 NN denotes 0.29 μg/g
T66624 25092-25093 -RRB- denotes )
T87690 25094-25097 CC denotes and
T47055 25098-25101 DT denotes the
T46042 25102-25105 NN denotes egg
T48696 25106-25108 IN denotes of
T59365 25109-25114 NN denotes quail
T45935 25115-25116 -LRB- denotes (
T43374 25116-25120 CD denotes 4.67
T68174 25121-25122 CC denotes ±
T58925 25123-25132 NN denotes 1.08 μg/g
T41203 25132-25133 -RRB- denotes )
T68835 25134-25142 VBZ denotes contains
T5139 25143-25147 JJ denotes high
T58590 25148-25162 NNS denotes concentrations
T50194 25163-25165 IN denotes of
T95116 25166-25172 NN denotes copper
T90276 25173-25174 -LRB- denotes [
T72554 25174-25176 CD denotes 34
T34750 25176-25177 -RRB- denotes ]
T30828 25180-25181 CD denotes 9
T16242 25183-25193 NN denotes Conclusion
T34609 25194-25197 DT denotes The
T89640 25198-25203 JJ denotes novel
T90255 25204-25215 NN denotes coronavirus
T47494 25215-25216 -COMMA- denotes ,
T92057 25217-25226 NN denotes SARS-CoV2
T86476 25226-25227 -COMMA- denotes ,
T90050 25228-25231 MD denotes can
T44793 25232-25237 VB denotes cause
T83762 25238-25239 DT denotes a
T24737 25240-25251 RB denotes potentially
T30756 25252-25257 JJ denotes fatal
T98647 25258-25265 NN denotes disease
T39699 25265-25266 -COMMA- denotes ,
T83416 25267-25275 NN denotes COVID-19
T88854 25275-25276 -COMMA- denotes ,
T23368 25277-25279 IN denotes in
T6658 25280-25286 NNS denotes humans
T83401 25288-25291 DT denotes The
T88396 25292-25301 NN denotes infection
T41360 25302-25304 IN denotes of
T54757 25305-25310 JJ denotes human
T45506 25311-25316 NNS denotes cells
T35377 25317-25319 IN denotes by
T7551 25320-25329 NN denotes SARS-CoV2
T69934 25330-25338 VBZ denotes includes
T86235 25339-25342 CD denotes two
T83907 25343-25353 JJ denotes sequential
T31606 25354-25359 NNS denotes steps
T8581 25359-25360 -COLON- denotes :
T92030 25361-25371 NN denotes attachment
T73554 25372-25374 IN denotes of
T8936 25375-25378 DT denotes the
T8983 25379-25384 NN denotes virus
T66380 25385-25387 TO denotes to
T19797 25388-25391 DT denotes the
T19295 25392-25399 NN denotes surface
T35146 25400-25408 NN denotes receptor
T47614 25409-25411 IN denotes of
T61527 25412-25418 NN denotes target
T54919 25419-25424 NNS denotes cells
T84322 25425-25428 CC denotes and
T41319 25429-25432 DT denotes the
T5207 25433-25439 NN denotes fusion
T80511 25440-25442 IN denotes of
T69288 25443-25448 JJ denotes viral
T56752 25449-25452 CC denotes and
T14937 25453-25457 NN denotes host
T80253 25458-25467 NNS denotes membranes
T25258 25469-25472 DT denotes The
T76019 25473-25479 JJ denotes former
T58724 25480-25488 VBZ denotes requires
T9128 25489-25491 IN denotes at
T32276 25492-25497 JJS denotes least
T24570 25498-25499 DT denotes a
T92436 25500-25516 JJ denotes receptor-binding
T64204 25517-25523 NN denotes domain
T40189 25524-25526 IN denotes on
T26075 25527-25530 DT denotes the
T84125 25531-25540 NN denotes SARS-CoV2
T91232 25541-25546 NN denotes Spike
T75548 25547-25554 NN denotes protein
T15500 25555-25559 WDT denotes that
T13216 25560-25563 MD denotes can
T74634 25564-25572 VB denotes interact
T94971 25573-25577 IN denotes with
T93734 25578-25579 DT denotes a
T75854 25580-25584 NN denotes cell
T13409 25585-25592 NN denotes surface
T62139 25593-25601 NN denotes receptor
T99372 25601-25602 -COMMA- denotes ,
T52645 25603-25606 IN denotes for
T45934 25607-25614 NN denotes example
T7202 25614-25615 -COMMA- denotes ,
T57327 25616-25620 NN denotes ACE2
T94908 25620-25621 -COMMA- denotes ,
T89289 25622-25631 VBN denotes expressed
T98989 25632-25634 IN denotes on
T1718 25635-25640 JJ denotes human
T54799 25641-25646 NNS denotes cells
T35873 25648-25651 DT denotes The
T71668 25652-25658 JJ denotes latter
T77029 25659-25667 VBZ denotes requires
T58629 25668-25670 IN denotes at
T56483 25671-25676 JJS denotes least
T97030 25677-25680 DT denotes the
T96744 25681-25685 NN denotes host
T15927 25686-25694 NN denotes protease
T76016 25694-25695 -LRB- denotes (
T39360 25695-25696 NNS denotes s
T19744 25696-25697 -RRB- denotes )
T6084 25698-25700 TO denotes to
T44730 25701-25708 VB denotes mediate
T91735 25709-25720 JJ denotes proteolytic
T36459 25721-25729 NN denotes cleavage
T4317 25730-25732 IN denotes of
T57535 25733-25736 DT denotes the
T19590 25737-25746 NN denotes SARS-CoV2
T61296 25747-25752 NN denotes Spike
T59765 25753-25760 NN denotes protein
T37338 25761-25765 IN denotes into
T49962 25766-25768 NN denotes S1
T42599 25769-25772 CC denotes and
T28541 25773-25775 NN denotes S2
T69297 25776-25784 NNS denotes subunits
T86274 25785-25788 CC denotes and
T27045 25789-25801 RB denotes consequently
T2068 25802-25809 VBP denotes promote
T89079 25810-25813 DT denotes the
T65082 25814-25820 NN denotes fusion
T32005 25821-25823 IN denotes of
T46413 25824-25829 JJ denotes viral
T37466 25830-25833 CC denotes and
T12807 25834-25838 NN denotes host
T52032 25839-25848 NNS denotes membranes
T8599 25850-25854 RB denotes Also
T75642 25854-25855 -COMMA- denotes ,
T77995 25856-25865 NN denotes SARS-CoV2
T83579 25866-25875 VBZ denotes possesses
T13485 25876-25877 DT denotes a
T30948 25878-25887 JJ denotes polybasic
T88376 25888-25896 NN denotes cleavage
T13257 25897-25901 NN denotes site
T62080 25902-25906 WDT denotes that
T72593 25907-25910 MD denotes can
T68497 25911-25918 VB denotes explain
T75684 25919-25922 DT denotes the
T70730 25923-25927 JJ denotes high
T67108 25928-25941 NN denotes pathogenicity
T52147 25942-25944 IN denotes of
T97526 25945-25954 NN denotes SARS-CoV2
T37933 25954-25955 -COMMA- denotes ,
T70141 25956-25965 NNS denotes N-glycans
T39330 25966-25969 CC denotes and
T24202 25970-25979 NNS denotes O-glycans
T7384 25980-25984 WDT denotes that
T5681 25985-25989 VBP denotes make
T60584 25990-25993 DT denotes the
T39050 25994-25999 JJ denotes dense
T21027 26000-26010 NN denotes decoration
T27410 26011-26013 IN denotes of
T7435 26014-26023 NN denotes SARS-CoV2
T14256 26024-26025 NN denotes S
T13014 26026-26033 NN denotes protein
T24915 26033-26034 -COMMA- denotes ,
T65635 26035-26038 CC denotes and
T97815 26039-26045 JJ denotes cyclic
T48498 26046-26053 NNS denotes regions
T47927 26054-26058 WDT denotes that
T83674 26059-26062 MD denotes can
T49668 26063-26071 VB denotes interact
T28141 26072-26076 IN denotes with
T82773 26077-26089 JJ denotes cell-surface
T16887 26090-26095 NN denotes GRP78
T32660 26097-26106 JJ denotes Essential
T82280 26107-26115 NNS denotes elements
T81648 26116-26120 IN denotes that
T14044 26121-26128 NN denotes process
T34906 26129-26138 NN denotes SARS-CoV2
T11727 26139-26143 NN denotes cell
T51771 26144-26149 NN denotes entry
T42633 26150-26153 CC denotes and
T86737 26154-26162 JJ denotes specific
T22570 26163-26178 NNS denotes characteristics
T8091 26179-26183 WDT denotes that
T39623 26184-26189 VBP denotes allow
T42798 26190-26199 NN denotes SARS-CoV2
T73233 26200-26202 TO denotes to
T53867 26203-26209 VB denotes escape
T40812 26210-26213 DT denotes the
T43928 26214-26220 JJ denotes immune
T80777 26221-26227 NN denotes system
T33950 26228-26232 VBP denotes have
T72049 26233-26236 DT denotes the
T50749 26237-26246 NN denotes potential
T76482 26247-26249 IN denotes as
T86110 26250-26257 NNS denotes targets
T97786 26258-26261 IN denotes for
T96599 26262-26270 NN denotes COVID-19
T67580 26271-26278 NN denotes therapy
T2209 26280-26284 NN denotes Lack
T82418 26285-26287 IN denotes of
T17483 26288-26296 JJ denotes specific
T11435 26297-26307 NNS denotes treatments
T58860 26308-26311 IN denotes for
T97288 26312-26320 NN denotes COVID-19
T14954 26321-26324 CC denotes and
T67635 26325-26328 DT denotes the
T14560 26329-26333 RB denotes very
T29994 26334-26348 JJ denotes time-consuming
T54347 26349-26356 NN denotes process
T43425 26357-26359 IN denotes of
T40405 26360-26367 NN denotes vaccine
T65584 26368-26379 NN denotes development
T26632 26380-26384 VBP denotes lead
T87212 26385-26387 PRP denotes us
T4319 26388-26390 TO denotes to
T17398 26391-26396 VB denotes trust
T39922 26397-26408 JJ denotes traditional
T59832 26409-26416 NNS denotes notions
T79640 26417-26419 IN denotes of
T39982 26420-26432 NN denotes immunization
T68886 26433-26438 VBG denotes using
T59526 26439-26446 JJ denotes passive
T93112 26447-26455 NN denotes transfer
T2403 26456-26458 IN denotes of
T97514 26459-26466 JJ denotes humoral
T67166 26467-26475 NN denotes immunity
T8460 26477-26484 JJ denotes Passive
T78989 26485-26497 NN denotes immunization
T37380 26498-26501 MD denotes can
T3292 26502-26504 VB denotes be
T87394 26505-26509 VBN denotes done
T83285 26510-26515 VBG denotes using
T80590 26516-26522 NN denotes plasma
T40394 26523-26530 NN denotes therapy
T28898 26531-26534 CC denotes and
T56173 26535-26539 NN denotes IVIG
T89662 26540-26547 NN denotes therapy
T43126 26549-26555 NN denotes Plasma
T98086 26556-26560 IN denotes from
T4913 26561-26569 NNS denotes patients
T85558 26570-26579 VBN denotes recovered
T54139 26580-26584 IN denotes from
T65005 26585-26593 NN denotes COVID-19
T70575 26594-26598 WDT denotes that
T50076 26599-26607 VBZ denotes contains
T23714 26608-26618 NNS denotes antibodies
T54709 26619-26626 IN denotes against
T26763 26627-26636 NN denotes SARS-CoV2
T82790 26637-26640 VBZ denotes has
T72786 26641-26646 VBN denotes shown
T96449 26647-26656 JJ denotes promising
T61880 26657-26664 NNS denotes results
T36158 26665-26667 IN denotes in
T98710 26668-26676 NNS denotes patients
T52661 26677-26681 IN denotes with
T93981 26682-26688 JJ denotes severe
T61440 26689-26697 NN denotes COVID-19
T56097 26699-26703 RB denotes Also
T27399 26703-26704 -COMMA- denotes ,
T46672 26705-26713 NN denotes SARS-CoV
T4016 26714-26717 CC denotes and
T5488 26718-26727 NN denotes SARS-CoV2
T49089 26728-26731 VBP denotes are
T63728 26732-26739 RB denotes ideally
T58020 26740-26747 JJ denotes similar
T17353 26748-26750 IN denotes in
T77583 26751-26754 DT denotes the
T84845 26755-26764 NN denotes structure
T63353 26765-26768 CC denotes and
T19500 26769-26772 DT denotes the
T16312 26773-26777 NN denotes cell
T15071 26778-26783 NN denotes entry
T65845 26784-26792 NN denotes receptor
T64776 26793-26796 CC denotes and
T5365 26797-26805 NN denotes protease
T91360 26807-26814 NNS denotes Studies
T61175 26815-26819 VBP denotes show
T3464 26820-26824 IN denotes that
T71594 26825-26830 NN denotes serum
T59411 26831-26835 IN denotes from
T50943 26836-26848 JJ denotes convalescent
T99070 26849-26853 NN denotes SARS
T52714 26854-26862 NNS denotes patients
T30344 26863-26866 CC denotes and
T97752 26867-26872 NN denotes serum
T56749 26873-26877 IN denotes from
T81227 26878-26885 NNS denotes rabbits
T65088 26886-26895 VBN denotes immunized
T9531 26896-26900 IN denotes with
T3496 26901-26905 NNS denotes SARS
T18753 26906-26909 VBP denotes are
T56305 26910-26914 DT denotes both
T22390 26915-26919 JJ denotes able
T89303 26920-26922 TO denotes to
T72802 26923-26933 VB denotes neutralize
T57194 26934-26943 NN denotes SARS-CoV2
T63708 26944-26955 RB denotes efficiently
T61132 26957-26964 RB denotes However
T21857 26964-26965 -COMMA- denotes ,
T14229 26966-26971 NN denotes serum
T89468 26972-26976 IN denotes from
T75820 26977-26981 NNS denotes bats
T4213 26982-26991 VBN denotes immunized
T87498 26992-26996 IN denotes with
T5484 26997-27006 JJ denotes SARS-lice
T47898 27007-27018 NN denotes coronavirus
T5732 27019-27025 NN denotes SL-CoV
T45225 27026-27029 NN denotes Rp3
T42100 27030-27035 MD denotes could
T14407 27036-27039 RB denotes not
T21817 27040-27045 VB denotes exert
T34384 27046-27050 JJ denotes such
T15054 27051-27053 DT denotes an
T64476 27054-27060 NN denotes effect
T80575 27062-27064 PRP denotes It
T5249 27065-27067 VBZ denotes is
T88108 27068-27071 JJ denotes due
T14481 27072-27074 TO denotes to
T48691 27075-27076 DT denotes a
T43979 27077-27087 JJ denotes noticeable
T25730 27088-27094 NN denotes degree
T63462 27095-27097 IN denotes of
T72538 27098-27108 NN denotes difference
T22468 27109-27111 IN denotes in
T50331 27112-27115 DT denotes the
T61223 27116-27118 NN denotes S1
T8313 27119-27125 NN denotes domain
T42013 27126-27128 IN denotes in
T41693 27129-27132 DT denotes the
T41576 27133-27135 NN denotes S1
T33017 27136-27142 NN denotes domain
T6643 27143-27150 IN denotes between
T73200 27151-27154 DT denotes the
T38226 27155-27158 NN denotes bat
T96665 27159-27165 NN denotes SL-CoV
T68744 27166-27169 NN denotes Rp3
T25467 27170-27176 NN denotes strain
T80157 27177-27180 CC denotes and
T9673 27181-27190 NN denotes SARS-CoV2
T92096 27192-27193 DT denotes A
T21466 27194-27204 JJ denotes short-term
T18604 27205-27213 JJ denotes moderate
T45992 27214-27218 NN denotes dose
T31582 27219-27221 IN denotes of
T44685 27222-27226 NN denotes IVIG
T42097 27227-27235 VBN denotes combined
T36053 27236-27240 IN denotes with
T48662 27241-27254 NN denotes moderate-dose
T22507 27255-27257 IN denotes of
T9912 27258-27273 NNS denotes corticosteroids
T83835 27274-27279 MD denotes might
T7774 27280-27287 VB denotes improve
T16718 27288-27295 NN denotes patient
T30604 27296-27304 NNS denotes outcomes
T91513 27306-27313 NNS denotes Studies
T81529 27314-27318 VBP denotes show
T7530 27319-27323 IN denotes that
T31986 27324-27327 DT denotes the
T73402 27328-27333 JJ denotes viral
T42028 27334-27337 NN denotes RNA
T66238 27338-27340 IN denotes of
T77066 27341-27350 NN denotes SARS-CoV2
T7474 27351-27358 VBZ denotes reaches
T81899 27359-27362 PRP-DOLLAR- denotes its
T82598 27363-27367 NN denotes peak
T40173 27368-27374 IN denotes during
T31013 27375-27378 DT denotes the
T16396 27379-27384 JJ denotes first
T75325 27385-27389 NN denotes week
T4182 27390-27393 CC denotes and
T18300 27394-27398 RB denotes then
T56358 27399-27408 RB denotes gradually
T76094 27409-27418 VBZ denotes decreases
T20828 27419-27422 CC denotes and
T83224 27423-27427 IN denotes that
T96146 27428-27431 NN denotes IgG
T47796 27432-27435 CC denotes and
T69933 27436-27439 NN denotes IgM
T32800 27440-27445 VBP denotes begin
T67925 27446-27448 TO denotes to
T47586 27449-27453 VB denotes rise
T31692 27454-27458 IN denotes from
T7968 27459-27462 DT denotes the
T13466 27463-27467 JJ denotes 10th
T6862 27468-27471 NN denotes day
T3983 27472-27474 IN denotes so
T20802 27475-27479 IN denotes that
T89923 27480-27484 JJS denotes most
T68511 27485-27493 NNS denotes patients
T75930 27494-27498 VBP denotes have
T84637 27499-27509 JJ denotes anti-viral
T76069 27510-27520 NNS denotes antibodies
T50453 27521-27523 IN denotes by
T78621 27524-27527 DT denotes the
T91971 27528-27532 JJ denotes 14th
T55876 27533-27536 NN denotes day
T58337 27538-27545 JJ denotes Passive
T80315 27546-27558 NN denotes immunization
T58229 27559-27567 VBZ denotes protects
T77600 27568-27575 IN denotes against
T79174 27576-27583 NN denotes disease
T49092 27583-27584 -COMMA- denotes ,
T77811 27585-27588 CC denotes and
T60601 27589-27591 IN denotes so
T49810 27592-27594 PRP denotes it
T35724 27595-27601 MD denotes should
T59058 27602-27604 VB denotes be
T47054 27605-27617 VBN denotes administered
T78182 27618-27620 RB denotes as
T58224 27621-27626 RB denotes early
T10653 27627-27629 IN denotes as
T65232 27630-27638 JJ denotes possible
T7135 27639-27643 WRB denotes when
T74033 27644-27647 DT denotes the
T73325 27648-27655 NN denotes patient
T59206 27656-27658 VBZ denotes is
T72256 27659-27668 VBN denotes diagnosed
T60314 27670-27678 NN denotes Evidence
T35183 27679-27684 VBZ denotes links
T72324 27685-27693 NN denotes COVID-19
T95206 27694-27696 TO denotes to
T97915 27697-27705 JJ denotes variable
T92397 27706-27713 NNS denotes degrees
T70831 27714-27716 IN denotes of
T73708 27717-27729 NN denotes inflammation
T93832 27731-27746 NNS denotes Corticosteroids
T86571 27747-27752 VBP denotes offer
T20640 27753-27754 DT denotes a
T11737 27755-27761 JJ denotes potent
T13881 27762-27779 JJ denotes anti-inflammatory
T85869 27780-27786 NN denotes option
T39590 27788-27795 RB denotes However
T9841 27795-27796 -COMMA- denotes ,
T82570 27797-27801 PRP denotes they
T33328 27802-27804 VBP denotes do
T52824 27805-27808 RB denotes not
T27396 27809-27816 VB denotes dictate
T37147 27817-27824 JJ denotes precise
T31383 27825-27832 NNS denotes actions
T30144 27833-27836 CC denotes and
T43608 27837-27842 MD denotes might
T71924 27843-27848 VB denotes cause
T87293 27849-27860 NN denotes suppression
T66079 27861-27863 IN denotes of
T8269 27864-27874 JJ denotes anti-viral
T52172 27875-27881 JJ denotes immune
T20124 27882-27891 NNS denotes responses
T85154 27892-27894 RB denotes as
T9965 27895-27899 RB denotes well
T92497 27901-27908 NNS denotes Studies
T44468 27909-27913 VBP denotes show
T92811 27914-27918 IN denotes that
T62828 27919-27922 DT denotes the
T64812 27923-27926 NN denotes use
T90977 27927-27929 IN denotes of
T15178 27930-27945 NNS denotes corticosteroids
T25429 27946-27951 MD denotes might
T69842 27952-27962 VB denotes accelerate
T80684 27963-27971 NN denotes recovery
T88404 27972-27976 IN denotes from
T21137 27977-27985 NN denotes COVID-19
T1899 27987-27992 EX denotes There
T21793 27993-27996 VBP denotes are
T48698 27997-27999 DT denotes no
T88569 28000-28010 JJ denotes controlled
T72804 28011-28019 JJ denotes clinical
T97339 28020-28026 NNS denotes trials
T48573 28027-28031 WDT denotes that
T30904 28032-28036 VBP denotes show
T93994 28037-28044 IN denotes whether
T4378 28045-28048 DT denotes the
T44216 28049-28052 NN denotes use
T95916 28053-28055 IN denotes of
T36033 28056-28071 NNS denotes corticosteroids
T95640 28072-28075 MD denotes can
T86415 28076-28082 VB denotes reduce
T37383 28083-28099 JJ denotes COVID-19-related
T11797 28100-28105 NN denotes death
T74879 28107-28115 RB denotes Moreover
T90599 28115-28116 -COMMA- denotes ,
T98284 28117-28120 DT denotes the
T49609 28121-28137 JJ denotes pro-inflammatory
T24072 28138-28146 NN denotes cytokine
T64274 28147-28150 NN denotes IL6
T39845 28151-28153 VBZ denotes is
T48453 28154-28157 DT denotes the
T6053 28158-28173 JJ denotes best-documented
T54874 28174-28182 NN denotes cytokine
T84071 28183-28185 IN denotes in
T3462 28186-28194 NN denotes COVID-19
T4397 28195-28205 VBD denotes correlated
T53541 28206-28210 IN denotes with
T9169 28211-28219 NN denotes severity
T52339 28219-28220 -COMMA- denotes ,
T9027 28221-28232 NN denotes criticality
T63816 28232-28233 -COMMA- denotes ,
T3842 28234-28239 JJ denotes viral
T33160 28240-28244 NN denotes load
T71418 28244-28245 -COMMA- denotes ,
T44925 28246-28249 CC denotes and
T24005 28250-28259 NN denotes prognosis
T43722 28260-28262 IN denotes of
T77279 28263-28271 NNS denotes patients
T53860 28272-28276 IN denotes with
T83045 28277-28285 NN denotes COVID-19
T91725 28287-28298 NNP denotes Tocilizumab
T13491 28298-28299 -COMMA- denotes ,
T55969 28300-28301 DT denotes a
T88153 28302-28312 JJ denotes monoclonal
T13966 28313-28321 NN denotes antibody
T87639 28322-28329 IN denotes against
T20271 28330-28333 NN denotes IL6
T22072 28333-28334 -COMMA- denotes ,
T26781 28335-28340 MD denotes could
T93033 28341-28347 VB denotes confer
T66151 28348-28356 JJ denotes clinical
T39668 28357-28364 NN denotes benefit
T93255 28365-28367 IN denotes in
T16710 28368-28376 NNS denotes patients
T86610 28377-28381 IN denotes with
T16499 28382-28386 JJ denotes high
T41273 28387-28390 NN denotes IL6
T27148 28391-28397 NNS denotes levels
R1000 T1007 T1008 arg1Of linked,to
R1001 T1016 T1008 arg2Of residues,to
R1002 T1016 T1009 arg1Of residues,the
R1003 T1016 T1010 arg1Of residues,amino
R1004 T1016 T1011 arg1Of residues,acid
R1005 T1016 T1012 arg1Of residues,asparagine
R10059 T24866 T92743 arg1Of transition,the
R1006 T1016 T1013 arg1Of residues,(
R1007 T1014 T1013 arg2Of Asn,(
R1008 T1015 T1013 arg3Of ),(
R1009 T1016 T1017 arg1Of residues,(
R1010 T1020 T1017 arg2Of acids,(
R1011 T1027 T1017 arg3Of ),(
R10115 T96902 T81416 arg1Of existed,to
R1012 T1020 T1018 arg1Of acids,Asn-any
R10122 T97737 T30067 arg1Of protease,","
R1013 T1020 T1019 arg1Of acids,amino
R1014 T1022 T1021 arg1Of for,except
R1015 T1020 T1022 arg1Of acids,for
R1016 T1025 T1022 arg2Of or,for
R10165 T74634 T94971 arg1Of interact,with
R1017 T1025 T1023 arg1Of or,proline-
R10178 T33581 T76245 arg2Of 26,[
R1018 T1024 T1025 arg1Of Ser,or
R1019 T1026 T1025 arg2Of Thr,or
R1020 T1016 T1028 arg1Of residues,utilizing
R1021 T1031 T1028 arg2Of bond,utilizing
R10212 T80315 T58337 arg1Of immunization,Passive
R1022 T1031 T1029 arg1Of bond,an
R1023 T1031 T1030 arg1Of bond,N-glycosidic
R10231 T49810 T59058 arg1Of it,be
R1024 T1031 T1032 arg1Of bond,","
R10241 T98710 T36158 arg2Of patients,in
R1025 T1034 T1032 arg2Of N-acetylglucosamine,","
R10257 T99923 T37838 arg1Of role,of
R1026 T1034 T1033 arg1Of N-acetylglucosamine,mostly
R1027 T1035 T1036 arg1Of O-glycans,are
R10272 T38342 T45580 arg1Of Rp3,and
R1028 T1037 T1036 arg2Of attached,are
R1029 T1035 T1037 arg2Of O-glycans,attached
R1030 T1037 T1038 arg1Of attached,to
R1031 T1051 T1038 arg2Of residues,to
R1032 T1051 T1039 arg1Of residues,the
R1033 T1042 T1040 arg1Of serine,amino
R1034 T1042 T1041 arg1Of serine,acid
R10340 T87582 T75308 arg1Of rise,so
R1035 T1051 T1042 arg1Of residues,serine
R10355 T66875 T91226 arg1Of patients,most
R10356 T60936 T17683 arg2Of SARS-2-S,and
R1036 T1042 T1043 arg1Of serine,(
R1037 T1044 T1043 arg2Of Ser,(
R10371 T37833 T46706 arg2Of target,to
R1038 T1045 T1043 arg3Of ),(
R10382 T20179 T13570 arg1Of molecules,pro-inflammatory
R1039 T1042 T1046 arg1Of serine,and
R1040 T1047 T1046 arg2Of threonine,and
R1041 T1051 T1047 arg1Of residues,threonine
R1042 T1047 T1048 arg1Of threonine,(
R1043 T1049 T1048 arg2Of Thr,(
R1044 T1050 T1048 arg3Of ),(
R1045 T1037 T1052 arg1Of attached,by
R1046 T1054 T1052 arg2Of addition,by
R1047 T1054 T1053 arg1Of addition,the
R1048 T1054 T1055 arg1Of addition,of
R10483 T16296 T6873 arg2Of infection,to
R1049 T1058 T1055 arg2Of galactosamine,of
R1050 T1058 T1056 arg1Of galactosamine,an
R1051 T1058 T1057 arg1Of galactosamine,N-acetyl
R10518 T98095 T5967 arg1Of chains,light
R1052 T1058 T1059 arg1Of galactosamine,(
R1053 T1060 T1059 arg2Of GalNAc,(
R1054 T1061 T1059 arg3Of ),(
R1055 T1089 T1062 arg1Of and,For
R1056 T1063 T1062 arg2Of example,For
R1057 T1089 T1064 arg1Of and,","
R1058 T1065 T1066 arg1Of N-glycans,exist
R10580 T49731 T12498 arg2Of E,(
R1059 T1066 T1067 arg1Of exist,in
R1060 T1081 T1067 arg2Of and,in
R1061 T1069 T1068 arg1Of virus,Hendra
R1062 T1069 T1070 arg1Of virus,","
R1063 T1071 T1070 arg2Of SARS-CoV,","
R1064 T1070 T1072 arg1Of ",",","
R1065 T1074 T1072 arg2Of virus,","
R1066 T1074 T1073 arg1Of virus,influenza
R10665 T89603 T52542 arg1Of coordination,of
R1067 T1072 T1075 arg1Of ",",","
R1068 T1077 T1075 arg2Of virus,","
R1069 T1077 T1076 arg1Of virus,hepatitis
R10698 T65845 T64776 arg1Of receptor,and
R1070 T1075 T1078 arg1Of ",",","
R10701 T32201 T94518 arg1Of treatment,","
R10707 T74893 T71956 arg1Of pathway,surface
R1071 T1079 T1078 arg2Of HIV-1,","
R1072 T1081 T1080 arg1Of and,","
R1073 T1078 T1081 arg1Of ",",and
R10738 T17100 T86473 arg2Of mice,immunized
R1074 T1084 T1081 arg2Of virus,and
R1075 T1083 T1082 arg1Of Nile,West
R10750 T21677 T87902 arg3Of ],[
R1076 T1084 T1083 arg1Of virus,Nile
R1077 T1084 T1085 arg1Of virus,[
R1078 T1086 T1085 arg2Of 6,[
R1079 T1087 T1085 arg3Of ],[
R1080 T1089 T1088 arg1Of and,","
R10807 T27403 T62199 arg2Of 25,[
R1081 T1066 T1089 arg1Of exist,and
R1082 T1092 T1089 arg2Of occurred,and
R1083 T1090 T1091 arg1Of O-glycans,have
R10830 T45118 T86655 arg1Of levels,antibody
R10836 T71701 T38328 arg1Of sequence,acid
R1084 T1092 T1091 arg2Of occurred,have
R1085 T1090 T1092 arg1Of O-glycans,occurred
R10854 T68835 T90276 arg1Of contains,[
R1086 T1092 T1093 arg1Of occurred,in
R1087 T1096 T1093 arg2Of virus,in
R10873 T83272 T20599 arg1Of polyprotein,replicase
R1088 T1096 T1094 arg1Of virus,the
R1089 T1096 T1095 arg1Of virus,Ebola
R10896 T63070 T65028 arg1Of levels,lymphocyte
R1090 T1100 T1097 arg1Of protein,The
R1091 T1100 T1098 arg1Of protein,2019-nCoV
R1092 T1100 T1099 arg1Of protein,S
R1093 T1100 T1101 arg1Of protein,includes
R1094 T1106 T1101 arg2Of sequons,includes
R10947 T68894 T97000 arg1Of that,of
R1095 T1106 T1102 arg1Of sequons,13
R1096 T1106 T1103 arg1Of sequons,and
R1097 T1106 T1104 arg1Of sequons,9N-linked
R10976 T8983 T66380 arg1Of virus,to
R1098 T1106 T1105 arg1Of sequons,glycosylation
R1099 T1106 T1107 arg1Of sequons,in
R10991 T86520 T22143 arg1Of immunization,protects
R1100 T1112 T1107 arg2Of subunit,in
R1101 T1112 T1108 arg1Of subunit,the
R11011 T64893 T64532 arg1Of IFNs,play
R1102 T1112 T1109 arg1Of subunit,S1
R11025 T39838 T50077 arg1Of decrease,Through
R1103 T1109 T1110 arg1Of S1,and
R1104 T1111 T1110 arg2Of S2,and
R1105 T1112 T1111 arg1Of subunit,S2
R1106 T1106 T1113 arg1Of sequons,","
R1107 T1106 T1114 arg1Of sequons,respectively
R1108 T1101 T1115 arg1Of includes,[
R11084 T95952 T16420 arg1Of differences,occur
R1109 T1116 T1115 arg2Of 3,[
R1110 T1117 T1115 arg3Of ],[
R1111 T1118 T1119 arg1Of All,of
R1112 T1120 T1119 arg2Of these,of
R1113 T1118 T1121 arg1Of All,have
R1114 T1123 T1121 arg2Of occurred,have
R1115 T1123 T1122 arg1Of occurred,previously
R11155 T2209 T82418 arg1Of Lack,of
R1116 T1118 T1123 arg1Of All,occurred
R1117 T1123 T1124 arg1Of occurred,in
R11170 T20946 T7432 arg2Of genomes,of
R11171 T49434 T74174 arg1Of include,in
R1118 T1128 T1124 arg2Of glycoprotein,in
R1119 T1128 T1125 arg1Of glycoprotein,the
R1120 T1128 T1126 arg1Of glycoprotein,SARS-CoV
R1121 T1128 T1127 arg1Of glycoprotein,S
R1122 T1123 T1129 arg1Of occurred,","
R11221 T70930 T74238 arg3Of ),(
R11228 T45337 T30995 arg1Of and,were
R1123 T1131 T1130 arg1Of for,except
R1124 T1123 T1131 arg1Of occurred,for
R1125 T1134 T1131 arg2Of sequons,for
R1126 T1134 T1132 arg1Of sequons,four-linked
R1127 T1134 T1133 arg1Of sequons,glycosylation
R11270 T42144 T39632 arg1Of responses,immune
R1128 T1134 T1135 arg1Of sequons,in
R11280 T7048 T69120 arg1Of late,early
R1129 T1137 T1135 arg2Of S1,in
R1130 T1137 T1136 arg1Of S1,the
R1131 T1163 T1138 arg1Of are,Also
R1132 T1163 T1139 arg1Of are,","
R11328 T50007 T39219 arg1Of domain,S1
R1133 T1141 T1140 arg1Of to,due
R11336 T67504 T7728 arg1Of analysis,phylogenetic
R1134 T1163 T1141 arg1Of are,to
R1135 T1143 T1141 arg2Of existence,to
R1136 T1143 T1142 arg1Of existence,the
R1137 T1143 T1144 arg1Of existence,of
R11370 T45006 T20264 arg1Of 2019-nCoV,the
R1138 T1148 T1144 arg2Of proline,of
R1139 T1148 T1145 arg1Of proline,an
R1140 T1148 T1146 arg1Of proline,amino
R1141 T1148 T1147 arg1Of proline,acid
R1142 T1148 T1149 arg1Of proline,in
R1143 T1153 T1149 arg2Of site,in
R1144 T1153 T1150 arg1Of site,the
R11446 T98211 T71821 arg1Of processing,to
R1145 T1153 T1151 arg1Of site,polybasic
R11456 T27148 T86610 arg2Of levels,with
R1146 T1153 T1152 arg1Of site,cleavage
R1147 T1148 T1154 arg1Of proline,","
R1148 T1148 T1155 arg1Of proline,which
R11481 T33016 T77949 arg1Of S,ZXC21
R1149 T1148 T1156 arg1Of proline,makes
R11494 T39437 T18576 arg1Of groups,differ
R1150 T1160 T1156 arg2Of PRRA,makes
R1151 T1160 T1157 arg1Of PRRA,the
R1152 T1160 T1158 arg2Of PRRA,inserted
R1153 T1160 T1159 arg1Of PRRA,sequence
R11531 T3352 T81337 arg2Of them,of
R11535 T98040 T34896 arg1Of symptoms,and
R1154 T1163 T1161 arg1Of are,","
R1155 T1162 T1163 arg1Of there,are
R1156 T1166 T1163 arg2Of glycans,are
R1157 T1166 T1164 arg1Of glycans,three
R1158 T1166 T1165 arg1Of glycans,O-linked
R1159 T1166 T1167 arg2Of glycans,introduced
R11593 T25388 T9522 arg2Of course,from
R1160 T1167 T1168 arg1Of introduced,to
R1161 T1177 T1168 arg2Of and,to
R1162 T1177 T1169 arg1Of and,the
R1163 T1172 T1170 arg1Of residues,2019-nCoV
R1164 T1172 T1171 arg1Of residues,RBD
R1165 T1177 T1172 arg1Of and,residues
R1166 T1173 T1174 arg1Of S673,","
R11663 T62169 T22492 arg1Of introduced,probably
R1167 T1175 T1174 arg2Of T678,","
R1168 T1177 T1176 arg1Of and,","
R1169 T1174 T1177 arg1Of ",",and
R1170 T1178 T1177 arg2Of S686,and
R1171 T1177 T1179 arg1Of and,[
R11715 T78080 T98368 arg1Of and,In
R1172 T1180 T1179 arg2Of 7,[
R1173 T1181 T1179 arg3Of ],[
R1174 T1186 T1182 arg1Of domain,3.1.3
R11743 T95515 T28355 arg1Of virus,the
R1175 T1186 T1183 arg1Of domain,SARS-CoV2
R1176 T1186 T1184 arg1Of domain,receptor
R1177 T1186 T1185 arg1Of domain,binding
R1178 T1186 T1187 arg1Of domain,contains
R1179 T1190 T1187 arg2Of acids,contains
R1180 T1190 T1188 arg1Of acids,six
R11800 T37602 T98869 arg2Of needed,is
R11805 T88382 T8711 arg1Of strain,the
R1181 T1190 T1189 arg1Of acids,amino
R11811 T44856 T20306 arg2Of therapy,without
R11819 T63285 T37916 arg1Of died,on
R1182 T1190 T1191 arg1Of acids,providing
R1183 T1193 T1191 arg2Of positions,providing
R1184 T1193 T1192 arg1Of positions,favorable
R1185 T1193 T1194 arg1Of positions,for
R11853 T85900 T55417 arg1Of attained,Hence
R11857 T81462 T7177 arg1Of deal,effectively
R1186 T1195 T1194 arg2Of binding,for
R1187 T1195 T1196 arg1Of binding,to
R11871 T83960 T65863 arg1Of pool,a
R1188 T1198 T1196 arg2Of ACE2,to
R1189 T1198 T1197 arg1Of ACE2,human
R1190 T1216 T1199 arg1Of showed,When
R11905 T59365 T45935 arg1Of quail,(
R1191 T1200 T1199 arg2Of compared,When
R11915 T68058 T82553 arg1Of virus,rubella
R1192 T1200 T1201 arg1Of compared,to
R1193 T1203 T1201 arg2Of SB,to
R11936 T20348 T98671 arg1Of outcome,the
R1194 T1203 T1202 arg1Of SB,SARS-CoV
R1195 T1216 T1204 arg1Of showed,","
R11953 T57783 T33080 arg1Of sequences,in
R1196 T1206 T1205 arg1Of motif,the
R1197 T1206 T1207 arg1Of motif,binding
R1198 T1210 T1207 arg2Of ACE2,binding
R1199 T1210 T1208 arg1Of ACE2,the
R11993 T22774 T85435 arg1Of recovered,from
R1200 T1210 T1209 arg1Of ACE2,human
R12004 T7474 T40173 arg1Of reaches,during
R1201 T1210 T1211 arg1Of ACE2,to
R1202 T1215 T1211 arg2Of SB,to
R12027 T81378 T78835 arg1Of degree,of
R1203 T1215 T1212 arg1Of SB,the
R1204 T1215 T1213 arg1Of SB,SARS-CoV
R1205 T1215 T1214 arg1Of SB,2
R1206 T1206 T1216 arg1Of motif,showed
R1207 T1221 T1216 arg2Of affinity,showed
R1208 T1225 T1216 arg3Of as,showed
R12080 T6862 T7968 arg1Of day,the
R1209 T1221 T1217 arg1Of affinity,a
R12091 T60803 T44490 arg1Of improvement,in
R1210 T1219 T1218 arg1Of higher,relatively
R1211 T1221 T1219 arg1Of affinity,higher
R1212 T1221 T1220 arg1Of affinity,binding
R1213 T1221 T1222 arg1Of affinity,for
R1214 T1224 T1222 arg2Of ACE2,for
R1215 T1224 T1223 arg1Of ACE2,human
R12153 T82446 T51616 arg1Of ACE2,","
R1216 T1226 T1225 arg2Of indicated,as
R1217 T1226 T1227 arg1Of indicated,in
R12170 T62141 T88887 arg2Of arthritis,","
R1218 T1231 T1227 arg2Of constant,in
R1219 T1231 T1228 arg1Of constant,smaller
R1220 T1231 T1229 arg1Of constant,equilibrium
R1221 T1231 T1230 arg1Of constant,dissociation
R1222 T1231 T1232 arg1Of constant,(
R12224 T80577 T76245 arg3Of ],[
R1223 T1233 T1232 arg2Of 2.9 nM,(
R12230 T43412 T19399 arg2Of N,(
R12232 T15065 T39782 arg1Of ",",and
R12235 T13191 T51521 arg2Of IL-6,","
R1224 T1236 T1232 arg3Of ),(
R1225 T1233 T1234 arg1Of 2.9 nM,vs.
R1226 T1235 T1234 arg2Of 7.7 nM,vs.
R1227 T1216 T1237 arg1Of showed,[
R1228 T1238 T1237 arg2Of 3,[
R1229 T1239 T1237 arg3Of ],[
R12291 T25763 T50471 arg1Of leukocytes,and
R1230 T1241 T1240 arg1Of analysis,Structural
R12304 T58392 T22912 arg2Of particular,In
R1231 T1241 T1242 arg1Of analysis,has
R12315 T73561 T85647 arg1Of patients,these
R1232 T1243 T1242 arg2Of demonstrated,has
R1233 T1241 T1243 arg1Of analysis,demonstrated
R12336 T37933 T39330 arg1Of ",",and
R1234 T1248 T1243 arg2Of take,demonstrated
R12341 T13737 T78456 arg1Of inhibit,to
R1235 T1248 T1244 arg1Of take,that
R1236 T1246 T1245 arg1Of positions,fourteen
R12367 T90848 T44446 arg1Of infections,Nocardia
R1237 T1248 T1247 arg1Of take,critically
R12375 T2642 T10299 arg2Of RNA,were
R1238 T1246 T1248 arg1Of positions,take
R1239 T1249 T1248 arg2Of part,take
R1240 T1248 T1250 arg1Of take,in
R1241 T1253 T1250 arg2Of domain,in
R1242 T1253 T1251 arg1Of domain,the
R1243 T1253 T1252 arg1Of domain,receptor-binding
R12434 T48832 T18888 arg1Of diversity,produce
R1244 T1253 T1254 arg1Of domain,of
R1245 T1257 T1254 arg2Of SB,of
R1246 T1257 T1255 arg1Of SB,the
R1247 T1257 T1256 arg1Of SB,SARS-CoV
R12475 T15987 T11095 arg1Of arteritis,cell
R1248 T1257 T1258 arg1Of SB,that
R12484 T95208 T44068 arg1Of Rational,5.2
R1249 T1257 T1259 arg1Of SB,contain
R1250 T1281 T1259 arg2Of and,contain
R1251 T1281 T1260 arg1Of and,eight
R1252 T1281 T1261 arg1Of and,conserved
R1253 T1280 T1262 arg1Of positions,(
R12539 T22929 T50644 arg1Of agents,and
R1254 T1277 T1262 arg2Of and,(
R12543 T5300 T23999 arg3Of ),(
R1255 T1279 T1262 arg3Of ),(
R12551 T71668 T35873 arg1Of latter,The
R1256 T1263 T1264 arg1Of T402,","
R1257 T1265 T1264 arg2Of Y436,","
R1258 T1264 T1266 arg1Of ",",","
R12583 T14229 T42100 arg1Of serum,could
R1259 T1267 T1266 arg2Of Y440,","
R12595 T33761 T77477 arg1Of spectrum,of
R1260 T1266 T1268 arg1Of ",",","
R1261 T1269 T1268 arg2Of N473,","
R1262 T1268 T1270 arg1Of ",",","
R12626 T87404 T95865 arg2Of neutralize,able
R1263 T1271 T1270 arg2Of Y475,","
R1264 T1270 T1272 arg1Of ",",","
R1265 T1273 T1272 arg2Of T486,","
R1266 T1272 T1274 arg1Of ",",","
R1267 T1275 T1274 arg2Of G488,","
R1268 T1277 T1276 arg1Of and,","
R1269 T1274 T1277 arg1Of ",",and
R12695 T56787 T11269 arg1Of assumes,2
R1270 T1278 T1277 arg2Of Y491,and
R1271 T1280 T1281 arg1Of positions,and
R1272 T1310 T1281 arg2Of substitutions,and
R12726 T37666 T71611 arg1Of diseases,share
R1273 T1283 T1282 arg1Of semi-conserved,six
R12734 T54874 T6053 arg1Of cytokine,best-documented
R1274 T1310 T1283 arg1Of substitutions,semi-conserved
R1275 T1283 T1284 arg1Of semi-conserved,(
R1276 T1296 T1284 arg2Of ",",(
R1277 T1309 T1284 arg3Of ),(
R1278 T1285 T1286 arg1Of R426,to
R12784 T4246 T68154 arg1Of report,of
R1279 T1287 T1286 arg2Of N448,to
R12797 T18879 T2889 arg1Of inhibitors,","
R1280 T1287 T1288 arg1Of N448,","
R12801 T11788 T21382 arg1Of detect,to
R12802 T14810 T86991 arg2Of ORF3b,","
R12803 T58846 T44828 arg2Of 9,[
R12805 T25315 T50563 arg1Of coronavirus,had
R1281 T1289 T1288 arg2Of Y442,","
R1282 T1289 T1290 arg1Of Y442,to
R12822 T62157 T60868 arg1Of VSV-G,receptors
R1283 T1291 T1290 arg2Of L464,to
R1284 T1287 T1292 arg1Of N448,","
R1285 T1293 T1292 arg2Of L472,","
R12851 T1935 T84543 arg1Of present,but
R1286 T1293 T1294 arg1Of L472,to
R12867 T60636 T5267 arg2Of compounds,Among
R1287 T1295 T1294 arg2Of F495,to
R1288 T1285 T1296 arg1Of R426,","
R1289 T1305 T1296 arg2Of and,","
R1290 T1297 T1298 arg1Of N479,to
R1291 T1299 T1298 arg2Of Q502,to
R1292 T1299 T1300 arg1Of Q502,","
R1293 T1301 T1300 arg2Of Y484,","
R1294 T1301 T1302 arg1Of Y484,to
R1295 T1303 T1302 arg2Of Q507,to
R1296 T1305 T1304 arg1Of and,","
R1297 T1297 T1305 arg1Of N479,and
R12975 T85498 T10956 arg1Of Antiserum,hinder
R1298 T1306 T1305 arg2Of T487,and
R1299 T1305 T1307 arg1Of and,to
R1300 T1308 T1307 arg2Of N510,to
R1301 T1259 T1311 arg1Of contain,with
R1302 T1312 T1311 arg2Of respect,with
R1303 T1317 T1311 arg3Of SB,with
R13035 T34750 T90276 arg3Of ],[
R1304 T1311 T1313 arg1Of with,to
R1305 T1317 T1314 arg1Of SB,the
R1306 T1317 T1315 arg1Of SB,SARS-CoV
R1307 T1317 T1316 arg1Of SB,2
R13076 T87601 T88528 arg1Of patients,convalescent
R1308 T1322 T1318 arg1Of domain,3.1.4
R1309 T1322 T1319 arg1Of domain,SARS-CoV2
R1310 T1322 T1320 arg1Of domain,receptor
R13100 T41895 T37814 arg2Of antibodies,develop
R1311 T1322 T1321 arg1Of domain,binding
R13112 T96815 T6431 arg2Of rabbits,immunized
R1312 T1322 T1323 arg1Of domain,contains
R1313 T1325 T1323 arg2Of regions,contains
R13130 T30755 T96610 arg2Of CRP,and
R1314 T1325 T1324 arg1Of regions,cyclic
R13146 T26283 T50157 arg1Of known,also
R1315 T1325 T1326 arg1Of regions,that
R13154 T85855 T7496 arg1Of use,be
R1316 T1325 T1327 arg1Of regions,can
R1317 T1328 T1327 arg2Of make,can
R13170 T57783 T83153 arg2Of sequences,in
R1318 T1325 T1328 arg1Of regions,make
R13185 T72256 T59206 arg2Of diagnosed,is
R1319 T1329 T1328 arg2Of interaction,make
R1320 T1329 T1330 arg1Of interaction,with
R1321 T1332 T1330 arg2Of GRP78,with
R1322 T1332 T1331 arg1Of GRP78,cell-surface
R1323 T1333 T1334 arg1Of Pep42,is
R1324 T1337 T1334 arg2Of oligopeptide,is
R1325 T1337 T1335 arg1Of oligopeptide,a
R1326 T1337 T1336 arg1Of oligopeptide,cyclic
R13264 T44301 T99769 arg1Of inflammation,hyper
R1327 T1337 T1338 arg1Of oligopeptide,that
R13275 T62294 T15497 arg2Of encephalitis,","
R13277 T84322 T73554 arg2Of and,of
R1328 T1347 T1339 arg1Of interact,","
R1329 T1347 T1340 arg1Of interact,with
R1330 T1343 T1340 arg2Of character,with
R1331 T1343 T1341 arg1Of character,its
R1332 T1343 T1342 arg1Of character,hydrophobic
R1333 T1347 T1344 arg1Of interact,","
R1334 T1337 T1345 arg1Of oligopeptide,can
R1335 T1347 T1345 arg2Of interact,can
R1336 T1347 T1346 arg1Of interact,selectively
R1337 T1337 T1347 arg1Of oligopeptide,interact
R1338 T1347 T1348 arg1Of interact,with
R1339 T1350 T1348 arg2Of surface,with
R13398 T64809 T8248 arg2Of PON,from
R1340 T1350 T1349 arg1Of surface,cell
R1341 T1350 T1351 arg2Of surface,glucose‐regulated
R1342 T1352 T1351 arg3Of protein,glucose‐regulated
R1343 T1352 T1353 arg1Of protein,78
R1344 T1352 T1354 arg1Of protein,(
R13443 T72786 T82790 arg2Of shown,has
R1345 T1355 T1354 arg2Of GRP78,(
R1346 T1356 T1354 arg3Of ),(
R13465 T46803 T33924 arg1Of diseases,several
R1347 T1352 T1357 arg1Of protein,","
R13473 T11269 T5490 arg1Of 2,)
R1348 T1359 T1357 arg2Of member,","
R1349 T1359 T1358 arg1Of member,a
R1350 T1359 T1360 arg1Of member,of
R1351 T1364 T1360 arg2Of proteins,of
R1352 T1364 T1361 arg1Of proteins,70 kDa
R13520 T75671 T99202 arg2Of act,appeared
R1353 T1364 T1362 arg1Of proteins,heat
R13530 T35146 T66380 arg2Of receptor,to
R1354 T1364 T1363 arg1Of proteins,shock
R1355 T1365 T1366 arg1Of GRP78,","
R1356 T1368 T1367 arg1Of known,also
R1357 T1365 T1368 arg2Of GRP78,known
R13579 T5150 T43666 arg1Of recovery,from
R1358 T1368 T1369 arg1Of known,as
R1359 T1371 T1369 arg2Of or,as
R1360 T1370 T1371 arg1Of BiP,or
R1361 T1372 T1371 arg2Of HSPA5,or
R13617 T60390 T21723 arg1Of cells,primary
R1362 T1389 T1373 arg1Of and,","
R1363 T1389 T1374 arg1Of and,under
R13635 T27754 T31036 arg1Of receptor,the
R13636 T99993 T3009 arg1Of SARS-CoV,and
R1364 T1377 T1374 arg2Of stress,under
R1365 T1377 T1375 arg1Of stress,endoplasmic
R1366 T1377 T1376 arg1Of stress,reticulum
R13660 T25132 T29516 arg1Of degree,in
R1367 T1389 T1378 arg1Of and,","
R1368 T1365 T1379 arg1Of GRP78,can
R1369 T1381 T1379 arg2Of translocated,can
R13690 T46450 T23533 arg1Of sequencing,detect
R1370 T1365 T1380 arg1Of GRP78,be
R1371 T1381 T1380 arg2Of translocated,be
R1372 T1365 T1381 arg2Of GRP78,translocated
R1373 T1381 T1382 arg1Of translocated,from
R1374 T1385 T1382 arg2Of reticulum,from
R1375 T1385 T1383 arg1Of reticulum,the
R1376 T1385 T1384 arg1Of reticulum,endoplasmic
R13764 T19375 T51998 arg2Of favorable,are
R1377 T1385 T1386 arg1Of reticulum,to
R1378 T1388 T1386 arg2Of membrane,to
R1379 T1388 T1387 arg1Of membrane,the
R1380 T1381 T1389 arg1Of translocated,and
R1381 T1390 T1389 arg2Of helps,and
R13811 T2304 T44373 arg2Of antibodies,have
R1382 T1365 T1390 arg1Of GRP78,helps
R13827 T81617 T95958 arg1Of ciclesonide,induced
R1383 T1392 T1390 arg2Of maintain,helps
R1384 T1392 T1391 arg1Of maintain,to
R13846 T54336 T58340 arg1Of bats,horseshoe
R1385 T1365 T1392 arg1Of GRP78,maintain
R1386 T1394 T1392 arg2Of integrity,maintain
R1387 T1394 T1393 arg1Of integrity,cellular
R1388 T1392 T1395 arg1Of maintain,under
R1389 T1399 T1395 arg2Of stress,under
R1390 T1399 T1396 arg1Of stress,physiologic
R1391 T1396 T1397 arg1Of physiologic,and
R1392 T1398 T1397 arg2Of pathological,and
R1393 T1399 T1398 arg1Of stress,pathological
R1394 T1402 T1401 arg1Of contributes,critically
R13940 T53710 T7152 arg1Of pathway,cathepsin/endosomal
R13941 T73531 T42629 arg1Of cells,E6
R1395 T1400 T1402 arg1Of It,contributes
R1396 T1402 T1403 arg1Of contributes,to
R13961 T64875 T87687 arg1Of patients,convalescent
R1397 T1405 T1403 arg2Of functions,to
R1398 T1405 T1404 arg1Of functions,various
R1399 T1405 T1406 arg1Of functions,ranging
R13996 T9153 T37916 arg2Of day,on
R1400 T1406 T1407 arg1Of ranging,from
R14004 T66055 T89299 arg1Of condition,whose
R14005 T54783 T57340 arg2Of levels,having
R1401 T1413 T1407 arg2Of and,from
R14017 T7214 T10678 arg1Of effective,more
R1402 T1409 T1408 arg1Of folding,protein
R14025 T49191 T37620 arg2Of help,might
R1403 T1409 T1410 arg1Of folding,","
R1404 T1411 T1410 arg2Of transportation,","
R1405 T1413 T1412 arg1Of and,","
R1406 T1410 T1413 arg1Of ",",and
R14066 T46450 T28843 arg1Of sequencing,Genome
R1407 T1414 T1413 arg2Of degradation,and
R14075 T71973 T7216 arg1Of production,of
R1408 T1405 T1415 arg1Of functions,to
R1409 T1426 T1415 arg2Of and,to
R1410 T1421 T1416 arg1Of ",",cell-signaling
R1411 T1421 T1417 arg1Of ",",","
R1412 T1418 T1419 arg1Of proliferation,","
R1413 T1420 T1419 arg2Of survival,","
R14139 T14954 T26632 arg1Of and,lead
R1414 T1419 T1421 arg1Of ",",","
R1415 T1422 T1421 arg2Of apoptosis,","
R1416 T1421 T1423 arg1Of ",",","
R1417 T1424 T1423 arg2Of inflammation,","
R1418 T1426 T1425 arg1Of and,","
R1419 T1423 T1426 arg1Of ",",and
R14196 T72973 T20341 arg1Of inoculated,with
R1420 T1427 T1426 arg2Of immunity,and
R1421 T1429 T1428 arg1Of expression,The
R1422 T1429 T1430 arg1Of expression,of
R1423 T1431 T1430 arg2Of GRP78,of
R1424 T1429 T1432 arg1Of expression,decreases
R1425 T1432 T1433 arg1Of decreases,with
R1426 T1434 T1433 arg2Of age,with
R1427 T1445 T1435 arg1Of corresponding,On
R1428 T1439 T1435 arg2Of protein,On
R14281 T83045 T53860 arg2Of COVID-19,with
R1429 T1439 T1436 arg1Of protein,the
R1430 T1439 T1437 arg1Of protein,2019-nCoV
R1431 T1439 T1438 arg1Of protein,spike
R1432 T1445 T1440 arg1Of corresponding,","
R14327 T70918 T21084 arg2Of similar,is
R1433 T1443 T1441 arg1Of bonds,13
R14331 T84428 T78509 arg1Of combat,to
R1434 T1443 T1442 arg1Of bonds,disulfide
R1435 T1443 T1444 arg1Of bonds,are
R14351 T55131 T12529 arg2Of 25,[
R14356 T75820 T89468 arg2Of bats,from
R1436 T1445 T1444 arg2Of corresponding,are
R1437 T1443 T1445 arg1Of bonds,corresponding
R1438 T1445 T1446 arg1Of corresponding,to
R14380 T54347 T67635 arg1Of process,the
R1439 T1450 T1446 arg2Of regions,to
R1440 T1450 T1447 arg1Of regions,13
R14407 T21718 T64168 arg1Of study,[
R1441 T1450 T1448 arg1Of regions,different
R14410 T94817 T39961 arg1Of terms,of
R1442 T1450 T1449 arg1Of regions,cyclic
R1443 T1450 T1451 arg2Of regions,thought
R1444 T1453 T1451 arg3Of be,thought
R1445 T1453 T1452 arg1Of be,to
R1446 T1450 T1453 arg1Of regions,be
R1447 T1454 T1453 arg2Of similar,be
R1448 T1450 T1454 arg1Of regions,similar
R14488 T29466 T5151 arg2Of antibody,of
R1449 T1454 T1455 arg1Of similar,to
R1450 T1458 T1455 arg2Of form,to
R1451 T1458 T1456 arg1Of form,the
R1452 T1458 T1457 arg1Of form,cyclic
R1453 T1458 T1459 arg1Of form,of
R1454 T1460 T1459 arg2Of Pep42,of
R1455 T1460 T1461 arg1Of Pep42,[
R1456 T1462 T1461 arg2Of 8,[
R1457 T1463 T1461 arg3Of ],[
R1458 T1470 T1464 arg1Of take,Among
R1459 T1465 T1464 arg2Of these,Among
R14592 T4187 T8453 arg1Of it,be
R1460 T1470 T1466 arg1Of take,","
R1461 T1469 T1467 arg1Of I-IV,four
R1462 T1469 T1468 arg1Of I-IV,regions
R1463 T1469 T1470 arg1Of I-IV,take
R1464 T1471 T1470 arg2Of place,take
R1465 T1470 T1472 arg1Of take,in
R1466 T1475 T1472 arg2Of surface,in
R1467 T1475 T1473 arg1Of surface,the
R14672 T87007 T67550 arg1Of glycoproteins,membrane
R1468 T1475 T1474 arg1Of surface,outer
R1469 T1475 T1476 arg1Of surface,of
R1470 T1480 T1476 arg2Of domain,of
R1471 T1480 T1477 arg1Of domain,a
R1472 T1480 T1478 arg1Of domain,putative
R1473 T1480 T1479 arg1Of domain,receptor-binding
R1474 T1480 T1481 arg1Of domain,(
R1475 T1482 T1481 arg2Of RBD,(
R1476 T1483 T1481 arg3Of ),(
R14765 T96891 T68840 arg1Of Hypothesis,attenuate
R14767 T8033 T25177 arg1Of frames,open
R1477 T1480 T1484 arg1Of domain,on
R1478 T1487 T1484 arg2Of spike.,on
R1479 T1487 T1485 arg1Of spike.,the
R14799 T45316 T12863 arg1Of protein,coronavirus
R1480 T1487 T1486 arg1Of spike.,viral
R1481 T1475 T1488 arg1Of surface,","
R1482 T1475 T1489 arg1Of surface,including
R1483 T1496 T1489 arg2Of and,including
R1484 T1490 T1491 arg1Of C361,","
R1485 T1492 T1491 arg2Of C379,","
R1486 T1491 T1493 arg1Of ",",","
R1487 T1494 T1493 arg2Of C391,","
R1488 T1496 T1495 arg1Of and,","
R1489 T1493 T1496 arg1Of ",",and
R14892 T86672 T5267 arg1Of was,Among
R1490 T1497 T1496 arg2Of C480,and
R14909 T58895 T10929 arg1Of outcomes,the
R1491 T1499 T1498 arg1Of regions,These
R14919 T26456 T39392 arg1Of negative,SARS-CoV2
R1492 T1499 T1500 arg1Of regions,share
R1493 T1502 T1500 arg2Of similarity,share
R1494 T1502 T1501 arg1Of similarity,sequence
R1495 T1500 T1503 arg1Of share,with
R1496 T1504 T1503 arg2Of Pep42,with
R14961 T89813 T53446 arg1Of SARS-S,target
R14968 T11797 T37383 arg1Of death,COVID-19-related
R1497 T1500 T1505 arg1Of share,","
R1498 T1499 T1506 arg1Of regions,ranging
R14983 T27658 T8138 arg1Of Corticosteroids,are
R1499 T1512 T1506 arg2Of %,ranging
R14996 T16892 T44829 arg2Of compared,When
R1500 T1500 T1506 modOf share,ranging
R15007 T84785 T49412 arg2Of antibodies,of
R1501 T1506 T1507 arg1Of ranging,from
R15014 T34931 T62798 arg1Of PON,Rabbit
R1502 T1509 T1507 arg2Of %,from
R1503 T1509 T1508 arg1Of %,15.38
R15037 T3648 T94095 arg3Of ),(
R1504 T1512 T1510 arg1Of %,to
R15040 T95631 T94847 arg1Of interacting,with
R1505 T1512 T1511 arg1Of %,46.15
R1506 T1528 T1513 arg1Of is,However
R1507 T1528 T1514 arg1Of is,","
R15075 T96461 T67884 arg2Of IL-10,and
R1508 T1516 T1515 arg1Of one,only
R15083 T36542 T96428 arg1Of and,","
R1509 T1516 T1517 arg1Of one,of
R1510 T1518 T1517 arg2Of them,of
R1511 T1516 T1519 arg1Of one,","
R1512 T1516 T1520 arg1Of one,i.e.
R1513 T1522 T1520 arg2Of region,i.e.
R1514 T1520 T1521 arg1Of i.e.,","
R1515 T1522 T1523 arg1Of region,IV
R15150 T48431 T54967 arg2Of levels,increased
R1516 T1522 T1524 arg1Of region,(
R1517 T1525 T1524 arg2Of GRAVY = 0.08,(
R1518 T1526 T1524 arg3Of ),(
R1519 T1528 T1527 arg1Of is,","
R1520 T1516 T1528 arg1Of one,is
R1521 T1531 T1528 arg2Of region,is
R1522 T1531 T1529 arg1Of region,a
R1523 T1531 T1530 arg1Of region,hydrophobic
R1524 T1528 T1532 arg1Of is,","
R1525 T1528 T1533 arg1Of is,like
R1526 T1534 T1533 arg2Of Pep42,like
R1527 T1534 T1535 arg1Of Pep42,(
R1528 T1536 T1535 arg2Of GRAVY = 1.1,(
R1529 T1537 T1535 arg3Of ),(
R15297 T78989 T3292 arg1Of immunization,be
R1530 T1539 T1538 arg1Of models,Structural
R15307 T34731 T94019 arg1Of strain,the
R1531 T1539 T1540 arg1Of models,evaluate
R1532 T1543 T1540 arg2Of contribution,evaluate
R1533 T1543 T1541 arg1Of contribution,the
R15336 T21018 T38759 arg1Of pressure,blood
R1534 T1543 T1542 arg1Of contribution,energy
R1535 T1543 T1544 arg1Of contribution,for
R1536 T1545 T1544 arg2Of region,for
R1537 T1545 T1546 arg1Of region,IV
R1538 T1545 T1547 arg1Of region,as
R15380 T70143 T94916 arg1Of examples,The
R1539 T1549 T1547 arg2Of part,as
R15396 T25878 T28417 arg1Of mAb,inhibit
R1540 T1549 T1548 arg1Of part,a
R15400 T2430 T34278 arg1Of entry,the
R1541 T1549 T1550 arg1Of part,of
R1542 T1551 T1550 arg2Of region,of
R1543 T1551 T1552 arg1Of region,III
R15437 T2963 T5339 arg1Of Paraoxonases,are
R1544 T1543 T1553 arg1Of contribution,to
R15441 T43996 T48594 arg1Of coronaviruses,The
R1545 T1555 T1553 arg2Of GRP78,to
R15458 T43323 T74931 arg2Of and,at
R1546 T1555 T1554 arg1Of GRP78,the
R15467 T37378 T70298 arg1Of –,","
R1547 T1557 T1556 arg1Of be,to
R1548 T1555 T1556 modOf GRP78,to
R1549 T1555 T1557 arg2Of GRP78,be
R15494 T87261 T96660 arg1Of Studies,show
R1550 T1557 T1558 arg1Of be,about
R1551 T1558 T1559 arg1Of about,(
R15514 T64204 T58724 arg2Of domain,requires
R1552 T1562 T1559 arg2Of of,(
R1553 T1564 T1559 arg3Of ),(
R15531 T77671 T99390 arg1Of ",",","
R1554 T1562 T1561 arg1Of of,out
R1555 T1560 T1562 arg1Of −9.8,of
R1556 T1563 T1562 arg2Of −14.0 kcal/mol,of
R1557 T1566 T1565 arg1Of and,","
R15573 T75671 T10168 arg1Of act,as
R1558 T1540 T1566 arg1Of evaluate,and
R1559 T1570 T1566 arg2Of proposes,and
R15596 T26799 T13824 arg1Of was,Interestingly
R15599 T22570 T42633 arg2Of characteristics,and
R1560 T1569 T1567 arg1Of platform,the
R15604 T51771 T42633 arg1Of entry,and
R1561 T1569 T1568 arg1Of platform,docking
R1562 T1569 T1570 arg1Of platform,proposes
R1563 T1571 T1570 arg2Of region,proposes
R15634 T50829 T76607 arg1Of Calu-3,cell
R15638 T51732 T32607 arg1Of viruses,e.g.
R1564 T1571 T1572 arg1Of region,IV
R15646 T15191 T79753 arg1Of revealed,","
R1565 T1570 T1573 arg1Of proposes,as
R1566 T1576 T1573 arg2Of region,as
R1567 T1576 T1574 arg1Of region,the
R1568 T1576 T1575 arg1Of region,best
R1569 T1576 T1577 arg1Of region,binding
R1570 T1577 T1578 arg1Of binding,to
R1571 T1579 T1578 arg2Of GRP78,to
R1572 T1581 T1580 arg1Of region,The
R15724 T69281 T90838 arg1Of identical,almost
R15728 T78691 T18580 arg1Of %,and
R1573 T1581 T1582 arg1Of region,IV
R1574 T1581 T1583 arg1Of region,can
R1575 T1585 T1583 arg2Of linked,can
R1576 T1581 T1584 arg1Of region,be
R1577 T1585 T1584 arg2Of linked,be
R15771 T89944 T11032 arg1Of reduce,[
R1578 T1581 T1585 arg2Of region,linked
R15788 T62294 T79163 arg1Of encephalitis,","
R1579 T1585 T1586 arg1Of linked,to
R1580 T1590 T1586 arg2Of β,to
R1581 T1590 T1587 arg1Of β,the
R1582 T1590 T1588 arg1Of β,substrate-binding
R1583 T1590 T1589 arg1Of β,domain
R15830 T47586 T32800 arg2Of rise,begin
R1584 T1590 T1591 arg1Of β,(
R1585 T1592 T1591 arg2Of SBDB,(
R1586 T1593 T1591 arg3Of ),(
R1587 T1590 T1594 arg1Of β,of
R1588 T1595 T1594 arg2Of GRP78,of
R1589 T1595 T1596 arg1Of GRP78,using
R1590 T1610 T1596 arg2Of and,using
R1591 T1598 T1597 arg1Of H-bonds,five
R1592 T1598 T1599 arg1Of H-bonds,(
R1593 T1600 T1599 arg2Of through,(
R1594 T1609 T1599 arg3Of ),(
R1595 T1607 T1600 arg2Of and,through
R1596 T1601 T1602 arg1Of P479,","
R1597 T1603 T1602 arg2Of N481,","
R15972 T37402 T65661 arg1Of fever,and
R1598 T1602 T1604 arg1Of ",",","
R1599 T1605 T1604 arg2Of E484,","
R1600 T1607 T1606 arg1Of and,","
R16005 T53057 T52808 arg1Of domain,conveys
R1601 T1604 T1607 arg1Of ",",and
R1602 T1608 T1607 arg2Of N487,and
R1603 T1598 T1610 arg1Of H-bonds,and
R16030 T95232 T83801 arg1Of IFN,can
R1604 T1613 T1610 arg2Of interactions,and
R1605 T1613 T1611 arg1Of interactions,four
R16058 T66003 T83677 arg1Of peptide,inhibitory
R1606 T1613 T1612 arg1Of interactions,hydrophobic
R1607 T1613 T1614 arg1Of interactions,(
R1608 T1615 T1614 arg2Of through,(
R1609 T1622 T1614 arg3Of ),(
R1610 T1620 T1615 arg2Of and,through
R1611 T1616 T1617 arg1Of T478,","
R1612 T1618 T1617 arg2Of E484,","
R1613 T1620 T1619 arg1Of and,","
R1614 T1617 T1620 arg1Of ",",and
R1615 T1621 T1620 arg2Of F486,and
R1616 T1625 T1623 arg1Of immunization,4
R1617 T1625 T1624 arg1Of immunization,Passive
R1618 T1626 T1627 arg1Of There,are
R1619 T1630 T1627 arg2Of ways,are
R16195 T39838 T68802 arg2Of decrease,can
R1620 T1630 T1628 arg1Of ways,two
R1621 T1630 T1629 arg1Of ways,main
R1622 T1632 T1631 arg1Of induce,to
R1623 T1630 T1631 modOf ways,to
R1624 T1633 T1632 arg2Of protection,induce
R1625 T1633 T1634 arg1Of protection,against
R1626 T1635 T1634 arg2Of infections,against
R1627 T1633 T1636 arg1Of protection,:
R1628 T1640 T1637 arg1Of immunization,active
R1629 T1637 T1638 arg1Of active,and
R1630 T1639 T1638 arg2Of passive,and
R16309 T39437 T32526 arg1Of groups,two
R1631 T1640 T1639 arg1Of immunization,passive
R1632 T1632 T1640 arg1Of induce,immunization
R1633 T1642 T1641 arg1Of immunization,Active
R16336 T81462 T91822 arg1Of deal,with
R1634 T1642 T1643 arg1Of immunization,comes
R1635 T1645 T1643 arg2Of exist,comes
R1636 T1645 T1644 arg1Of exist,to
R1637 T1642 T1645 arg1Of immunization,exist
R16377 T54347 T43425 arg1Of process,of
R1638 T1645 T1646 arg1Of exist,when
R16383 T42812 T56973 arg1Of cysteine,endosomal
R1639 T1654 T1646 arg2Of produce,when
R1640 T1648 T1647 arg1Of body,the
R1641 T1652 T1649 arg1Of system,'s
R1642 T1648 T1649 arg2Of body,'s
R16425 T41765 T55852 arg1Of mesylate,","
R1643 T1652 T1650 arg1Of system,own
R1644 T1652 T1651 arg1Of system,immune
R16446 T47874 T45480 modOf affinity,is
R16448 T77475 T98779 arg1Of Rhinolophus,and
R1645 T1652 T1653 arg1Of system,can
R16455 T16242 T30828 arg1Of Conclusion,9
R1646 T1654 T1653 arg2Of produce,can
R1647 T1652 T1654 arg1Of system,produce
R1648 T1655 T1654 arg2Of antibodies,produce
R1649 T1657 T1656 arg1Of following,actively
R1650 T1655 T1657 arg1Of antibodies,following
R1651 T1658 T1657 arg2Of exposure,following
R16518 T7214 T95142 arg2Of effective,is
R1652 T1658 T1659 arg1Of exposure,to
R1653 T1662 T1659 arg2Of antigen,to
R1654 T1662 T1660 arg1Of antigen,a
R1655 T1662 T1661 arg1Of antigen,viral
R16551 T73930 T90719 arg2Of day,by
R1656 T1668 T1663 arg1Of is,On
R1657 T1665 T1663 arg2Of contrary,On
R16578 T20679 T44741 arg2Of COVID19,of
R1658 T1665 T1664 arg1Of contrary,the
R1659 T1668 T1666 arg1Of is,","
R16595 T13966 T13491 arg2Of antibody,","
R1660 T1667 T1668 arg1Of there,is
R16601 T51616 T8679 arg1Of ",",","
R1661 T1670 T1668 arg2Of passive,is
R1662 T1670 T1669 arg1Of passive,a
R16622 T57029 T17052 arg2Of cells,in
R1663 T1670 T1671 arg1Of passive,working
R1664 T1672 T1671 arg2Of mode,working
R16640 T77995 T83579 arg1Of SARS-CoV2,possesses
R16643 T98211 T87109 arg1Of processing,proteolytic
R1665 T1672 T1673 arg1Of mode,of
R1666 T1676 T1673 arg2Of system,of
R1667 T1676 T1674 arg1Of system,the
R16675 T42652 T83308 arg1Of treatment,I
R1668 T1676 T1675 arg1Of system,immune
R16681 T33761 T82586 arg1Of spectrum,similar
R1669 T1676 T1677 arg1Of system,that
R16698 T27008 T45941 arg1Of acted,not
R1670 T1676 T1678 arg1Of system,would
R1671 T1679 T1678 arg2Of appear,would
R1672 T1676 T1679 arg1Of system,appear
R1673 T1679 T1680 arg1Of appear,following
R1674 T1682 T1680 arg2Of transfer,following
R16749 T10805 T51590 arg1Of ",",and
R1675 T1682 T1681 arg1Of transfer,the
R16754 T72732 T85670 arg1Of %,76
R1676 T1682 T1683 arg1Of transfer,of
R16765 T83579 T75642 arg1Of possesses,","
R1677 T1684 T1683 arg2Of antibodies,of
R16771 T13833 T13700 arg2Of and,","
R1678 T1684 T1685 arg1Of antibodies,that
R16785 T37738 T99202 arg1Of protein,appeared
R1679 T1684 T1686 arg1Of antibodies,act
R1680 T1686 T1687 arg1Of act,directly
R1681 T1689 T1688 arg1Of neutralize,to
R16819 T76496 T58135 arg1Of received,of
R1682 T1686 T1688 modOf act,to
R1683 T1684 T1689 arg1Of antibodies,neutralize
R1684 T1691 T1689 arg2Of infectivity,neutralize
R16846 T57549 T26331 arg1Of produce,[
R1685 T1691 T1690 arg1Of infectivity,viral
R1686 T1694 T1692 arg1Of therapy,4.1
R16863 T14835 T13628 arg2Of infection,","
R16864 T58552 T52445 arg1Of WBC,","
R1687 T1694 T1693 arg1Of therapy,Serum
R16905 T68003 T84711 arg1Of trials,ongoing
R16942 T51771 T14044 arg1Of entry,process
R16949 T63658 T78080 arg2Of SARS-2-S.,and
R16981 T89289 T98989 arg1Of expressed,on
R16983 T14997 T50903 arg3Of ],[
R17029 T86080 T42365 arg1Of IgG,and
R1707 T76019 T58724 arg1Of former,requires
R17122 T2491 T39715 arg2Of domain,with
R17167 T91889 T6021 arg1Of species,two
R17185 T85869 T20640 arg1Of option,a
R17219 T21718 T77014 arg1Of study,decreased
R17226 T80710 T48141 arg1Of plasma,can
R17282 T82201 T43180 arg1Of regulation,differential
R17337 T48276 T76904 arg3Of ],[
R17401 T53416 T3946 arg1Of inhibitor,of
R17475 T68140 T76951 arg1Of affinities,for
R17527 T71562 T20678 arg1Of and,and
R17542 T6163 T48110 arg1Of improved,","
R1755 T46478 T71562 arg2Of L,and
R17566 T56884 T37378 arg1Of binding,–
R17590 T58084 T8820 arg1Of in,and
R17601 T27842 T27205 arg2Of COVID-19,with
R17630 T71403 T91527 arg1Of difference,may
R17667 T77904 T33747 arg2Of SARS-CoV,neutralize
R1770 T77014 T13833 arg1Of decreased,and
R17700 T50860 T3162 arg1Of is,respectively
R17703 T39551 T64424 arg1Of identical,%
R17724 T41916 T9559 arg1Of interact,to
R17857 T93066 T60294 arg1Of eggshell,the
R17888 T21434 T41840 arg1Of possibility,the
R17891 T71668 T77029 arg1Of latter,requires
R17912 T92189 T85187 arg2Of 293 T,","
R17928 T37752 T82417 arg1Of fluid,bronchoalveolar
R17941 T36302 T59239 arg2Of fluticasone,and
R17963 T83162 T88144 arg1Of with,but
R1800 T89187 T8138 arg2Of used,are
R18015 T52580 T48202 arg1Of methylprednisolone,since
R18020 T36698 T81462 arg1Of Mometasone,deal
R18021 T53882 T17221 arg1Of FDA,approved
R18026 T19443 T83672 arg1Of as,such
R18045 T48684 T8813 arg1Of patients,Most
R18068 T98401 T99198 arg1Of rats,hypertensive
R18077 T74021 T3019 arg1Of and,by
R18127 T84414 T2990 arg1Of therapy,without
R18185 T75001 T6150 arg2Of ORF,(
R18211 T53907 T57340 arg1Of sera,having
R1825 T98110 T47759 arg2Of 16,[
R18320 T62340 T6873 arg1Of susceptible,to
R18378 T57882 T21828 arg1Of pH,endosomal
R18397 T5371 T88463 arg1Of Hypothesis,4.1.1.1
R18503 T11435 T82418 arg2Of treatments,of
R18514 T62169 T64814 arg2Of introduced,–
R18532 T41345 T28857 arg1Of infection,","
R18552 T31126 T98810 arg1Of to,due
R18562 T6622 T6733 arg2Of SARS-CoV,and
R18564 T34284 T13934 arg1Of virus,the
R18576 T68058 T70474 arg2Of virus,","
R18584 T17277 T84685 arg2Of SARS-CoV,and
R18642 T69842 T44468 arg2Of accelerate,show
R18662 T34931 T82559 arg1Of PON,differs
R18684 T42839 T91527 arg2Of be,may
R18775 T82506 T23050 arg1Of share,[
R18787 T82047 T66951 arg2Of NSP15,in
R18836 T45992 T92096 arg1Of dose,A
R1890 T7060 T20581 arg1Of accompany,that
R18975 T52544 T59239 arg1Of ",",and
R18986 T65980 T6067 arg1Of saturation,oxygen
R18993 T19745 T66697 arg1Of those,for
R19016 T62562 T4817 arg3Of ],[
R19027 T32795 T89944 arg1Of Sera,reduce
R19129 T72324 T35183 arg2Of COVID-19,links
R19161 T25890 T44174 arg2Of patients,recovered
R19206 T53845 T78207 arg1Of measured,by
R19260 T54700 T68837 arg2Of arthritis,","
R19276 T24185 T56416 arg1Of antibody,a
R19338 T67108 T68497 arg2Of pathogenicity,explain
R19341 T3471 T26060 arg1Of ratio,PaO2/FIO2
R19346 T80777 T43928 arg1Of system,immune
R19355 T71594 T59411 arg1Of serum,from
R19361 T49434 T44828 arg1Of include,[
R19448 T2642 T19318 arg1Of RNA,SARS-CoV2
R19463 T44925 T71418 arg1Of and,","
R19479 T50781 T71821 arg2Of degree,to
R19499 T27640 T74776 arg1Of SARS-CoV,and
R19525 T16685 T79314 arg1Of parameters,including
R19535 T77639 T15138 arg1Of fatalities,further
R19610 T18985 T72564 arg1Of group,and
R19622 T25132 T10566 arg1Of degree,high
R19625 T94564 T47629 arg1Of utilize,","
R19626 T43308 T73327 arg1Of related,previously
R19638 T30470 T76737 arg1Of and,","
R19665 T32201 T34533 arg1Of treatment,ranging
R19666 T47496 T22981 arg1Of SARS-CoV,2003
R19722 T56862 T58084 arg1Of similarity,in
R19763 T20348 T65200 arg1Of outcome,of
R19889 T86672 T50162 arg1Of was,","
R1991 T75325 T31013 arg1Of week,the
R19939 T58682 T70573 arg2Of spike,","
R19944 T43956 T66824 arg1Of as,such
R1995 T99202 T55931 arg1Of appeared,For
R19973 T39553 T56433 arg1Of pandemic,of
R20075 T38116 T31483 arg1Of ",",","
R20107 T21817 T61132 arg1Of exert,However
R2013 T44722 T40275 arg1Of modulate,","
R2019 T9709 T71708 arg1Of titer,causes
R20207 T57517 T3020 arg1Of plasma,convalescent
R20295 T14128 T5339 arg2Of enzymes,are
R20369 T75386 T47825 arg1Of require,that
R20385 T33446 T88407 arg2Of patients,included
R20386 T31219 T83162 arg2Of SARS-2-S,with
R20426 T63048 T62400 arg1Of and,","
R20444 T37738 T75671 arg1Of protein,act
R20459 T80684 T69842 arg2Of recovery,accelerate
R2046 T90061 T65200 arg2Of patients,of
R20551 T60636 T36393 arg1Of compounds,the
R20587 T25878 T16199 arg1Of mAb,can
R20598 T55163 T31522 arg2Of severe,and
R2062 T97128 T40209 arg1Of and,each
R20630 T27396 T33328 arg2Of dictate,do
R20697 T67208 T77083 arg1Of results,in
R20700 T40275 T56698 arg1Of ",",that
R20734 T80969 T24580 arg2Of severe,for
R2074 T32769 T5412 arg1Of occurred,in
R20768 T42842 T18623 arg3Of ),(
R20783 T13644 T28790 arg1Of substitution,An
R20807 T51386 T32237 arg2Of and,against
R20816 T69082 T76487 arg1Of as,such
R20851 T35011 T71611 arg2Of origin,share
R20864 T81658 T88887 arg1Of ",",","
R20867 T80157 T73200 arg1Of and,the
R20900 T32652 T65734 arg1Of responses,vital
R2092 T61033 T21523 arg2Of reveal,could
R20951 T19573 T35997 arg1Of study,investigated
R21012 T40034 T51029 arg1Of was,For
R21122 T87212 T26632 arg2Of us,lead
R21152 T80710 T37520 arg1Of plasma,from
R2126 T51053 T84303 arg1Of Rp3,the
R21271 T24005 T43722 arg1Of prognosis,of
R21319 T90762 T87578 arg1Of domain,S1
R21330 T7551 T35377 arg2Of SARS-CoV2,by
R21351 T25132 T87365 arg1Of degree,of
R21352 T70278 T74174 arg2Of 2015,in
R21368 T24628 T15777 arg1Of patients,with
R21425 T95168 T79137 arg3Of ],[
R2145 T50829 T55102 arg1Of Calu-3,line
R21455 T95212 T84611 arg1Of Hypothesis,:
R2152 T51672 T85433 arg1Of infection,[
R21524 T24185 T26777 arg1Of antibody,receptor
R21542 T61968 T81337 arg1Of both,of
R21546 T50104 T2438 arg2Of chloride,by
R21552 T5207 T80511 arg1Of fusion,of
R21561 T52808 T34590 arg1Of conveys,and
R21596 T35511 T75185 arg1Of entry,the
R21604 T21137 T88404 arg2Of COVID-19,from
R21619 T34900 T94537 arg2Of and,and
R2170 T52032 T37466 arg2Of membranes,and
R21753 T30838 T21841 arg2Of SARS,with
R21771 T25315 T87395 arg1Of coronavirus,SARS-like
R2179 T50571 T85435 arg2Of COVID-19,from
R21833 T62169 T13328 arg1Of introduced,from
R21959 T36705 T34694 arg1Of syndrome,release
R21977 T81575 T30323 arg2Of markers,","
R22009 T87875 T62169 arg2Of It,introduced
R22045 T86603 T75403 arg2Of lie,may
R22057 T31095 T77014 arg2Of count,decreased
R22070 T72452 T50493 arg1Of 24–48 h,after
R22102 T47054 T59058 arg2Of administered,be
R22109 T23466 T51386 arg1Of NP,and
R2213 T35336 T19523 arg2Of COVID-19,from
R22133 T78861 T75685 arg1Of plasma,convalescent
R22138 T71668 T2068 arg1Of latter,promote
R22163 T24869 T29802 arg2Of possible,as
R22174 T82402 T86199 arg1Of site,S2′
R22208 T42028 T66238 arg1Of RNA,of
R22256 T46450 T48337 arg1Of sequencing,could
R22284 T72350 T85433 arg2Of 25,[
R22355 T70281 T75519 arg1Of after,days
R22357 T10956 T70219 arg1Of hinder,while
R2236 T36698 T83057 arg1Of Mometasone,could
R22400 T44301 T65527 arg2Of inflammation,of
R22449 T98539 T69670 arg1Of nor,Neither
R22469 T64138 T21425 arg1Of effect,of
R22489 T65117 T45353 arg1Of study,[
R22588 T69995 T64051 arg2Of cells,Vero
R22614 T17217 T91679 arg2Of COVID-19,with
R22619 T76795 T90831 arg1Of Nile,West
R2263 T24185 T88685 arg1Of antibody,IL6
R22660 T64776 T16312 arg1Of and,cell
R22662 T84435 T44273 arg1Of treatment,with
R22776 T82196 T5298 arg2Of resistance,conferred
R22781 T18333 T77242 arg1Of cells,human
R22782 T92497 T44468 arg1Of Studies,show
R22804 T64654 T32904 arg2Of SARS-CoV,of
R2282 T67481 T77671 arg2Of ferritin,","
R22866 T98647 T83762 arg1Of disease,a
R22872 T18064 T59456 arg1Of and,[
R22891 T16399 T13646 arg3Of ),(
R22893 T52328 T75912 arg2Of pigeon,of
R22914 T98139 T55347 arg1Of repertoires,express
R22926 T71403 T42839 arg1Of difference,be
R22941 T36198 T16735 arg1Of flares,of
R22992 T14503 T99239 arg2Of HEK,(
R23015 T91889 T20399 arg1Of species,the
R23123 T29624 T20040 arg1Of reaction,(
R2313 T62340 T89464 arg2Of susceptible,are
R23171 T57882 T70941 arg1Of pH,limit
R23184 T30995 T76216 arg1Of were,","
R23204 T65005 T50076 arg1Of COVID-19,contains
R23224 T62294 T76795 arg1Of encephalitis,Nile
R23329 T89439 T49866 arg2Of group,in
R23338 T7184 T21860 arg2Of line,of
R23347 T32229 T37620 arg1Of Copper,might
R2337 T41758 T5759 arg1Of ",",and
R2338 T16710 T86610 arg1Of patients,with
R23414 T75829 T39220 arg1Of subunit,the
R23449 T3461 T39714 arg2Of entry,of
R23464 T73342 T89375 arg1Of bats,with
R23478 T60629 T78080 arg1Of SARS-S,and
R2351 T19375 T89702 arg1Of favorable,more
R23512 T67208 T10629 arg2Of results,shown
R23527 T67511 T16526 arg1Of binding,receptor
R23540 T84364 T36295 arg1Of and,in
R23547 T6188 T99442 arg2Of antibodies,contain
R23596 T45006 T44437 arg2Of 2019-nCoV,of
R23607 T66003 T34098 arg1Of peptide,an
R23617 T3419 T37378 arg2Of block,–
R23710 T2642 T76428 arg1Of RNA,positive
R23718 T50074 T60149 arg1Of activity,RAS
R2373 T29199 T65675 arg2Of protease,and
R23772 T21537 T6014 arg1Of ACE2,[
R23798 T1819 T13278 arg1Of VSV-G,and
R23820 T97074 T39838 arg1Of IRW,decrease
R23833 T9970 T8625 arg2Of domain,against
R23835 T26871 T3946 arg2Of CatB/L,of
R23852 T97598 T89892 arg1Of arthritis,idiopathic
R23868 T85972 T29990 arg1Of and,that
R23893 T26978 T64695 arg3Of virus,pseudotyped
R2391 T7888 T30816 arg1Of compete,specifically
R23970 T62169 T28188 arg2Of introduced,been
R24035 T54798 T74264 arg1Of improvement,faster
R24043 T38362 T76951 arg2Of interacting,for
R24045 T84845 T77583 arg1Of structure,the
R24069 T92001 T66778 arg2Of rabbits,from
R24087 T24185 T79548 arg1Of antibody,humanized
R24093 T36698 T32973 arg1Of Mometasone,help
R24105 T44730 T77029 arg3Of mediate,requires
R24201 T40953 T84867 arg1Of coronaviruses,","
R24256 T7157 T16625 arg1Of bat,being
R24267 T74975 T66580 arg2Of response,in
R24279 T45934 T52645 arg2Of example,for
R24341 T43255 T79015 arg1Of as,such
R24390 T37602 T74715 arg1Of needed,","
R2443 T57327 T7202 arg2Of ACE2,","
R24447 T14674 T39029 arg1Of inflammation,hyper
R24465 T33036 T48542 arg3Of ],[
R24478 T47054 T7135 arg1Of administered,when
R24484 T85645 T96681 arg1Of IFNs,Type
R24501 T93066 T75912 arg1Of eggshell,of
R24559 T75815 T75489 arg2Of degree,shows
R24570 T89662 T56173 arg1Of therapy,IVIG
R24587 T40953 T19443 arg1Of coronaviruses,as
R24598 T92082 T32575 arg1Of are,ideally
R24626 T80386 T79863 arg3Of ),(
R24639 T67580 T96599 arg1Of therapy,COVID-19
R24659 T36559 T29454 arg2Of developed,and
R24705 T26799 T97722 arg1Of was,","
R24714 T40665 T71867 arg1Of antibodies,cross
R24725 T26913 T10299 arg1Of patients,were
R2474 T64138 T29390 arg1Of effect,the
R24762 T84414 T96732 arg2Of therapy,received
R24883 T84543 T40034 arg2Of but,was
R24887 T35808 T13978 arg1Of saturation,oxygen
R24947 T42028 T7474 arg1Of RNA,reaches
R24950 T38357 T99851 arg1Of and,older
R24969 T62247 T55724 arg1Of deficiencies,[
R24971 T25730 T22468 arg1Of degree,in
R24972 T68140 T41139 arg1Of affinities,","
R25031 T85369 T77390 arg1Of viral,and
R25043 T98779 T26256 arg2Of and,to
R25082 T22631 T6254 arg2Of help,:
R25087 T23341 T20580 arg2Of transfusion,Following
R25101 T79439 T5826 arg1Of domain,S2
R25118 T31717 T27996 arg3Of ],[
R25119 T28417 T16199 arg2Of inhibit,can
R25179 T38385 T65035 arg1Of Serum,from
R25207 T6658 T23368 arg2Of humans,in
R25227 T64673 T9982 arg1Of lesions,lung
R25292 T42278 T9092 arg2Of patient,of
R25309 T58218 T42547 arg1Of group,first
R25333 T65830 T56952 arg1Of patients,with
R25355 T46672 T4016 arg1Of SARS-CoV,and
R25360 T33856 T54452 arg1Of origin,the
R25376 T66546 T88322 arg2Of IRW,as
R25403 T3490 T44653 arg1Of severe,or
R2541 T50396 T59179 arg2Of patients,accompanied
R25437 T95515 T31802 arg1Of virus,2019-nCoV
R25441 T39838 T24097 arg1Of decrease,","
R25449 T53777 T68425 arg1Of junctions,absolutely
R25456 T32800 T83224 arg2Of begin,that
R2548 T53426 T93176 arg1Of RNA,reaches
R25499 T35438 T50077 arg2Of up-regulation,Through
R25517 T89003 T94847 arg2Of subunit,with
R2563 T82872 T63033 arg1Of immunoglobulin,20 g/d
R25631 T47460 T57607 arg1Of look,A
R25674 T11971 T91181 arg1Of used,in
R2570 T66184 T63565 arg2Of cells,in
R25704 T98139 T47163 arg2Of repertoires,containing
R25745 T40275 T49682 arg2Of ",",means
R258 T267 T266 arg1Of Introduction,1
R25803 T79772 T47524 arg1Of week,first
R2585 T36179 T74019 arg1Of week,second
R25853 T35183 T95206 arg1Of links,to
R2587 T6733 T66580 arg1Of and,in
R25886 T13854 T66871 arg2Of ACE,(
R259 T269 T268 arg1Of generations,Several
R25939 T89678 T20122 arg1Of history,the
R25978 T49089 T56097 arg1Of are,Also
R260 T269 T270 arg1Of generations,have
R26006 T80253 T56752 arg2Of membranes,and
R26081 T29994 T14560 arg1Of time-consuming,very
R26094 T18879 T12218 arg1Of inhibitors,","
R261 T272 T270 arg2Of exposed,have
R26123 T16756 T20306 arg1Of receiving,without
R26135 T56862 T17027 arg1Of similarity,90
R262 T269 T271 arg1Of generations,been
R26206 T29701 T86722 arg2Of and,at
R26225 T73202 T49682 arg1Of latter,means
R26263 T97193 T84364 arg1Of nafamostat,and
R26290 T39927 T42920 arg2Of sequence,in
R26291 T98647 T30756 arg1Of disease,fatal
R26292 T59480 T16934 arg1Of inhibition,the
R263 T272 T271 arg2Of exposed,been
R26303 T44667 T25201 arg1Of inhibition,of
R2631 T97802 T80013 arg2Of begin,that
R26320 T95417 T50853 arg1Of IVIG,contains
R26327 T42278 T49696 arg1Of patient,a
R26368 T74776 T82506 arg1Of and,share
R26377 T5389 T55726 arg1Of resemblance,of
R26398 T7828 T86158 arg2Of patients,from
R264 T269 T272 arg2Of generations,exposed
R26413 T6163 T32422 arg1Of improved,After
R26417 T45789 T84858 arg1Of they,be
R26450 T42893 T58084 arg2Of nucleotides,in
R26476 T61880 T72786 arg2Of results,shown
R26497 T1931 T51998 arg1Of branches,are
R26499 T85869 T11737 arg1Of option,potent
R265 T272 T273 arg1Of exposed,to
R26520 T89508 T88322 arg1Of known,as
R26531 T80270 T32817 arg2Of remedy,as
R26551 T71641 T61270 arg1Of protein,S
R26554 T83078 T5000 arg2Of treatment,for
R26598 T58026 T85532 arg3Of ),(
R266 T274 T273 arg2Of COVID-19,to
R26619 T82065 T15003 arg1Of –,the
R26625 T48924 T79954 arg1Of effect,an
R26629 T13833 T79561 arg1Of and,e.g.
R26632 T48662 T22507 arg1Of moderate-dose,of
R2665 T97598 T13999 arg1Of arthritis,systematic
R267 T272 T275 arg1Of exposed,under
R26730 T20946 T69163 arg1Of genomes,the
R26738 T20513 T40582 arg2Of viruses,of
R26741 T97526 T37933 arg1Of SARS-CoV2,","
R268 T277 T275 arg2Of conditions,under
R26850 T48569 T69281 arg1Of isolate,identical
R26862 T45992 T18604 arg1Of dose,moderate
R26875 T27055 T9724 arg1Of effect,patient
R269 T277 T276 arg1Of conditions,different
R26904 T85855 T78367 arg2Of use,recommended
R26919 T28601 T59987 arg2Of entry,reduced
R2693 T54798 T37085 arg2Of improvement,achieved
R26977 T53907 T33747 arg1Of sera,neutralize
R26981 T31105 T21671 arg2Of SARS-2-S,and
R270 T277 T278 arg1Of conditions,of
R27005 T7566 T88144 arg2Of in,but
R27015 T33160 T63816 arg2Of load,","
R27028 T16710 T93255 arg2Of patients,in
R27054 T7184 T59673 arg1Of line,embryonic
R27076 T17915 T64464 arg3Of ],[
R27084 T42133 T24092 arg1Of outbreak,the
R271 T279 T278 arg2Of life,of
R27124 T96902 T31590 arg1Of existed,","
R27176 T58020 T17353 arg1Of similar,in
R27190 T60580 T19399 arg1Of nucleocapsid,(
R27191 T23626 T98539 arg1Of effects,nor
R272 T272 T280 arg1Of exposed,at
R27208 T45371 T86603 arg1Of It,lie
R27252 T93924 T30867 arg1Of H2L2,chimeric
R27294 T1824 T31388 arg2Of absorbed,was
R273 T282 T280 arg2Of locations,at
R27383 T59200 T13336 arg3Of ],[
R274 T282 T281 arg1Of locations,varying
R27403 T93212 T48141 arg2Of treat,can
R27411 T58244 T74170 arg2Of confirm,will
R27449 T83078 T64198 arg1Of treatment,tocilizumab
R275 T282 T283 arg1Of locations,around
R27501 T51141 T36542 arg2Of score,and
R2751 T85333 T4126 arg1Of identity,of
R2759 T62141 T31599 arg1Of arthritis,polyarticular
R27595 T24866 T7060 arg2Of transition,accompany
R276 T285 T283 arg2Of world,around
R27603 T55893 T84276 arg1Of protein,of
R27614 T14538 T20437 arg1Of similarity,of
R27615 T48129 T64443 arg1Of therapy,accelerate
R27618 T32075 T98023 arg2Of pseudotypes,of
R27621 T86955 T55812 arg1Of risk,in
R27628 T87582 T97802 arg2Of rise,begin
R27649 T51998 T82603 arg1Of are,in
R27652 T26722 T73113 arg2Of plasma,offers
R27664 T29454 T13828 arg1Of and,and
R27687 T81378 T25066 arg2Of degree,is
R277 T285 T284 arg1Of world,the
R27711 T11971 T84858 arg2Of used,be
R27738 T5476 T18906 arg1Of Corticosteroids,modulate
R27739 T61991 T21073 arg2Of study,In
R27740 T76927 T21523 arg1Of sequencing,could
R27741 T39330 T5681 arg1Of and,make
R27747 T94564 T92800 arg1Of utilize,Also
R27749 T42602 T70474 arg1Of virus,","
R27767 T68740 T23496 arg1Of plasma,convalescent
R27770 T75325 T40173 arg2Of week,during
R27782 T5721 T21671 arg1Of SARS-S,and
R278 T287 T286 arg1Of long,As
R27833 T59832 T39922 arg1Of notions,traditional
R27865 T10314 T77548 arg1Of effect,of
R27880 T10954 T45480 arg2Of important,is
R27887 T17221 T24580 arg1Of approved,for
R279 T303 T287 arg1Of increased,long
R27976 T73930 T66178 arg1Of day,the
R280 T288 T287 arg2Of as,long
R2805 T87852 T72254 arg2Of leukocytes,of
R28065 T10303 T7764 arg1Of they,can
R28069 T51053 T84085 arg1Of Rp3,(
R28087 T5376 T64814 arg1Of Hypothesis,–
R281 T291 T288 arg2Of continues,as
R28120 T12723 T39296 arg1Of proteins,structural
R28137 T80710 T77485 arg1Of plasma,Convalescent
R28161 T38385 T98558 arg1Of Serum,4.1.3
R28181 T27914 T8453 arg2Of administered,be
R282 T290 T289 arg1Of COVID-19,the
R28208 T35511 T1792 arg1Of entry,of
R28224 T54792 T41003 arg1Of ciclesonide,","
R28227 T10629 T97483 arg1Of shown,","
R28299 T57882 T2438 arg1Of pH,by
R283 T290 T291 arg1Of COVID-19,continues
R28343 T57783 T5455 arg1Of sequences,genome
R28351 T63640 T96099 arg3Of ],[
R284 T293 T291 arg2Of spread,continues
R28408 T50457 T21885 arg1Of notion,different
R28455 T9385 T93008 arg2Of 90,than
R28465 T23786 T45333 arg1Of moderate,and
R28496 T65635 T24915 arg1Of and,","
R285 T293 T292 arg1Of spread,to
R28532 T25577 T79456 arg2Of protein,Targeting
R28577 T7184 T98832 arg1Of line,human
R286 T290 T293 arg1Of COVID-19,spread
R2860 T91011 T23827 arg3Of ],[
R28624 T52785 T92712 arg1Of and,severe
R28653 T47586 T67925 arg1Of rise,to
R28660 T73696 T7458 arg1Of replication,of
R28676 T89782 T96392 arg1Of serum,from
R287 T303 T294 arg1Of increased,","
R28703 T28149 T84544 arg2Of ",",with
R28733 T9761 T69880 arg1Of replication,reaches
R28796 T28228 T71564 arg1Of Tor2,and
R288 T296 T295 arg1Of power,its
R28808 T44373 T75308 arg2Of have,so
R28844 T93891 T28149 arg2Of envelope,","
R28884 T90573 T50903 arg1Of decrease,[
R28892 T27506 T38004 arg1Of ovotransferrin,Egg
R289 T296 T297 arg1Of power,of
R28920 T43323 T54178 arg1Of and,proteins
R28962 T52934 T16269 arg1Of –,encodes
R28970 T61968 T94564 arg1Of both,utilize
R28995 T9832 T13628 arg1Of sepsis,","
R290 T299 T297 arg2Of modification,of
R29015 T52866 T91181 arg2Of form,in
R29016 T16756 T15733 modOf receiving,to
R29028 T70141 T37933 arg2Of N-glycans,","
R29067 T86110 T76482 arg2Of targets,as
R29083 T52375 T27748 arg2Of sample,of
R291 T299 T298 arg1Of modification,genome
R29116 T51393 T29543 arg1Of detection,in
R29123 T18064 T9269 arg1Of and,","
R29180 T69102 T88119 arg2Of revealed,after
R292 T296 T300 arg1Of power,would
R29203 T48569 T20680 arg1Of isolate,of
R29264 T44653 T80340 arg2Of or,was
R29265 T85333 T51362 arg1Of identity,high
R29294 T65344 T46398 arg2Of CatB/L,(
R293 T303 T300 arg2Of increased,would
R2931 T49967 T2352 arg1Of transfusion,of
R294 T303 T301 arg1Of increased,probably
R2941 T52732 T71483 arg1Of rates,mutation
R29418 T35671 T71867 arg2Of neutralize,cross
R29456 T69348 T39007 arg1Of course,disease
R29470 T47796 T47586 arg1Of and,rise
R295 T296 T302 arg1Of power,be
R29507 T50104 T55605 arg1Of chloride,ammonium
R29518 T68003 T5000 arg1Of trials,for
R29523 T15000 T78684 arg1Of patient,with
R2953 T72581 T23282 arg1Of formation,syncytia
R29558 T17096 T50493 arg2Of infection,after
R29591 T53624 T2868 arg2Of and,from
R296 T303 T302 arg2Of increased,be
R29604 T88114 T80638 arg2Of injury,treat
R29631 T92397 T70831 arg1Of degrees,of
R297 T296 T303 arg2Of power,increased
R2970 T25963 T66169 arg1Of corticosteroid,moderate-dose
R2971 T41203 T45935 arg3Of ),(
R29719 T59765 T19590 arg1Of protein,SARS-CoV2
R29783 T29960 T25638 arg1Of patient,the
R298 T304 T305 arg1Of What,concerns
R29816 T2491 T63623 arg1Of domain,same
R29860 T27007 T55724 arg2Of 21,[
R29876 T45789 T91069 arg1Of they,can
R29888 T31606 T86235 arg1Of steps,two
R29891 T40602 T14267 arg2Of able,is
R299 T306 T305 arg2Of us,concerns
R29937 T12338 T80948 arg2Of ACE2,express
R29960 T97339 T30904 arg1Of trials,show
R29965 T17280 T32273 arg2Of bats,of
R29995 T53777 T82506 arg2Of junctions,share
R300 T307 T305 arg3Of more,concerns
R30007 T49542 T83536 arg1Of activity,more
R30046 T7628 T28138 arg1Of strain,the
R30054 T2522 T48589 arg1Of 1,:
R30062 T42834 T27205 arg1Of patients,with
R30096 T26913 T55829 arg1Of patients,turned
R301 T304 T308 arg1Of What,is
R30131 T77430 T49707 arg1Of system,immune
R30150 T12942 T83444 arg1Of binding,of
R3018 T59480 T64120 arg1Of inhibition,of
R30185 T16420 T17928 arg1Of occur,merely
R302 T327 T308 arg2Of fitted,is
R30204 T17766 T91507 arg1Of effect,of
R30207 T82392 T16735 arg2Of diseases,of
R30216 T55185 T10219 arg2Of avium,","
R30238 T88396 T41360 arg1Of infection,of
R303 T327 T309 arg1Of fitted,that
R30321 T97752 T30344 arg2Of serum,and
R3036 T59765 T61296 arg1Of protein,Spike
R30372 T98349 T84544 arg1Of correlate,with
R3039 T79215 T5404 arg1Of patients,with
R304 T311 T310 arg1Of 2019-nCoV,the
R30421 T88382 T5367 arg2Of strain,from
R30440 T48129 T90120 arg1Of therapy,might
R30475 T65630 T2677 arg2Of tuberculosis,","
R305 T327 T312 arg1Of fitted,","
R30509 T27554 T52886 arg1Of subunit,S1
R30550 T8033 T98349 arg1Of frames,correlate
R3058 T40210 T92515 arg1Of strains,Rp3
R306 T327 T313 arg1Of fitted,by
R30604 T26763 T54709 arg2Of SARS-CoV2,against
R30611 T23558 T93581 arg1Of circumstances,the
R307 T315 T313 arg2Of process,by
R30751 T78997 T69102 arg1Of onset,revealed
R30772 T89187 T91474 arg1Of used,commonly
R30779 T33446 T16300 arg1Of patients,46
R308 T315 T314 arg1Of process,the
R30812 T2068 T86274 arg2Of promote,and
R30813 T93924 T69919 arg1Of H2L2,effective
R30825 T71868 T54079 arg1Of %,and
R30853 T86603 T91829 arg1Of lie,in
R30895 T50396 T53728 arg1Of patients,ten
R309 T315 T316 arg1Of process,of
R30944 T42466 T16443 arg1Of B,cathepsin
R30994 T45532 T48184 arg1Of replication,viral
R310 T317 T316 arg2Of modification,of
R31050 T75815 T40843 arg1Of degree,in
R31078 T58590 T50194 arg1Of concentrations,of
R31087 T64515 T30704 arg1Of days,14
R31098 T61673 T59345 arg1Of signal,is
R311 T317 T318 arg1Of modification,of
R31135 T11971 T68994 arg1Of used,In
R31165 T64204 T92436 arg1Of domain,receptor-binding
R312 T320 T318 arg2Of structure,of
R31206 T57783 T89898 arg1Of sequences,the
R31230 T39154 T80047 arg1Of domains,main
R31237 T87690 T68835 arg1Of and,contains
R31240 T8679 T32352 arg1Of ",",and
R31293 T53535 T71577 arg2Of activity,blocking
R313 T320 T319 arg1Of structure,genome
R31307 T10629 T44219 arg2Of shown,has
R31347 T98815 T75376 arg1Of COVID-19,demonstrated
R31375 T75582 T5404 arg2Of COVID-19,with
R31379 T18879 T61277 arg1Of inhibitors,serine
R31390 T18384 T4817 arg2Of 16,[
R314 T327 T321 arg1Of fitted,","
R31404 T79253 T84917 arg1Of hand,the
R31420 T69880 T96177 arg1Of reaches,In
R315 T311 T322 arg1Of 2019-nCoV,might
R31512 T17398 T26632 arg3Of trust,lead
R31515 T37666 T30663 arg1Of diseases,that
R31571 T75815 T56235 arg1Of degree,a
R316 T327 T322 arg2Of fitted,might
R31601 T19520 T87934 arg1Of structure,and
R31620 T4274 T67075 arg1Of %,94
R31644 T49266 T10805 arg2Of laboratory,","
R31648 T64598 T35896 arg1Of range,The
R3169 T58899 T90021 arg2Of outbreak,and
R317 T311 T323 arg1Of 2019-nCoV,become
R31752 T53029 T33850 arg2Of outbreaks,of
R31769 T65830 T31198 arg2Of patients,included
R31772 T71701 T52612 arg1Of sequence,of
R318 T327 T323 arg2Of fitted,become
R31825 T40953 T7458 arg2Of coronaviruses,of
R31881 T33015 T53625 arg1Of samples,fecal
R31887 T80253 T14937 arg1Of membranes,host
R319 T327 T324 arg1Of fitted,more
R31914 T40198 T87895 arg2Of 12,[
R31915 T84364 T12218 arg2Of and,","
R31926 T15256 T39714 arg1Of reduction,of
R31979 T9970 T76093 arg1Of domain,of
R31986 T22570 T8091 arg1Of characteristics,that
R320 T324 T325 arg1Of more,and
R32011 T90447 T61529 arg3Of ),(
R32051 T70519 T48403 arg1Of patients,convalescent
R32057 T20769 T53543 arg2Of neutralize,able
R32091 T45315 T13278 arg2Of MERS-S,and
R321 T326 T325 arg2Of more,and
R32128 T10303 T28508 arg1Of they,enter
R32155 T28738 T95580 arg2Of protein,and
R322 T327 T326 arg1Of fitted,more
R32206 T90255 T34609 arg1Of coronavirus,The
R32244 T97737 T80974 arg1Of protease,their
R32288 T32416 T22714 arg1Of entry,the
R323 T311 T327 arg2Of 2019-nCoV,fitted
R32306 T60314 T35183 arg1Of Evidence,links
R32316 T6733 T17651 arg2Of and,between
R32317 T57345 T30814 arg1Of antibody,decreased
R3232 T12601 T14267 arg1Of serum,is
R32394 T22929 T58621 arg1Of agents,anti-viral
R324 T327 T328 arg1Of fitted,to
R32415 T4274 T73088 arg1Of %,and
R32436 T66546 T45851 arg1Of IRW,","
R32473 T65630 T67405 arg1Of tuberculosis,Mycobacterium
R325 T329 T328 arg2Of humans,to
R32534 T99917 T85323 arg2Of binding,for
R32545 T15191 T44829 arg1Of revealed,When
R32577 T74401 T41163 arg2Of mAb,:
R326 T332 T330 arg1Of affect,to
R32622 T39073 T25723 arg2Of SARS-2-S,and
R32657 T89944 T31387 arg1Of reduce,effectively
R32666 T32201 T47689 arg1Of treatment,immunomodulatory
R3268 T12526 T42165 arg2Of 12,[
R327 T329 T330 modOf humans,to
R32703 T3983 T20802 arg1Of so,that
R32719 T17328 T96682 arg1Of Hypothesis,6.1.1
R32731 T38590 T37156 arg1Of safety,and
R32754 T64776 T19500 arg1Of and,the
R32776 T81462 T32973 arg2Of deal,help
R328 T332 T331 arg1Of affect,profoundly
R32841 T8090 T96099 arg1Of Toronto,[
R32875 T53586 T54198 arg1Of recruitment,the
R32883 T89053 T50644 arg2Of care,and
R329 T333 T332 arg2Of those,affect
R32916 T20067 T28168 arg1Of and,and
R32918 T52998 T62090 arg1Of sequencing,whole-genome
R3294 T31327 T10621 arg2Of 22,[
R32948 T47275 T30995 arg2Of able,were
R330 T333 T334 arg1Of those,who
R33041 T50749 T33950 arg2Of potential,have
R33081 T71924 T9965 arg1Of cause,well
R331 T333 T335 arg1Of those,have
R33107 T33017 T42013 arg2Of domain,in
R33111 T9027 T52339 arg2Of criticality,","
R33115 T93112 T59526 arg1Of transfer,passive
R33132 T55876 T91971 arg1Of day,14th
R33152 T71594 T30344 arg1Of serum,and
R33163 T64285 T67888 arg1Of all,of
R33164 T28601 T66409 arg1Of entry,the
R33193 T71072 T98716 arg1Of effects,anti-inflammatory
R332 T337 T335 arg2Of escaped,have
R33232 T80270 T73367 arg1Of remedy,the
R33240 T80516 T98862 arg1Of IVIG,improve
R33248 T30470 T43255 arg2Of and,as
R33260 T92502 T8496 arg1Of Corticosteroids,accelerate
R33270 T62479 T19773 arg1Of receptor,ACE2
R33275 T59818 T18282 arg1Of addition,to
R333 T337 T336 arg1Of escaped,already
R33352 T86123 T22569 arg2Of VCAM-1,and
R33385 T25454 T15312 arg1Of It,safe
R334 T333 T337 arg1Of those,escaped
R33407 T14361 T80094 arg1Of inhibit,","
R33432 T64274 T24072 arg1Of IL6,cytokine
R33460 T54347 T14954 arg2Of process,and
R335 T340 T337 arg2Of and,escaped
R3351 T49362 T71892 arg1Of through,than
R33522 T39927 T98118 arg1Of sequence,the
R33556 T47949 T53819 arg1Of onset,infection
R33558 T86415 T93994 arg1Of reduce,whether
R336 T339 T338 arg1Of children,–
R33601 T14876 T91231 arg2Of 2019-nCoV,contained
R33669 T85498 T54727 arg1Of Antiserum,that
R33688 T39330 T65635 arg1Of and,and
R33694 T48435 T43362 arg2Of protect,could
R33698 T47796 T32800 arg1Of and,begin
R337 T339 T340 arg1Of children,and
R33735 T64138 T71428 arg2Of effect,evaluate
R33791 T99851 T19164 arg2Of older,and
R338 T342 T340 arg2Of people,and
R33807 T84385 T20825 arg1Of reduce,","
R33815 T7474 T4182 arg1Of reaches,and
R33852 T98862 T88012 arg1Of improve,to
R33869 T76844 T88673 arg2Of species,between
R33893 T62247 T68999 arg2Of deficiencies,in
R339 T342 T341 arg1Of people,young
R33918 T78742 T43059 arg1Of degree,lesser
R33937 T56920 T78221 arg2Of regions,and
R3397 T47874 T83196 arg1Of affinity,a
R33983 T74827 T27915 arg1Of used,Recently
R340 T337 T343 arg1Of escaped,without
R3402 T44174 T26910 arg1Of recovered,from
R34037 T68003 T74304 arg1Of trials,clinical
R34046 T62139 T75854 arg1Of receptor,cell
R34054 T42640 T56297 arg1Of subunit,the
R34056 T48129 T55251 arg1Of therapy,IVIG
R34099 T58224 T78182 arg1Of early,as
R341 T346 T343 arg2Of condition,without
R34116 T49329 T91601 arg1Of outcomes,of
R34129 T11859 T80531 arg2Of and,decreased
R34142 T95515 T37831 arg2Of virus,of
R34146 T53611 T22569 arg1Of ICAM-1,and
R3415 T33017 T41576 arg1Of domain,S1
R34196 T13891 T38357 arg2Of children,and
R342 T346 T344 arg1Of condition,a
R34213 T32529 T86722 arg1Of inhibit,at
R34230 T39553 T90021 arg1Of pandemic,and
R34245 T15127 T87902 arg2Of 10,[
R3429 T73209 T1981 arg2Of corticosteroids,and
R343 T346 T345 arg1Of condition,pre-existing
R34313 T21161 T45933 arg1Of agent,the
R34331 T31059 T77548 arg2Of chloride,of
R34363 T37814 T61939 arg1Of develop,after
R34375 T70918 T20327 arg1Of similar,to
R344 T348 T347 arg1Of one,No
R34441 T17328 T61727 arg1Of Hypothesis,:
R34450 T62247 T52471 arg1Of deficiencies,antibodies
R345 T348 T349 arg1Of one,can
R34529 T10299 T59448 arg1Of were,before
R34537 T77495 T16541 arg1Of MERS-CoV,the
R34556 T89003 T41606 arg1Of subunit,of
R34567 T7654 T71050 arg1Of plasma,from
R346 T350 T349 arg2Of tell,can
R34622 T79253 T41471 arg1Of hand,other
R34637 T94029 T18906 arg2Of inflammation,modulate
R34638 T73342 T79102 arg2Of bats,from
R34640 T59765 T57535 arg1Of protein,the
R34673 T62855 T26039 arg1Of kinetics,viral
R34689 T39551 T99566 arg2Of identical,remain
R347 T348 T350 arg1Of one,tell
R3470 T16685 T50188 arg2Of parameters,in
R3471 T37204 T13336 arg2Of 12,[
R34720 T3419 T43926 arg2Of block,does
R34762 T20124 T52172 arg1Of responses,immune
R34792 T76540 T40602 arg2Of neutralize,able
R348 T351 T350 arg2Of how,tell
R34809 T32129 T58635 arg2Of prednisolone,","
R34814 T35672 T18282 arg2Of regimen,to
R34824 T14267 T39971 arg1Of is,not
R3485 T19375 T86256 arg1Of favorable,therefore
R34870 T63353 T17353 arg2Of and,in
R349 T352 T351 arg1Of much,how
R34990 T99819 T40027 arg1Of i.e.,","
R350 T355 T352 arg1Of takes,much
R35026 T44497 T44722 arg1Of corticosteroids,modulate
R35046 T64285 T38661 arg1Of all,switching
R35060 T73930 T38757 arg1Of day,14th
R35077 T20513 T48639 arg1Of viruses,these
R351 T352 T353 arg1Of much,time
R35124 T95208 T91019 arg1Of Rational,:
R35129 T57882 T24686 arg1Of pH,the
R35135 T36466 T69055 arg1Of patients,have
R35148 T12942 T21955 arg1Of binding,the
R35158 T58635 T52544 arg1Of ",",","
R35190 T62855 T13471 arg1Of kinetics,the
R352 T354 T355 arg1Of it,takes
R35205 T86415 T95640 arg2Of reduce,can
R35214 T86532 T85825 arg1Of High-content,A
R35220 T84785 T86080 arg1Of antibodies,IgG
R35227 T13001 T2287 arg1Of modulation,of
R3528 T98634 T55070 arg2Of S2,and
R353 T357 T355 arg2Of reach,takes
R35318 T2572 T97128 arg1Of SARS-S,and
R35338 T21671 T49586 arg1Of and,utilize
R35363 T5389 T78835 arg2Of resemblance,of
R35365 T21018 T30544 arg1Of pressure,in
R354 T357 T356 arg1Of reach,to
R3544 T77495 T91861 arg2Of MERS-CoV,of
R35442 T18322 T80297 arg1Of patients,with
R35461 T36179 T87676 arg2Of week,during
R35498 T76285 T93115 arg1Of cells,TMPRSS2 + Caco-2
R355 T354 T357 arg1Of it,reach
R35568 T67874 T96660 arg2Of and,show
R35581 T33160 T3842 arg1Of load,viral
R356 T360 T357 arg2Of level,reach
R35623 T20355 T89944 arg2Of entry,reduce
R35699 T88407 T41758 arg1Of included,","
R357 T360 T358 arg1Of level,a
R35710 T37814 T32237 arg1Of develop,against
R35747 T56884 T46706 arg1Of binding,to
R35751 T42652 T1853 arg2Of treatment,to
R35783 T44216 T86415 arg1Of use,reduce
R358 T360 T359 arg1Of level,new
R35818 T27689 T97114 arg2Of increasing,for
R35854 T64598 T57549 arg1Of range,produce
R359 T360 T361 arg1Of level,of
R35953 T1931 T94548 arg1Of branches,for
R360 T362 T361 arg2Of perfection,of
R36008 T97752 T56749 arg1Of serum,from
R36020 T74666 T46614 arg1Of polymerase,(
R36023 T10219 T2677 arg1Of ",",","
R36046 T4913 T85558 arg2Of patients,recovered
R36055 T55070 T83444 arg2Of and,of
R36058 T59832 T79640 arg1Of notions,of
R36062 T40953 T58259 arg1Of coronaviruses,human
R36099 T65675 T92132 arg1Of and,entry
R361 T361 T363 arg1Of of,","
R36109 T85972 T67874 arg1Of and,and
R36176 T52785 T6178 arg1Of and,and
R362 T361 T364 arg1Of of,and
R36223 T24248 T42365 arg2Of IgM,and
R36266 T26913 T16466 arg1Of patients,seven
R363 T365 T364 arg2Of that,and
R3636 T91196 T1893 arg2Of ACE2,to
R36361 T71552 T91525 arg1Of efficiency,higher
R36370 T43668 T31501 arg1Of replication,SARS-CoV2
R364 T360 T365 arg1Of level,that
R36473 T86955 T79896 arg1Of risk,of
R36475 T99577 T85900 arg1Of it,attained
R3648 T16845 T94095 arg1Of sequence,(
R365 T373 T365 arg2Of is,that
R36526 T21885 T59931 arg2Of different,is
R36534 T59765 T4317 arg2Of protein,of
R36556 T76296 T46693 arg2Of shown,has
R36595 T55876 T78621 arg1Of day,the
R366 T367 T366 arg1Of development,the
R36619 T88382 T62453 arg1Of strain,SL-CoV
R36622 T91618 T27562 arg2Of plus,of
R36640 T39360 T76016 arg2Of s,(
R36647 T42602 T39629 arg1Of virus,positive-strand
R367 T367 T368 arg1Of development,of
R36734 T53867 T39623 arg3Of escape,allow
R36752 T84435 T6426 arg1Of treatment,plus
R368 T369 T368 arg2Of vaccines,of
R36890 T24144 T18888 arg2Of differences,produce
R369 T367 T370 arg1Of development,for
R36916 T37833 T40788 arg1Of target,the
R36961 T53710 T16554 arg1Of pathway,the
R36970 T25388 T7048 arg1Of course,late
R370 T372 T370 arg2Of immunization,for
R37042 T18877 T80580 arg1Of receptor,ACE2
R37061 T95212 T56020 arg1Of Hypothesis,4.2.1
R37082 T57345 T44833 arg1Of antibody,displayed
R37095 T70941 T36913 arg2Of limit,could
R37097 T98040 T23999 arg1Of symptoms,(
R371 T372 T371 arg1Of immunization,active
R37108 T22398 T15962 arg1Of 47D11,carried
R37128 T36459 T4317 arg1Of cleavage,of
R37154 T50829 T21513 arg1Of Calu-3,both
R37157 T45090 T8679 arg2Of ABCB-1,","
R37164 T55893 T64906 arg1Of protein,S
R37168 T64476 T34384 arg1Of effect,such
R372 T367 T373 arg1Of development,is
R37221 T17683 T50423 arg2Of and,of
R37229 T8033 T31208 arg1Of frames,and
R37231 T98539 T50204 arg1Of nor,occurred
R37239 T77475 T40616 arg1Of Rhinolophus,(
R37253 T11300 T96346 arg1Of ",",and
R3726 T37161 T59345 arg2Of present,is
R373 T376 T373 arg2Of process,is
R37332 T72667 T27689 arg2Of and,increasing
R37356 T50007 T41545 arg1Of domain,the
R37373 T51393 T33598 arg1Of detection,against
R37376 T39598 T81023 arg1Of defense,host
R37384 T81456 T44465 arg1Of and,both
R374 T376 T374 arg1Of process,a
R3741 T32652 T92448 arg1Of responses,immune
R37459 T80531 T13833 arg2Of decreased,and
R37476 T40665 T54239 arg1Of antibodies,can
R3748 T42144 T52542 arg2Of responses,of
R37482 T85613 T46259 arg1Of has,","
R37496 T39927 T60639 arg1Of sequence,between
R375 T376 T375 arg1Of process,long
R37501 T66576 T61388 arg1Of years,two
R37530 T80638 T46139 arg2Of treat,can
R37588 T32795 T88629 arg1Of Sera,from
R376 T386 T377 arg1Of are,Moreover
R37625 T6987 T41127 arg1Of mesylate,camostat
R37635 T72133 T81416 arg2Of extent,to
R37642 T59443 T14412 arg1Of down-regulation,of
R37658 T77029 T86274 arg1Of requires,and
R37668 T37619 T43323 arg2Of N.,and
R37669 T50457 T44962 arg2Of notion,supports
R377 T386 T378 arg1Of are,","
R37706 T4784 T41606 arg2Of SARS-S,of
R37712 T86961 T43097 arg1Of role,the
R3776 T86110 T97786 arg1Of targets,for
R37777 T10243 T94164 arg1Of Study,has
R37793 T96625 T75572 arg1Of Patients,who
R37795 T93826 T27767 arg1Of due,to
R378 T379 T380 arg1Of most,of
R37840 T13628 T43956 arg2Of ",",as
R37865 T80315 T58229 arg1Of immunization,protects
R37867 T51504 T98332 arg1Of subunit,of
R3787 T29624 T74170 arg1Of reaction,will
R379 T385 T380 arg2Of agents,of
R37915 T50002 T41374 arg1Of cells,that
R3792 T65405 T27300 arg2Of mAb,(
R37940 T58590 T5139 arg1Of concentrations,high
R37944 T17027 T88762 arg1Of 90,%
R37965 T27396 T52824 arg1Of dictate,not
R380 T385 T381 arg1Of agents,the
R38001 T51393 T60810 arg1Of detection,among
R38065 T98647 T44793 arg2Of disease,cause
R38076 T7550 T23827 arg1Of infection,[
R381 T383 T382 arg1Of available,best
R382 T385 T383 arg1Of agents,available
R38202 T95152 T64168 arg3Of ],[
R3822 T57517 T2352 arg2Of plasma,of
R38259 T97339 T72804 arg1Of trials,clinical
R38280 T71552 T15191 arg2Of efficiency,revealed
R383 T385 T384 arg1Of agents,anti-viral
R38349 T51053 T40481 arg1Of Rp3,isolate
R38398 T55032 T54166 arg2Of SARS,with
R384 T379 T386 arg1Of most,are
R38432 T18576 T50188 arg1Of differ,in
R385 T388 T386 arg2Of helpful,are
R38579 T81326 T85814 arg1Of isolated,in
R38585 T67947 T51866 arg2Of 90,than
R386 T386 T387 arg1Of are,not
R38640 T65675 T96172 arg1Of and,cell
R38672 T56752 T80511 arg2Of and,of
R38683 T97737 T89215 arg1Of protease,","
R387 T379 T388 arg1Of most,helpful
R38722 T7154 T39745 arg2Of COVID-19,from
R38725 T50457 T59931 arg1Of notion,is
R3874 T2491 T57621 arg1Of domain,of
R38756 T90499 T46430 arg1Of treat,to
R388 T386 T389 arg1Of are,in
R38806 T4240 T2183 arg1Of increase,an
R38807 T30144 T39590 arg1Of and,However
R38821 T32201 T26744 arg1Of treatment,currently
R38873 T9582 T19789 arg1Of virus,respiratory
R389 T391 T389 arg2Of treatment,in
R38913 T28738 T84704 arg1Of protein,nucleocapsid
R38926 T33016 T45981 arg1Of S,","
R38960 T78742 T2565 arg2Of degree,e
R38976 T93891 T12498 arg1Of envelope,(
R38992 T60914 T95632 arg1Of 1–2 mg/kg/d,for
R390 T391 T390 arg1Of treatment,the
R39000 T39598 T27355 arg1Of defense,the
R39033 T51504 T69690 arg1Of subunit,S1
R39066 T32990 T32353 arg1Of suppress,generally
R39074 T22570 T39623 arg1Of characteristics,allow
R391 T391 T392 arg1Of treatment,of
R39175 T82101 T1902 arg1Of S1B,and
R392 T393 T392 arg2Of COVID-19,of
R39227 T82047 T16733 arg1Of NSP15,the
R39248 T64443 T89890 arg1Of accelerate,to
R39252 T82201 T93235 arg1Of regulation,aid
R39297 T22412 T36397 arg1Of CoV,SARS-like
R393 T397 T394 arg1Of trial,A
R39309 T52981 T49738 arg1Of H1N1,in
R39324 T13833 T58632 arg1Of and,","
R39377 T66003 T37276 arg2Of peptide,contains
R3939 T34896 T77136 arg2Of and,in
R39394 T93924 T21134 arg1Of H2L2,The
R39396 T87601 T11172 arg2Of patients,from
R394 T397 T395 arg2Of trial,randomized
R39436 T23714 T50076 arg2Of antibodies,contains
R39441 T77639 T14621 arg2Of fatalities,avoid
R39456 T71073 T8391 arg1Of conditions,inflammatory
R395 T397 T396 arg2Of trial,controlled
R39576 T62139 T94971 arg2Of receptor,with
R396 T397 T398 arg1Of trial,of
R39618 T82190 T9564 arg1Of 2019-nCoV,the
R3964 T96672 T78252 arg1Of variety,a
R39650 T87007 T95580 arg1Of glycoproteins,and
R39672 T75815 T89657 arg1Of degree,noticeable
R397 T401 T398 arg2Of adults,of
R39708 T94273 T56156 arg1Of 0.29 μg/g,4
R39715 T72581 T71888 arg2Of formation,induced
R39732 T42798 T53867 arg1Of SARS-CoV2,escape
R39759 T71577 T97443 arg1Of blocking,through
R398 T401 T399 arg1Of adults,199
R39863 T81104 T21841 arg1Of immunized,with
R39883 T52803 T28508 arg2Of cells,enter
R399 T401 T400 arg2Of adults,hospitalized
R3997 T89003 T18520 arg1Of subunit,S2
R39984 T56787 T34590 arg2Of assumes,and
R3999 T64673 T90980 arg2Of lesions,detected
R400 T401 T402 arg1Of adults,with
R40020 T50471 T18273 arg2Of and,of
R4003 T6426 T52543 arg2Of plus,following
R4008 T48589 T17226 arg2Of :,than
R40089 T85558 T54139 arg1Of recovered,from
R401 T404 T402 arg2Of COVID-19,with
R40101 T35266 T22680 arg2Of cells,In
R40147 T94153 T75975 arg2Of cortisone,","
R40198 T81326 T18272 arg2Of isolated,was
R402 T404 T403 arg2Of COVID-19,confirmed
R4025 T88599 T81348 arg1Of blocker,a
R40258 T91091 T79089 arg1Of day,the
R40262 T60914 T32544 arg2Of 1–2 mg/kg/d,(
R40263 T14835 T62406 arg1Of infection,Parvovirus
R403 T397 T405 arg1Of trial,demonstrated
R40351 T24326 T59786 arg1Of symptoms,worsening
R40363 T45225 T5484 arg1Of Rp3,SARS-lice
R40383 T63832 T88619 arg1Of caution,in
R404 T408 T405 arg2Of difference,demonstrated
R40473 T15927 T97030 arg1Of protease,the
R40479 T71443 T18696 arg2Of COVID-19,with
R40491 T61673 T18285 arg1Of signal,a
R405 T408 T406 arg1Of difference,no
R40504 T89813 T7888 arg1Of SARS-S,compete
R40508 T65980 T11859 arg2Of saturation,and
R40528 T39668 T93033 arg2Of benefit,confer
R40530 T71428 T15733 arg1Of evaluate,to
R40584 T67121 T55726 arg2Of %,of
R406 T408 T407 arg1Of difference,actual
R40601 T49668 T83674 arg2Of interact,can
R40627 T37156 T94632 arg1Of and,of
R40674 T73531 T89464 arg1Of cells,are
R40689 T82201 T72254 arg1Of regulation,of
R407 T408 T409 arg1Of difference,between
R40705 T25315 T82233 arg2Of coronavirus,of
R40741 T79772 T35185 arg1Of week,the
R4076 T13833 T83448 arg1Of and,","
R408 T410 T409 arg2Of patients,between
R40823 T36509 T87404 arg1Of Serum,neutralize
R40867 T7672 T83098 arg1Of study,showed
R409 T410 T411 arg1Of patients,who
R40933 T36542 T78207 arg2Of and,by
R4099 T71072 T2648 arg2Of effects,with
R410 T410 T412 arg1Of patients,received
R41002 T86417 T20040 arg3Of ),(
R41003 T51504 T49296 arg1Of subunit,the
R41008 T64338 T85298 arg1Of lacking,","
R41012 T54149 T19053 arg2Of and,through
R41036 T14000 T98332 arg2Of SARS-S,of
R41044 T51047 T56803 arg3Of ),(
R41066 T82598 T81899 arg1Of peak,its
R41067 T95799 T49362 arg1Of enter,through
R41074 T71868 T4274 arg1Of %,%
R41077 T92006 T18503 arg3Of ],[
R411 T414 T412 arg2Of and,received
R41127 T89545 T54246 arg1Of Studies,show
R41132 T20215 T19523 arg1Of recovered,from
R41139 T89464 T41368 arg1Of are,thus
R41169 T20828 T81529 arg2Of and,show
R41187 T86955 T19254 arg2Of risk,reduced
R412 T413 T414 arg1Of lopinavir-ritonavir,and
R4121 T69297 T37338 arg2Of subunits,into
R41247 T48498 T65635 arg2Of regions,and
R41252 T62247 T18422 arg1Of deficiencies,primary
R41260 T60445 T91733 arg1Of immunoglobulin,(
R41269 T90255 T47494 arg1Of coronavirus,","
R41275 T24477 T81104 arg2Of rabbits,immunized
R413 T415 T414 arg2Of patients,and
R41315 T92001 T54331 arg2Of rabbits,immunized
R41319 T90021 T49434 arg2Of and,include
R41346 T32652 T6432 arg1Of responses,are
R41388 T34731 T75489 arg1Of strain,shows
R414 T410 T416 arg1Of patients,who
R41419 T74666 T57901 arg2Of polymerase,and
R41497 T66546 T76296 arg2Of IRW,shown
R415 T410 T417 arg1Of patients,received
R41519 T45580 T60639 arg2Of and,between
R41521 T64285 T6163 arg1Of all,improved
R41529 T8983 T84322 arg1Of virus,and
R41530 T76285 T60629 arg1Of cells,SARS-S
R41534 T48924 T40034 arg1Of effect,was
R416 T419 T417 arg2Of care,received
R41612 T5150 T64443 arg2Of recovery,accelerate
R41615 T51141 T97739 arg1Of score,[
R41655 T49689 T32529 arg1Of Pretreatment,inhibit
R41659 T50853 T84611 arg2Of contains,:
R417 T419 T418 arg1Of care,standard
R41727 T68906 T27996 arg2Of 12,[
R418 T419 T420 arg1Of care,alone
R41813 T90339 T32990 arg1Of effects,suppress
R4189 T76094 T18300 arg1Of decreases,then
R419 T417 T421 arg1Of received,in
R41915 T58895 T63732 arg1Of outcomes,paraclinical
R41949 T36705 T68837 arg1Of syndrome,","
R41959 T41765 T96381 arg1Of mesylate,and
R420 T428 T421 arg2Of and,in
R42021 T42849 T60930 arg1Of situation,worsened
R42024 T88396 T69934 arg1Of infection,includes
R42046 T15987 T84650 arg1Of arteritis,giant
R42060 T95580 T31208 arg2Of and,and
R42067 T53967 T27300 arg3Of ),(
R42092 T72133 T53199 arg1Of extent,lesser
R421 T423 T422 arg1Of improvement,clinical
R42101 T26913 T47643 arg1Of patients,who
R42123 T70238 T85453 arg2Of doses,received
R42151 T96815 T73609 arg2Of rabbits,from
R42164 T73113 T32817 arg1Of offers,as
R42165 T37245 T44833 arg2Of activity,displayed
R42168 T55337 T23972 arg2Of 11,[
R42193 T68511 T75930 arg1Of patients,have
R422 T423 T424 arg1Of improvement,","
R42203 T7184 T37299 arg1Of line,cell
R42239 T16269 T15815 arg1Of encodes,and
R42253 T45225 T5732 arg1Of Rp3,SL-CoV
R42254 T3009 T92082 arg1Of and,are
R42265 T95468 T30678 arg1Of Rhinolophidae,family
R42281 T76542 T70219 arg2Of affected,while
R42283 T61619 T39961 arg2Of and,of
R423 T426 T424 arg2Of rate,","
R42302 T20124 T8269 arg1Of responses,anti-viral
R42305 T64615 T46489 arg1Of %,94
R4231 T52714 T50943 arg1Of patients,convalescent
R424 T426 T425 arg1Of rate,death
R42425 T64526 T51029 arg2Of SARS-CoV,For
R42427 T85015 T87582 arg1Of and,rise
R42475 T30756 T24737 arg1Of fatal,potentially
R425 T428 T427 arg1Of and,","
R42521 T15178 T90977 arg2Of corticosteroids,of
R4253 T46413 T37466 arg1Of viral,and
R42535 T41843 T35381 arg1Of neutralizing,","
R42573 T22676 T64695 arg2Of and,pseudotyped
R426 T424 T428 arg1Of ",",and
R42612 T75238 T83388 arg2Of shown,have
R42614 T24131 T44437 arg1Of protein,of
R42624 T30344 T72802 arg1Of and,neutralize
R42628 T99631 T37089 arg1Of pseudotypes,SARS-2-S
R42646 T93474 T62375 arg2Of 17,[
R427 T432 T428 arg2Of rate,and
R42735 T75548 T13216 arg1Of protein,can
R42740 T65082 T2068 arg2Of fusion,promote
R42781 T65734 T7857 arg1Of vital,for
R428 T432 T429 arg1Of rate,positive
R42805 T53543 T69045 arg2Of able,is
R42808 T59443 T10667 arg1Of down-regulation,the
R42816 T93176 T85972 arg1Of reaches,and
R42821 T97598 T88238 arg1Of arthritis,juvenile
R42871 T32652 T14361 arg2Of responses,inhibit
R42875 T58244 T28791 arg1Of confirm,seropositive
R42879 T98539 T9277 arg1Of nor,serious
R42896 T97867 T41175 arg2Of IVIG,(
R429 T432 T430 arg1Of rate,virus
R42977 T32769 T57863 arg1Of occurred,","
R42990 T33761 T84821 arg1Of spectrum,a
R430 T432 T431 arg1Of rate,test
R43001 T53426 T40522 arg1Of RNA,decreases
R43023 T58635 T68865 arg1Of ",",corticosteroids
R43068 T64958 T62199 arg1Of SARS-CoV,[
R431 T432 T433 arg1Of rate,at
R43148 T40210 T28228 arg1Of strains,Tor2
R432 T434 T433 arg2Of day,at
R4320 T52876 T70918 arg1Of It,similar
R4328 T64809 T26023 arg1Of PON,human
R43289 T96521 T30811 arg1Of bats,to
R433 T434 T435 arg1Of day,28
R43315 T92412 T42209 arg1Of replication,viral
R43356 T38146 T24019 arg1Of affect,","
R43366 T43308 T50563 arg2Of related,had
R43374 T54531 T22231 arg3Of ],[
R43398 T96263 T37600 arg1Of Rp3,SL-CoV
R434 T417 T436 arg1Of received,[
R43411 T82559 T99497 arg1Of differs,under
R43418 T4452 T60580 arg1Of proteins,nucleocapsid
R435 T437 T436 arg2Of 1,[
R43573 T60984 T76296 arg1Of that,shown
R436 T438 T436 arg3Of ],[
R4360 T69348 T3986 arg1Of course,the
R43602 T47874 T15962 arg2Of affinity,carried
R43619 T48498 T83674 arg1Of regions,can
R43666 T57029 T24463 arg1Of cells,TMPRSS2 + Caco-2
R43699 T35266 T64338 arg1Of cells,lacking
R437 T441 T439 arg1Of review,Here
R43732 T85869 T13881 arg1Of option,anti-inflammatory
R43774 T54331 T18102 arg1Of immunized,with
R43795 T64812 T69842 arg1Of use,accelerate
R438 T440 T441 arg1Of we,review
R43811 T98769 T44828 arg3Of ],[
R43834 T51998 T40424 arg1Of are,","
R43872 T1899 T21793 arg1Of There,are
R439 T443 T441 arg2Of indicators,review
R43912 T90339 T30802 arg1Of effects,potential
R43951 T46478 T46398 arg1Of L,(
R43963 T58895 T87507 arg1Of outcomes,clinical
R43998 T77430 T32412 arg1Of system,the
R440 T443 T442 arg1Of indicators,intermediate
R441 T443 T444 arg1Of indicators,of
R44114 T76540 T99887 arg1Of neutralize,efficiently
R44161 T13737 T43506 arg1Of inhibit,to
R44193 T68579 T52733 arg1Of IFN,5
R442 T446 T444 arg2Of pathogenesis,of
R44206 T82716 T22399 arg1Of Development,6
R44220 T74286 T39782 arg2Of cytokines,and
R44226 T72732 T56803 arg2Of %,(
R44270 T97128 T88888 arg2Of and,of
R44280 T38146 T32300 arg1Of affect,not
R443 T446 T445 arg1Of pathogenesis,the
R44320 T25625 T48435 arg2Of cells,protect
R44335 T14361 T84174 arg1Of inhibit,on
R444 T446 T447 arg1Of pathogenesis,of
R44421 T98040 T46765 arg1Of symptoms,clinical
R44438 T6788 T81456 arg2Of SARS-2-S,and
R4444 T31666 T59846 arg2Of autoimmune,and
R44466 T72802 T22390 arg2Of neutralize,able
R445 T448 T447 arg2Of COVID-19,of
R44540 T75325 T16396 arg1Of week,first
R44574 T39782 T79314 arg2Of and,including
R44599 T96617 T22931 arg1Of antibody,the
R446 T443 T449 arg1Of indicators,that
R44629 T42976 T76496 arg2Of methylprednisolone,received
R44640 T10431 T43810 arg2Of 16,[
R44663 T53057 T14573 arg1Of domain,the
R447 T443 T450 arg1Of indicators,have
R44712 T66003 T77918 arg1Of peptide,","
R44752 T42902 T4517 arg1Of reason,an
R4477 T92225 T55163 arg1Of COVID-19,severe
R448 T452 T450 arg2Of potential,have
R44862 T7628 T45580 arg2Of strain,and
R449 T452 T451 arg1Of potential,the
R44930 T78772 T31833 arg1Of IFN,I
R44939 T63329 T50127 arg1Of degree,similar
R44940 T58581 T97114 arg1Of Eggs,for
R44966 T38146 T72578 arg2Of affect,and
R44975 T10130 T1824 arg2Of opacity,absorbed
R44977 T9153 T54332 arg1Of day,14
R44986 T92057 T47494 arg2Of SARS-CoV2,","
R450 T452 T453 arg1Of potential,of
R45006 T80516 T69063 arg1Of IVIG,might
R45063 T27914 T10896 arg1Of administered,when
R451 T455 T453 arg2Of considered,of
R4510 T91321 T75450 arg1Of help,that
R45141 T84385 T56782 arg2Of reduce,can
R452 T455 T454 arg2Of considered,being
R45223 T40210 T39551 arg1Of strains,identical
R45246 T17546 T58982 arg2Of bats,to
R45292 T58244 T13336 arg1Of confirm,[
R453 T455 T456 arg1Of considered,for
R45343 T52328 T61958 arg1Of pigeon,(
R45347 T97422 T55724 arg3Of ],[
R45357 T36705 T47553 arg1Of syndrome,cytokine
R454 T458 T456 arg2Of treatment,for
R45413 T58229 T77600 arg1Of protects,against
R45433 T71857 T38163 arg1Of noticeable,more
R45491 T42028 T73402 arg1Of RNA,viral
R455 T458 T457 arg1Of treatment,the
R45507 T59987 T61995 modOf reduced,to
R45534 T64274 T98284 arg1Of IL6,the
R45567 T13828 T96472 arg1Of and,","
R45591 T37378 T96386 arg2Of –,that
R456 T458 T459 arg1Of treatment,of
R45638 T60636 T1788 arg1Of compounds,four
R45642 T22917 T47400 arg2Of dose,to
R45661 T90933 T64021 arg1Of more,before
R45666 T76626 T19053 arg1Of play,through
R45693 T34533 T96539 arg1Of ranging,to
R457 T460 T459 arg2Of COVID-19,of
R45703 T39330 T7384 arg1Of and,that
R45757 T81589 T68196 arg1Of antibodies,that
R45761 T36459 T44730 arg2Of cleavage,mediate
R45762 T90182 T48589 arg2Of 640,:
R45763 T78080 T53436 arg1Of and,both
R458 T464 T461 arg1Of entry,2
R45807 T32795 T18675 arg1Of Sera,could
R45826 T47874 T32288 arg1Of affinity,than
R45843 T56483 T58629 arg1Of least,at
R45855 T89662 T28898 arg2Of therapy,and
R459 T464 T462 arg1Of entry,SARS-CoV2
R4590 T7828 T20215 arg2Of patients,recovered
R45922 T32201 T83276 arg1Of treatment,an
R45963 T31415 T96381 arg2Of E-64d,and
R45973 T16617 T39745 arg1Of recovery,from
R460 T464 T463 arg1Of entry,cell
R46015 T35672 T38966 arg1Of regimen,daily
R46087 T61320 T4817 arg1Of was,[
R46099 T16845 T48942 arg2Of sequence,","
R461 T464 T465 arg1Of entry,is
R4610 T37752 T87849 arg1Of fluid,The
R46110 T49962 T42599 arg1Of S1,and
R46140 T28611 T53543 arg1Of Serum,able
R46142 T14621 T50380 arg1Of avoid,to
R46163 T50829 T68094 arg1Of Calu-3,cancer
R462 T467 T465 arg2Of complex,is
R4625 T84214 T64350 arg2Of S1B,of
R46266 T39845 T90599 arg1Of is,","
R463 T465 T466 arg1Of is,not
R46320 T13076 T79043 arg1Of Hypothesis,4.1.3.1
R464 T464 T467 arg1Of entry,complex
R46464 T54707 T29802 arg1Of early,as
R46469 T15256 T39475 arg1Of reduction,a
R46480 T81644 T34209 arg1Of presence,the
R465 T468 T469 arg1Of Fig.,1
R46504 T37912 T2287 arg2Of responses,of
R46515 T42640 T2907 arg2Of subunit,with
R466 T468 T470 arg1Of Fig.,is
R46612 T65830 T55004 arg1Of patients,ten
R46656 T28781 T80297 arg2Of and,with
R46659 T91321 T90120 arg2Of help,might
R46662 T82559 T8248 arg1Of differs,from
R46683 T28898 T83285 arg2Of and,using
R46687 T47949 T61939 arg2Of onset,after
R467 T473 T470 arg2Of illustration,is
R46705 T87507 T10805 arg1Of clinical,","
R46721 T10314 T96902 arg1Of effect,existed
R46727 T75671 T16450 arg1Of act,to
R46737 T79439 T56787 arg1Of domain,assumes
R468 T473 T471 arg1Of illustration,a
R46848 T49143 T52862 arg1Of SARS-CoV2,the
R46861 T89333 T78823 arg1Of Rational,4.1.4.2
R46891 T42133 T31651 arg2Of outbreak,of
R46895 T29466 T94716 arg1Of antibody,monoclonal
R469 T473 T472 arg1Of illustration,schematic
R46910 T64698 T66871 arg3Of ),(
R46916 T87875 T46333 arg1Of It,has
R46944 T55185 T3443 arg1Of avium,Mycobacterium
R470 T473 T474 arg1Of illustration,of
R47010 T74458 T38190 arg1Of residues,most
R47040 T26688 T69861 arg1Of methylprednisolone,1600 mg/d
R4705 T13076 T75604 arg1Of Hypothesis,:
R47055 T58925 T68174 arg2Of 1.08 μg/g,±
R471 T477 T474 arg2Of proteins,of
R47106 T67776 T67888 arg2Of patients,of
R47112 T87582 T15243 arg1Of rise,from
R47188 T29624 T34558 arg1Of reaction,chain
R472 T477 T475 arg1Of proteins,the
R47262 T21718 T80531 arg1Of study,decreased
R47267 T37655 T58021 arg1Of variety,a
R47275 T55924 T10680 arg1Of proteases,Two
R473 T477 T476 arg1Of proteins,minimum
R47300 T47242 T45981 arg2Of S,","
R47308 T9133 T51866 arg1Of greater,than
R47359 T86423 T81091 arg2Of infection,for
R47369 T73531 T60353 arg1Of cells,","
R47378 T89439 T26278 arg1Of group,the
R47382 T67121 T9133 arg1Of %,greater
R47395 T15927 T96744 arg1Of protease,host
R47396 T4602 T44962 arg1Of It,supports
R474 T477 T478 arg2Of proteins,required
R47400 T82065 T43926 arg1Of –,does
R47434 T42133 T26029 arg1Of outbreak,of
R4744 T13257 T68497 arg1Of site,explain
R475 T480 T479 arg1Of mediate,to
R4750 T93112 T68886 arg2Of transfer,using
R47508 T97598 T30470 arg2Of arthritis,and
R47510 T82402 T63048 arg1Of site,and
R47571 T2491 T48378 arg1Of domain,the
R47598 T18322 T82834 arg1Of patients,receiving
R476 T478 T479 modOf required,to
R47614 T43993 T64840 arg2Of is,and
R47659 T43668 T32529 arg2Of replication,inhibit
R47680 T9527 T89758 arg1Of saturation,peripheral
R477 T484 T480 arg2Of entry,mediate
R47705 T77066 T66238 arg2Of SARS-CoV2,of
R47706 T14876 T55260 arg1Of 2019-nCoV,the
R478 T484 T481 arg1Of entry,the
R47808 T76343 T40337 arg1Of shed,on
R47877 T41916 T92667 arg1Of interact,with
R47881 T2153 T23050 arg2Of 18,[
R47891 T74458 T20437 arg2Of residues,of
R479 T484 T482 arg1Of entry,SARS-CoV2
R47953 T36459 T37338 arg1Of cleavage,into
R47959 T54874 T48453 arg1Of cytokine,the
R47977 T7550 T93874 arg2Of infection,after
R480 T484 T483 arg1Of entry,cell
R48015 T68140 T99819 arg1Of affinities,i.e.
R48027 T7888 T34125 arg1Of compete,with
R48042 T56686 T68640 arg1Of differ,in
R48043 T63329 T78456 arg2Of degree,to
R481 T493 T485 arg1Of glycoprotein,The
R48104 T31794 T72017 arg1Of antibodies,against
R48113 T62455 T20341 arg2Of SARS-S,with
R482 T493 T486 arg1Of glycoprotein,trimeric
R48219 T6862 T31692 arg2Of day,from
R4822 T54336 T40616 arg2Of bats,(
R48240 T37738 T44869 arg1Of protein,15
R483 T486 T487 arg1Of trimeric,","
R4830 T18906 T19383 arg2Of modulate,can
R48307 T13257 T62080 arg1Of site,that
R48317 T37655 T58316 arg2Of variety,of
R48338 T24185 T58761 arg2Of antibody,is
R48343 T36887 T11592 arg1Of antibody,47D11
R48367 T95644 T10168 arg2Of target,as
R48373 T52676 T45640 arg2Of antibodies,of
R4839 T71403 T17651 arg1Of difference,between
R484 T488 T487 arg2Of transmembrane,","
R48403 T66184 T20519 arg2Of cells,inoculated
R48435 T37655 T87627 arg1Of variety,of
R48454 T37092 T65035 arg2Of patients,from
R48455 T86961 T56787 arg2Of role,assumes
R48458 T60930 T29454 arg1Of worsened,and
R48472 T45316 T34405 arg1Of protein,the
R48474 T65972 T95142 arg1Of Serum,is
R48482 T96346 T9479 arg1Of and,","
R48496 T85015 T97802 arg1Of and,begin
R485 T493 T488 arg1Of glycoprotein,transmembrane
R48507 T81904 T58859 arg1Of plasma,or
R48523 T17683 T12207 arg1Of and,both
R48533 T76542 T16218 arg1Of affected,not
R48539 T23714 T54709 arg1Of antibodies,against
R48542 T76343 T34741 arg2Of shed,:
R48546 T67884 T97649 arg1Of and,","
R48556 T69995 T3328 arg1Of cells,that
R48595 T44833 T11300 arg1Of displayed,","
R486 T493 T489 arg1Of glycoprotein,spike
R48610 T40522 T18711 arg1Of decreases,gradually
R48680 T17436 T17683 arg1Of SARS-S,and
R48681 T61991 T18474 arg1Of study,[
R487 T493 T490 arg1Of glycoprotein,(
R48701 T30704 T43796 arg1Of 14,more
R4871 T84785 T24248 arg1Of antibodies,IgM
R4872 T62980 T21998 arg3Of ],[
R48722 T32448 T6092 arg1Of protease,","
R48725 T31686 T72559 arg2Of CRP,in
R48726 T29681 T1981 arg1Of drugs,and
R48731 T59356 T69055 arg2Of signs,have
R4874 T85333 T86629 arg1Of identity,sequence
R48761 T64532 T15939 arg2Of play,:
R48789 T21027 T39050 arg1Of decoration,dense
R48790 T6178 T68999 arg1Of and,in
R488 T491 T490 arg2Of S,(
R48861 T97174 T19399 arg3Of ),(
R48879 T66624 T61958 arg3Of ),(
R489 T492 T490 arg3Of ),(
R48932 T14481 T5249 arg2Of to,is
R490 T493 T494 arg1Of glycoprotein,of
R49022 T54874 T39845 arg2Of cytokine,is
R49023 T53624 T75369 arg1Of and,the
R49039 T81543 T8306 arg1Of hand,the
R4907 T85855 T10850 arg1Of use,is
R49090 T93033 T93255 arg1Of confer,in
R491 T496 T494 arg2Of virus,of
R49171 T97970 T58994 arg1Of COVID-19,severe
R49184 T49689 T57406 arg1Of Pretreatment,could
R49189 T80575 T14481 arg1Of It,to
R492 T496 T495 arg1Of virus,the
R49206 T32990 T98869 modOf suppress,is
R49211 T1922 T22947 arg2Of is,as
R49235 T69281 T37427 arg2Of identical,was
R493 T493 T497 arg1Of glycoprotein,","
R49322 T74757 T72548 arg1Of use,the
R49359 T20519 T7566 arg1Of inoculated,in
R49394 T11805 T99442 arg1Of Plasma,contain
R494 T498 T497 arg2Of SARS-2-S,","
R49421 T1824 T60055 arg1Of absorbed,in
R49422 T37602 T93826 arg1Of needed,due
R49427 T44262 T25723 arg1Of SARS-S,and
R49439 T14257 T38116 arg2Of E,","
R4945 T52445 T15065 arg1Of ",",","
R49475 T58827 T61529 arg2Of P,(
R495 T500 T499 arg1Of includes,","
R49507 T96263 T84085 arg2Of Rp3,(
R49535 T99130 T66496 arg1Of role,a
R49580 T52785 T43956 arg1Of and,as
R496 T493 T500 arg1Of glycoprotein,includes
R49635 T13833 T52543 arg1Of and,following
R497 T504 T500 arg2Of subunits,includes
R49718 T26913 T26456 arg1Of patients,negative
R49728 T74893 T13882 arg2Of pathway,through
R49745 T37912 T72730 arg1Of responses,inflammatory
R49757 T75930 T3983 arg2Of have,so
R49758 T86423 T93402 arg1Of infection,lung
R4977 T88016 T45353 arg3Of ],[
R49772 T66370 T30686 arg1Of treated,with
R4978 T40695 T18064 arg2Of ORF6,and
R49789 T26913 T3255 arg1Of patients,all
R498 T504 T501 arg1Of subunits,two
R49835 T35357 T53693 arg1Of groups,control
R49840 T63388 T43810 arg3Of ],[
R49869 T82233 T8820 arg2Of of,and
R49876 T50457 T13974 arg1Of notion,","
R499 T504 T502 arg1Of subunits,main
R49902 T75930 T50453 arg1Of have,by
R49926 T14538 T63048 arg2Of similarity,and
R49957 T54149 T85138 arg1Of and,the
R49961 T85333 T85613 arg2Of identity,has
R49971 T55924 T2463 arg1Of proteases,for
R500 T504 T503 arg1Of subunits,functional
R50003 T25963 T65524 arg1Of corticosteroid,short-term
R50015 T99923 T40693 arg1Of role,the
R50036 T74458 T87029 arg1Of residues,essential
R50098 T55153 T65675 arg1Of receptor,and
R501 T504 T505 arg1Of subunits,:
R50103 T12601 T95726 arg1Of serum,Bat
R5011 T32075 T45315 arg1Of pseudotypes,MERS-S
R50111 T36509 T11172 arg1Of Serum,from
R50117 T3228 T74238 arg2Of BALF,(
R50127 T86256 T90160 arg1Of therefore,and
R502 T507 T505 arg2Of and,:
R50238 T53586 T84385 arg2Of recruitment,reduce
R5025 T21027 T5681 arg2Of decoration,make
R50258 T13615 T96732 arg1Of patients,received
R503 T506 T507 arg1Of S1,and
R5031 T20998 T79456 arg1Of 6.1,Targeting
R50313 T82190 T94548 arg2Of 2019-nCoV,for
R50332 T4452 T18709 arg1Of proteins,in
R50369 T21718 T18993 arg1Of study,The
R50386 T89099 T91733 arg3Of ),(
R504 T508 T507 arg2Of S2,and
R50435 T72133 T58350 arg1Of extent,a
R505 T510 T509 arg1Of former,The
R50503 T98303 T59456 arg3Of ],[
R50505 T45506 T41360 arg2Of cells,of
R50526 T21482 T58268 arg1Of S,the
R50529 T9969 T12001 arg1Of Hypothesis,5.1
R50549 T66003 T97147 arg1Of peptide,angiotensin-converting
R50584 T13257 T13485 arg1Of site,a
R5059 T24633 T10954 arg1Of It,important
R50591 T42602 T26171 arg1Of virus,another
R506 T515 T511 arg1Of consists,","
R50628 T50396 T89276 arg1Of patients,the
R50655 T88887 T30470 arg1Of ",",and
R50669 T66548 T59987 arg1Of Sera,reduced
R50675 T59040 T57582 arg1Of was,In
R507 T515 T512 arg1Of consists,in
R50736 T2209 T14954 arg1Of Lack,and
R50751 T95232 T95927 arg1Of IFN,Recombinant
R50792 T63048 T35396 arg2Of and,","
R50799 T27914 T50400 arg1Of administered,so
R508 T513 T512 arg2Of turn,in
R50810 T12723 T18237 arg1Of proteins,including
R50828 T51592 T20067 arg2Of inflammation,and
R50831 T96302 T22068 arg1Of Rational,4.1.3.2
R50864 T31415 T14631 arg1Of E-64d,","
R50898 T98095 T52540 arg1Of chains,human
R509 T515 T514 arg1Of consists,","
R50943 T64274 T39845 arg1Of IL6,is
R50945 T29960 T20464 arg1Of patient,is
R50948 T75548 T26075 arg1Of protein,the
R50965 T66286 T14012 arg1Of treatment,tocilizumab
R50969 T26321 T17226 arg1Of higher,than
R510 T510 T515 arg1Of former,consists
R51061 T82578 T84727 arg1Of system,the
R511 T515 T516 arg1Of consists,of
R5113 T86955 T75238 arg2Of risk,shown
R51130 T31332 T27527 arg1Of count,monocyte
R51148 T22631 T69063 arg2Of help,might
R51174 T31208 T64104 arg1Of and,","
R51176 T88144 T44086 arg1Of but,","
R512 T520 T516 arg2Of domains,of
R513 T520 T517 arg1Of domains,the
R51321 T61440 T52661 arg2Of COVID-19,with
R51347 T71403 T46096 arg1Of difference,The
R51354 T13014 T27410 arg2Of protein,of
R51383 T11435 T17483 arg1Of treatments,specific
R514 T520 T518 arg1Of domains,four
R51409 T3048 T18696 arg1Of patients,with
R51413 T51053 T13194 arg1Of Rp3,coronavirus
R51417 T67890 T83630 arg1Of engage,MERS-S
R51462 T67108 T52147 arg1Of pathogenicity,of
R51479 T50396 T61149 arg1Of patients,all
R51483 T73531 T71726 arg1Of cells,Vero
R51485 T27554 T57621 arg2Of subunit,of
R51498 T48832 T43993 arg1Of diversity,is
R515 T520 T519 arg1Of domains,core
R51502 T45806 T22199 arg1Of ciclesonide,only
R51539 T69995 T80806 arg1Of cells,express
R51576 T55154 T51616 arg2Of E-cadherin,","
R51585 T46091 T48884 arg2Of length,of
R516 T520 T521 arg1Of domains,","
R51607 T41916 T94564 arg3Of interact,utilize
R51680 T31332 T15065 arg2Of count,","
R517 T528 T521 arg2Of and,","
R5174 T70369 T49953 arg2Of hyperplasia,","
R51750 T27055 T98703 arg1Of effect,serum
R51784 T65005 T70575 arg1Of COVID-19,that
R518 T522 T523 arg1Of S1A,","
R51801 T72014 T69872 arg1Of Rationale,4.1.2.2
R51824 T14927 T80806 arg2Of TMPRSS2,express
R51826 T82065 T3419 arg1Of –,block
R51838 T13575 T75386 arg2Of TMPRSS2,require
R51850 T94537 T18203 arg2Of and,showed
R5188 T51732 T35282 arg1Of viruses,","
R51882 T5376 T34741 arg1Of Hypothesis,:
R519 T524 T523 arg2Of S1B,","
R51965 T67108 T70730 arg1Of pathogenicity,high
R51991 T5967 T65069 arg2Of light,and
R51996 T73531 T80948 arg1Of cells,express
R520 T523 T525 arg1Of ",",","
R52004 T45225 T47898 arg1Of Rp3,coronavirus
R52070 T13628 T15497 arg1Of ",",","
R52082 T19573 T94687 arg1Of study,A
R521 T526 T525 arg2Of S1C,","
R52117 T33747 T42258 arg1Of neutralize,to
R52150 T89678 T33850 arg1Of history,of
R522 T528 T527 arg1Of and,","
R5221 T76927 T61033 arg1Of sequencing,reveal
R52277 T82559 T47798 arg1Of differs,[
R523 T525 T528 arg1Of ",",and
R52362 T19745 T44026 arg2Of those,than
R524 T529 T528 arg2Of S1D,and
R52418 T58218 T55303 arg1Of group,The
R52481 T90762 T47778 arg1Of domain,of
R52486 T77887 T97770 arg1Of fusion,the
R525 T520 T530 arg1Of domains,","
R52507 T49668 T28141 arg1Of interact,with
R52512 T65082 T89079 arg1Of fusion,the
R52514 T63733 T48926 arg2Of entry,for
R52555 T7060 T54246 arg2Of accompany,show
R526 T520 T531 arg1Of domains,that
R52625 T10513 T93173 arg1Of SARS-CoV2,the
R52641 T29466 T64967 arg1Of antibody,human
R52673 T9153 T22231 arg1Of day,[
R52690 T20594 T58773 arg1Of study,investigated
R52693 T64812 T25429 arg1Of use,might
R527 T520 T532 arg1Of domains,contribute
R5275 T64958 T68614 arg2Of SARS-CoV,for
R52755 T48373 T85015 arg1Of IgG,and
R52768 T27754 T79207 arg1Of receptor,","
R528 T532 T533 arg1Of contribute,to
R52803 T51590 T95692 arg1Of and,","
R52856 T49810 T35724 arg1Of it,should
R52864 T96870 T42442 arg1Of improvement,of
R52889 T75548 T84125 arg1Of protein,SARS-CoV2
R5289 T45789 T90499 arg1Of they,treat
R529 T535 T533 arg2Of attachment,to
R52903 T15429 T85366 arg1Of inhibition,a
R52910 T75386 T88073 arg2Of require,indicating
R52920 T68610 T26256 arg1Of belonging,to
R52958 T40665 T11788 arg2Of antibodies,detect
R52999 T66055 T80340 arg1Of condition,was
R530 T535 T534 arg1Of attachment,the
R53013 T53426 T36950 arg1Of RNA,viral
R53041 T58078 T92236 arg1Of as,Currently
R53047 T74097 T73088 arg2Of 88,and
R53068 T96963 T31917 arg2Of level,had
R53099 T62960 T12678 arg3Of ),(
R531 T535 T536 arg1Of attachment,to
R53187 T96963 T24848 arg1Of level,mean
R532 T539 T536 arg2Of receptor,to
R53204 T55480 T85992 arg1Of failure,respiratory
R53215 T70143 T26901 arg1Of examples,recent
R533 T539 T537 arg1Of receptor,the
R53333 T58821 T70281 arg2Of treatment,after
R53372 T66875 T44373 arg1Of patients,have
R53389 T81227 T65088 arg2Of rabbits,immunized
R534 T539 T538 arg1Of receptor,surface
R53417 T89003 T20163 arg1Of subunit,the
R53418 T76285 T1792 arg2Of cells,of
R53455 T16685 T80686 arg1Of parameters,laboratory
R53458 T39437 T66784 arg1Of groups,the
R53466 T53491 T57582 arg2Of and,In
R53477 T90762 T35597 arg1Of domain,the
R53482 T2594 T83675 arg1Of peak,its
R535 T539 T540 arg1Of receptor,of
R53501 T52514 T30811 arg2Of men,to
R53561 T93832 T86571 arg1Of Corticosteroids,offer
R53572 T90762 T16269 arg2Of domain,encodes
R536 T542 T540 arg2Of cells,of
R53600 T90499 T11971 arg3Of treat,used
R53615 T16816 T41175 arg3Of ),(
R537 T542 T541 arg1Of cells,target
R53709 T18784 T21998 arg1Of bats,[
R53724 T27754 T36069 arg1Of receptor,entry
R5373 T90933 T6930 arg2Of more,of
R53731 T68554 T82775 arg1Of birds,domestic
R53734 T24534 T96881 arg2Of two,or
R53752 T80909 T71888 arg1Of and,induced
R53767 T86465 T1893 arg1Of binding,to
R53769 T88396 T35377 arg1Of infection,by
R53774 T82196 T54348 arg1Of resistance,to
R538 T547 T543 arg1Of coordinates,Then
R53814 T29466 T20950 arg1Of antibody,a
R53841 T76285 T63658 arg1Of cells,SARS-2-S.
R53873 T54783 T85409 arg1Of levels,high
R539 T547 T544 arg1Of coordinates,","
R53908 T51998 T44026 arg1Of are,than
R53920 T71641 T52612 arg2Of protein,of
R53923 T15359 T76304 arg2Of suffice,would
R53932 T74757 T88619 arg2Of use,in
R53989 T89696 T11399 arg1Of immunity,anti-viral
R53992 T58895 T49266 arg1Of outcomes,laboratory
R540 T546 T545 arg1Of latter,the
R54019 T9709 T49785 arg1Of titer,that
R54048 T92082 T75604 arg2Of are,:
R54057 T74286 T39990 arg1Of cytokines,(
R541 T546 T547 arg1Of latter,coordinates
R54102 T93532 T80345 arg1Of virus,the
R54150 T45806 T12794 arg1Of ciclesonide,capable
R542 T549 T547 arg2Of fusion,coordinates
R54223 T78367 T10850 arg2Of recommended,is
R5424 T2677 T52785 arg1Of ",",and
R54251 T68140 T69338 arg1Of affinities,similar
R54258 T31606 T83907 arg1Of steps,sequential
R543 T549 T548 arg1Of fusion,the
R5432 T17705 T6178 arg2Of infections,and
R54321 T42313 T79163 arg2Of HIV,","
R54339 T25625 T44775 arg1Of cells,VeroE6
R544 T549 T550 arg1Of fusion,of
R54403 T2182 T41175 arg1Of immunoglobulins,(
R54495 T48924 T5764 arg1Of effect,such
R545 T554 T550 arg2Of membranes,of
R54546 T85900 T40490 arg1Of attained,","
R54555 T57657 T37520 arg2Of patients,from
R54575 T15359 T64840 arg1Of suffice,and
R54593 T38563 T93829 arg1Of patients,with
R546 T554 T551 arg1Of membranes,viral
R54614 T49688 T48117 arg1Of RaTG13,[
R54619 T9761 T67170 arg1Of replication,SARS-CoV2
R54652 T85333 T77820 arg1Of identity,a
R54661 T37752 T74238 arg1Of fluid,(
R54662 T81737 T54387 arg1Of cell,the
R54690 T93112 T2403 arg1Of transfer,of
R547 T551 T552 arg1Of viral,and
R54748 T98095 T72563 arg1Of chains,heavy
R5477 T32520 T18229 arg2Of –,of
R548 T553 T552 arg2Of cellular,and
R54859 T56862 T61033 arg2Of similarity,reveal
R54860 T91091 T15243 arg2Of day,from
R54861 T11797 T86415 arg2Of death,reduce
R54869 T20946 T80745 arg1Of genomes,viral
R54888 T9709 T69880 arg2Of titer,reaches
R549 T554 T553 arg1Of membranes,cellular
R5494 T56884 T91479 arg1Of binding,the
R54949 T87850 T56623 arg1Of effect,cytopathic
R54968 T3323 T79102 arg1Of Serum,from
R550 T556 T555 arg1Of binding,Receptor
R55007 T19302 T20680 arg2Of coronaviruses,of
R55027 T45992 T31582 arg1Of dose,of
R551 T556 T557 arg1Of binding,activates
R55122 T12601 T40602 arg1Of serum,able
R55160 T18879 T73448 arg1Of inhibitors,e.g.
R552 T558 T557 arg2Of proteases,activates
R55206 T6862 T13466 arg1Of day,10th
R55214 T24171 T61844 arg1Of stability,more
R5522 T3048 T91601 arg2Of patients,of
R55232 T86520 T85504 arg1Of immunization,Passive
R55235 T45109 T21998 arg2Of 13,[
R55247 T92397 T95206 arg2Of degrees,to
R55274 T37666 T64366 arg1Of diseases,human
R5528 T4246 T96551 arg1Of report,a
R55295 T14229 T21817 arg1Of serum,exert
R553 T558 T559 arg1Of proteases,that
R55306 T75548 T74634 arg1Of protein,interact
R55335 T60390 T29104 arg1Of cells,human
R554 T558 T560 arg1Of proteases,can
R55406 T39553 T54973 arg1Of pandemic,the
R55425 T57345 T78516 arg1Of antibody,One
R55440 T17782 T30425 arg2Of help,might
R55450 T83272 T70573 arg1Of polyprotein,","
R55476 T4913 T98086 arg2Of patients,from
R555 T561 T560 arg2Of carry,can
R55504 T20355 T32181 arg1Of entry,the
R55505 T52375 T27295 arg1Of sample,a
R55511 T12942 T48321 arg1Of binding,to
R5554 T60803 T94537 arg1Of improvement,and
R55546 T49586 T41218 arg1Of utilize,that
R5555 T4182 T7530 arg1Of and,that
R55554 T8038 T49447 arg1Of infections,difficile
R55573 T42633 T81648 arg2Of and,that
R55576 T33177 T18503 arg2Of 26,[
R556 T558 T561 arg1Of proteases,carry
R55603 T57882 T36913 arg1Of pH,could
R55612 T24144 T88673 arg1Of differences,between
R55615 T7672 T46997 arg1Of study,The
R55634 T83960 T50853 arg2Of pool,contains
R55663 T25851 T93008 arg1Of more,than
R55692 T53416 T14631 arg2Of inhibitor,","
R557 T564 T561 arg2Of cleavage,carry
R55726 T96146 T47796 arg1Of IgG,and
R558 T561 T562 arg1Of carry,out
R5580 T25730 T48691 arg1Of degree,a
R55812 T3419 T69422 arg1Of block,not
R55825 T67952 T12678 arg2Of NSP15,(
R55856 T38342 T51508 arg1Of Rp3,SL-CoV
R55870 T59832 T68886 arg1Of notions,using
R5589 T45992 T21466 arg1Of dose,short-term
R559 T564 T563 arg1Of cleavage,proteolytic
R55934 T7654 T81207 arg1Of plasma,Convalescent
R55984 T80157 T96665 arg1Of and,SL-CoV
R55992 T16892 T48251 arg1Of compared,with
R560 T564 T565 arg1Of cleavage,of
R56002 T83416 T39699 arg2Of COVID-19,","
R56025 T51672 T69307 arg2Of infection,after
R56055 T66963 T20040 arg2Of PCR,(
R56074 T71701 T19117 arg1Of sequence,amino
R56076 T52998 T20323 arg1Of sequencing,and
R56085 T22917 T88178 arg1Of dose,double
R56090 T18784 T87528 arg2Of bats,to
R561 T568 T565 arg2Of protein,of
R56134 T32769 T49866 arg1Of occurred,in
R56159 T50204 T20973 arg1Of occurred,with
R56160 T70519 T51594 arg1Of patients,SARS
R562 T568 T566 arg1Of protein,the
R56229 T31606 T69934 arg2Of steps,includes
R563 T568 T567 arg1Of protein,S
R56313 T62141 T93322 arg1Of arthritis,juvenile
R56320 T36613 T59179 arg1Of and,accompanied
R564 T573 T569 arg1Of occurs,In
R5640 T27491 T52796 arg1Of MERS-CoV,the
R56468 T4016 T49089 arg1Of and,are
R565 T570 T569 arg2Of coronaviruses,In
R56550 T81737 T95799 arg2Of cell,enter
R566 T573 T571 arg1Of occurs,","
R56648 T9113 T95658 arg1Of day,8
R56670 T96381 T89506 arg1Of and,","
R56677 T50829 T39137 arg1Of Calu-3,human
R56679 T79772 T62926 arg2Of week,during
R567 T572 T573 arg1Of cleavage,occurs
R56727 T80948 T60658 arg1Of express,and
R56743 T98192 T20616 arg2Of plus,of
R568 T573 T574 arg1Of occurs,at
R56840 T64138 T54708 arg1Of effect,main
R569 T576 T574 arg2Of sites,at
R56902 T69919 T49873 arg2Of effective,be
R56923 T99130 T64532 arg2Of role,play
R5694 T58501 T45353 arg2Of 31,[
R56950 T20067 T91445 arg1Of and,","
R56953 T87404 T56983 arg1Of neutralize,efficiently
R56955 T68511 T89923 arg1Of patients,most
R56978 T8033 T31588 arg1Of frames,that
R570 T576 T575 arg1Of sites,two
R57039 T13882 T71892 arg2Of through,than
R57053 T53416 T42969 arg1Of inhibitor,an
R57057 T27055 T14991 arg1Of effect,in
R5706 T71857 T26799 arg2Of noticeable,was
R57062 T36509 T31307 arg1Of Serum,is
R57077 T52580 T30686 arg2Of methylprednisolone,with
R57082 T52981 T27857 arg1Of H1N1,A
R57097 T48498 T47927 arg1Of regions,that
R571 T576 T577 arg1Of sites,:
R57108 T17217 T80666 arg1Of COVID-19,severe
R57112 T59987 T35673 arg1Of reduced,and
R57154 T52732 T35366 arg2Of rates,with
R57168 T77880 T81456 arg1Of SARS-S,and
R57198 T25723 T75386 arg1Of and,require
R572 T580 T577 arg2Of junction,:
R57258 T90933 T81944 arg1Of more,than
R57291 T52934 T45076 arg1Of –,which
R57298 T59239 T91507 arg2Of and,of
R573 T580 T578 arg1Of junction,the
R57304 T58899 T16664 arg1Of outbreak,the
R5731 T70238 T24534 arg1Of doses,two
R57317 T41345 T46256 arg1Of infection,2009
R57386 T93176 T62926 arg1Of reaches,during
R57398 T86415 T30904 arg2Of reduce,show
R574 T580 T579 arg1Of junction,S1/S2
R57443 T9970 T55531 arg1Of domain,binding
R57449 T16845 T23620 arg1Of sequence,almost
R57493 T7628 T53721 arg1Of strain,which
R575 T574 T581 arg1Of at,and
R57525 T84685 T19443 arg2Of and,as
R57531 T39367 T35171 arg1Of therapy,standard
R576 T582 T581 arg2Of at,and
R57612 T92502 T17782 arg1Of Corticosteroids,help
R57671 T62141 T49595 arg1Of arthritis,idiopathic
R577 T573 T582 arg1Of occurs,at
R57726 T58682 T42366 arg1Of spike,the
R57766 T18211 T39196 arg1Of SARS-S,and
R57772 T14128 T35148 arg1Of enzymes,mammalian
R57789 T64812 T90977 arg1Of use,of
R57799 T45371 T75403 arg1Of It,may
R578 T584 T582 arg2Of S2′,at
R57803 T28541 T42599 arg2Of S2,and
R5782 T59949 T47798 arg2Of 20,[
R57869 T96337 T43810 arg1Of proteases,[
R57872 T54919 T47614 arg2Of cells,of
R579 T584 T583 arg1Of S2′,the
R57903 T63070 T34390 arg1Of levels,proportion
R57912 T46042 T47055 arg1Of egg,the
R57926 T49873 T22947 arg1Of be,as
R580 T584 T585 arg1Of S2′,","
R58032 T57783 T32904 arg1Of sequences,of
R58043 T45337 T48579 arg1Of and,all
R58046 T77390 T55259 arg2Of and,of
R58063 T48832 T76304 arg1Of diversity,would
R58092 T8195 T16483 arg2Of imaging,by
R58093 T77495 T11735 arg2Of MERS-CoV,mutated
R581 T587 T585 arg2Of region,","
R58114 T14011 T36351 arg2Of rabbits,immunized
R58115 T74051 T6180 arg2Of DPP4,and
R58146 T10243 T43431 arg1Of Study,shown
R58171 T87582 T54813 arg1Of rise,to
R582 T587 T586 arg1Of region,a
R58214 T53882 T32471 arg2Of FDA,by
R58217 T44722 T31300 arg1Of modulate,and
R58250 T17328 T16199 modOf Hypothesis,can
R58251 T82402 T47005 arg1Of site,cleavage
R5826 T68579 T83488 arg1Of IFN,Recombinant
R583 T587 T588 arg1Of region,close
R5834 T63733 T62543 arg1Of entry,cell
R58356 T10243 T21860 arg1Of Study,of
R58389 T63733 T50860 arg1Of entry,is
R584 T588 T589 arg1Of close,to
R58409 T40210 T14942 arg1Of strains,bat
R58460 T64204 T32276 arg1Of domain,least
R58480 T31794 T58025 arg2Of antibodies,contains
R58487 T30704 T66398 arg1Of 14,or
R585 T593 T589 arg2Of peptide,to
R58532 T11181 T35356 modOf tendency,to
R586 T593 T590 arg1Of peptide,the
R58615 T15000 T68154 arg2Of patient,of
R58662 T27506 T37276 arg1Of ovotransferrin,contains
R587 T593 T591 arg1Of peptide,viral
R58716 T37470 T22676 arg2Of SARS2-S,and
R58721 T67580 T97786 arg2Of therapy,for
R58725 T89333 T87452 arg1Of Rational,:
R58749 T14554 T48251 arg2Of serum,with
R58753 T95232 T46872 arg1Of IFN,I
R588 T593 T592 arg1Of peptide,fusion
R58839 T74401 T75556 arg1Of mAb,against
R5884 T29466 T27300 arg1Of antibody,(
R58848 T21735 T80547 arg2Of disease,against
R58851 T37245 T52983 arg1Of activity,a
R58884 T57397 T80510 arg2Of 2019-nCoV,against
R589 T593 T594 arg1Of peptide,[
R58901 T45316 T47778 arg2Of protein,of
R58904 T81378 T54103 arg1Of degree,a
R58905 T37089 T60207 arg2Of SARS-2-S,and
R58949 T85900 T87895 arg1Of attained,[
R58957 T48589 T94835 arg1Of :,on
R58960 T53492 T25066 arg1Of There,is
R58970 T67166 T97514 arg1Of immunity,humoral
R590 T595 T594 arg2Of 2,[
R59047 T33217 T69082 arg2Of and,as
R59048 T89678 T44003 arg2Of history,at
R59071 T14554 T63812 arg1Of serum,patient
R591 T596 T594 arg3Of ],[
R59105 T44856 T63670 arg1Of therapy,convalescent
R59110 T29313 T97739 arg2Of 28,[
R59126 T27754 T80074 arg1Of receptor,same
R59147 T34284 T28857 arg2Of virus,","
R59149 T88599 T30022 arg1Of blocker,of
R59163 T1902 T34125 arg2Of and,with
R59166 T14481 T88108 arg1Of to,due
R592 T598 T597 arg1Of cleavage,Proteolytic
R59200 T34731 T43891 arg1Of strain,SARS-CoV
R59227 T64443 T91321 arg2Of accelerate,help
R59263 T15927 T77029 arg2Of protease,requires
R59273 T21817 T42100 arg2Of exert,could
R593 T598 T599 arg1Of cleavage,of
R59317 T30144 T9841 arg1Of and,","
R59330 T60390 T43867 arg1Of cells,the
R594 T602 T599 arg2Of protein,of
R59428 T18985 T5683 arg1Of group,first
R59437 T54700 T30269 arg1Of arthritis,rheumatoid
R59452 T82559 T83097 arg1Of differs,in
R59467 T45806 T13593 arg1Of ciclesonide,inhibiting
R595 T602 T600 arg1Of protein,the
R59510 T82280 T81648 arg1Of elements,that
R59552 T59443 T78284 arg2Of down-regulation,by
R59565 T1832 T7555 arg1Of manner,a
R59576 T9137 T45333 arg2Of severe,and
R596 T602 T601 arg1Of protein,S
R59603 T49810 T47054 arg2Of it,administered
R59690 T78772 T74739 arg2Of IFN,with
R597 T598 T603 arg1Of cleavage,causes
R59705 T15154 T63966 arg1Of consists,:
R598 T605 T603 arg2Of changes,causes
R5982 T41345 T49738 arg2Of infection,in
R59825 T82872 T91618 arg2Of immunoglobulin,plus
R59827 T32201 T52317 arg2Of treatment,is
R59832 T15429 T16699 arg1Of inhibition,of
R59863 T77279 T53860 arg1Of patients,with
R59867 T61673 T89124 arg1Of signal,for
R59897 T35438 T34549 arg1Of up-regulation,the
R599 T605 T604 arg1Of changes,conformational
R59901 T95952 T83153 arg1Of differences,in
R59902 T76626 T64464 arg1Of play,[
R59905 T8090 T85814 arg2Of Toronto,in
R59919 T24326 T75376 arg2Of symptoms,demonstrated
R59931 T48841 T27337 arg1Of CoVs,bat
R59988 T32229 T49191 arg1Of Copper,help
R600 T603 T606 arg1Of causes,so
R60032 T20179 T14412 arg2Of molecules,of
R60061 T79439 T64378 arg1Of domain,the
R601 T611 T606 arg2Of revert,so
R60119 T36466 T17580 arg1Of patients,who
R60124 T81644 T58244 arg2Of presence,confirm
R60141 T49967 T59448 arg2Of transfusion,before
R60151 T21460 T66890 arg1Of death,one
R60172 T50829 T99828 arg1Of Calu-3,lung
R60175 T44497 T14361 arg1Of corticosteroids,inhibit
R60177 T9113 T48202 arg2Of day,since
R602 T606 T607 arg1Of so,that
R60201 T21537 T99917 arg2Of ACE2,binding
R60224 T71868 T74097 arg1Of %,88
R60239 T48892 T85015 arg2Of IgM,and
R60276 T8313 T61223 arg1Of domain,S1
R60299 T72578 T94349 arg1Of and,","
R603 T608 T609 arg1Of they,can
R60303 T71701 T55756 arg1Of sequence,the
R60332 T50644 T28925 arg2Of and,with
R60341 T39154 T15378 arg2Of domains,of
R60347 T30604 T7774 arg2Of outcomes,improve
R60363 T64490 T84543 arg2Of absent,but
R60391 T12131 T99269 arg1Of count,lymphocyte
R604 T611 T609 arg2Of revert,can
R60475 T92600 T77635 arg1Of entry,SARS-2-S
R60499 T22184 T1922 arg1Of it,is
R605 T611 T610 arg1Of revert,not
R60526 T75815 T92988 arg1Of degree,of
R60583 T34145 T59456 arg2Of 25,[
R60586 T65701 T99390 arg2Of counts,","
R60594 T83081 T39196 arg2Of SARS-2-S,and
R60596 T38135 T37905 arg2Of copper,of
R606 T608 T611 arg1Of they,revert
R6060 T4681 T2648 arg1Of associated,with
R60630 T74458 T68062 arg1Of residues,the
R60648 T16845 T14679 arg1Of sequence,same
R60659 T88154 T26683 arg2Of and,in
R60685 T32416 T89272 arg2Of entry,","
R607 T611 T612 arg1Of revert,to
R60719 T36351 T2907 arg1Of immunized,with
R60741 T48569 T45372 arg1Of isolate,an
R60748 T11646 T91858 arg1Of inhibition,of
R60777 T77430 T49191 arg2Of system,help
R60787 T14786 T56782 arg1Of IRW,can
R60794 T80777 T53867 arg2Of system,escape
R60797 T20124 T66079 arg2Of responses,of
R608 T615 T612 arg2Of structure,to
R60809 T85498 T58025 arg1Of Antiserum,contains
R60813 T45992 T7774 arg1Of dose,improve
R60823 T44730 T6084 arg1Of mediate,to
R60884 T51771 T11727 arg1Of entry,cell
R60896 T32416 T31064 arg1Of entry,SARS-2-S
R60898 T85613 T32040 arg1Of has,In
R609 T615 T613 arg1Of structure,the
R60939 T90119 T59846 arg1Of inflammatory,and
R6095 T27008 T42258 modOf acted,to
R610 T615 T614 arg1Of structure,original
R61000 T24202 T39330 arg2Of O-glycans,and
R61072 T88599 T55852 arg2Of blocker,","
R61089 T7048 T81312 arg1Of late,to
R61094 T78997 T33297 arg1Of onset,symptom
R611 T615 T616 arg1Of structure,and
R61124 T17398 T4319 arg1Of trust,to
R61171 T7401 T13593 arg2Of replication,inhibiting
R612 T615 T617 arg1Of structure,profound
R61217 T53624 T48926 arg1Of and,for
R61251 T2749 T61983 arg2Of COVID-19,with
R61252 T89439 T96270 arg1Of group,second
R6126 T92915 T55931 arg2Of MERS-CoV,For
R61261 T45118 T26321 arg1Of levels,higher
R613 T620 T617 arg2Of prime,profound
R614 T617 T618 arg1Of profound,enough
R61440 T58005 T98192 arg2Of therapy,plus
R61441 T58078 T32112 arg1Of as,","
R615 T620 T619 arg1Of prime,to
R6150 T50749 T72049 arg1Of potential,the
R61511 T16801 T16861 arg2Of and,of
R6154 T59356 T65527 arg1Of signs,of
R61551 T14228 T81402 arg1Of symptoms,clinical
R61578 T85869 T86571 arg2Of option,offer
R616 T623 T620 arg2Of subunit,prime
R61660 T65005 T54139 arg2Of COVID-19,from
R61697 T64476 T21817 arg2Of effect,exert
R617 T623 T621 arg1Of subunit,the
R61732 T19744 T76016 arg3Of ),(
R61734 T43382 T97423 arg1Of replication,viral
R61751 T22412 T89375 arg2Of CoV,with
R618 T623 T622 arg1Of subunit,S2
R619 T623 T624 arg1Of subunit,for
R61909 T3461 T40063 arg1Of entry,of
R620 T626 T624 arg2Of fusion,for
R62047 T82578 T32990 arg2Of system,suppress
R62097 T59040 T21310 arg1Of was,","
R621 T626 T625 arg1Of fusion,the
R62122 T71892 T21481 arg1Of than,rather
R62126 T49953 T20067 arg1Of ",",and
R62128 T65972 T7214 arg1Of Serum,effective
R62130 T75829 T95765 arg1Of subunit,S2
R62163 T88382 T66860 arg1Of strain,bat
R622 T626 T627 arg1Of fusion,of
R623 T631 T627 arg2Of membranes,of
R62325 T87007 T28810 arg1Of glycoproteins,(
R62361 T36887 T2922 arg1Of antibody,the
R62362 T17766 T58773 arg2Of effect,investigated
R62385 T6595 T61951 arg1Of useful,for
R624 T631 T628 arg1Of membranes,viral
R62417 T51290 T72721 arg1Of %,96
R62438 T39598 T7857 arg2Of defense,for
R62451 T8313 T22468 arg2Of domain,in
R62455 T95815 T39944 arg1Of inflammation,vascular
R62464 T78989 T8460 arg1Of immunization,Passive
R625 T628 T629 arg1Of viral,and
R62516 T26978 T79137 arg1Of virus,[
R62555 T51504 T18102 arg2Of subunit,with
R626 T630 T629 arg2Of cellular,and
R627 T631 T630 arg1Of membranes,cellular
R62701 T68842 T84996 arg1Of Serum,4.1.4
R62745 T38661 T32422 arg2Of switching,After
R62752 T34900 T84268 arg1Of and,for
R62759 T81474 T56686 arg1Of they,differ
R62774 T66440 T79549 arg1Of domain,the
R62783 T15927 T76016 arg1Of protease,(
R628 T634 T632 arg1Of Proteins,Fig.
R62865 T50829 T67184 arg1Of Calu-3,the
R629 T632 T633 arg1Of Fig.,1
R62931 T28717 T99239 arg3Of ),(
R62932 T33016 T24341 arg1Of S,SARSr-CoV
R62948 T7401 T5717 arg1Of replication,viral
R630 T634 T635 arg2Of Proteins,required
R63011 T17100 T66535 arg2Of mice,from
R63068 T53586 T18273 arg1Of recruitment,of
R631 T635 T636 arg1Of required,for
R63116 T78221 T14738 arg1Of and,the
R63159 T75386 T81091 arg1Of require,for
R63165 T43431 T15543 arg1Of shown,","
R63178 T45992 T83835 arg1Of dose,might
R632 T639 T636 arg2Of entry,for
R63232 T10956 T21969 arg2Of hinder,could
R63247 T64875 T5869 arg1Of patients,SARS
R63281 T10634 T47481 arg1Of disorders,autoimmune
R633 T639 T637 arg1Of entry,the
R6332 T30434 T28810 arg3Of ),(
R63324 T63732 T51590 arg2Of paraclinical,and
R63345 T18121 T28665 arg2Of and,is
R63354 T32276 T9128 arg1Of least,at
R63361 T99566 T15154 arg2Of remain,consists
R6337 T86188 T98181 arg1Of IL-2,","
R63382 T77279 T43722 arg2Of patients,of
R634 T639 T638 arg1Of entry,SARS-CoV2-cell
R6341 T70941 T77508 arg1Of limit,significantly
R63472 T77475 T16732 arg1Of Rhinolophus,the
R635 T642 T640 arg1Of characteristics,3
R63506 T69348 T45554 arg2Of course,of
R63519 T56686 T90671 arg1Of differ,However
R63553 T47054 T77811 arg2Of administered,and
R636 T642 T641 arg1Of characteristics,Certain
R63665 T92502 T30425 arg1Of Corticosteroids,might
R63671 T48287 T91679 arg1Of patients,with
R637 T642 T643 arg1Of characteristics,of
R6370 T72554 T90276 arg2Of 34,[
R63773 T83272 T61529 arg1Of polyprotein,(
R638 T644 T643 arg2Of SARS-CoV2,of
R63810 T79174 T77600 arg2Of disease,against
R63818 T37752 T31054 arg1Of fluid,lavage
R63842 T54798 T77136 arg1Of improvement,in
R63866 T35511 T70941 arg2Of entry,limit
R63867 T37161 T63565 arg1Of present,in
R63884 T10513 T22059 arg2Of SARS-CoV2,of
R6389 T35672 T76082 arg1Of regimen,a
R639 T646 T645 arg1Of SARS-CoV2,3.1
R63916 T58635 T41721 arg2Of ",",inhaled
R63993 T7214 T72082 arg1Of effective,than
R640 T646 T647 arg1Of SARS-CoV2,has
R64010 T78772 T62356 arg1Of IFN,recombinant
R64025 T22917 T27562 arg1Of dose,of
R64051 T13001 T54149 arg2Of modulation,and
R64065 T99631 T60794 arg1Of pseudotypes,both
R64073 T74757 T50691 arg1Of use,of
R64079 T27148 T41273 arg1Of levels,IL6
R641 T648 T647 arg2Of acquired,has
R64105 T75392 T66370 arg2Of COVID-19,treated
R642 T646 T648 arg1Of SARS-CoV2,acquired
R6420 T1902 T37015 arg1Of and,for
R64276 T83832 T16280 arg1Of Hypotheses,:
R64279 T16296 T68175 arg1Of infection,SARS-CoV2
R6429 T90324 T31483 arg2Of M,","
R643 T651 T648 arg2Of glycoprotein,acquired
R64318 T65699 T98539 arg2Of deaths,nor
R64331 T90339 T91545 arg1Of effects,the
R64377 T55924 T40938 arg1Of proteases,are
R644 T651 T649 arg1Of glycoprotein,an
R6445 T24980 T93829 arg2Of COVID19,with
R64474 T76985 T20072 arg1Of Analysis,collected
R645 T651 T650 arg1Of glycoprotein,S
R64524 T63832 T37602 arg2Of caution,needed
R64570 T42466 T71562 arg1Of B,and
R64586 T65117 T35160 arg1Of study,The
R64588 T75548 T40189 arg2Of protein,on
R646 T651 T652 arg1Of glycoprotein,that
R64616 T3726 T74021 arg1Of SARS-S,and
R6462 T44785 T43571 arg2Of atlizumab,as
R6463 T49873 T60557 arg1Of be,in
R64658 T96870 T83098 arg2Of improvement,showed
R647 T654 T653 arg1Of underwent,highly
R64711 T26722 T71269 arg1Of plasma,convalescent
R64712 T53777 T56482 arg1Of junctions,same
R648 T651 T654 arg1Of glycoprotein,underwent
R64820 T96891 T41163 arg1Of Hypothesis,:
R64833 T82392 T37577 arg1Of diseases,autoimmune
R64835 T67890 T53624 arg2Of engage,and
R64854 T82065 T4372 arg1Of –,S1B
R64885 T11181 T50088 arg2Of tendency,indicates
R649 T657 T654 arg2Of and,underwent
R64970 T24866 T9522 arg1Of transition,from
R64973 T80950 T3009 arg2Of SARS-CoV2,and
R650 T657 T655 arg1Of and,genetic
R65037 T70555 T85532 arg2Of H1N1pdm09,(
R651 T656 T657 arg1Of variation,and
R65190 T13615 T23681 arg1Of patients,20
R65194 T19573 T22655 arg1Of study,pilot
R652 T658 T657 arg2Of glycosylation,and
R65208 T31383 T37147 arg1Of actions,precise
R65213 T8033 T13269 arg1Of frames,reading
R65223 T92397 T97915 arg1Of degrees,variable
R65241 T81904 T53621 arg1Of plasma,convalescent
R65268 T91348 T96539 arg2Of deficiencies,to
R65283 T92755 T44041 arg1Of studies,Meta-analysis
R65288 T40210 T9407 arg1Of strains,SARS-CoV
R65296 T70659 T80018 arg1Of Ebola,African
R653 T662 T659 arg1Of site,3.1.1
R65301 T58761 T96810 arg1Of is,","
R65371 T13644 T5298 arg1Of substitution,conferred
R65396 T8349 T48117 arg2Of 3,[
R654 T662 T660 arg1Of site,Polybasic
R65488 T67274 T2290 arg2Of replication,on
R655 T662 T661 arg1Of site,cleavage
R65523 T94051 T40647 arg1Of MERS-CoV,the
R65549 T18888 T62259 arg1Of produce,to
R65562 T20594 T19799 arg1Of study,The
R656 T670 T663 arg1Of is,As
R65601 T70238 T20616 arg1Of doses,of
R65615 T95799 T13882 arg1Of enter,through
R65636 T87394 T3292 arg2Of done,be
R65646 T72012 T36716 arg1Of supernatants,were
R6567 T79226 T33377 arg1Of similar,in
R65672 T89437 T56176 arg3Of ],[
R657 T664 T663 arg2Of evidenced,As
R65706 T19573 T26265 arg1Of study,has
R65720 T5759 T83750 arg1Of and,","
R65744 T35988 T97443 arg2Of increasing,through
R65755 T72804 T88569 arg1Of clinical,controlled
R65763 T25454 T28665 arg1Of It,is
R658 T664 T665 arg1Of evidenced,by
R65883 T72802 T89303 arg1Of neutralize,to
R65884 T32075 T1819 arg1Of pseudotypes,VSV-G
R65895 T24185 T29074 arg1Of antibody,anti-human
R65896 T22966 T35366 arg1Of regions,with
R65897 T39845 T74879 arg1Of is,Moreover
R659 T667 T665 arg2Of analysis,by
R65903 T79958 T26331 arg2Of 12,[
R65914 T43996 T94005 arg1Of coronaviruses,possess
R65917 T86961 T18963 arg1Of role,of
R65938 T85613 T62529 arg1Of has,with
R660 T667 T666 arg1Of analysis,sequence
R66017 T95799 T35356 arg1Of enter,to
R66024 T73708 T70831 arg2Of inflammation,of
R66056 T96870 T5017 arg1Of improvement,clinical
R661 T670 T668 arg1Of is,","
R6618 T73325 T72256 arg2Of patient,diagnosed
R66187 T94273 T26914 arg1Of 0.29 μg/g,±
R66191 T51732 T3387 arg1Of viruses,RNA
R662 T669 T670 arg1Of there,is
R66219 T39782 T70281 arg1Of and,after
R66257 T87807 T47759 arg3Of ],[
R663 T673 T670 arg2Of insertion,is
R66336 T23341 T23846 arg1Of transfusion,of
R66376 T13365 T15815 arg2Of contains,and
R664 T673 T671 arg1Of insertion,a
R66400 T58020 T49089 arg2Of similar,are
R66473 T59893 T6736 arg1Of virus,the
R665 T673 T672 arg1Of insertion,residue
R66576 T97339 T21793 arg2Of trials,are
R66579 T26456 T55829 arg2Of negative,turned
R66581 T28841 T32544 arg3Of ),(
R666 T673 T674 arg2Of insertion,formed
R66606 T11181 T80437 arg1Of tendency,the
R66611 T70519 T80239 arg2Of patients,from
R66632 T69297 T49962 arg1Of subunits,S1
R66652 T55062 T19426 arg3Of ),(
R66672 T5207 T41319 arg1Of fusion,the
R66698 T53907 T27008 arg1Of sera,acted
R66699 T81543 T80434 arg2Of hand,On
R667 T674 T675 arg1Of formed,of
R66734 T98815 T69048 arg1Of COVID-19,who
R66754 T33856 T40337 arg2Of origin,on
R66763 T43308 T56176 arg1Of related,[
R66768 T11646 T70471 arg1Of inhibition,complete
R66797 T59239 T48772 arg1Of and,","
R668 T678 T675 arg2Of acids,of
R66809 T14228 T44490 arg2Of symptoms,in
R66835 T74827 T56144 arg1Of used,","
R669 T678 T676 arg1Of acids,four
R66912 T72581 T30814 arg2Of formation,decreased
R66943 T85855 T54987 arg1Of use,the
R66954 T24269 T26765 arg1Of There,are
R66955 T52032 T12807 arg1Of membranes,host
R66967 T9912 T22507 arg2Of corticosteroids,of
R670 T678 T677 arg1Of acids,amino
R67016 T47738 T84690 arg1Of plasma,convalescent
R67028 T70419 T13646 arg2Of S,(
R6704 T78533 T51548 arg1Of role,primary
R67089 T37466 T32005 arg2Of and,of
R671 T678 T679 arg1Of acids,(
R67132 T70238 T98598 arg1Of doses,one
R67139 T74827 T36716 arg2Of used,were
R67158 T62855 T64125 arg1Of kinetics,replication
R67161 T22676 T19104 arg2Of and,against
R67187 T72256 T7135 arg2Of diagnosed,when
R672 T681 T679 arg2Of nucleotides,(
R67204 T53417 T66297 arg2Of COVID-19,with
R67236 T71708 T47272 arg1Of causes,in
R67249 T37156 T95987 arg1Of and,contain
R6725 T37245 T30646 arg1Of activity,cross-neutralizing
R673 T682 T679 arg3Of ),(
R67300 T86465 T37015 arg2Of binding,for
R67328 T63866 T12507 arg2Of particular,In
R67339 T65584 T40405 arg1Of development,vaccine
R67342 T73696 T16699 arg2Of replication,of
R6737 T64598 T32273 arg1Of range,of
R67370 T64615 T78691 arg1Of %,%
R674 T681 T680 arg1Of nucleotides,12
R67482 T67884 T39990 arg2Of and,(
R675 T674 T683 arg1Of formed,at
R67530 T89289 T52645 arg1Of expressed,for
R67593 T13828 T97762 arg1Of and,However
R676 T685 T683 arg2Of boundary,at
R67632 T15429 T95958 arg2Of inhibition,induced
R67675 T62139 T89289 arg2Of receptor,expressed
R67688 T87293 T71924 arg2Of suppression,cause
R6769 T74327 T15313 arg1Of membranes,host-cell
R67692 T75964 T34900 arg2Of normalization,and
R677 T685 T684 arg1Of boundary,the
R67701 T28611 T20769 arg1Of Serum,neutralize
R6776 T91345 T83198 arg1Of Hypothesis,:
R67798 T39579 T91622 arg1Of decrease,a
R678 T670 T686 arg1Of is,between
R6780 T7888 T95236 arg2Of compete,could
R67825 T63329 T84667 arg1Of degree,a
R67837 T72012 T74827 arg2Of supernatants,used
R67841 T2963 T18623 arg1Of Paraoxonases,(
R67856 T72564 T5412 arg2Of and,in
R67857 T58244 T57534 arg1Of confirm,for
R679 T690 T686 arg2Of subunits,between
R67917 T74893 T96928 arg1Of pathway,TMPRSS2/cell
R67933 T1832 T14991 arg2Of manner,in
R67960 T51640 T22676 arg1Of SARS-S,and
R680 T690 T687 arg1Of subunits,S1
R6800 T51386 T55833 arg1Of and,the
R68003 T43357 T8605 arg2Of therapy,of
R6804 T36310 T48409 arg1Of infection,SARS-CoV2
R68043 T66365 T82079 arg2Of 30,[
R68061 T1922 T38972 arg1Of is,vitro
R68071 T42902 T84855 arg1Of reason,apparent
R681 T687 T688 arg1Of S1,and
R68118 T9582 T16801 arg2Of virus,and
R6815 T47054 T60601 arg1Of administered,so
R68163 T83272 T7216 arg2Of polyprotein,of
R682 T689 T688 arg2Of S2,and
R68217 T83073 T87404 arg2Of SARS-CoV2,neutralize
R68253 T18576 T61059 arg1Of differ,Moreover
R68265 T9169 T53541 arg2Of severity,with
R68271 T30323 T36542 arg1Of ",",and
R68274 T83224 T20828 arg2Of that,and
R68299 T91627 T62375 arg3Of ],[
R683 T690 T689 arg1Of subunits,S2
R68308 T41087 T46398 arg3Of ),(
R6831 T71552 T68477 arg1Of efficiency,in
R68311 T40394 T80590 arg1Of therapy,plasma
R68332 T9527 T65661 arg2Of saturation,and
R68379 T86991 T18064 arg1Of ",",and
R684 T690 T691 arg1Of subunits,of
R6844 T14128 T4681 arg2Of enzymes,associated
R68452 T47460 T44003 arg1Of look,at
R68459 T16887 T28141 arg2Of GRP78,with
R68462 T52714 T99070 arg1Of patients,SARS
R68469 T21434 T32751 arg2Of possibility,poses
R68489 T27055 T56518 arg1Of effect,The
R685 T695 T691 arg2Of S.,of
R68501 T15256 T59040 arg2Of reduction,was
R68506 T35357 T13795 arg2Of groups,were
R68576 T69297 T28541 arg1Of subunits,S2
R686 T695 T692 arg1Of S.,the
R68604 T11280 T11917 arg2Of SARS-S,of
R6863 T41408 T28737 arg2Of coronavirus,of
R68664 T49873 T85248 arg2Of be,might
R68691 T44685 T42097 arg2Of IVIG,combined
R687 T695 T693 arg1Of S.,SARS-CoV
R6870 T11815 T63608 arg1Of Rational,6.1.2
R6871 T96386 T80967 arg1Of that,for
R68735 T67504 T20323 arg2Of analysis,and
R68776 T49689 T74739 arg1Of Pretreatment,with
R68783 T56677 T12498 arg3Of ),(
R688 T695 T694 arg1Of S.,2
R68805 T54707 T25991 arg1Of early,as
R6883 T74021 T3764 arg1Of and,both
R68832 T67776 T16788 arg1Of patients,the
R68842 T37092 T20625 arg1Of patients,convalescent
R68866 T41843 T53652 arg1Of neutralizing,By
R68878 T30995 T94597 arg1Of were,For
R689 T696 T697 arg1Of It,defines
R68969 T95631 T77580 arg2Of interacting,for
R68981 T75975 T58635 arg1Of ",",","
R68983 T79226 T92082 arg2Of similar,are
R68991 T95558 T79137 arg2Of 26,[
R690 T695 T697 arg2Of S.,defines
R69010 T78989 T37380 arg1Of immunization,can
R69030 T39782 T62470 arg1Of and,","
R69068 T32529 T93874 arg1Of inhibit,after
R69085 T51053 T85900 arg2Of Rp3,attained
R691 T702 T698 arg1Of site,a
R69132 T70519 T68000 arg1Of patients,three
R69157 T39437 T87016 arg1Of groups,did
R69166 T87850 T71708 arg2Of effect,causes
R692 T702 T699 arg1Of site,polybasic
R69236 T24131 T37699 arg1Of protein,the
R6925 T45806 T78874 arg1Of ciclesonide,the
R69272 T24661 T37156 arg2Of effect,and
R69283 T69785 T73262 arg1Of combination,of
R693 T702 T700 arg1Of site,furin
R69341 T11788 T74827 arg3Of detect,used
R69371 T82402 T5992 arg1Of site,a
R69387 T22929 T68950 arg1Of agents,regular
R694 T702 T701 arg1Of site,cleavage
R69428 T65675 T87934 arg2Of and,and
R69453 T27491 T25492 arg2Of MERS-CoV,of
R69456 T24628 T76208 arg2Of patients,in
R695 T702 T703 arg1Of site,of
R69542 T49542 T61619 arg1Of activity,and
R69581 T22143 T80547 arg1Of protects,against
R696 T704 T703 arg2Of RRAR,of
R69603 T5207 T84322 arg2Of fusion,and
R69633 T21695 T91858 arg2Of entry,of
R69637 T97339 T48573 arg1Of trials,that
R69640 T94005 T64690 arg1Of possess,commonly
R69683 T47874 T61532 arg1Of affinity,higher
R697 T702 T705 arg1Of site,for
R69719 T79617 T2754 arg1Of cytokines,pro-inflammatory
R6977 T95116 T50194 arg2Of copper,of
R69779 T13014 T7435 arg1Of protein,SARS-CoV2
R69781 T84385 T78284 arg1Of reduce,by
R698 T708 T705 arg2Of SARS-CoV,for
R69810 T95468 T98779 arg2Of Rhinolophidae,and
R69829 T77594 T50088 arg1Of It,indicates
R69842 T72014 T36633 arg1Of Rationale,:
R69846 T5488 T4016 arg2Of SARS-CoV2,and
R69868 T75489 T84749 arg1Of shows,","
R6989 T76094 T4182 arg2Of decreases,and
R699 T708 T706 arg1Of SARS-CoV,the
R69901 T3009 T79226 arg1Of and,similar
R69904 T10314 T25862 arg1Of effect,the
R69912 T77887 T18963 arg2Of fusion,of
R6992 T36887 T11559 arg2Of antibody,of
R6993 T37814 T10621 arg1Of develop,[
R6996 T98095 T35586 arg1Of chains,immunoglobulin
R700 T708 T707 arg1Of SARS-CoV,human
R70060 T50396 T42442 arg2Of patients,of
R70066 T33265 T15244 arg1Of concentration,same
R70070 T52249 T13795 arg1Of There,were
R7008 T64476 T15054 arg1Of effect,an
R70086 T34654 T35671 arg2Of and,neutralize
R701 T708 T709 arg1Of SARS-CoV,2
R702 T702 T710 arg1Of site,that
R70225 T45118 T95987 arg2Of levels,contain
R70229 T95815 T50471 arg2Of inflammation,and
R70294 T52375 T62671 arg1Of sample,fecal
R703 T702 T711 arg1Of site,was
R70326 T90061 T66297 arg1Of patients,with
R70338 T15000 T38317 arg1Of patient,the
R70394 T60580 T57901 arg1Of nucleocapsid,and
R704 T712 T711 arg2Of absent,was
R70416 T97492 T51383 arg1Of replication,SARS-CoV2
R705 T702 T712 arg1Of site,absent
R70505 T94051 T91822 arg2Of MERS-CoV,with
R70515 T70659 T20739 arg1Of Ebola,Western
R70559 T12723 T37519 arg1Of proteins,","
R70591 T16420 T18957 arg1Of occur,in
R706 T712 T713 arg1Of absent,in
R70600 T87850 T52777 arg1Of effect,the
R70624 T34731 T54296 arg1Of strain,Tor2
R707 T721 T713 arg2Of and,in
R70728 T21695 T17052 arg1Of entry,in
R70730 T38972 T72123 arg1Of vitro,in
R70734 T71072 T63688 arg1Of effects,anti-oxidant
R70744 T79240 T30106 arg2Of Rp3,","
R70763 T8195 T31403 arg1Of imaging,CT
R70781 T2594 T93176 arg2Of peak,reaches
R70792 T8033 T52748 arg1Of frames,five
R708 T715 T714 arg1Of SARS-CoV,human
R7081 T94273 T61958 arg2Of 0.29 μg/g,(
R70872 T42652 T87892 arg1Of treatment,type
R709 T715 T716 arg1Of SARS-CoV,","
R70932 T80516 T22631 arg1Of IVIG,help
R70938 T13966 T88153 arg1Of antibody,monoclonal
R70941 T75489 T22912 arg1Of shows,In
R70976 T25963 T99668 arg1Of corticosteroid,a
R70993 T36802 T24370 arg1Of Corticosteroids,7
R710 T719 T716 arg2Of CoVs,","
R7103 T58859 T16756 arg2Of or,receiving
R711 T719 T717 arg1Of CoVs,bat
R71138 T71906 T11963 arg2Of MERS-CoV,of
R71140 T47738 T82834 arg2Of plasma,receiving
R712 T719 T718 arg1Of CoVs,SARS-like
R71223 T37738 T12678 arg1Of protein,(
R71234 T88396 T83401 arg1Of infection,The
R71243 T65088 T9531 arg1Of immunized,with
R71258 T73325 T59206 arg1Of patient,is
R71267 T60390 T53491 arg2Of cells,and
R71283 T44373 T90719 arg1Of have,by
R71284 T58581 T33004 arg1Of Eggs,8
R713 T721 T720 arg1Of and,","
R71339 T62855 T20327 arg2Of kinetics,to
R71366 T92495 T36003 arg1Of epidemic,in
R71375 T32520 T74591 arg1Of –,SARS-CoV
R714 T716 T721 arg1Of ",",and
R71444 T97288 T58860 arg2Of COVID-19,for
R71489 T53777 T48942 arg1Of junctions,","
R715 T725 T721 arg2Of while,and
R71573 T2068 T27045 arg1Of promote,consequently
R71574 T73531 T62340 arg1Of cells,susceptible
R716 T725 T722 arg1Of while,pangolin
R71640 T25315 T43308 arg1Of coronavirus,related
R71645 T15312 T18121 arg1Of safe,and
R71664 T21445 T58316 arg1Of modulation,of
R71674 T85855 T75237 arg1Of use,can
R71679 T41035 T6014 arg2Of 16,[
R71697 T3462 T63816 arg1Of COVID-19,","
R717 T725 T723 arg1Of while,SARS-like
R71721 T21695 T75023 arg1Of entry,SARS-2-S
R71731 T68271 T69307 arg1Of 48 h,after
R71752 T53535 T94566 arg1Of activity,CatB/L
R718 T725 T724 arg1Of while,CoV
R71875 T38342 T27996 arg1Of Rp3,[
R7189 T1832 T3238 arg1Of manner,dose-dependent
R719 T702 T726 arg1Of site,might
R71902 T91321 T21434 arg2Of help,possibility
R720 T727 T726 arg2Of be,might
R72037 T13257 T83579 arg2Of site,possesses
R72062 T11181 T22059 arg1Of tendency,of
R721 T690 T726 modOf subunits,might
R72130 T68842 T82613 arg1Of Serum,from
R72167 T96672 T75647 arg1Of variety,of
R722 T702 T727 arg1Of site,be
R72223 T9113 T45554 arg1Of day,of
R7224 T7628 T18272 arg1Of strain,was
R72270 T94385 T31311 arg2Of 24 h,at
R723 T728 T727 arg2Of present,be
R72360 T51521 T67884 arg1Of ",",and
R724 T702 T728 arg1Of site,present
R72409 T17094 T86991 arg1Of NSP3,","
R72412 T72578 T65340 arg1Of and,Also
R72421 T6071 T23827 arg2Of 25,[
R72430 T76094 T56358 arg1Of decreases,gradually
R72431 T25132 T56803 arg1Of degree,(
R72465 T14525 T24485 arg1Of 1,)
R725 T728 T729 arg1Of present,in
R72524 T44216 T4378 arg1Of use,the
R72528 T41408 T98581 arg1Of coronavirus,the
R72554 T59345 T43431 arg2Of is,shown
R726 T731 T729 arg2Of species,in
R72618 T20769 T43055 arg1Of neutralize,efficiently
R72696 T83617 T75556 arg2Of IL6,against
R72699 T60390 T3411 arg1Of cells,lung
R727 T731 T730 arg1Of species,other
R7270 T35146 T19295 arg1Of receptor,surface
R72739 T91345 T3294 arg1Of Hypothesis,7.1
R72743 T18576 T87016 arg2Of differ,did
R72772 T59356 T71996 arg1Of signs,warning
R72776 T7184 T85187 arg1Of line,","
R72778 T22570 T86737 arg1Of characteristics,specific
R728 T727 T732 arg1Of be,[
R72806 T92755 T75238 arg1Of studies,shown
R72835 T87293 T66079 arg1Of suppression,of
R72853 T79511 T72667 arg2Of copper,and
R72877 T35438 T84846 arg1Of up-regulation,of
R72889 T90255 T44793 arg1Of coronavirus,cause
R7289 T77811 T49092 arg1Of and,","
R72891 T57549 T49538 arg1Of produce,","
R729 T733 T732 arg2Of 3,[
R72901 T65734 T6432 arg2Of vital,are
R72922 T88154 T68700 arg1Of and,of
R72924 T57657 T22774 arg2Of patients,recovered
R72933 T50601 T19300 arg1Of count,lymphocyte
R72949 T73739 T6758 arg2Of samples,of
R72983 T78367 T54453 arg1Of recommended,","
R730 T734 T732 arg3Of ],[
R73040 T3323 T16328 arg1Of Serum,4.1.2
R73050 T59443 T5913 arg1Of down-regulation,","
R73057 T33017 T41693 arg1Of domain,the
R73092 T11646 T87218 arg1Of inhibition,the
R731 T760 T735 arg1Of take,After
R73101 T23558 T99497 arg2Of circumstances,under
R73123 T53426 T81080 arg1Of RNA,the
R73124 T78691 T87988 arg1Of %,100
R732 T737 T735 arg2Of introduction,After
R73215 T57345 T43362 arg1Of antibody,could
R73246 T32769 T7710 arg1Of occurred,However
R73275 T65661 T23999 arg2Of and,(
R73284 T43126 T72786 arg1Of Plasma,shown
R733 T737 T736 arg1Of introduction,the
R73328 T52934 T18957 arg2Of –,in
R73378 T13644 T66951 arg1Of substitution,in
R73394 T89396 T64464 arg2Of 24,[
R734 T737 T738 arg1Of introduction,of
R73412 T14011 T88629 arg2Of rabbits,from
R73426 T13966 T55969 arg1Of antibody,a
R73449 T13737 T47275 arg2Of inhibit,able
R73472 T93924 T49873 arg1Of H2L2,be
R735 T739 T738 arg2Of mutation,of
R73525 T29877 T32551 arg1Of effect,their
R73540 T45337 T47275 arg1Of and,able
R73544 T15927 T56483 arg1Of protease,least
R73596 T78772 T67333 arg1Of IFN,type
R736 T737 T740 arg1Of introduction,to
R737 T747 T740 arg2Of site,to
R73729 T65134 T94632 arg2Of plasma,of
R73746 T9969 T15939 arg1Of Hypothesis,:
R7377 T37156 T64844 arg1Of and,that
R73778 T46091 T84416 arg1Of length,greater
R738 T747 T741 arg1Of site,the
R73808 T21460 T72564 arg2Of death,and
R73815 T4246 T35641 arg2Of report,is
R73869 T20355 T50423 arg1Of entry,of
R73891 T21817 T14407 arg1Of exert,not
R739 T747 T742 arg1Of site,residue
R73905 T27554 T77993 arg1Of subunit,the
R73916 T25577 T56819 arg1Of protein,S
R73941 T35997 T26265 arg2Of investigated,has
R73965 T68140 T88888 arg1Of affinities,of
R7397 T12037 T52317 arg1Of IVIG,is
R73986 T86955 T72067 arg1Of risk,a
R740 T747 T743 arg1Of site,insertion
R741 T743 T744 arg1Of insertion,and
R74118 T3048 T6238 arg1Of patients,ten
R74139 T57345 T83927 arg1Of antibody,H2L2
R74181 T36033 T95916 arg2Of corticosteroids,of
R74189 T33265 T81647 arg2Of concentration,at
R742 T745 T744 arg2Of furin,and
R74216 T31126 T42839 arg2Of to,be
R7429 T54874 T84071 arg1Of cytokine,in
R74296 T53867 T73233 arg1Of escape,to
R74298 T44667 T68477 arg2Of inhibition,in
R743 T747 T745 arg1Of site,furin
R74345 T48569 T77212 arg1Of isolate,which
R74391 T52732 T42165 arg1Of rates,[
R744 T747 T746 arg1Of site,cleavage
R74424 T98598 T96881 arg1Of one,or
R74425 T31483 T43323 arg1Of ",",and
R74451 T40210 T87890 arg1Of strains,SL-CoV
R74499 T8160 T57534 arg2Of SARS-CoV,for
R745 T760 T748 arg1Of take,","
R74510 T26901 T85352 arg1Of recent,most
R74536 T87212 T17398 arg1Of us,trust
R74556 T68835 T12507 arg1Of contains,In
R74572 T95232 T3712 arg1Of IFN,type
R746 T751 T749 arg1Of cleavage,the
R74668 T83470 T34654 arg2Of SARS-2-S,and
R747 T751 T750 arg1Of cleavage,S1/S2
R74716 T48435 T19104 arg1Of protect,against
R7472 T24005 T44925 arg2Of prognosis,and
R74727 T54079 T29543 arg2Of and,in
R74735 T62479 T92667 arg2Of receptor,with
R74746 T64875 T96392 arg2Of patients,from
R74784 T68840 T67953 arg2Of attenuate,can
R748 T751 T752 arg1Of cleavage,of
R74845 T46489 T18580 arg2Of 94,and
R749 T756 T752 arg2Of S,of
R74916 T17100 T66245 arg1Of mice,transgenic
R74963 T79215 T85453 arg1Of patients,received
R74972 T13120 T76540 arg2Of SARS-CoV,neutralize
R74990 T39367 T58859 arg2Of therapy,or
R74996 T76626 T65875 arg1Of play,in
R750 T756 T753 arg1Of S,the
R75080 T33217 T24128 arg1Of and,","
R751 T756 T754 arg1Of S,SARS-CoV
R75113 T18879 T13399 arg2Of inhibitors,than
R75140 T27008 T40921 arg2Of acted,why
R75166 T81456 T2463 arg2Of and,for
R75181 T30814 T11300 arg2Of decreased,","
R752 T756 T755 arg1Of S,2
R75209 T90339 T67748 arg2Of effects,associated
R753 T751 T757 arg1Of cleavage,did
R75326 T85453 T21073 arg1Of received,In
R754 T760 T757 arg2Of take,did
R75414 T64598 T68610 arg1Of range,belonging
R75498 T52981 T99958 arg1Of H1N1,influenza
R755 T760 T758 arg1Of take,not
R75502 T10263 T91733 arg2Of 10 g/d,(
R7552 T54792 T87735 arg1Of ciclesonide,three
R75542 T59987 T3889 arg1Of reduced,","
R75547 T35627 T29701 arg1Of 24,and
R75573 T49329 T94835 arg2Of outcomes,on
R756 T760 T759 arg1Of take,longer
R75655 T60984 T46693 arg1Of that,has
R7566 T65117 T88407 arg1Of study,included
R75667 T80710 T93212 arg1Of plasma,treat
R757 T751 T760 arg1Of cleavage,take
R75716 T54390 T7377 arg1Of 6.2,Targeting
R7573 T53426 T78293 arg1Of RNA,of
R75777 T51011 T23410 arg1Of ACE2,human
R75797 T95865 T31307 arg2Of able,is
R758 T761 T760 arg2Of place,take
R75826 T96963 T15301 arg1Of level,a
R75887 T32300 T62462 arg1Of not,while
R75892 T15927 T44730 arg1Of protease,mediate
R75895 T84414 T97501 arg1Of therapy,standard
R75896 T64776 T63353 arg2Of and,and
R759 T774 T762 arg1Of remained,However
R75916 T69842 T25429 arg2Of accelerate,might
R75925 T49089 T27399 arg1Of are,","
R75974 T59040 T81391 arg1Of was,","
R760 T774 T763 arg1Of remained,","
R761 T768 T764 arg1Of entry,the
R76104 T41529 T48683 arg2Of patients,of
R76106 T56862 T82233 arg1Of similarity,of
R76164 T13644 T72966 arg1Of substitution,amino
R76165 T42902 T43993 arg2Of reason,is
R7618 T71973 T28149 arg1Of production,","
R76194 T42976 T32544 arg1Of methylprednisolone,(
R762 T768 T765 arg1Of entry,SARS-CoV
R76205 T72564 T52171 arg1Of and,the
R76207 T82578 T72594 arg1Of system,immune
R7624 T17705 T68317 arg1Of infections,recurrent
R76244 T48832 T88085 arg1Of diversity,This
R76248 T25388 T44741 arg1Of course,of
R76274 T66430 T64168 arg2Of 23,[
R76291 T45532 T13737 arg2Of replication,inhibit
R763 T768 T766 arg1Of entry,2
R76318 T58899 T11963 arg1Of outbreak,of
R76331 T68835 T96163 arg1Of contains,","
R76335 T84385 T88206 arg1Of reduce,","
R76339 T18576 T42838 arg1Of differ,not
R764 T768 T767 arg1Of entry,S
R76424 T53029 T21640 arg1Of outbreaks,viral
R76438 T42640 T11917 arg1Of subunit,of
R765 T768 T769 arg2Of entry,raised
R76504 T69785 T56133 arg1Of combination,yielded
R76507 T32652 T58197 arg1Of responses,that
R76529 T59818 T68994 arg2Of addition,In
R76550 T58130 T31522 arg1Of critical,and
R76562 T46042 T48696 arg1Of egg,of
R76565 T65232 T10653 arg2Of possible,as
R766 T769 T770 arg1Of raised,for
R76601 T5371 T65084 arg1Of Hypothesis,:
R76622 T36509 T95865 arg1Of Serum,able
R76627 T13682 T79896 arg2Of mortality,of
R76656 T27658 T89187 arg2Of Corticosteroids,used
R76662 T9673 T80157 arg2Of SARS-CoV2,and
R7667 T25878 T32221 arg1Of mAb,A
R76677 T27148 T16499 arg1Of levels,high
R76678 T41003 T45337 arg1Of ",",and
R767 T772 T770 arg2Of cells,for
R76701 T55480 T36559 arg2Of failure,developed
R76744 T80157 T38226 arg1Of and,bat
R76746 T43431 T94164 arg2Of shown,has
R76759 T36302 T2290 arg1Of fluticasone,on
R76769 T92225 T58130 arg1Of COVID-19,critical
R76774 T14674 T44722 arg2Of inflammation,modulate
R76775 T4016 T58020 arg1Of and,similar
R76777 T69842 T92811 arg1Of accelerate,that
R7678 T59345 T43613 arg1Of is,that
R76787 T25730 T63462 arg1Of degree,of
R76790 T82402 T47763 arg1Of site,","
R768 T772 T771 arg1Of cells,VeroE6
R76811 T26283 T43571 arg1Of known,as
R76838 T4182 T20828 arg1Of and,and
R76856 T47054 T58224 arg1Of administered,early
R76858 T64274 T49609 arg1Of IL6,pro-inflammatory
R76876 T61673 T37161 arg1Of signal,present
R76879 T93532 T76093 arg2Of virus,of
R769 T768 T773 arg1Of entry,and
R76986 T75548 T15500 arg1Of protein,that
R770 T768 T774 arg1Of entry,remained
R77066 T23258 T6150 arg3Of ),(
R77067 T48832 T15359 arg1Of diversity,suffice
R771 T775 T774 arg2Of high,remained
R77190 T66576 T19164 arg1Of years,and
R77199 T20348 T98862 arg2Of outcome,improve
R772 T768 T775 arg1Of entry,high
R77219 T63733 T54619 arg1Of entry,that
R773 T775 T776 arg1Of high,in
R77316 T54016 T97739 arg3Of ],[
R77322 T87934 T33377 arg2Of and,in
R77326 T47242 T58714 arg1Of S,ZC45
R77337 T10634 T57537 arg2Of disorders,from
R77343 T48662 T36053 arg2Of moderate-dose,with
R77344 T73531 T83400 arg1Of cells,which
R77360 T38357 T89869 arg1Of and,both
R7737 T56920 T32531 arg1Of regions,immunoglobulin
R77390 T97339 T48698 arg1Of trials,no
R774 T778 T776 arg2Of cells,in
R77408 T50200 T31121 arg1Of inhibit,effectively
R7741 T44216 T95916 arg1Of use,of
R77420 T12131 T18383 arg2Of count,in
R7749 T78861 T21425 arg2Of plasma,of
R77496 T52375 T30106 arg1Of sample,","
R775 T778 T777 arg1Of cells,BHK
R77514 T47874 T96386 arg1Of affinity,that
R77534 T24185 T17221 arg2Of antibody,approved
R7755 T52934 T30016 arg1Of –,the
R7756 T32529 T5100 arg1Of inhibit,effectively
R77580 T9527 T63703 arg1Of saturation,oxygen
R77595 T48569 T18234 arg1Of isolate,","
R776 T778 T779 arg1Of cells,that
R77637 T12179 T10629 arg1Of IVIG,shown
R777 T778 T780 arg1Of cells,express
R77711 T28149 T88926 arg1Of ",",the
R77720 T31426 T45337 arg2Of lopinavir,and
R778 T782 T780 arg2Of ACE,express
R77806 T40665 T56747 arg1Of antibodies,that
R77868 T48841 T69082 arg1Of CoVs,as
R779 T782 T781 arg1Of ACE,human
R77915 T87404 T8130 arg1Of neutralize,to
R77927 T59832 T17398 arg2Of notions,trust
R77955 T56133 T27079 arg1Of yielded,","
R7798 T59480 T65875 arg2Of inhibition,in
R780 T786 T783 arg1Of seems,Therefore
R78022 T66055 T55941 arg1Of condition,critical
R78024 T95707 T98181 arg2Of IL-4,","
R78087 T43356 T32769 arg1Of deaths,occurred
R781 T786 T784 arg1Of seems,","
R78116 T62169 T46333 arg2Of introduced,has
R78190 T47874 T77580 arg1Of affinity,for
R782 T785 T786 arg1Of it,seems
R78212 T25963 T44273 arg2Of corticosteroid,with
R78219 T80909 T44111 arg2Of and,by
R78223 T87394 T83285 modOf done,using
R78283 T73209 T7707 arg1Of corticosteroids,that
R783 T792 T786 arg2Of depend,seems
R78306 T53799 T10621 arg3Of ],[
R78333 T32842 T38357 arg1Of adults,and
R78348 T33947 T50903 arg2Of 33,[
R784 T792 T787 arg1Of depend,that
R78407 T74021 T40063 arg2Of and,of
R78424 T64673 T34896 arg2Of lesions,and
R78431 T96672 T61951 arg2Of variety,for
R78448 T35997 T92410 arg1Of investigated,recently
R78454 T12723 T40582 arg1Of proteins,of
R78491 T71403 T31126 arg1Of difference,to
R785 T789 T788 arg1Of transmissibility,SARS-CoV2
R78514 T44685 T31582 arg2Of IVIG,of
R78526 T78533 T51847 arg1Of role,a
R78533 T42834 T11331 arg2Of patients,in
R7854 T69934 T92030 arg1Of includes,attachment
R78542 T99923 T52808 arg2Of role,conveys
R78547 T67511 T37838 arg2Of binding,of
R78599 T64594 T41003 arg2Of mometasone,","
R786 T789 T790 arg1Of transmissibility,does
R7863 T9582 T17323 arg1Of virus,syncytial
R78642 T84664 T9387 arg1Of treatment,tocilizumab
R7867 T40781 T11032 arg3Of ],[
R787 T792 T790 arg2Of depend,does
R78762 T21495 T91380 arg1Of 2TMPRSS2,serine
R78785 T24756 T16801 arg1Of ",",and
R788 T792 T791 arg1Of depend,not
R78842 T98095 T78221 arg1Of chains,and
R78843 T41378 T26910 arg2Of COVID-19,from
R78893 T12982 T36003 arg2Of 2014,in
R78894 T72909 T77083 arg2Of case,in
R789 T789 T792 arg1Of transmissibility,depend
R7895 T65134 T56352 arg1Of plasma,convalescent
R78959 T50200 T83801 arg2Of inhibit,can
R78982 T92600 T25201 arg2Of entry,of
R78999 T5376 T58124 arg1Of Hypothesis,4.1.2.1
R790 T792 T793 arg1Of depend,on
R79010 T55829 T74721 arg1Of turned,","
R79029 T31095 T40148 arg1Of count,lymphocyte
R791 T796 T793 arg2Of cleavage,on
R79137 T51592 T30801 arg1Of inflammation,vascular
R79151 T56884 T11559 arg1Of binding,of
R79160 T50860 T7846 arg1Of is,","
R792 T796 T794 arg1Of cleavage,the
R79215 T51290 T94095 arg2Of %,(
R79224 T58895 T27596 arg2Of outcomes,in
R79226 T15191 T24898 arg1Of revealed,to
R79228 T79215 T77821 arg1Of patients,21
R79231 T93033 T26781 arg2Of confer,could
R79272 T48431 T27422 arg1Of levels,immunoglobulin
R79286 T50002 T64051 arg1Of cells,Vero
R793 T796 T795 arg1Of cleavage,S1/S2
R79302 T57345 T48435 arg1Of antibody,protect
R794 T800 T797 arg1Of site,A
R79405 T2430 T76542 arg3Of entry,affected
R79425 T56445 T77065 arg2Of SARS,with
R7945 T50002 T36295 arg2Of cells,in
R79461 T72012 T55915 arg1Of supernatants,hybridoma
R795 T800 T798 arg1Of site,polybasic
R79509 T29624 T58244 arg1Of reaction,confirm
R79527 T74401 T35174 arg1Of mAb,A
R79540 T60445 T6426 arg2Of immunoglobulin,plus
R79576 T22917 T27854 arg1Of dose,the
R79578 T12834 T40616 arg3Of ),(
R79591 T68554 T68700 arg2Of birds,of
R796 T800 T799 arg1Of site,cleavage
R79602 T84704 T19426 arg1Of nucleocapsid,(
R79646 T33015 T18709 arg2Of samples,in
R79664 T84543 T33679 arg1Of but,at
R79687 T92225 T15777 arg2Of COVID-19,with
R797 T800 T801 arg1Of site,explains
R79700 T52785 T60726 arg1Of and,","
R79733 T18753 T61175 arg2Of are,show
R79737 T64515 T20072 arg2Of days,collected
R79769 T47496 T66659 arg1Of SARS-CoV,the
R79793 T51998 T26826 arg1Of are,Moreover
R79797 T37752 T91231 arg1Of fluid,contained
R798 T803 T801 arg2Of virus,explains
R79812 T21368 T74776 arg2Of SARS-CoV2,and
R79816 T96617 T96372 arg1Of antibody,SARS-CoV
R79824 T2467 T18121 arg2Of effective,and
R79844 T68837 T81658 arg1Of ",",","
R79868 T53057 T2720 arg1Of domain,S1
R79879 T87875 T28188 arg1Of It,been
R799 T803 T802 arg1Of virus,a
R79904 T33950 T76482 arg1Of have,as
R79916 T84664 T64021 arg2Of treatment,before
R79940 T99202 T45016 arg1Of appeared,","
R79941 T66286 T20973 arg2Of treatment,with
R800 T803 T804 arg1Of virus,that
R80027 T86423 T10997 arg1Of infection,a
R80044 T2304 T45012 arg1Of antibodies,anti-viral
R80079 T66440 T94564 arg2Of domain,utilize
R801 T803 T805 arg1Of virus,is
R80156 T64776 T15071 arg1Of and,entry
R80184 T69933 T47796 arg2Of IgM,and
R80185 T26744 T6595 arg1Of currently,useful
R80186 T36613 T83510 arg2Of and,by
R80187 T82587 T48117 arg3Of ],[
R80199 T19375 T58982 arg1Of favorable,to
R802 T806 T805 arg2Of highly-pathogenic,is
R80207 T53777 T5709 arg1Of junctions,cleavage
R80214 T17766 T62943 arg1Of effect,the
R80215 T48287 T93212 arg2Of patients,treat
R8023 T21482 T53333 arg1Of S,protein
R80234 T68579 T93217 arg1Of IFN,type
R80254 T49688 T33217 arg2Of RaTG13,and
R803 T803 T806 arg1Of virus,highly-pathogenic
R80345 T27754 T14629 arg1Of receptor,i.e.
R80362 T81543 T52921 arg1Of hand,other
R80380 T52785 T79863 arg2Of and,(
R804 T806 T807 arg1Of highly-pathogenic,for
R80403 T78002 T54161 arg1Of entry,the
R80450 T8341 T18474 arg2Of 27,[
R80452 T85645 T76626 arg1Of IFNs,play
R80466 T43382 T38146 arg2Of replication,affect
R80485 T43126 T82790 arg1Of Plasma,has
R805 T808 T807 arg2Of humans,for
R80539 T92030 T73554 arg1Of attachment,of
R80549 T45806 T86672 arg1Of ciclesonide,was
R806 T801 T809 arg1Of explains,while
R80609 T65176 T33598 arg2Of NP,against
R80630 T4452 T74666 arg1Of proteins,polymerase
R80634 T53907 T70648 arg1Of sera,bat
R80643 T7184 T99239 arg1Of line,(
R80657 T76296 T28156 modOf shown,to
R80683 T4213 T87498 arg1Of immunized,with
R80686 T66576 T46590 arg1Of years,of
R807 T811 T809 arg2Of is,while
R80780 T66003 T89508 arg2Of peptide,known
R808 T810 T811 arg1Of it,is
R80801 T14361 T40275 arg2Of inhibit,","
R80817 T24131 T85613 arg1Of protein,has
R80841 T75548 T91232 arg1Of protein,Spike
R80889 T85498 T76542 arg2Of Antiserum,affected
R80891 T46450 T27748 arg1Of sequencing,of
R80894 T58622 T53652 arg2Of contrast,By
R80896 T81904 T11852 arg1Of plasma,alone
R809 T812 T811 arg2Of low-pathogenic,is
R80908 T32529 T57406 arg2Of inhibit,could
R80924 T85289 T43666 arg2Of COVID-19,from
R810 T810 T812 arg1Of it,low-pathogenic
R81037 T18576 T97295 arg1Of differ,","
R81041 T91091 T92830 arg1Of day,10th
R81045 T18048 T78293 arg2Of 2019-nCoV,of
R81075 T51998 T48884 arg1Of are,of
R811 T812 T813 arg1Of low-pathogenic,for
R81126 T83960 T68527 arg1Of pool,large
R81151 T68894 T32288 arg2Of that,than
R81194 T55941 T44653 arg2Of critical,or
R812 T815 T813 arg2Of species,for
R81217 T31829 T42165 arg3Of ],[
R81229 T76069 T84637 arg1Of antibodies,anti-viral
R81252 T43126 T98086 arg1Of Plasma,from
R81263 T42633 T33950 arg1Of and,have
R813 T815 T814 arg1Of species,other
R81304 T38357 T39207 arg2Of and,for
R81333 T28753 T88154 arg2Of eggshells,and
R81373 T81644 T22237 arg1Of presence,if
R814 T833 T816 arg1Of developed,For
R81402 T27055 T61320 arg1Of effect,was
R81415 T58682 T13646 arg1Of spike,(
R8147 T18064 T18237 arg2Of and,including
R81496 T50601 T52445 arg2Of count,","
R815 T817 T816 arg2Of example,For
R81506 T48569 T23533 arg2Of isolate,detect
R81516 T7157 T47566 arg1Of bat,an
R81517 T48498 T49668 arg1Of regions,interact
R81532 T46182 T39990 arg3Of ),(
R81579 T25577 T24060 arg1Of protein,the
R81582 T65117 T76496 arg1Of study,received
R816 T833 T818 arg1Of developed,","
R81607 T92600 T81647 arg1Of entry,at
R81621 T48924 T64490 arg1Of effect,absent
R81635 T29877 T26799 arg1Of effect,was
R817 T822 T819 arg2Of tools,using
R81725 T58218 T37085 arg1Of group,achieved
R81734 T47986 T23106 arg1Of %,80–98
R81743 T69880 T97012 arg1Of reaches,","
R81779 T9013 T48542 arg2Of 29,[
R81797 T97267 T51386 arg2Of RBD,and
R818 T833 T819 modOf developed,using
R81820 T17027 T57735 arg1Of 90,about
R8185 T96625 T18203 arg1Of Patients,showed
R81856 T13257 T30948 arg1Of site,polybasic
R81876 T1935 T31311 arg1Of present,at
R81898 T27396 T30144 arg1Of dictate,and
R819 T821 T820 arg1Of genetic,reverse
R81932 T52981 T85532 arg1Of H1N1,(
R81984 T97737 T81238 arg2Of protease,of
R81985 T1824 T31791 arg1Of absorbed,Also
R820 T822 T821 arg1Of tools,genetic
R82007 T74975 T1853 arg1Of response,to
R82049 T98167 T54348 arg2Of ciclesonide,to
R82064 T72909 T84121 arg1Of case,of
R82088 T18877 T18503 arg1Of receptor,[
R821 T833 T823 arg1Of developed,","
R82123 T67748 T22188 arg1Of associated,with
R82137 T64532 T16405 arg1Of play,in
R82140 T31699 T72940 arg1Of Rationale,4.2.2
R82170 T38106 T28810 arg2Of M,(
R82193 T77887 T55259 arg1Of fusion,of
R82198 T76927 T41253 arg1Of sequencing,RNA
R822 T827 T824 arg1Of type,an
R82228 T89464 T12529 arg1Of are,[
R82243 T58590 T68835 arg2Of concentrations,contains
R82268 T82570 T71924 arg1Of they,cause
R82274 T90573 T28156 arg1Of decrease,to
R82277 T48569 T37427 arg1Of isolate,was
R823 T827 T825 arg1Of type,avian
R82327 T69996 T88154 arg1Of eggs,and
R82331 T43975 T56176 arg2Of 14,[
R8236 T55893 T47180 arg1Of protein,the
R824 T827 T826 arg1Of type,paramyxovirus
R82408 T37738 T52727 arg1Of protein,nonstructural
R82420 T83832 T35613 arg1Of Hypotheses,4.1.4.1
R82422 T96617 T57549 arg2Of antibody,produce
R8244 T63070 T84268 arg2Of levels,for
R82456 T52934 T55882 arg1Of –,S
R82494 T68602 T35641 arg1Of There,is
R82498 T4187 T38504 arg1Of it,should
R825 T827 T828 arg1Of type,7
R82541 T39579 T72559 arg1Of decrease,in
R8259 T25467 T80157 arg1Of strain,and
R826 T827 T829 arg1Of type,(
R827 T830 T829 arg2Of APMV-7,(
R82740 T63081 T72667 arg1Of ACE2,and
R82759 T45337 T89636 arg1Of and,","
R828 T831 T829 arg3Of ),(
R82801 T76019 T25258 arg1Of former,The
R82814 T37666 T75647 arg2Of diseases,of
R82868 T86439 T26283 arg2Of Tocilizumab,known
R82882 T85645 T4789 arg1Of IFNs,I
R829 T827 T832 arg1Of type,was
R82903 T29701 T26971 arg1Of and,both
R82929 T73696 T25584 arg1Of replication,viral
R82941 T75851 T54040 arg2Of 80 mg/d,(
R82963 T90848 T52785 arg2Of infections,and
R82985 T80638 T76208 arg1Of treat,in
R82994 T61991 T65150 arg1Of study,the
R830 T833 T832 arg2Of developed,was
R83087 T37156 T35997 arg2Of and,investigated
R83092 T7184 T56471 arg1Of line,kidney
R83097 T35266 T74423 arg1Of cells,293 T
R831 T827 T833 arg2Of type,developed
R83120 T2182 T55819 arg1Of immunoglobulins,4.2
R83125 T86439 T21494 arg1Of Tocilizumab,","
R83132 T34284 T92495 arg1Of virus,epidemic
R83152 T89187 T38824 arg1Of used,for
R83183 T11868 T46614 arg3Of ),(
R832 T833 T834 arg1Of developed,by
R83211 T98716 T88373 arg2Of anti-inflammatory,and
R83234 T47460 T14621 arg1Of look,avoid
R83237 T95644 T19735 arg1Of target,of
R83256 T44793 T90050 arg2Of cause,can
R83284 T52803 T77477 arg2Of cells,of
R833 T835 T834 arg2Of mutating,by
R83353 T72578 T92623 arg1Of and,","
R8336 T82402 T7278 arg1Of site,similar
R83390 T51141 T88469 arg1Of score,H
R834 T843 T835 arg2Of site,mutating
R83427 T2901 T32352 arg2Of IRF-8,and
R83433 T67274 T25492 arg1Of replication,of
R8345 T37092 T20197 arg1Of patients,SARS
R83493 T94954 T26331 arg3Of ],[
R83498 T21161 T31651 arg1Of agent,of
R83499 T73993 T11032 arg2Of 16,[
R835 T843 T836 arg1Of site,the
R83525 T51011 T72017 arg2Of ACE2,against
R83532 T91725 T13491 arg1Of Tocilizumab,","
R83550 T49586 T50457 arg2Of utilize,notion
R83564 T51998 T36143 arg1Of are,","
R836 T843 T837 arg1Of site,fusion
R83600 T6987 T3019 arg2Of mesylate,by
R83662 T25730 T14481 arg2Of degree,to
R83692 T67274 T42645 arg1Of replication,the
R837 T843 T838 arg1Of site,(
R83702 T18888 T15359 arg2Of produce,suffice
R83757 T30604 T16718 arg1Of outcomes,patient
R8377 T76069 T75930 arg2Of antibodies,have
R83793 T13644 T10430 arg1Of substitution,acid
R838 T839 T838 arg2Of F,(
R83808 T55829 T20580 arg1Of turned,Following
R83809 T44925 T84071 arg2Of and,in
R839 T840 T838 arg3Of ),(
R83908 T72129 T75975 arg1Of ciclesonide,","
R83925 T48626 T96099 arg2Of 15,[
R83938 T83170 T37227 arg1Of Rationale,7.2
R83956 T13966 T87639 arg1Of antibody,against
R840 T843 T841 arg1Of site,protein
R84017 T58127 T80909 arg2Of SARS2-S,and
R84018 T59365 T48696 arg2Of quail,of
R84032 T35146 T47614 arg1Of receptor,of
R8404 T37245 T94688 arg1Of activity,such
R84051 T68140 T48175 arg1Of affinities,its
R84073 T96891 T67953 arg1Of Hypothesis,can
R84082 T68140 T71055 arg1Of affinities,","
R841 T843 T842 arg1Of site,cleavage
R84108 T77482 T6733 arg1Of SARS-CoV2,and
R84172 T75582 T89299 arg2Of COVID-19,whose
R842 T835 T844 arg1Of mutating,[
R84216 T21445 T38824 arg2Of modulation,for
R84230 T81589 T7888 arg2Of antibodies,compete
R84268 T50074 T49953 arg1Of activity,","
R84281 T80575 T5249 arg1Of It,is
R84283 T45225 T87498 arg2Of Rp3,with
R843 T845 T844 arg2Of 4,[
R84305 T84704 T76152 arg1Of nucleocapsid,the
R84332 T3706 T87509 arg1Of Rationale,:
R84362 T23533 T48337 arg2Of detect,could
R84379 T48841 T84276 arg2Of CoVs,of
R84386 T60580 T93490 arg1Of nucleocapsid,SARS-CoV
R844 T846 T844 arg3Of ],[
R845 T849 T847 arg1Of APMV-7,The
R84505 T51053 T28667 arg1Of Rp3,SARS-like
R84591 T70143 T49434 arg1Of examples,include
R846 T849 T848 arg2Of APMV-7,constructed
R84668 T77475 T46544 arg1Of Rhinolophus,genus
R84671 T32973 T83057 arg2Of help,could
R847 T849 T850 arg1Of APMV-7,showed
R84704 T40522 T60597 arg1Of decreases,then
R84710 T95958 T72578 arg1Of induced,and
R84750 T23533 T51658 arg1Of detect,","
R84751 T89053 T22041 arg1Of care,supportive
R84762 T26439 T83961 arg1Of trees,phylogenomic
R848 T852 T850 arg2Of cleavage,showed
R84803 T76844 T38511 arg1Of species,the
R84805 T7157 T64813 arg1Of bat,individual
R8489 T50781 T76662 arg1Of degree,some
R84898 T66548 T80239 arg1Of Sera,from
R849 T852 T851 arg1Of cleavage,furin
R84902 T12794 T91797 arg1Of capable,of
R84932 T53845 T7496 arg2Of measured,be
R84947 T91360 T61175 arg1Of Studies,show
R84997 T32448 T68064 arg1Of protease,transmembrane
R850 T850 T853 arg1Of showed,and
R85039 T31118 T87365 arg2Of similarity,of
R8504 T67208 T45168 arg1Of results,promising
R85056 T20769 T27081 arg1Of neutralize,to
R85080 T93066 T87690 arg1Of eggshell,and
R85093 T23094 T95632 arg2Of 5–7 days,for
R851 T854 T853 arg2Of increased,and
R85149 T66440 T64350 arg1Of domain,of
R85160 T69288 T56752 arg1Of viral,and
R85163 T73637 T99819 arg2Of S1B,i.e.
R8517 T59443 T42843 arg1Of down-regulation,","
R85170 T32448 T20678 arg2Of protease,and
R85183 T98539 T15021 arg1Of nor,adverse
R85187 T39196 T24571 arg1Of and,both
R852 T849 T854 arg1Of APMV-7,increased
R85206 T50450 T57480 arg2Of antibodies,of
R8521 T64598 T96367 arg1Of range,","
R85229 T76540 T35003 arg1Of neutralize,to
R85256 T8313 T50331 arg1Of domain,the
R85296 T44216 T95640 arg1Of use,can
R853 T856 T854 arg2Of and,increased
R85301 T93924 T85248 arg1Of H2L2,might
R85317 T66003 T86608 arg1Of peptide,enzyme
R85360 T91889 T33080 arg2Of species,in
R854 T855 T856 arg1Of replication,and
R85443 T49089 T63728 arg1Of are,ideally
R85448 T38357 T66576 arg1Of and,years
R85482 T78367 T58078 arg1Of recommended,as
R85485 T39579 T36613 arg2Of decrease,and
R855 T858 T856 arg2Of formation,and
R8551 T99869 T6180 arg1Of LDLR,and
R85515 T96381 T73262 arg2Of and,of
R85549 T50829 T53491 arg1Of Calu-3,and
R856 T858 T857 arg1Of formation,syncytium
R85602 T49873 T92338 arg1Of be,not
R8563 T68140 T91829 arg2Of affinities,in
R85642 T8038 T29310 arg1Of infections,Clostridium
R85646 T51393 T69102 arg2Of detection,revealed
R85690 T52866 T55573 arg1Of form,the
R857 T854 T859 arg1Of increased,in
R85705 T67288 T38598 arg1Of %,90
R85714 T22390 T18753 arg2Of able,are
R858 T861 T859 arg2Of cultures,in
R85800 T42893 T28737 arg1Of nucleotides,of
R85824 T57345 T34464 arg1Of antibody,chimeric
R859 T861 T860 arg1Of cultures,cell
R85915 T56231 T84364 arg2Of camostat,and
R85928 T43308 T34259 arg1Of related,","
R85967 T48841 T65227 arg1Of CoVs,SARS-like
R85975 T30344 T22390 arg1Of and,able
R85994 T83484 T2990 arg2Of methylprednisolone,without
R85999 T14991 T61320 arg2Of in,was
R860 T871 T862 arg1Of exhibit,However
R86001 T40210 T87202 arg1Of strains,The
R86004 T72411 T46139 arg1Of Tocilizumab,can
R86011 T80270 T23573 arg1Of remedy,only
R86044 T43055 T92493 arg1Of efficiently,very
R861 T871 T863 arg1Of exhibit,","
R86134 T62479 T6335 arg1Of receptor,the
R86136 T12115 T23050 arg3Of ],[
R8614 T25890 T71050 arg2Of patients,from
R86142 T44793 T23368 arg1Of cause,in
R86147 T97737 T24041 arg1Of protease,main
R86154 T95952 T47685 arg1Of differences,The
R86157 T45506 T54757 arg1Of cells,human
R86184 T40259 T38116 arg1Of P,","
R86188 T2182 T56180 arg1Of immunoglobulins,Intravenous
R862 T864 T865 arg2Of chicken,exposed
R86212 T46803 T90119 arg1Of diseases,inflammatory
R86230 T65584 T43425 arg2Of development,of
R86253 T66440 T81034 arg1Of domain,same
R86274 T35011 T4369 arg1Of origin,an
R863 T865 T866 arg1Of exposed,to
R86356 T80684 T88404 arg1Of recovery,from
R86364 T73202 T98970 arg1Of latter,The
R86398 T48924 T1935 arg1Of effect,present
R864 T868 T866 arg2Of virus,to
R86414 T39982 T79640 arg2Of immunization,of
R865 T868 T867 arg1Of virus,the
R86526 T21718 T31198 arg1Of study,included
R86586 T45316 T32427 arg1Of protein,spike
R866 T864 T869 arg1Of chicken,did
R86622 T28508 T7764 arg2Of enter,can
R867 T871 T869 arg2Of exhibit,did
R86711 T39196 T80967 arg2Of and,for
R868 T871 T870 arg1Of exhibit,not
R86835 T71073 T87627 arg2Of conditions,of
R869 T864 T871 arg1Of chicken,exhibit
R86911 T54246 T44838 arg1Of show,consistently
R86934 T18121 T39207 arg1Of and,for
R86954 T15154 T15378 arg1Of consists,of
R86976 T65635 T52147 arg2Of and,of
R870 T872 T871 arg2Of infection,exhibit
R87076 T9965 T85154 arg1Of well,as
R871 T874 T873 arg1Of Glycosylation,3.1.2
R87106 T23141 T45488 arg1Of differences,in
R87111 T72538 T63462 arg2Of difference,of
R8712 T96732 T5759 arg2Of received,and
R87137 T73561 T58135 arg2Of patients,of
R87180 T13257 T88376 arg1Of site,cleavage
R87187 T3462 T4397 arg2Of COVID-19,correlated
R872 T875 T876 arg1Of Glycosylation,and
R87204 T74893 T1912 arg1Of pathway,the
R87206 T28611 T66778 arg1Of Serum,from
R87209 T88382 T71117 arg1Of strain,Rp3
R87244 T73113 T50380 modOf offers,to
R87251 T62157 T53624 arg1Of VSV-G,and
R8726 T98139 T85324 arg1Of repertoires,that
R87268 T56920 T19776 arg1Of regions,origin
R87272 T42812 T96337 arg1Of cysteine,proteases
R873 T882 T876 arg2Of ",",and
R8733 T8195 T90980 arg1Of imaging,detected
R87330 T83272 T15921 arg1Of polyprotein,the
R87348 T89317 T28925 arg1Of combined,with
R874 T882 T877 arg1Of ",",its
R87454 T29624 T31150 arg1Of reaction,Polymerase
R87462 T63285 T13828 arg2Of died,and
R87480 T96424 T23241 arg1Of serum,rabbit
R87485 T46803 T31666 arg1Of diseases,autoimmune
R875 T879 T878 arg1Of products,related
R87525 T55924 T43316 arg1Of proteases,main
R87538 T85855 T53845 arg2Of use,measured
R87567 T32517 T97000 arg2Of SARS-2-S.,of
R876 T879 T880 arg1Of products,","
R87600 T22966 T13365 arg2Of regions,contains
R8765 T51925 T82079 arg3Of ],[
R87653 T28611 T69045 arg1Of Serum,is
R87665 T25454 T2467 arg1Of It,effective
R877 T879 T881 arg1Of products,i.e.
R8771 T34731 T82008 arg1Of strain,human
R87714 T25132 T89215 arg2Of degree,","
R87740 T17626 T48238 arg2Of 2019-nCoV,of
R87747 T84428 T49191 arg3Of combat,help
R87768 T39927 T35947 arg1Of sequence,nucleotide
R878 T879 T882 arg1Of products,","
R87834 T22143 T4169 arg1Of protects,and
R879 T883 T882 arg2Of glycans,","
R87904 T11646 T56133 arg2Of inhibition,yielded
R87937 T21027 T27410 arg1Of decoration,of
R87952 T39551 T74931 arg1Of identical,at
R87967 T52866 T8605 arg1Of form,of
R87983 T35671 T54239 arg2Of neutralize,can
R87985 T83960 T57480 arg1Of pool,of
R880 T885 T884 arg1Of introduce,","
R8803 T33017 T6643 arg1Of domain,between
R88041 T14538 T36374 arg1Of similarity,the
R88065 T64204 T24570 arg1Of domain,a
R88068 T57194 T72802 arg2Of SARS-CoV2,neutralize
R88085 T92915 T42084 arg1Of MERS-CoV,the
R88091 T40034 T41819 arg1Of was,","
R881 T876 T885 arg1Of and,introduce
R88130 T96902 T22680 arg1Of existed,In
R882 T886 T885 arg2Of changes,introduce
R88200 T75386 T85073 arg1Of require,partially
R8823 T47054 T35724 arg2Of administered,should
R88239 T52981 T56433 arg2Of H1N1,of
R88261 T96963 T84688 arg1Of level,IL6
R88271 T43382 T16861 arg1Of replication,of
R88299 T63070 T30755 arg1Of levels,CRP
R883 T886 T887 arg1Of changes,to
R88306 T86532 T5313 arg1Of High-content,exists
R8839 T87394 T37380 arg2Of done,can
R884 T890 T887 arg2Of envelope,to
R88402 T68497 T72593 arg2Of explain,can
R88405 T39598 T97712 arg1Of defense,against
R88441 T12794 T86672 arg2Of capable,was
R88451 T8033 T6150 arg1Of frames,(
R88472 T7628 T93675 arg1Of strain,Tor2
R88474 T52732 T87135 arg1Of rates,high
R885 T890 T888 arg1Of envelope,the
R88503 T36198 T90499 arg2Of flares,treat
R88560 T77445 T34654 arg1Of SARS-S,and
R88561 T64424 T25851 arg1Of %,more
R88593 T16617 T8496 arg2Of recovery,accelerate
R886 T890 T889 arg1Of envelope,viral
R88677 T81264 T51845 arg1Of Rationale,4.1.1.2
R887 T886 T891 arg1Of changes,that
R8876 T37814 T87676 arg1Of develop,during
R88768 T35357 T16756 arg1Of groups,receiving
R88773 T89944 T18675 arg2Of reduce,could
R8879 T62139 T13409 arg1Of receptor,surface
R888 T886 T892 arg1Of changes,make
R8881 T18322 T55812 arg2Of patients,in
R88823 T47586 T31692 arg1Of rise,from
R88827 T90255 T89640 arg1Of coronavirus,novel
R88840 T92412 T64120 arg2Of replication,of
R88878 T86532 T37905 arg1Of High-content,of
R88883 T34590 T14525 arg1Of and,1
R889 T894 T892 arg2Of virus,make
R88924 T32352 T84846 arg2Of and,of
R88979 T47738 T87902 arg1Of plasma,[
R890 T894 T893 arg1Of virus,the
R89002 T18753 T3464 arg1Of are,that
R89041 T25569 T52262 arg1Of infections,viral
R89048 T54783 T45640 arg1Of levels,of
R89055 T98181 T51521 arg1Of ",",","
R89076 T88455 T77671 arg1Of IL6,","
R89083 T18753 T56305 arg1Of are,both
R89087 T13014 T14256 arg1Of protein,S
R891 T894 T895 arg2Of virus,fitted
R89109 T24477 T82613 arg2Of rabbits,from
R89140 T4169 T15590 arg1Of and,","
R8917 T40665 T35671 arg1Of antibodies,neutralize
R89182 T25963 T54040 arg1Of corticosteroid,(
R892 T895 T896 arg1Of fitted,for
R8921 T89782 T72082 arg2Of serum,than
R89241 T27842 T23786 arg1Of COVID-19,moderate
R89244 T84845 T63353 arg1Of structure,and
R89296 T14229 T89468 arg1Of serum,from
R893 T897 T896 arg2Of interaction,for
R8931 T92103 T32040 arg2Of particular,In
R89343 T15241 T19426 arg2Of N,(
R8936 T97074 T68802 arg1Of IRW,can
R89371 T33761 T47763 arg2Of spectrum,","
R89374 T75308 T98992 arg1Of so,that
R8938 T72452 T96177 arg2Of 24–48 h,In
R89388 T18879 T95334 arg1Of inhibitors,protease
R894 T897 T898 arg1Of interaction,with
R89421 T78002 T48418 arg1Of entry,of
R89495 T25315 T40001 arg1Of coronavirus,that
R895 T902 T898 arg2Of membrane,with
R89519 T69934 T8581 arg1Of includes,:
R89530 T34533 T57537 arg1Of ranging,from
R89583 T90021 T49803 arg1Of and,","
R896 T902 T899 arg1Of membrane,the
R89636 T55250 T72973 arg2Of cells,inoculated
R89642 T35671 T76245 arg1Of neutralize,[
R89644 T63688 T88373 arg1Of anti-oxidant,and
R89670 T90339 T84923 arg1Of effects,side
R89677 T75392 T78684 arg2Of COVID-19,with
R897 T902 T900 arg1Of membrane,host
R89732 T3036 T10896 arg2Of diagnosed,when
R89736 T47496 T66697 arg2Of SARS-CoV,for
R89760 T28678 T12529 arg3Of ],[
R898 T902 T901 arg1Of membrane,cell
R89839 T27198 T76904 arg2Of 19,[
R89880 T89464 T60658 arg2Of are,and
R89881 T85855 T69355 arg1Of use,of
R89899 T68912 T98192 arg1Of Tocilizumab,plus
R899 T902 T903 arg1Of membrane,[
R8993 T65701 T23484 arg1Of counts,platelet
R89938 T91104 T97128 arg2Of SARS-2-S,and
R89954 T67288 T60055 arg2Of %,in
R89986 T38563 T60810 arg2Of patients,among
R900 T904 T903 arg2Of 5,[
R90018 T94116 T9665 arg2Of ACE2,","
R90019 T71443 T93206 arg1Of COVID-19,severe
R9002 T3706 T41884 arg1Of Rationale,6.2.2
R90023 T59443 T68303 arg1Of down-regulation,e.g.
R90026 T82280 T32660 arg1Of elements,Essential
R90058 T7628 T81326 arg2Of strain,isolated
R9006 T3461 T49107 arg1Of entry,the
R90071 T21161 T53102 arg1Of agent,causative
R901 T905 T903 arg3Of ],[
R90100 T55250 T7566 arg2Of cells,in
R90123 T31208 T94005 arg2Of and,possess
R90147 T20323 T76343 arg1Of and,shed
R9016 T68740 T23846 arg2Of plasma,of
R90193 T28168 T39838 arg2Of and,decrease
R902 T909 T906 arg1Of are,Generally
R90200 T82196 T91861 arg1Of resistance,of
R90208 T62139 T93734 arg1Of receptor,a
R90227 T80157 T68744 arg1Of and,Rp3
R90242 T98862 T22631 arg2Of improve,help
R90293 T64204 T40189 arg1Of domain,on
R903 T909 T907 arg1Of are,","
R90351 T5476 T19383 arg1Of Corticosteroids,can
R90367 T73561 T95602 arg1Of patients,26
R904 T908 T909 arg1Of glycans,are
R90411 T56686 T39710 arg1Of differ,","
R90414 T11435 T58860 arg1Of treatments,for
R90433 T51732 T53501 arg1Of viruses,negative-strand
R90434 T24131 T72545 arg1Of protein,S
R90438 T75820 T4213 arg2Of bats,immunized
R90450 T10130 T31388 arg1Of opacity,was
R9046 T68174 T45935 arg2Of ±,(
R9047 T87029 T85323 arg1Of essential,for
R90482 T88114 T14365 arg1Of injury,lung
R90486 T87601 T76648 arg1Of patients,SARS
R90497 T95644 T75263 arg1Of target,the
R905 T910 T909 arg2Of oligosaccharides,are
R90538 T46803 T80969 arg1Of diseases,severe
R906 T910 T911 arg2Of oligosaccharides,linked
R90604 T73531 T47272 arg2Of cells,in
R90654 T66055 T3490 arg1Of condition,severe
R90661 T16685 T92910 arg1Of parameters,","
R90666 T59893 T97712 arg2Of virus,against
R90684 T14786 T84385 arg1Of IRW,reduce
R90696 T43356 T19219 arg1Of deaths,two
R907 T911 T912 arg1Of linked,to
R90719 T21885 T2868 arg1Of different,from
R90752 T20678 T96337 arg2Of and,proteases
R90774 T35808 T34900 arg1Of saturation,and
R90780 T97492 T50200 arg2Of replication,inhibit
R908 T915 T912 arg2Of decoration,to
R90818 T13593 T91797 arg2Of inhibiting,of
R90827 T48153 T29701 arg2Of 48 h,and
R909 T915 T913 arg1Of decoration,the
R90910 T1824 T31152 arg1Of absorbed,","
R90913 T70918 T68614 arg1Of similar,for
R9092 T82570 T33328 arg1Of they,do
R90985 T70941 T35988 arg2Of limit,increasing
R90990 T98139 T24138 arg1Of repertoires,antibody
R910 T915 T914 arg1Of decoration,dense
R91008 T34963 T62199 arg3Of ],[
R91010 T18877 T48321 arg2Of receptor,to
R91021 T93924 T42126 arg1Of H2L2,47D11
R91035 T77150 T24898 arg2Of us,to
R91050 T71924 T30144 arg2Of cause,and
R9107 T86756 T47798 arg3Of ],[
R91084 T67288 T48683 arg1Of %,of
R911 T915 T916 arg1Of decoration,of
R91106 T90255 T90050 arg1Of coronavirus,can
R91107 T91348 T92790 arg1Of deficiencies,antibody
R91116 T20072 T88119 arg1Of collected,after
R91140 T51386 T48238 arg1Of and,of
R91161 T65675 T72009 arg1Of and,the
R91166 T57345 T13041 arg1Of antibody,47D11
R91188 T78002 T10956 arg2Of entry,hinder
R91193 T1931 T19375 arg1Of branches,favorable
R912 T919 T916 arg2Of glycoprotein,of
R91222 T29681 T5158 arg1Of drugs,corticosteroid
R91228 T96625 T31917 arg1Of Patients,had
R91259 T33950 T81648 arg3Of have,that
R91296 T39927 T7432 arg1Of sequence,of
R913 T919 T917 arg1Of glycoprotein,the
R91325 T42849 T63285 arg1Of situation,died
R914 T919 T918 arg1Of glycoprotein,spike
R91436 T12582 T28781 arg2Of influenza,and
R9144 T30344 T18753 arg1Of and,are
R91466 T21495 T6092 arg2Of 2TMPRSS2,","
R91476 T82716 T5151 arg1Of Development,of
R915 T926 T920 arg1Of shown,In
R91506 T78221 T55347 arg2Of and,express
R91543 T20594 T82079 arg1Of study,[
R9155 T33856 T37831 arg1Of origin,of
R91588 T27914 T4169 arg2Of administered,and
R916 T921 T920 arg2Of particular,In
R91610 T10485 T64338 arg2Of 2TMPRSS2,lacking
R9162 T91725 T26781 arg1Of Tocilizumab,could
R91675 T54799 T98989 arg2Of cells,on
R917 T926 T922 arg1Of shown,","
R91702 T59040 T88073 modOf was,indicating
R91747 T12601 T76540 arg1Of serum,neutralize
R91756 T86439 T58761 arg1Of Tocilizumab,is
R91771 T50007 T40843 arg2Of domain,in
R91773 T25878 T8625 arg1Of mAb,against
R91783 T45981 T33217 arg1Of ",",and
R918 T924 T923 arg1Of oligosaccharides,these
R91823 T49143 T94597 arg2Of SARS-CoV2,For
R91830 T42028 T76094 arg1Of RNA,decreases
R91845 T48684 T37814 arg1Of patients,develop
R91863 T14942 T71564 arg2Of bat,and
R91887 T67108 T75684 arg1Of pathogenicity,the
R9189 T61880 T96449 arg1Of results,promising
R919 T924 T925 arg1Of oligosaccharides,have
R91907 T45789 T11971 arg2Of they,used
R91937 T42602 T38146 arg1Of virus,affect
R920 T926 T925 arg2Of shown,have
R92060 T6163 T27596 arg1Of improved,in
R921 T924 T926 arg1Of oligosaccharides,shown
R92110 T4397 T53541 arg1Of correlated,with
R92120 T63816 T44925 arg1Of ",",and
R92122 T81575 T72053 arg1Of markers,inflammatory
R92127 T62157 T44853 arg1Of VSV-G,primary
R92175 T15404 T46590 arg2Of age,of
R92187 T98401 T30544 arg2Of rats,in
R92198 T72411 T80638 arg1Of Tocilizumab,treat
R922 T928 T927 arg1Of influence,to
R92204 T45337 T13737 arg1Of and,inhibit
R92213 T9970 T32030 arg1Of domain,the
R9222 T50457 T82487 arg1Of notion,which
R92245 T2670 T46614 arg2Of P,(
R92270 T96891 T42975 arg1Of Hypothesis,6.2.1
R9228 T94051 T69218 arg2Of MERS-CoV,mutated
R92294 T56920 T28318 arg1Of regions,rat
R923 T926 T927 modOf shown,to
R92327 T2565 T61995 arg1Of e,to
R92357 T42278 T77065 arg1Of patient,with
R92376 T69785 T12695 arg1Of combination,A
R92393 T35808 T83697 arg1Of saturation,peripheral
R924 T930 T928 arg2Of folding,influence
R92400 T65972 T73609 arg1Of Serum,from
R92430 T24633 T45480 arg1Of It,is
R92448 T66488 T20769 arg2Of SARS-CoV2,neutralize
R92489 T40115 T69355 arg2Of Tocilizumab,of
R925 T930 T929 arg1Of folding,the
R92508 T73098 T54079 arg2Of RBD,and
R92565 T99390 T30323 arg1Of ",",","
R92577 T3471 T11859 arg1Of ratio,and
R92578 T58224 T10653 arg1Of early,as
R92582 T32448 T62149 arg1Of protease,the
R92599 T50457 T87111 arg1Of notion,the
R926 T930 T931 arg1Of folding,of
R92607 T52934 T98573 arg1Of –,gene
R92610 T24185 T43255 arg1Of antibody,as
R92669 T12179 T44219 arg1Of IVIG,has
R92697 T45429 T19735 arg2Of ciclesonide,of
R927 T935 T931 arg2Of and,of
R92709 T54178 T24944 arg1Of proteins,the
R92720 T36466 T61983 arg1Of patients,with
R92728 T38362 T39715 arg1Of interacting,with
R92749 T99631 T68393 arg1Of pseudotypes,SARS-S
R92776 T82506 T81238 arg1Of share,of
R928 T935 T932 arg1Of and,the
R92859 T29751 T24756 arg2Of influenza,","
R92880 T82598 T7474 arg2Of peak,reaches
R92888 T53777 T18098 arg1Of junctions,the
R929 T934 T933 arg1Of protein,S
R92901 T62139 T99372 arg1Of receptor,","
R92905 T31198 T13700 arg1Of included,","
R92907 T94817 T83097 arg2Of terms,in
R930 T934 T935 arg1Of protein,and
R93053 T53710 T49362 arg2Of pathway,through
R93097 T16845 T31417 arg1Of sequence,the
R931 T937 T935 arg2Of process,and
R93142 T45405 T22231 arg2Of 32,[
R93157 T2430 T98023 arg1Of entry,of
R93190 T51732 T24756 arg1Of viruses,","
R932 T937 T936 arg1Of process,proteolytic
R9329 T7566 T98702 arg1Of in,not
R93295 T6735 T32751 arg1Of It,poses
R933 T928 T938 arg1Of influence,so
R93335 T97737 T35396 arg1Of protease,","
R93364 T78989 T87394 arg2Of immunization,done
R93366 T72012 T47163 arg1Of supernatants,containing
R93374 T51998 T18117 arg1Of are,","
R934 T941 T938 arg2Of facilitate,so
R93413 T75348 T50691 arg2Of corticosteroids,of
R93465 T79617 T7377 arg2Of cytokines,Targeting
R9347 T3036 T20464 arg2Of diagnosed,is
R93481 T11805 T86158 arg1Of Plasma,from
R935 T938 T939 arg1Of so,that
R93501 T42640 T15332 arg1Of subunit,S1
R936 T940 T941 arg1Of they,facilitate
R9363 T85498 T21969 arg1Of Antiserum,could
R93633 T75829 T89124 arg2Of subunit,for
R9364 T77430 T84428 arg1Of system,combat
R937 T945 T941 arg2Of entry,facilitate
R93722 T27053 T18623 arg2Of PON,(
R93727 T36219 T76343 arg2Of light,shed
R93749 T74634 T13216 arg2Of interact,can
R93750 T27754 T64684 arg1Of receptor,primary
R93763 T76496 T41758 arg2Of received,","
R93772 T82570 T43608 arg1Of they,might
R9378 T4452 T94659 arg2Of proteins,of
R938 T945 T942 arg1Of entry,the
R93865 T79787 T87895 arg3Of ],[
R93882 T89603 T54149 arg1Of coordination,and
R93896 T37752 T9092 arg1Of fluid,of
R93897 T41765 T77261 arg1Of mesylate,camostat
R939 T945 T943 arg1Of entry,virus
R93906 T4681 T76904 arg1Of associated,[
R93910 T89696 T16405 arg2Of immunity,in
R93919 T24144 T72744 arg1Of differences,functional
R93944 T78367 T33042 arg1Of recommended,for
R93961 T42652 T81934 arg1Of treatment,IFN
R93975 T54799 T1718 arg1Of cells,human
R93978 T37602 T8787 arg1Of needed,However
R9398 T8983 T8936 arg1Of virus,the
R940 T945 T944 arg1Of entry,cell
R94081 T24171 T61619 arg2Of stability,and
R94093 T73739 T88720 arg1Of samples,serum
R94096 T47460 T73113 arg1Of look,offers
R941 T954 T946 arg1Of gains,Moreover
R94118 T37738 T62094 arg1Of protein,a
R94130 T46042 T87690 arg2Of egg,and
R94172 T93033 T22072 arg1Of confer,","
R94197 T8038 T10219 arg1Of infections,","
R942 T954 T947 arg1Of gains,","
R94218 T7734 T52544 arg2Of dexamethasone,","
R94229 T22569 T5913 arg2Of and,","
R94232 T4187 T27914 arg2Of it,administered
R94262 T68003 T26765 arg2Of trials,are
R94278 T63832 T98869 arg1Of caution,is
R943 T949 T948 arg1Of virus,a
R94308 T61440 T93981 arg1Of COVID-19,severe
R94310 T53845 T58078 arg2Of measured,as
R94349 T29877 T71857 arg1Of effect,noticeable
R9435 T36310 T28417 arg2Of infection,inhibit
R94363 T51053 T99794 arg1Of Rp3,name
R94369 T75581 T81944 arg2Of 100 pg/ml,than
R94383 T91513 T81529 arg1Of Studies,show
R94399 T25569 T84428 arg2Of infections,combat
R944 T949 T950 arg1Of virus,with
R94411 T31383 T27396 arg2Of actions,dictate
R94493 T42849 T36559 arg1Of situation,developed
R945 T953 T950 arg2Of glycoprotein,with
R94505 T48129 T91321 arg1Of therapy,help
R94510 T19520 T59896 arg1Of structure,the
R9452 T14361 T48542 arg1Of inhibit,[
R94533 T72563 T65069 arg1Of heavy,and
R94556 T92661 T68840 arg2Of inflammation,attenuate
R94582 T32352 T32702 arg1Of and,","
R94590 T82506 T61038 arg1Of share,","
R946 T953 T951 arg1Of glycoprotein,the
R94604 T6188 T80510 arg1Of antibodies,against
R94657 T35357 T15563 arg1Of groups,no
R94676 T98139 T66535 arg1Of repertoires,from
R947 T953 T952 arg2Of glycoprotein,glycosylated
R94705 T27914 T38504 arg2Of administered,should
R94736 T98647 T39699 arg1Of disease,","
R94776 T27008 T78461 arg1Of acted,efficiently
R94792 T91348 T18270 arg1Of deficiencies,primary
R948 T949 T954 arg1Of virus,gains
R94809 T71857 T13399 arg1Of noticeable,than
R9487 T68271 T33679 arg2Of 48 h,at
R949 T957 T954 arg2Of feature,gains
R94930 T51393 T49412 arg1Of detection,of
R94945 T33129 T59040 arg1Of there,was
R94949 T7774 T83835 arg2Of improve,might
R94996 T20271 T87639 arg2Of IL6,against
R950 T957 T955 arg1Of feature,an
R95003 T7184 T41284 arg1Of line,the
R9501 T80157 T6643 arg2Of and,between
R95020 T24277 T1902 arg2Of S2,and
R951 T957 T956 arg1Of feature,extra
R95106 T19573 T23972 arg1Of study,[
R95128 T98710 T52661 arg1Of patients,with
R95143 T43374 T68174 arg1Of 4.67,±
R952 T957 T958 arg1Of feature,for
R95215 T35011 T95969 arg1Of origin,idiopathic
R95276 T43382 T72944 arg1Of replication,the
R953 T960 T958 arg2Of escape,for
R95339 T96728 T23972 arg3Of ],[
R95354 T12723 T45488 arg2Of proteins,in
R954 T960 T959 arg1Of escape,an
R95414 T92755 T83388 arg1Of studies,have
R95470 T83078 T11331 arg1Of treatment,in
R95481 T16887 T82773 arg1Of GRP78,cell-surface
R95496 T75851 T15835 arg1Of 80 mg/d,methylprednisolone
R955 T960 T961 arg1Of escape,from
R95545 T25132 T68838 arg1Of degree,a
R95558 T44793 T88854 arg1Of cause,","
R95568 T18333 T86725 arg1Of cells,lung
R956 T964 T961 arg2Of responses,from
R95610 T81644 T94659 arg1Of presence,of
R95633 T21482 T15154 arg1Of S,consists
R9566 T63406 T85433 arg3Of ],[
R9567 T81264 T56248 arg1Of Rationale,:
R95673 T14835 T99835 arg1Of infection,B19
R95689 T50450 T98962 arg1Of antibodies,human
R957 T964 T962 arg1Of responses,the
R95761 T78742 T89272 arg1Of degree,","
R95770 T33446 T87886 arg1Of patients,with
R958 T964 T963 arg1Of responses,immune
R95893 T71641 T55072 arg1Of protein,their
R959 T968 T965 arg1Of are,Therefore
R95901 T15429 T21714 arg1Of inhibition,significant
R95905 T90339 T82688 arg1Of effects,serious
R95907 T52375 T93555 arg1Of sample,bat
R95922 T4240 T36613 arg1Of increase,and
R95994 T42133 T76932 arg1Of outbreak,SARS-CoV
R960 T968 T966 arg1Of are,","
R96008 T29960 T3036 arg2Of patient,diagnosed
R96060 T8496 T17782 arg2Of accelerate,help
R96077 T55876 T50453 arg2Of day,by
R96084 T83170 T22490 arg1Of Rationale,:
R96087 T79253 T84174 arg2Of hand,on
R96088 T96963 T6930 arg1Of level,of
R96095 T10571 T28781 arg1Of SARS-CoV,and
R961 T967 T968 arg1Of glycans,are
R96158 T42028 T31986 arg1Of RNA,the
R962 T971 T968 arg2Of target,are
R96220 T26439 T82603 arg2Of trees,in
R96241 T64812 T62828 arg1Of use,the
R96279 T34284 T70659 arg1Of virus,Ebola
R963 T971 T969 arg1Of target,a
R96321 T48435 T96346 arg2Of protect,and
R9633 T55893 T62529 arg2Of protein,with
R96381 T98211 T68640 arg2Of processing,in
R964 T971 T970 arg1Of target,good
R9640 T82201 T28168 arg2Of regulation,and
R96417 T68579 T64716 arg1Of IFN,I
R96435 T9169 T52339 arg1Of severity,","
R96440 T47586 T3983 arg1Of rise,so
R96444 T42144 T13645 arg1Of responses,anti-viral
R96446 T11971 T41748 arg1Of used,","
R96452 T7869 T80909 arg1Of SARS-S,and
R965 T971 T972 arg1Of target,for
R96502 T40210 T16130 arg1Of strains,human
R96557 T71924 T43608 arg2Of cause,might
R96558 T36459 T91735 arg1Of cleavage,proteolytic
R966 T974 T972 arg2Of design,for
R9661 T98815 T56952 arg2Of COVID-19,with
R967 T974 T973 arg1Of design,vaccine
R96735 T40210 T99566 arg1Of strains,remain
R96775 T89813 T95236 arg1Of SARS-S,could
R968 T977 T975 arg1Of types,Two
R96809 T21817 T21857 arg1Of exert,","
R96826 T42097 T36053 arg1Of combined,with
R96832 T33265 T93940 arg1Of concentration,the
R96842 T53845 T75237 arg2Of measured,can
R96844 T28601 T72671 arg1Of entry,SARS-S
R96845 T80013 T67874 arg2Of that,and
R96846 T15987 T81658 arg2Of arteritis,","
R969 T977 T976 arg1Of types,main
R96928 T11971 T91069 arg2Of used,can
R96954 T36466 T33042 arg2Of patients,for
R96957 T26688 T91618 arg1Of methylprednisolone,plus
R96985 T77130 T92988 arg2Of difference,of
R970 T977 T978 arg1Of types,of
R9700 T7654 T34096 arg1Of plasma,4.1.1
R9702 T27754 T9665 arg1Of receptor,","
R97056 T21027 T60584 arg1Of decoration,the
R97074 T43323 T13349 arg1Of and,","
R97077 T83579 T8599 arg1Of possesses,Also
R971 T979 T978 arg2Of glycans,of
R97104 T27842 T9137 arg1Of COVID-19,severe
R97110 T54347 T29994 arg1Of process,time-consuming
R97116 T84385 T80434 arg1Of reduce,On
R97129 T82065 T31100 arg1Of –,domain
R97152 T35146 T19797 arg1Of receptor,the
R97154 T43357 T21111 arg1Of therapy,pulse
R97168 T34390 T96610 arg1Of proportion,and
R97198 T97970 T87886 arg2Of COVID-19,with
R972 T977 T980 arg1Of types,are
R97280 T7676 T26029 arg2Of 2002–2003,of
R973 T981 T980 arg2Of N-linked,are
R9730 T96521 T13328 arg2Of bats,from
R97353 T58005 T20706 arg1Of therapy,standard
R9737 T49120 T55070 arg1Of S1B,and
R974 T977 T981 arg2Of types,N-linked
R9744 T64615 T69539 arg2Of %,in
R97441 T36179 T56543 arg1Of week,the
R975 T984 T981 arg3Of glycans,N-linked
R97536 T37156 T92380 arg1Of and,the
R9754 T48498 T97815 arg1Of regions,cyclic
R97543 T38661 T47400 arg1Of switching,to
R976 T984 T982 arg1Of glycans,and
R97607 T65082 T32005 arg1Of fusion,of
R97670 T39668 T66151 arg1Of benefit,clinical
R977 T984 T983 arg1Of glycans,O-linked
R97705 T67166 T2403 arg2Of immunity,of
R97711 T96302 T46108 arg1Of Rational,:
R97731 T1981 T22188 arg2Of and,with
R97743 T91725 T93033 arg1Of Tocilizumab,confer
R97799 T20519 T83162 arg1Of inoculated,with
R978 T985 T986 arg1Of Both,are
R97819 T17221 T13017 arg1Of approved,","
R97853 T6180 T50860 arg2Of and,is
R97859 T64338 T71577 modOf lacking,blocking
R97873 T64840 T33948 arg1Of and,","
R979 T987 T986 arg2Of released,are
R980 T985 T987 arg2Of Both,released
R98023 T18333 T60557 arg2Of cells,in
R9808 T71701 T29516 arg2Of sequence,in
R98083 T26913 T47829 arg1Of patients,the
R981 T987 T988 arg1Of released,from
R98182 T66003 T66871 arg1Of peptide,(
R982 T989 T988 arg2Of glycoproteins,from
R98214 T52934 T13365 arg1Of –,contains
R98220 T85453 T29393 arg1Of received,","
R98228 T44793 T86476 arg1Of cause,","
R98234 T82506 T62375 arg1Of share,[
R98284 T76985 T6758 arg1Of Analysis,of
R98291 T73325 T74033 arg1Of patient,the
R98296 T40953 T20174 arg1Of coronaviruses,other
R983 T1000 T990 arg1Of perform,Whereas
R98342 T56920 T16968 arg1Of regions,constant
R98361 T80777 T40812 arg1Of system,the
R98383 T15140 T84085 arg3Of ),(
R9839 T78533 T76626 arg2Of role,play
R984 T992 T990 arg2Of fulfill,Whereas
R98402 T27914 T54707 arg1Of administered,early
R98406 T52676 T58628 arg1Of antibodies,cross-reactive
R98416 T72802 T63708 arg1Of neutralize,efficiently
R98431 T52876 T21084 arg1Of It,is
R98484 T49329 T20257 arg1Of outcomes,clinical
R985 T991 T992 arg1Of enzymes,fulfill
R98500 T42849 T86008 arg1Of situation,his
R98509 T21018 T90573 arg2Of pressure,decrease
R98567 T74327 T77390 arg2Of membranes,and
R98576 T42602 T10581 arg1Of virus,RNA
R98591 T25066 T42920 arg1Of is,in
R986 T994 T992 arg2Of construction,fulfill
R98630 T96424 T15191 arg1Of serum,revealed
R9864 T42798 T39623 arg2Of SARS-CoV2,allow
R98693 T95468 T38088 arg1Of Rhinolophidae,the
R987 T994 T993 arg1Of construction,the
R98700 T51771 T34906 arg1Of entry,SARS-CoV2
R98709 T6178 T84121 arg2Of and,of
R98776 T41345 T7553 arg1Of infection,virus
R988 T994 T995 arg1Of construction,of
R9880 T4240 T18383 arg1Of increase,in
R98807 T7157 T22237 arg2Of bat,if
R98822 T92661 T2426 arg1Of inflammation,hyper
R98847 T43308 T87528 arg1Of related,to
R98878 T8313 T42013 arg1Of domain,in
R98880 T95232 T50200 arg1Of IFN,inhibit
R989 T996 T995 arg2Of N-glycans,of
R98900 T13257 T72593 arg1Of site,can
R98915 T25730 T43979 arg1Of degree,noticeable
R98942 T75519 T71095 arg1Of days,six
R98943 T81227 T56749 arg2Of rabbits,from
R98961 T54919 T61527 arg1Of cells,target
R98966 T40170 T30022 arg2Of TMPRSS2,of
R98967 T41408 T54378 arg1Of coronavirus,novel
R98978 T81378 T67673 arg1Of degree,significant
R990 T1000 T997 arg1Of perform,","
R99006 T5365 T64776 arg2Of protease,and
R9904 T10130 T51431 arg1Of opacity,lesion
R99041 T95806 T84685 arg1Of HCoV-229E,and
R99048 T81589 T41843 arg1Of antibodies,neutralizing
R99082 T45934 T94908 arg1Of example,","
R991 T999 T998 arg1Of methods,chemical
R99138 T10130 T79595 arg1Of opacity,lung
R99172 T6431 T54166 arg1Of immunized,with
R992 T999 T1000 arg1Of methods,perform
R99263 T62294 T72325 arg1Of encephalitis,virus
R99271 T27754 T49586 arg2Of receptor,utilize
R99275 T45934 T7202 arg1Of example,","
R99280 T58229 T77811 arg1Of protects,and
R993 T1002 T1000 arg2Of release,perform
R99309 T52785 T73958 arg1Of and,","
R99315 T40522 T85972 arg2Of decreases,and
R99347 T5313 T26683 arg1Of exists,in
R99384 T10243 T47759 arg1Of Study,[
R99391 T42902 T40921 arg1Of reason,why
R994 T1002 T1001 arg1Of release,the
R99403 T38308 T74021 arg2Of SARS-2-S,and
R9941 T10629 T23275 arg1Of shown,Also
R99410 T52714 T59411 arg2Of patients,from
R99421 T68393 T60207 arg1Of SARS-S,and
R99439 T3496 T9531 arg2Of SARS,with
R99441 T23141 T31126 arg2Of differences,to
R99456 T72786 T36158 arg1Of shown,in
R99461 T48841 T43941 arg1Of CoVs,","
R99492 T40394 T28898 arg1Of therapy,and
R99494 T47986 T4126 arg2Of %,of
R995 T1002 T1003 arg1Of release,of
R9958 T8340 T6014 arg3Of ],[
R99597 T31699 T6254 arg1Of Rationale,:
R99599 T82570 T27396 arg1Of they,dictate
R996 T1004 T1003 arg2Of O-glycans,of
R99609 T12942 T3419 arg2Of binding,block
R99613 T39154 T8893 arg1Of domains,two
R99617 T31059 T48002 arg1Of chloride,ammonium
R99688 T96337 T40938 arg2Of proteases,are
R997 T1005 T1006 arg1Of N-glycans,are
R9970 T48589 T89317 arg2Of :,combined
R99722 T75489 T5367 arg1Of shows,from
R99727 T7628 T18229 arg1Of strain,of
R99734 T89053 T63224 arg1Of care,standard
R99739 T54079 T69539 arg1Of and,in
R99770 T69281 T30703 arg1Of identical,to
R998 T1007 T1006 arg2Of linked,are
R99800 T55858 T54040 arg3Of ),(
R99853 T21161 T30703 arg2Of agent,to
R99891 T6430 T18474 arg3Of ],[
R99899 T99631 T48418 arg2Of pseudotypes,of
R999 T1005 T1007 arg2Of N-glycans,linked
R9994 T48431 T7060 arg1Of levels,accompany
R99987 T11815 T73902 arg1Of Rational,: